<SEC-DOCUMENT>0001683168-21-005701.txt : 20211115
<SEC-HEADER>0001683168-21-005701.hdr.sgml : 20211115
<ACCEPTANCE-DATETIME>20211115161122
ACCESSION NUMBER:		0001683168-21-005701
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		63
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211115
DATE AS OF CHANGE:		20211115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACACIA RESEARCH CORP
		CENTRAL INDEX KEY:			0000934549
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				954405754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37721
		FILM NUMBER:		211410648

	BUSINESS ADDRESS:	
		STREET 1:		767 3RD AVENUE
		STREET 2:		SUITE 602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		949-480-8300

	MAIL ADDRESS:	
		STREET 1:		767 3RD AVENUE
		STREET 2:		SUITE 602
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>acacia_i10q-93021.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ACTG="http://acaciaresearch.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_ACTG_acaciaresearch.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20210101_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000934549 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Integer_0_Integer -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityCentralIndexKey">0000934549</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-09-30" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31" id="xdx2ixbrl0134" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0419" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-07-012021-09-30" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0478" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0498" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0526" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0527" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0528" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0539" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0573" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0581" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0584" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0614" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0625" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0637" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0646" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0649" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl0652" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0656" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0659" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0661" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0670" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0671" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0674" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0678" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" id="xdx2ixbrl1363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" id="xdx2ixbrl1454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" id="xdx2ixbrl1455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" id="xdx2ixbrl1479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" id="xdx2ixbrl1484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl1633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl1638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="actg-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ThreeLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ThreeLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_RSAsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RSAsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquitySecuritesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquitySecuritesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_LFFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_LFFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_LFFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_LFFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-11-012019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-11-01</xbrli:startDate>
        <xbrli:endDate>2019-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-19</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-012020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-01</xbrli:startDate>
        <xbrli:endDate>2020-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeptemberRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeptemberRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_DecemberRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:DecemberRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_NewNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:NewNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NewNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:NewNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-05_custom_StockRepurchaseProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-202020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-20</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-23_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesAWarrantsMember50317218">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember50317234">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesAWarrantsMember50317250">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember50317265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SeriesBWarrantsMember50317281">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember50317296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_SeriesBWarrantsMember50317312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember50317328">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>ACTG:Integer</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><a href="#septq1">Table of Contents</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20210101__20210930_zpyjC57ixX1"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--DocumentQuarterlyReport_c20210101__20210930_zx6NwvmMvUm7"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span> QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the quarterly period ended <b><span id="xdx_906_edei--DocumentPeriodEndDate_c20210101__20210930_zj3Ky1GyLbK3"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">September 30,
2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OR</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--DocumentTransitionReport_c20210101__20210930_zZUfT462Zo61"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span> TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from ____________ to
______________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <span id="xdx_902_edei--EntityFileNumber_c20210101__20210930_z1CZ6S1k2wo3"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityFileNumber">1-37721</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_906_edei--EntityRegistrantName_c20210101__20210930_zIzlyrMLTdzl" style="font-size: 12pt"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityRegistrantName">Acacia
Research Corporation</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20210101__20210930_zb5Nnc42hepj"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 50%; text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20210101__20210930_zoBP56cjbOD7"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">95-4405754</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of Incorporation or Organization)</span></td>
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 50%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20210101__20210930_zpLUCdmmkB7f"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine1">767 THIRD AVENUE</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20210101__20210930_znttX2O8gUqg"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine2">SUITE 602</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20210101__20210930_z11IAM2apNAb"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20210101__20210930_zxSxYPI87cX9"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span></b></span></td>
    <td style="width: 50%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20210101__20210930_zuCd78xz0vEd"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressPostalZipCode">10017</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--CityAreaCode_c20210101__20210930_zOhVIqzIeEr1"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:CityAreaCode">(949)</ix:nonNumeric></span> <span id="xdx_907_edei--LocalPhoneNumber_c20210101__20210930_z4OPVpqeXAsf"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:LocalPhoneNumber">480-8300</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">N/A</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address and former fiscal
year, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Title of Each Class</span></span></td>
    <td style="width: 30%; text-indent: 0.35pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol</span></span></td>
    <td style="width: 37%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Name of Each Exchange on Which Registered</span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Common Stock</span></td>
    <td style="text-align: center; text-indent: 0.35pt"><span style="font: 10pt Times New Roman, Times, Serif">ACTG</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The Nasdaq Stock Market, LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
<span id="xdx_901_edei--EntityCurrentReportingStatus_c20210101__20210930_zm4xbvENRyx6"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746;&#160;&#160;&#160;&#160;&#160;No &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20210101__20210930_z6MP8RHB7l87"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;&#160;&#160;&#160;&#160;&#160;No
&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
&#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth
company&#8221; in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 67%"><span style="font: 10pt Times New Roman, Times, Serif">Large accelerated Filer &#9744;</span></td>
    <td style="width: 33%"><span style="font: 10pt Times New Roman, Times, Serif">Accelerated Filer &#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityFilerCategory_c20210101__20210930_zwUMlAEstVEb"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span> &#9746;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Smaller reporting company <span id="xdx_903_edei--EntitySmallBusiness_c20210101__20210930_zEmqQChurR41"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Emerging Growth Company <span id="xdx_907_edei--EntityEmergingGrowthCompany_c20210101__20210930_zChcWZafyxog"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). Yes &#9744; &#160;&#160; <span id="xdx_904_edei--EntityShellCompany_c20210101__20210930_zaAvgqNQdHa4"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of shares outstanding of the registrant&#8217;s common stock,
par value $0.001 per share, as of November 8, 2021, was <span id="xdx_90C_edei--EntityCommonStockSharesOutstanding_iI_c20211108_zEn30hjNmIBk"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-11-08" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,591,852</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM 10-Q</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE QUARTERLY PERIOD ENDED</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30, 2021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="septq1"></span><b>INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 10%">&#160;</td>
    <td style="width: 80%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq6"><span style="font: 10pt Times New Roman, Times, Serif"><b>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>PART I.</b></span></td>
    <td><a href="#septq2"><span style="font: 10pt Times New Roman, Times, Serif"><b>FINANCIAL INFORMATION</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
    <td><a href="#septq3"><span style="font: 10pt Times New Roman, Times, Serif">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq4"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq5"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq7"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders' Equity for the Three and Nine Months Ended September 30, 2021 and 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">6</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq8"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#septq9"><span style="font: 10pt Times New Roman, Times, Serif">Notes to Unaudited Condensed Consolidated Financial Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">9</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 2.</span></td>
    <td><a href="#septq10"><span style="font: 10pt Times New Roman, Times, Serif">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">31</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
    <td><a href="#septq11"><span style="font: 10pt Times New Roman, Times, Serif">Quantitative and Qualitative Disclosures about Market Risk</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">46</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 4.</span></td>
    <td><a href="#septq12"><span style="font: 10pt Times New Roman, Times, Serif">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">47</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>Part II.</b></span></td>
    <td><a href="#septq13"><span style="font: 10pt Times New Roman, Times, Serif"><b>OTHER INFORMATION</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">48</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
    <td><a href="#septq14"><span style="font: 10pt Times New Roman, Times, Serif">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">48</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1A.</span></td>
    <td><a href="#septq15"><span style="font: 10pt Times New Roman, Times, Serif">Risk Factors</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 2.&#160;</span></td>
    <td><a href="#septq16"><span style="font: 10pt Times New Roman, Times, Serif">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 3.&#160;</span></td>
    <td><a href="#septq17"><span style="font: 10pt Times New Roman, Times, Serif">Defaults Upon Senior Securities</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 4.&#160;</span></td>
    <td><a href="#septq18"><span style="font: 10pt Times New Roman, Times, Serif">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 5.&#160;</span></td>
    <td><a href="#septq19"><span style="font: 10pt Times New Roman, Times, Serif">Other Information</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 6.</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#septq20">Exhibits</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">50</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq6"></span>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Quarterly Report on Form 10-Q for the three months ended September
30, 2021, or this Report, contains forward-looking statements within the meaning of the federal securities laws, which statements are
subject to substantial risks and uncertainties. These forward-looking statements are intended to qualify for the safe harbor from liability
established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included
in this Report, or incorporated by reference into this Report, are forward-looking statements. Throughout this Report, we have attempted
to identify forward-looking statements by using words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;could,&#8221;
&#8220;project,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221;
&#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;forecasts,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;intend,&#8221; &#8220;predict,&#8221;
other forms of these words or similar words or expressions or the negative thereof, although not all forward-looking statements contain
these terms. Such statements address future events and conditions concerning, among other things, intellectual property, or IP, acquisition
and development, licensing and enforcement activities, other related business activities, the impact of the COVID-19 pandemic, capital
expenditures, earnings, litigation, regulatory matters, markets for our services, liquidity and capital resources and accounting matters.
Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as our ability
to invest in new technologies and patents, future global economic conditions, changes in demand for our services, legislative, regulatory
and competitive developments in markets in which we and our subsidiaries operate, results of litigation and other circumstances affecting
anticipated revenues and costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have based our forward-looking statements on management&#8217;s
current expectations and projections about trends affecting our business and industry and other future events. Although we do not make
forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Forward-looking
statements are subject to substantial risks and uncertainties that could cause our future business, financial condition, results of operations
or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained
in this Report. Some of the risks and uncertainties that may cause actual results to differ from those expressed or implied in the forward-looking
statements are described in &#8220;Risk Factors&#8221; included in Part II, Item1A of this Report, and in &#8220;Risk Factors&#8221; included
in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the Securities and Exchange
Commission, or the Securities and Exchange Commission (&#8220;SEC&#8221;), on March 29, 2021, or our Annual Report, as well as in our
other public filings with the SEC. In addition, actual results may differ as a result of additional risks and uncertainties of which we
are currently unaware or which we do not currently view as material to our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in this Report is not a complete description
of our business or the risks associated with an investment in our common stock. We urge you to carefully review and consider the various
disclosures made by us in this Report and in our other reports filed with the SEC. You should read this Report in its entirety, together
with the documents that we file as exhibits to this Report and the documents that we incorporate by reference into this Report, with the
understanding that our future results may be materially different from what we currently expect. The forward-looking statements we make
speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements
after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by
applicable law or the rules of The Nasdaq Stock Market, LLC. If we do update or correct any forward-looking statements, investors should
not conclude that we will make additional updates or corrections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We qualify all of our forward-looking statements by these cautionary
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq2"></span>PART I--FINANCIAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq3"></span><b>Item 1. Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq4"></span>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share and per share data)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<table cellpadding="0" cellspacing="0" id="xdx_30A_111_pn3n3_zqFZcLhwD7R5" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_492_20210930" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_494_20201231" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zHmrn4VZ0a6f" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td colspan="8" style="font-size: 10pt; font-weight: bold; text-align: center">ASSETS</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrentAbstract_i01B_zjy1l7lcPxF4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Current assets:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzNtd_z5cVndaWOXsg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">217,957</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">165,546</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RestrictedCash_i02I_d0_maCzNtd_z5AWfVmrWWZh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Restricted cash</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">761</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="AsOf2020-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--EquitySecuritiesFvNi_i02I_maCzNtd_zFqP8fYPIajb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Equity securities at fair value</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNi" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">387,120</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNi" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,103</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EquitySecuritiesWithoutReadilyDeterminableFairValue_i02I_maCzNtd_z5XGBFelmpzi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Equity securities without readily determinable fair value</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,816</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143,257</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--EquityMethodInvestmentsCurrent_i02I_maCzNtd_zw7xcqikiTu5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Investment securities - equity method investments</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:EquityMethodInvestmentsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,840</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:EquityMethodInvestmentsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,673</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherInvestments_i02I_d0_maCzNtd_zYCN7IHq2Hu6" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Investment at fair value</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherInvestments" contextRef="AsOf2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherInvestments" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,752</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzNtd_zhEZYLqnO3I" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">412</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">506</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherReceivablesNetCurrent_i02I_d0_maCzNtd_z40eRnbAMxO3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Other receivable (Note 3)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,539</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2020-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzNtd_z3Kf2baOYnL1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,986</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,832</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrent_i02TI_mtCzNtd_maCzhtg_zSWzYihcZCTd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">669,431</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">457,669</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RestrictedCashAndInvestmentsNoncurrent_i01I_maCzhtg_zBUNTlpqvJ8h" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term restricted cash</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,424</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_i01I_maCzhtg_zq27QfFOiTui" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Patents, net of accumulated amortization</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,826</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,912</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzhtg_zTZud1gxU3nd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Leased right-of-use assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">951</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherAssetsNoncurrent_i01I_maCzhtg_zHqyWoqZoPp4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other non-current assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,482</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,988</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Assets_i01TI_mtCzhtg_zZjwHymyWRsh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">749,834</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515,520</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_znXbEoq5dRsb" style="vertical-align: bottom; background-color: White">
    <td colspan="8" style="font-size: 10pt; font-weight: bold; text-align: center; padding-left: 10pt">LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrentAbstract_i01B_zTEGVCTKYK2f" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Current liabilities:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsPayableCurrent_i02I_maCzbO5_zdT0vemLb6xd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,196</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,019</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maCzbO5_zTWEgOdSdd9j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued expenses and other current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,586</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,707</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_maCzbO5_zarmj4IGdp3g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued compensation</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,019</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,265</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--RoyaltiesAndContingentLegalFeesPayable_i02I_maCzbO5_z9w9P2HtZH5d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Royalties and contingent legal fees payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:RoyaltiesAndContingentLegalFeesPayable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,793</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:RoyaltiesAndContingentLegalFeesPayable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,162</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccruedPatentInvestmentCostsCurrent_i02I_d0_maCzbO5_zjzFNunXbLHd" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accrued patent investment costs</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccruedPatentInvestmentCostsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccruedPatentInvestmentCostsCurrent" contextRef="AsOf2020-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SecuredDebtCurrent_i02I_maCzbO5_zvzPGOIOuJyf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Senior Secured Notes Payable</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">182,855</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,663</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_i02TI_mtCzbO5_maCz2Wr_zc4FqCKpZY8g" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204,449</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124,816</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DerivativeLiabilitiesNoncurrent_i01I_maCz2Wr_z2HjZ8M7JeV3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Series A warrant liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,527</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_i01I_maCz2Wr_zEwMoVBgRjJh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series A embedded derivative liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,411</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,728</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DerivativeLiabilitiesNoncurrent1_i01I_maCz2Wr_z2DyLxNPC7a5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Series B warrant liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:DerivativeLiabilitiesNoncurrent1" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229,637</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:DerivativeLiabilitiesNoncurrent1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,341</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCz2Wr_zedTrN3yGTTk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Long-term lease liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">951</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maCz2Wr_zn4eOQIjy1q7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,591</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">591</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtCz2Wr_maCzLIr_z3l6jBtCzxI6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500,286</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">212,067</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_zC9RwUbIFKe7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Commitments and contingencies</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">&#8211;</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0134">&#8211;</span></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PreferredStockRedemptionAmount_i01I_maCzLIr_z0p7HxYWk3j7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series A redeemable convertible preferred stock, par value $<span id="xdx_905_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zGfqWpCvoZge" title="Series A redeemable convertible preferred stock, par value"><span id="xdx_902_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zrcvWDaiClte" title="Series A redeemable convertible preferred stock, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share; stated value $<span id="xdx_90C_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pid_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_z14wbzkmMWs9" title="Series A redeemable convertible preferred stock, value per share"><span id="xdx_902_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pid_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zqtL6jmPAVbd" title="Series A redeemable convertible preferred stock, value per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">100</ix:nonFraction></ix:nonFraction></span></span> per share; <span id="xdx_90F_eus-gaap--TemporaryEquitySharesAuthorized_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_pdd" title="Series A redeemable convertible preferred stock, shares authorized"><span id="xdx_909_eus-gaap--TemporaryEquitySharesAuthorized_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_pdd" title="Series A redeemable convertible preferred stock, shares authorized"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, issued and outstanding as of September 30, 2021 and December 31, 2020; aggregate liquidation preference of $<span id="xdx_90C_eus-gaap--TemporaryEquityLiquidationPreference_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_pn3n3" title="Series A redeemable convertible preferred stock, liquidation preference"><span id="xdx_90A_eus-gaap--TemporaryEquityLiquidationPreference_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_pn3n3" title="Series A redeemable convertible preferred stock, liquidation preference"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,000</ix:nonFraction></ix:nonFraction></span></span> as of September 30, 2021 and December 31, 2020</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockRedemptionAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,686</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockRedemptionAmount" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,924</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB_zpjG5lBmDjvk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Stockholders' equity:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i01I_maTARCSz4iS_zjfUh0O3EIJk" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210930_zk91gJCPzIw4" title="Common stock, par value"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20201231_zFc8JISgqEe3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share; <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20210930_pdd" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20201231_pdd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares
    authorized; <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_c20210930_pdd" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_c20210930_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,591,852</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--CommonStockSharesIssued_c20201231_pdd" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,279,453</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of September 30, 2021 and
    December 31, 2020, respectively</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--TreasuryStockValue_i01NI_di_msTARCSz4iS_z3EL0mZVmMJc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Treasury stock, at cost, <span id="xdx_90B_eus-gaap--TreasuryStockShares_c20210930_pdd" title="Treasury stock, shares"><span id="xdx_901_eus-gaap--TreasuryStockShares_c20201231_pdd" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,604,365</ix:nonFraction></ix:nonFraction></span></span> shares as of September 30, 2021 and December 31, 2020</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,270</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,270</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--AdditionalPaidInCapital_i01I_maTARCSz4iS_zHKh7YDrZI52" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Additional paid-in capital</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">649,349</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,416</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maTARCSz4iS_zFcF6Wg1Ldde" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">382,215</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">326,708</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_i01TI_mtTARCSz4iS_maCz7QJ_z7XRAZMmL708" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total Acacia Research Corporation stockholders' equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">223,914</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281,487</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterest_i01I_maCz7QJ_zhzKSsycIJb3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Noncontrolling interests</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,948</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,042</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtCz7QJ_maCzLIr_znpp0SLNbKK9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total stockholders' equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235,862</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">292,529</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzLIr_zxuMnxuMAZaj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">749,834</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">515,520</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq5"></span>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share and per share data)</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_pn3n3_zOatf78tYzmk" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt; width: 44%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td id="xdx_49B_20210701_20210930" style="font-size: 10pt; text-align: right; width: 11%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td id="xdx_499_20200701_20200930" style="font-size: 10pt; text-align: right; width: 11%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td id="xdx_495_20210101_20210930" style="font-size: 10pt; text-align: right; width: 11%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td><td id="xdx_493_20200101_20200930" style="font-size: 10pt; text-align: right; width: 11%">&#160;</td><td style="font-size: 10pt; text-align: left; width: 1%">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">Three Months Ended</span></td><td><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>Nine Months Ended</b></span></td><td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">September
    30,</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30,</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCzBk7_maNPILzMzw_zU1g1YzqPjrj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Revenues</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,582</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,466</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,785</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,399</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CostOfRevenueAbstract_iB_zBEwLXHQqyI5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Patent portfolio operations:</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RoyaltyExpense_i01_maCzyA1_zm1C6gKqXTUj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Inventor royalties</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">280</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,772</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">823</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,843</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ContingentLegalFees_i01_maCzyA1_zdyJnGU3lc7d" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Contingent legal fees</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">285</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,609</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,735</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,855</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--LitigationAndLicensingExpensesPatents_i01_maCzyA1_zS5aorx4QjM8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Litigation and licensing expenses
    - patents</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">782</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,001</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,881</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AmortizationOfIntangibleAssets_i01_maCzyA1_z3Nwmfwu2bF1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Amortization of patents</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,612</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,174</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,086</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,522</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherOperatingIncomeExpenseNet_i01N_di0_msCzyA1_z9IoQdciBix3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Other patent
    portfolio income</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">308</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--CostOfGoodsAndServicesSold_i01T_mtCzyA1_msCzBk7_msNPILzMzw_z8A4RVMbjNXc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Patent portfolio
    expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,959</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,556</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,525</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,409</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--NetPortfolioIncomeLoss_i01T_maCzcHT_mtNPILzMzw_zyo7eYkPT43d" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt"><span style="font-size: 10pt">Net patent portfolio (loss) income</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,377</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,910</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,260</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,990</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--GeneralAndAdministrativeExpense_i01_msCzcHT_z1BMMw5JOTH4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">General and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,345</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,692</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,014</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,089</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_i01T_mtCzcHT_maCzHHq_z1Wg4TZ94zrj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><span style="font-size: 10pt">Operating loss</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,722</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,782</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16,754</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,099</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zesGuv1Dw6Q5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Other income (expense):</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--UnrealizedGainLossOnInvestments_i01_d0_maCzP29_zocCSccIXwNi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Change in fair value of investment,
    net</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,081</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,752</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--GainLossOnSaleOfInvestments_i01_d0_maCzP29_z1PalCAVdpSl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Gain (loss) on sale of investment</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,591</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,762</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_maCzP29_zeSsU4KynsK" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt"><span style="font-size: 10pt">Change in fair value of the Series
    A and B warrants and embedded derivatives</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">619</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,672</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">203,866</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,612</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--GainLossOnSaleOfDerivatives_i01_d0_maCzP29_zMstx9z5h6Gk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Gain on sale of prepaid investment
    and derivative</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ChangeInFairValueOfEquitySecurities_i01_maCzP29_zx1SXqxsShUj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Change in fair value of equity securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66,502</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,488</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,509</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99,449</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EquitySecuritiesFvNiRealizedGainLoss_i01_maCzP29_zM6cDFT2ULPg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Gain (loss) on sale of equity securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,688</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,737</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,124</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,272</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--EarningsOnEquityInvestmentInJointVenture_i01_d0_maCzP29_zfdYTTQjuCN6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Earnings on equity investment in
    joint venture</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:EarningsOnEquityInvestmentInJointVenture" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:EarningsOnEquityInvestmentInJointVenture" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:EarningsOnEquityInvestmentInJointVenture" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,737</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:EarningsOnEquityInvestmentInJointVenture" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01_maCzP29_z3qCZneRKM2b" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Loss on foreign currency exchange</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">48</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">193</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,938</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--InterestExpenseDebt_i01N_di_msCzP29_zXt6gDCZCzA3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt"><span style="font-size: 10pt">Interest expense on Senior Secured
    Notes</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,531</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,410</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,601</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,178</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40A_ecustom--InterestIncomeExpenseAndOther_i01_maCzP29_z8XebeeAApA" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-size: 10pt">Interest income
    and other</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:InterestIncomeExpenseAndOther" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:InterestIncomeExpenseAndOther" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:InterestIncomeExpenseAndOther" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:InterestIncomeExpenseAndOther" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzP29_maCzHHq_zSU9ljSvwN41" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt"><span style="font-size: 10pt">Total other
    income (expense)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102,337</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,213</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37,316</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,047</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzHHq_maCzhA3_z72W0VW4x2V" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Income (loss) before income taxes</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,615</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,431</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54,070</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,948</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzhA3_ztwiBqdUp7mg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Income tax (expense) benefit</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">531</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,257</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iT_mtCzhA3_maCz0cF_z2XjjssIyZo1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Net income (loss) including noncontrolling interests
    in subsidiaries</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,604</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54,601</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di0_msCz0cF_zdX13wpwW049" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net income attributable to noncontrolling
    interests in subsidiaries</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">906</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_iT_mtCz0cF_zEYRVh9ciYx4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Net income (loss) attributable
    to Acacia Research Corporation</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,604</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,507</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_pid_zgD3KC0klFYa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Net income (loss) attributable
    to common stockholders - Basic</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">72,984</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30,529</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">59,054</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">24,838</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasicAndDiluted_pid_z4AToafKiajk" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic net
    income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.49</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.63</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.21</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.51</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zDONrStxNhC8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Weighted average number of shares
    outstanding - Basic</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,949,504</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,467,885</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,759,873</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,949,706</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zVz5G1R34wsa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Net income (loss) attributable
    to common stockholders - Diluted</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">80,171</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,204</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">59,054</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,380</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pid_zESMHFQjsN42" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"><span style="font-size: 10pt">Diluted net
    income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.86</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.32</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.21</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.36</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pid_zAEdQ1PhdSnd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Weighted average number of shares
    outstanding - Diluted</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,081,502</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,624,702</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,759,873</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,153,773</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="septq7"></span><b>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share data)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30E_114_pn3n3_zHRzV1wl7gb5" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--SeriesARedeemableConvertiblePreferredStockMember_zlZWZ1pO0Zzf" style="font-size: 10pt; text-align: right">&#160;</td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zbtYwW0afF7c" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zOvTB1h1JjT4" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zLDVQQDbEOk7" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zmBf0qhyqvm9" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zvKLSKPbtH7d" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B7_zCvCHYOGp5Fb" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">For
    the Three Months Ended September 30, 2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -5pt; text-align: center; padding-left: 5pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">Common
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Treasury
    </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional<br />
    Paid-in</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Noncontrolling<br />
    Interests in<br /> Operating</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total<br />
    Stockholders'</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-bottom: 1pt; text-align: center; padding-left: 5pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Stock</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Capital</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Subsidiaries</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Equity</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr id="xdx_430_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_znAgmZ8riRjh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; width: 26%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance
    at June 30, 2021</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zGf7tK5M5JDf" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,695</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; width: 2%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJg8VeDtHpqi" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,616,602</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,194</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">471,819</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,948</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,103</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--NetIncomeIncludingNoncontrollingInterestsInSubsidiaries_zcc2CWm0UoW4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income including
    noncontrolling interests in subsidiaries</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0384">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0387">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,604</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0389">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,604</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_iN_pn3n3_di_zFlEJK9Wnih7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series
    A Redeemable Convertible Preferred Stock to redemption value</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">991</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0394">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">991</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0396">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0397">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">991</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_zrumv2N9rHD" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0400">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0402">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">262</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">262</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options exercised</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zk7w131GgOvf" title="Stock options exercised, Shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0409">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0410">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0412">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">108</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_zCVHZyHuro32" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common
    stock for unvested restricted stock awards, net of forfeitures</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0418">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98B_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7y5Y37y0qKd" title="Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">54,750</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0419">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0421">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0423">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zFocmRxQquRi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Compensation
    expense for share-based awards</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8211;</span></span></td><td style="border-right: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0429">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0430">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0433">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_437_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zBqEPj1n74H3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance
    at September 30, 2021</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zbZggr2xHbv6" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,686</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYiOCjM653Ha" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,591,852</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">649,349</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">382,215</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,948</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235,862</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">For
    the Three Months Ended September 30, 2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -5pt; text-align: center; padding-left: 5pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">Common
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Treasury
    </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional<br />
    Paid-in</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Noncontrolling<br />
    Interests in<br /> Operating</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total<br />
    Stockholders'</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-bottom: 1pt; text-align: center; padding-left: 5pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Stock</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Capital</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Subsidiaries</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Equity</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr id="xdx_43A_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zg0vbuJp7N5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; width: 26%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance at June 30, 2020</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zfp3LRtC2E4f" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,400</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; width: 2%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4LP4SjJ74U2" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,306,137</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,843</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">444,799</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164,656</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iP3us-gaap--SharesOutstanding_z97hYK9r3PN" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income attributable to Acacia Research Corporation</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0460">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0463">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0465">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_iN_pn3n3_di_zZvaqDJuvOg1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series A Redeemable Convertible Preferred
Stock to redemption value</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">734</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">734</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0472">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">734</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_zNbZYK50H141" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series A Redeemable Convertible Preferred
    Stock</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0478">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0480">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_zmpQ8DIu2KX1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common stock for unvested restricted stock
awards, net of forfeitures</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_981_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_pid_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQTgl0A6Zfgf" title="Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">26,684</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0485">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0486">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0487">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0488">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0489">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0490">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zYVIWqUe97V6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Compensation expense for share-based
    awards</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8211;</span></span></td><td style="border-right: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0495">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0498">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_433_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zhQKNtHU1szf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance at September 30, 2020</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zhA88KCFTj1g" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,134</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziV7XpJeaS65" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,279,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,130</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">406,451</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,291</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share data)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(continued)</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">For
    the Nine Months Ended September 30, 2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 5pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">Common
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Treasury
    </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional<br />
    Paid-in</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Noncontrolling<br />
    Interests in<br /> Operating</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total<br />
    Stockholders'</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: center; padding-left: 5pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Stock</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Capital</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Subsidiaries</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Equity</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_433_c20210101__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zoELXLTsaX03" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 26%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance
    at December 31, 2020</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zOWzo2mTVgz3" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,924</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; width: 2%"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTKmzhjykSN6" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,279,453</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,416</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">326,708</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,042</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">292,529</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--NetIncomeIncludingNoncontrollingInterestsInSubsidiaries_z16z0O1gIgUf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net (loss) income
    including noncontrolling interests in subsidiaries</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0526">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0527">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0528">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0529">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,507</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">906</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54,601</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_400_ecustom--AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_iN_pn3n3_di_z3a0EeLfsP7k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series
    A Redeemable Convertible Preferred Stock to redemption value</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,762</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0535">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0536">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,762</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0538">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0539">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,762</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_zk2hls56mpX3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0542">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0543">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0544">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">785</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0546">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">785</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zpIfEkPjQsih" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options exercised</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0550">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKQOOZYVuAP" title="Stock options exercised, Shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0552">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0554">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0555">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--IssuanceOfCommonStockForVestingOfRestrictedStockUnits_iP3us-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_z6DlNIMwnhij" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common
    stock for vesting of restricted stock units</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_982_ecustom--IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_iP3custom--IssuanceOfCommonStockForVestingOfRestrictedStockUnits_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbkdKdqDeHke" title="Issuance of common stock for vesting of restricted stock units, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,834</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0561">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0562">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0564">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_zEi1g7m23b5l" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common
    stock for unvested restricted stock awards, net of forfeitures</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0570">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIRCqnxf4Ys2" title="Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">223,565</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0571">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0572">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0573">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0574">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0575">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0576">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zbzvzqvtdoO1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Compensation
    expense for share-based awards</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0580">&#8211;</span></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0581">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0582">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,279</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0584">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0585">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,279</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_435_c20210101__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zfSo5tgyIv03" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance
    at September 30, 2021</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zJvUFurUQqV8" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,686</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z23F0dhZmiTj" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,591,852</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">649,349</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">382,215</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,948</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235,862</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">For
    the Nine Months Ended September 30, 2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -5pt; text-align: center; padding-left: 5pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Series
    A Redeemable Convertible Preferred Stock</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">Common
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Treasury
    </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional<br />
    Paid-in</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Noncontrolling<br />
    Interests in<br /> Operating</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total<br />
    Stockholders'</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-bottom: 1pt; text-align: center; padding-left: 5pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td>
    <td style="border-right: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Stock</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Capital</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Subsidiaries</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Equity</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr id="xdx_436_c20200101__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zyHQ3Gkn48cc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 26%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance at December 31, 2019</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_ziOZ45qP9REg" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,089</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; width: 2%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeUsly58bKic" title="Balance at beginning, shares" style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,370,987</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">652,003</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">439,656</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 6%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174,958</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income attributable to Acacia Research Corporation</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0617">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_iN_pn3n3_di_z6w9htvUMG13" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series A Redeemable Convertible Preferred
Stock to redemption value</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,045</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0624">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_zjHUd5ljx2cd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series A Redeemable Convertible Preferred
    Stock</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0628">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0629">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0630">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,119</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0632">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0633">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,119</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zHnV9R8Eugl4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options exercised</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0636">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEQNyFRd5oXk" title="Stock options exercised, Shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0638">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0640">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0641">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--IssuanceOfCommonStockForVestingOfRestrictedStockUnits_zR4ShDfxefLc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common stock for vesting of restricted stock
    units</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0646">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_ecustom--IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLtqkSMSjtxe" title="Issuance of common stock for vesting of restricted stock units, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,354</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0647">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0648">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0649">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0650">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0651">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0652">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_zZOtjcdz6gve" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Issuance of common stock for unvested restricted stock
awards, net of forfeitures</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0656">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_989_ecustom--IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBF3q6dGfACf" title="Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">565,316</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0658">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0659">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0660">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0661">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0662">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zbFqppKEcFUi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Compensation expense for share-based awards</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0666">&#8211;</span></span></td><td style="border-right: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0667">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0668">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0670">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0671">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockRepurchasedAndRetiredDuringPeriodValue_iNP3us-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_pn3n3_di_zX77dmcDo0Ok" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Repurchase of common stock</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8211;</span></span></td><td style="border-right: Black 1pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_iP3us-gaap--StockRepurchasedAndRetiredDuringPeriodValue_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zULx8BFz6MLc" title="Repurchase of common stock, Shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,684,537</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,998</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0677">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0679">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,999</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_439_c20200101__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zDHHl9HyXkg6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance at September 30, 2020</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zXR2ffOdgrE1" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,134</ix:nonFraction></span></td><td style="border-right: Black 1pt solid; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zw6K3DgcgZv7" title="Balance at ending, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,279,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,130</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">406,451</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,291</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</i>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq8"></span>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_pn3n3_zLuPbmJCV9ei" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49B_20210101__20210930_ztzZByZB2oZ1" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_493_20200101__20200930_zjBipFfclPe2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="5" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zEN2TliE4O8k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from operating activities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01_maCzB5x_zymjkhuEnOJ" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; font-size: 10pt; text-align: left">Net (loss) income including noncontrolling interests in subsidiaries</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54,601</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_z3PuRCFGPsV9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash (used in) provided by operating activities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--UnrealizedGainLossOnInvestments_i01N_di_msCzB5x_zYq3S4b3WtBe" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Change in fair value of investment, net</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,752</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--GainLossOnSaleOfInvestments_i01N_di_msCzB5x_zkzph1lYrJf7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">(Gain) loss on sale of investment</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,591</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,762</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationAndAmortization_i01_maCzB5x_z2UoG5rqxR5a" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Depreciation and amortization</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,198</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,609</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i01_maCzB5x_zKRWhYp6DbPf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Amortization of debt discount and issuance costs</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">460</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">955</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_i01N_di_msCzB5x_zUkujlDuPQp2" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,683</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,708</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--UnrealizedGainLossOnDerivatives_i01N_di_msCzB5x_zNPXdGe5xNEf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Change in fair value of Series A warrants</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,887</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,036</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--UnrealizedGainLossOnDerivatives1_i01N_di_msCzB5x_zRbGXJijfrkk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Change in fair value of Series B warrants</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:UnrealizedGainLossOnDerivatives1" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">177,296</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:UnrealizedGainLossOnDerivatives1" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36,867</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ShareBasedCompensation_i01_maCzB5x_zktcMw2CAXX" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Non-cash stock compensation</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,279</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_i01N_di_msCzB5x_zLBoY7UoYpqi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Loss on foreign currency exchange</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">193</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,938</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ChangeInFairValueOfEquitySecurities_i01N_di_msCzB5x_zgOcabZ8W5R" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Change in fair value of equity securities</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,509</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfEquitySecurities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99,449</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EquitySecuritiesFvNiRealizedGainLoss_i01N_di_msCzB5x_z4w9m5oByKG" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">(Gain) loss on sale of equity securities</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,124</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,272</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_i01N_di0_msCzB5x_ziIsLWSZcwBf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Gain on sale of prepaid investment and derivative</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromEquityMethodInvestments_i01N_di0_msCzB5x_zjju7ldS9Xp5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Earnings on equity investment in joint venture, net of distributions received</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">907</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zkzEBlUdbRq8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Changes in assets and liabilities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzB5x_z85jCgHla244" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">94</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">248</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzB5x_z4Ms8bNkp9p2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Prepaid expenses and other assets</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,345</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,038</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maCzB5x_z0A7qI7MFdFj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts payable and accrued expenses</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,002</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">614</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_i01_maCzB5x_zSFmUZ9jqwj5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Royalties and contingent legal fees payable</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">369</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,052</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzB5x_maCzTKD_zs9BEo7DUU6e" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Net cash (used in) provided by operating activities</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,602</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,549</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z4MrFIPUboCg" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from investing activities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCz90S_zk3Jk972rlU" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Patent acquisition</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,780</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_i01_maCz90S_zIpvhCih6CY7" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sale of investment at fair value</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,591</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,460</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireShortTermInvestments_i01N_di_msCz90S_zvUu5uCMUMvf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Purchases of equity securities</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57,978</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,800</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_i01_maCz90S_zr1PJ4iUyg7k" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Maturities and sales of equity securities</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64,235</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">316,746</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PurchasesOfPrepaidInvestment_i01_d0_maCz90S_zV2NtSEJ9jK3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Purchases of prepaid investment</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PurchasesOfPrepaidInvestment" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:PurchasesOfPrepaidInvestment" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">276,275</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--EquitySecuritiesDerivativeAndForwardContractAcquisitionCost_i01_d0_maCz90S_zhyGJMPKsx1c" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative and forward contract acquisition cost</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,989</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCz90S_zSkJmlDOfiK5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">177</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCz90S_maCzTKD_z1dRMqlcsYr9" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Net cash used in investing activities</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,219</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,815</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zuTqJ6Kn4aU" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Cash flows from financing activities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsForRepurchaseOfCommonStock_i01N_di0_msCzz8f_zNxKgjz9yfLe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Repurchase of common stock</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,998</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromIssuanceOfDebt_i01_maCzz8f_zFxsoHJqM5q3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Issuance of Senior Secured Notes, net of lender fee</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,437</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--SeniorSecuredNotesIssuanceCostsPaidToOtherParties_i01N_di0_msCzz8f_zo2SgkcXnx46" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Senior Secured Notes issuance costs paid to other parties</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsOfDividends_i01N_di_msCzz8f_zlvRm5pLkRi" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Dividend on Series A Redeemable Convertible Preferred Stock</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">785</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,120</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromIssuanceOfWarrants_i01_d0_maCzz8f_z4QU3ivJO37e" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,600</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maCzz8f_zOGqYz3CMbCl" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Proceeds from exercise of stock options</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RepaymentsOfSecuredDebt_i01N_pn3n3_di0_msCzz8f_zhtCFaz1T9T" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Paydown of Senior Secured Notes</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_i01_pn3n3_d0_maCzz8f_zgKCAFdAId04" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Reissuance of Senior Secured Notes</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzz8f_maCzTKD_zfdugSnzLRd2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Net cash provided by financing activities</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64,417</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,471</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCzTKD_zpwAlAtndvud" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Increase in cash and cash equivalents and restricted cash</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,596</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,205</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zU6fSqDNLRG" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Cash and cash equivalents and restricted cash, beginning</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,546</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iE_zcn4cyLyPJzc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents and restricted cash, ending</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254,142</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197,564</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zu2rMbQwIGg5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left">Supplemental schedule of cash flow information:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInPrepaidInterest_i01_d0_zdXolkSE7PWj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Interest paid</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,340</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidInterest" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxesPaid_i01_zQgXbbxU3Df" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Income taxes paid</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--NoncashInvestingActivitesAbstract_i01B_zBhzsBk0srq3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Noncash investing activities:</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--TradeDateReceivableFromSaleOfEquitySecuritiesNote3_i02_d0_zXMV8cn1F15a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Trade date receivable from sale of equity securities (Note 3)</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,539</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--PatentAcquisitionInExchangeOfNotesReceivable_i01_d0_zHeqRwrApys" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Patent acquisition in exchange of notes receivable</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionInExchangeOfNotesReceivable" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionInExchangeOfNotesReceivable" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PatentAcquisitionAccruedLiabilityShortTerm_i01_pn3n3_d0_za0QMiS18s66" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Patent acquisition accrued liability - short-term</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionAccruedLiabilityShortTerm" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionAccruedLiabilityShortTerm" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PatentAcquisitionAccruedLiabilityLongTerm_i01_pn3n3_d0_zbL1sU2dYC07" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Patent acquisition accrued liability - long-term</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionAccruedLiabilityLongTerm" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PatentAcquisitionAccruedLiabilityLongTerm" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--AcquisitionOfPrepaidInvestmentSecurities_i01_d0_zT9aaJ1UAe3e" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Acquisition of prepaid investment securities</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AcquisitionOfPrepaidInvestmentSecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AcquisitionOfPrepaidInvestmentSecurities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">231,480</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral part
of these unaudited condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i></i></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="septq9"></span><b>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS</b></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:BusinessDescriptionTextBlock"><p id="xdx_808_ecustom--BusinessDescriptionTextBlock_zLQd26KmL4Da" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. <span id="xdx_823_zVPOKEhMhwLg">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:DescriptionOfBusinessPolicyTextBlock"><p id="xdx_84A_ecustom--DescriptionOfBusinessPolicyTextBlock_znfMED2mVuqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_861_z58pdAAvzUra">Description of Business</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled
operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia was incorporated on January 25, 1993 under the laws of the State
of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia acquires businesses and operating assets that the Company believes
to be undervalued and where the Company believes it can leverage its resources and skill sets to realize and unlock value. The Company
intends to leverage its (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and
operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount
and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions
of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. Acacia
seeks to identify opportunities where the Company believes it is an advantaged buyer, where the Company can avoid structured sale processes
and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to the Company&#8217;s
unique capabilities, relationships, or expertise, or where Acacia believes the target would be worth more to the Company than to other
buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia operates its business based on three key principles of People,
Process and Performance and has built a management team with identified expertise in Research, Execution and Operation of the Company&#8217;s
targeted acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia, through its operating subsidiaries, also currently engages
in its legacy business of investing in, licensing and enforcing patented technologies. Acacia&#8217;s operating subsidiaries partner with
inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented
inventions. In recent years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships
developed as a leader in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities
will complement and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries generate revenues and related
cash flows from the granting of IP rights (hereinafter, &#8220;IP Rights&#8221;) for the use of patented technologies that its operating
subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through
the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries are principals in the licensing
and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia&#8217;s
operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through
its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s operating subsidiaries
are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based
opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23B_zWNgyouatFJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z2afz5SvLxDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zwlifsC8uz3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_23D_z7NLYudeMOc4" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zdgRB0xrdDa" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zqkyodWonVU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, Acacia obtained
control of one <span id="xdx_90D_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20210101__20210930_zFPmsscH2NBj" title="Number of new patent portfolios acquired" style="display: none"><ix:nonFraction name="ACTG:NumberOfPatentPortfoliosAcquired" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></span>
new patent portfolio. During fiscal year 2020, Acacia obtained control of five <span id="xdx_907_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20200101__20201231_z0DlQoQ7KXz8" title="Number of new patent portfolios acquired" style="display: none"><ix:nonFraction name="ACTG:NumberOfPatentPortfoliosAcquired" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">5</ix:nonFraction></span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:BasisOfAccountingPoliesPolicyTextBlock"><p id="xdx_846_ecustom--BasisOfAccountingPoliesPolicyTextBlock_zTkfyraUtA34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zJRRpXQOfCwi">Basis of Presentation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;)
for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information
and note disclosures required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly
reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed consolidated financial
statements and notes hereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2020, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March 29, 2021, as well as in our other
public filings with the SEC. The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring
nature which, in the opinion of management, are necessary for a fair statement of Acacia&#8217;s consolidated financial position as of
September 30, 2021, and results of its operations and its cash flows for the interim periods presented. The consolidated results of operations
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal
year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reclassifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain prior period amounts in the consolidated financial statements
have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated
results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:Covid19PandemicAndCaresActPolicyTextBlock"><p id="xdx_84E_ecustom--Covid19PandemicAndCaresActPolicyTextBlock_zazWKBu653X5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zJQM5ugWaLIa">COVID-19 Pandemic</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#8217;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zxLzCpbkUtD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. <span id="xdx_82F_zUjdVBQzojDh">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1ORXFzaCLxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zDJple5wwSO8">Accounting Principles</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The consolidated financial statements and accompanying notes are prepared
on the accrual basis of accounting in accordance with U.S. GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zZGNypmCv9a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zfiRWS9j1Ysd">Principles of Consolidation</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited consolidated financial statements include
the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Noncontrolling interests in Acacia&#8217;s majority-owned and controlled
operating subsidiaries (&#8220;noncontrolling interests&#8221;) are separately presented as a component of stockholders&#8217; equity.
Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated
statements of operations. Refer to the accompanying Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders&#8217;
Equity for total noncontrolling interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_233_zGnOyGjnx8zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z8sUdrumfAe7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z0sF5mxH6OC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_23E_z1nwxB4MUegl" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23B_zO0cPrEFht1a" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zC3uAz9FM0Ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2020, in connection with the transaction with Link Fund Solutions
Limited, which is more fully described in Note 3, the Company acquired equity securities of Malin J1 Limited (&#8220;MalinJ1&#8221;).
MalinJ1 is included in the Company&#8217;s consolidated financial statements because the Company, through its interest in the equity securities
of MalinJ1, has the ability to control the operations and activities of MalinJ1. Viamet HoldCo LLC, a Delaware limited liability company
and wholly-owned subsidiary of Acacia, is the majority shareholder of MalinJ1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A wholly-owned subsidiary of Acacia is the general partner of the Acacia
Intellectual Property Fund, L.P. (the &#8220;Acacia IP Fund&#8221;), which was formed in August 2010. The Acacia IP Fund has been included
in the Company&#8217;s consolidated financial statements since 2010, as Acacia&#8217;s wholly-owned subsidiary, the general partner of
Acacia IP Fund, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia IP Fund was terminated as of
December 31, 2017 and dissolved in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:SegmentReportingPolicyTextBlock"><p id="xdx_844_ecustom--SegmentReportingPolicyTextBlock_zADk5K4ldVx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zeJga3udMrb8">Segment Reporting</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia uses the management approach, which designates the internal
organization that is used by management for making operating decisions and assessing performance as the basis of Acacia&#8217;s reportable
segments. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:EstimatesPolicytextBlock"><p id="xdx_84C_ecustom--EstimatesPolicytextBlock_z7iuQVnnEnC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zSX0sSXVwUHk">Use of Estimates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described
herein, the accounting policies associated with revenue recognition, the valuation of the equity instruments, the valuation of Series
A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible Preferred Stock&#8221;), embedded derivatives, Series
A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series B Warrants&#8221;), stock-based compensation expense,
impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income
taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zp4pqpx2Pche" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z0axyN6kaGS5">Revenue Recognition</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue is recognized upon transfer of control (i.e., by the granting)
of promised bundled IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they
exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition
criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods presented, revenue contracts executed by the Company
primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain
IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based revenue contracts,
the majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on quarterly
sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may also include court ordered settlements
or awards related to our patent portfolio or sales of our patent portfolio. IP Rights granted included the following, as applicable: (i)
the grant of a non-exclusive, future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue,
(iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were generally
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for
as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to grant combined items
to which the promised IP Rights are inputs and (ii) the Company's promise to grant each individual IP right described above to the customer
is not separately identifiable from other promises to grant IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23D_z2Ks0Jf7p5xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zTflzC44sJt5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zqwAiDNchvV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_232_zr2QBUUQPE16" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_z2PytDQNhhik" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zOORaYZle468" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the promised IP Rights are not individually distinct, the Company
combined each individual IP Right in the contract into a bundle of IP Rights that is distinct, and accounted for all of the IP Rights
promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional IP rights&#8221; that have significant
standalone functionality. Acacia&#8217;s subsequent activities do not substantively change that functionality and do not significantly
affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect
to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support
or services. The contracts provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon
execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process
is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition
criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 15-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are
generally non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the
amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently
resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later
of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been
allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues from contracts with significant financing components (either
explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash
for the IP Rights when they are granted to the licensee. In determining the transaction price, the Company adjusts the promised amount
of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount
of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between
when the entity grants promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In general, the Company is required to make certain judgments and estimates
in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in
the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct
from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating
the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and
estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Revenues
were comprised of the following for the periods presented:&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none">Disaggregation
    of revenue</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Paid-up
    revenue agreements</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,100</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,385</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,110</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,477</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Recurring
    Revenue Agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">482</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">922</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,582</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,466</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,785</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,399</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AE_z9c4bc72xOyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b></b></span><span style="font: 10pt Times New Roman, Times, Serif">Refer to &#8220;<i>Inventor Royalties and
Contingent Legal Expenses</i>&#8221; below for information on related direct costs of revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:PatentPortfolioOperationsPolicyTextBlock"><p id="xdx_847_ecustom--PatentPortfolioOperationsPolicyTextBlock_zt9WnCalrHff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zqjcrZxcdwW3">Patent Portfolio Operations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cost of revenues include the costs and expenses incurred in connection
with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, patent maintenance
and prosecution costs, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent
counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related
investment costs. These costs are included under the caption &#8220;Patent portfolio operations&#8221; in the consolidated statements
of operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<ix:exclude><p id="xdx_233_z3IBlud97Pj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_231_zJBHDMdREjm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_238_zfnXy6vQbUO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_230_zsPWLhxBhrsi" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_z5iWD1PoOppe" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zgjXDcoRe1Ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalties are expensed in the consolidated statements of operations
in the period that the related revenues are recognized. Patent costs, including any upfront advances paid to patent owners by Acacia&#8217;s
operating subsidiaries, that are recoverable from future net revenues are amortized over the estimated economic useful life of the related
patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period
recovered and included in amortization expense in the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contingent legal fees are expensed in the consolidated statements of
operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers,
no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain out of pocket legal costs
incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalty and contingent legal agreements generally provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments
are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:ConcentrationsPolicyTextBlock"><p id="xdx_845_ecustom--ConcentrationsPolicyTextBlock_zdCisWyLDcGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_z629mh8x2Fg3">Concentrations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, equity securities and accounts receivable. Acacia places its cash equivalents and equity securities
primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in
deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Four licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z08Z9l632Sma" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">32</ix:nonFraction></span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z3sOv6LAIQUd" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zxTh9mIiCwge" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zLScaSSvNJK9" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% of
revenues recognized during the three months ended September 30, 2021, and one licensee accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z30FpxRpeW0k" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">98</ix:nonFraction></span>% of revenues recognized during
the three months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_znyPUuufBOm3" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zx39kZPTH5Yd" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zENUWIIMvvqc" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% of revenues recognized during the
nine months ended September 30, 2021, and two licensees accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee3Member_z2vQAS6oMQnh" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z7RGndZS4Sr1" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% of revenues recognized during the nine months ended September
30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company does not have any material foreign operations. Based on
the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for the three
and nine months ended September 30, 2021, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zXbwkFsoK2F8" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_z9U13b52KX1g" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions.
For the three and nine months ended September 30, 2020, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zzAcapFYsMyg" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zdyx2eenqfSb" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Two licensees represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zlW1ntM3cEX8" title="Concentration risk percentage"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zPMhqdsSsote"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></ix:nonFraction></span></span>% of accounts receivable at September
30, 2021. Two licensees individually represented approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zg6fPuOeDpqc" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">62</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zVRo2X70XVZk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% of accounts receivable at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:RelatedPartyTransactionsPolicyTextBlock"><p id="xdx_842_ecustom--RelatedPartyTransactionsPolicyTextBlock_zUtnhFN0ysLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zZ9svsDlVKPl">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2019, the Company purchased shares of common stock of Drive
Shack, Inc. (&#8220;Drive Shack&#8221;) for an aggregate purchase price of $2.4 million. At the time, Drive Shack and Clifford Press,
Chief Executive Officer and director of Acacia, were related parties as Mr. Press was a board member of Drive Shack until June 2021. The
market value of the investment was $1.4 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company
sold its investment receiving proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromSaleOfLongtermInvestments_pn3n3_dm_c20210101__20210930_z8wZGQ7XLEvl" title="Proceeds from sale of investment"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfLongtermInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.8</ix:nonFraction> </span>million and recognized a loss of $<span id="xdx_909_eus-gaap--LossOnSaleOfInvestments_pn3p0_c20210101__20210930_zbEpXupgctJj" title="Loss on sale of investment"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">515,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znBggoYpGtE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zApTIkBILrjc">Cash and Cash Equivalents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia considers all highly liquid, equity securities with original
maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash equivalents are
comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic
commercial paper and securities issued or guaranteed by the U.S. government or its agencies. Acacia&#8217;s cash equivalents are measured
at fair value using observable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23E_zhdB1vmjFLy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zA8hbutegWo8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zvTtmNTW7Zb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_232_zs4426KIeyoh" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_z2J6TMTjyQM2" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zkdiKymM9XIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:EquitySecuritiesAtFairValuePolicyTextBlock"><p id="xdx_845_ecustom--EquitySecuritiesAtFairValuePolicyTextBlock_zKwKzjxaIxTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zMr6TNNWWq8h">Equity Securities at Fair Value </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments in equity securities are reported at fair value on a recurring
basis, with related realized and unrealized gains and losses in the value of such securities recorded in the consolidated statements of
operations in other income or (expense). Dividend income is included in the consolidated statements of operations in other income or (expense).
Refer to Note 7 for additional information related to fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity securities at fair value for the periods presented were comprised
of the following:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:EquityMethodInvestmentsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Security
    Type</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Cost</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Gain</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br />
    Unrealized<br /> Loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Fair
    Value</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - Life Sciences Portfolio (Note 3)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" title="Equity securities - cost" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62,042</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">288,508</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" title="Available-for-sale Securities, Gross Unrealized Loss" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,812</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" title="Equity securities at fair value" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">348,738</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Equity securities - cost" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,178</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,289</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Equity securities at fair value" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,382</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" title="Equity securities - cost" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97,220</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">291,797</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,897</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" title="Equity securities at fair value" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">387,120</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    - Life Sciences Portfolio (Note 3)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" title="Equity securities - cost" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,765</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,689</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" title="Available-for-sale Securities, Gross Unrealized Loss" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" title="Equity securities at fair value" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104,871</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Equity securities - cost" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,086</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,410</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,264</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" title="Equity securities at fair value" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,232</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" title="Equity securities - cost" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,851</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74,099</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,847</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" title="Equity securities at fair value" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,103</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8A6_zpdhH9K9HW7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"><p id="xdx_84E_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_zA5jIua165jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_ztj8KnAgfmB2">Equity Securities Without Readily Determinable Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For equity securities that do not have readily determinable fair value,
the Company elected to report them under the measurement alternative. They are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The
fair values of the private company securities were estimated based on recent financing transactions and secondary market transactions
and factoring in any adjustments for illiquidity or preference of these securities. Changes in fair value are reported in the consolidated
statements of operations in other income or (expense). Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:EquityMethodInvestmentsPolicy"><p id="xdx_844_eus-gaap--EquityMethodInvestmentsPolicy_zEKMmci1k7Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_zLpxVmZXnVai">Equity Method Investments </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity investments in common stock and in-substance common stock without
readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted
for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees
in earnings on equity investment in joint venture in the consolidated statements of operations. Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_znHRNqpxtPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zSHlKiT5CP7b">Investment at Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On an individual investment basis, Acacia may elect to account for
investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of
the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under the equity
method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and
warrants). We elected the fair value method for our investment in Veritone, Inc. (&#8220;Veritone&#8221;) upon acquisition of the investment.
Since March 2021, we have no more investment in Veritone stocks and warrants. Refer to Note 4 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_232_zOEkWq9Sp78d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zvFDesFV92ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z4Ug5EgtTvWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_23F_zctwYX9AcqX8" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_232_zmJcESHfZ3gd" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z2J78yqLqD6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:ImpairmentOfInvestmentPolicyTextBlock"><p id="xdx_847_ecustom--ImpairmentOfInvestmentPolicyTextBlock_zRWgCZILRST4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z8aUtYt7Lw5e">Impairment of Investments</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative
evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates,
among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_847_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zLoyDWm9Wmw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_z2TQncf3udej">Long-Term Restricted Cash </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted cash relates primarily to the proceeds received from the
issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account (refer to Note 6). The amounts are to
be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii)
the conversion of Series A Redeemable Convertible Preferred Stock into common stock. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Refer to Note 11 for additional information related to the subsequent
period acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zuh4nTi8mO3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zoKMVuQnHAik">Patents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Patents include the cost of patents or patent rights acquired from
third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over
their remaining economic useful lives. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zruaHSR5TAmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zpvZ1zkYyGje">Impairment of Long-lived Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not
be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying
amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying value over its fair
value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If
quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value
of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic useful
life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including an estimated
rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based
on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are
based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license
fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and
enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status
and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent
information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:SeriesAandBWarrantsPolicyTextBlock"><p id="xdx_84C_ecustom--SeriesAandBWarrantsPolicyTextBlock_zuTOJOxjyock" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_zVQjbnwmj3A4">Series A and B Warrants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the Series A and B Warrants are estimated using a
Black-Scholes option-pricing model. Refer to Notes 6 and 7 for additional information related to the Series A and B Warrants and their
fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:DerivativesEmbeddedDerivatives"><p id="xdx_84F_eus-gaap--DerivativesEmbeddedDerivatives_zRArdVHPPach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zIbQuddiHXx5">Embedded derivatives</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Embedded derivatives that are required to be bifurcated from their
host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded
derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019. Refer to Notes 6 and 7 for additional
information related to the embedded derivatives and their fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_230_zUOFEfQNEg6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zcNjAQ59rwPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_ze0DE8pyEImh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_23D_zIodOypZylYk" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zcqolvOeEcS6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zhyDWJbt59Bj" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zuex9YZt7VF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zAgIWGu5eFW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zIEBNkgpHQm3">Fair Value Measurements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. Refer to Note 7 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:StockholdersEquityPolicyTextBlock"><p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zLIMZCIP7dyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_z8pF6IErMmu4">Treasury Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Repurchases of the Company&#8217;s outstanding common stock are accounted
for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive
retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital and
reflected as treasury stock in the consolidated balance sheets. Refer to Note 9 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvPvcmTx8j3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_zIGubIqJW9Il">Stock-Based Compensation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The compensation cost for all stock-based awards is measured at the
grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite
service period (generally the vesting period of the equity award) which is generally one to three years. The fair value of restricted
stock awards (&#8220;RSAs&#8221;) and restricted stock units (&#8220;RSUs&#8221;) are determined by the product of the number of shares
or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the
date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RSUs granted in September 2019 with market-based vesting conditions
vest based upon the Company achieving specified stock price targets over a three-year period. The effect of a market condition is reflected
in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized
with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition
is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique, that resulted in a fair value of $1.42 per
unit, included: estimated risk-free interest rate of <span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">1.38 percent</ix:nonNumeric></span>; term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z0Hir3knAOO2" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">3.00 years</ix:nonNumeric></span>; expected volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">38 percent</ix:nonNumeric></span>; and expected
dividend yield of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0 percent</ix:nonNumeric></span>. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues.
The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations
regarding dividend payments. During the nine months ended September 30, 2021, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfsoNSr2NIc5" title="Option Forfeited"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="Shares">450,000</ix:nonFraction></span> RSUs were forfeited, leaving <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkA1kLOVQEc" title="Option Forfeited"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">450,000</ix:nonFraction></span> units with
market-based vesting conditions outstanding and unvested at period end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, the Company granted
<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zJ99UTGtC3i7" title="Weighted Average Grant"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_RSAsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">324,401</ix:nonFraction></span> RSAs at a weighted average grant-date fair value of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zXdwiRqa7Bg2" title="Weighted average grant-date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_RSAsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.56</ix:nonFraction> </span>per share, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3I4cREBWCte"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">473,000</ix:nonFraction></span> RSUs at a weighted average grant-date fair value
of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsbs1hsoSqb" title="Weighted average grant-date fair value"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.86</ix:nonFraction></span> per unit and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEBfRxUcHaa6"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">393,750</ix:nonFraction></span> non-qualified stock options at a grant-date fair value of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zogY04uAPWJa"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.79</ix:nonFraction></span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stock-based compensation is reported in the consolidated statements
of operations in general and administrative expenses. Total stock-based compensation for the three and nine months ended September 30,
2021 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_pn3p0_c20210701__20210930_zmrcwGz6Jdza" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">300,000</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210101__20210930_pn3p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">1,279,000</ix:nonFraction></span>, respectively. Total unrecognized stock-based compensation expense as of September 30, 2021 was $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20210930_pn3p0" title="Unrecognized stock-based compensation expense"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">5,952,000</ix:nonFraction></span>,
which will be amortized over a weighted average remaining vesting period of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930_zdmyqOeYYNDb" title="Weighted-average remaining vesting period"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">2.20</ix:nonNumeric></span> years. Total stock-based compensation for the three and
nine months ended September 30, 2020 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930_pn3p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">488,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200930_pn3p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">1,243,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Profits Interest Units (&#8220;PIUs&#8221;) were accounted for in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221; The vesting conditions
did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the PIUs were classified as
liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion of the requisite service period
rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite service period (generally
the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended
September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period. The Company has a purchase
option to purchase the vested PIUs that are not otherwise forfeited after termination of continuous service. The exercise price of the
purchase option is the fair market value of the PIUs on the date of termination of continuous service. The individuals holding PIUs are
no longer employed by the Company. Included in other long-term liabilities in the consolidated balance sheets as of September 30, 2021
and December 31, 2020, the PIUs totaled $591,000, which was their fair value as of December 31, 2018 after termination of service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_233_zGG5OI83MPXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zoVbcRh6Kobb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zMlfjGMGpymk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_230_znJdzh2WVs42" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zeBR3VKTouC4" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zMWCiXgwg7g1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhkUQWPPd5J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_za3TxTxZzFm3">Income Taxes</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income taxes are accounted for using an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been
recognized in Acacia&#8217;s consolidated financial statements or consolidated income tax returns. A valuation allowance is established
to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that
there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The provision for income taxes for interim periods is determined using
an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant
period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative
adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s effective tax rates were <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210701__20210930_z11XD73sdRb4" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>% and (<span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210930_zpSd4wOSJbW3" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>%) for the three
and nine months ended September 30, 2021, respectively, and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200701__20200930_zgvk1NgPLcZh" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>% and (<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20200930_z9kHwwZ0ewu9" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span>%) for the three and nine months ended September 30, 2020, respectively.
Tax expense/benefit for the periods presented primarily reflects the impact of state taxes and foreign tax withholding (or refund) incurred
on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. The Company has recorded a full valuation
allowance against our net deferred tax assets as of September 30, 2021 and December 31, 2020. These assets primarily consist of foreign
tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZXOl0XkMU5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zviHK9QTSmF9">Recent Accounting Pronouncements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December of 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes.&#8221; The update removed certain exceptions to the general principles in Topic 740 in U.S. GAAP. The Company adopted the update
on January 1, 2021. The adoption of the update did not have a material effect on the Company&#8217;s financial position, results of operations
or financial statement disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Not Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments&#8212;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset,
including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected
credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019,
the FASB issued ASU No. 2019-04, &#8220;Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments,&#8221; to clarify the inclusion of recoveries of trade receivables previously
written off when estimating an allowance for credit losses. The amendments in these updates will currently be effective for the Company
on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments in these updates
may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity,&#8221; to simplify the accounting for convertible
instruments by eliminating large sections of the existing guidance in this area. It also eliminates several triggers for derivative accounting,
including a requirement to settle certain contracts by delivering registered shares. This update reduces the number of accounting models
for convertible instruments, revises the derivatives scope exception, and provides targeted improvements for earnings per share. Upon
adoption, companies have the option to apply a modified or full retrospective transition approach. The amendments in this update will
currently be effective for the Company on January 1, 2024, with early adoption permitted. Management is currently evaluating the impact
that the amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_23D_zO8RnIg8B183" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zCMk6kdKUyb7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zL1lzVc6Kmyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_23B_zKW8htW9CPca" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zF8CEy4TngE7" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zcCCZeFqbEy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2021, the FASB issued ASU No. 2021-08, &#8220;Business Combinations
(Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,&#8221; to require that an acquirer
recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with &#8220;Revenue from
Contracts with Customers (Topic 606).&#8221; At the acquisition date, an acquirer should account for the related revenue contracts in
accordance with Topic 606 as if it had originated the contracts. The amendments in this update should be applied prospectively and will
be effective for the Company on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the
amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_800_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zsvFU5CLq6Uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. <span id="xdx_823_zq6fDjbnU4I3">EQUITY SECURITIES PORTFOLIO INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 3, 2020, the Company entered into an Option Agreement with
LF Equity Income Fund (&#8220;Seller&#8221;), which included general terms through which the Company was provided the option to purchase
life sciences equity securities in a portfolio of public and private companies (&#8220;Life Sciences Portfolio&#8221;) for an aggregate
purchase price of &#163;223.9 million, approximately $<span id="xdx_90F_eus-gaap--PaymentsToAcquireInvestments_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zwMDlfL5mK6e" title="Payment to acquire equity securities"><ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">277.5</ix:nonFraction></span> million at the exchange rate on April 3, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2020, the Company executed the Transaction Agreement between
Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the Company agreed to purchase from Seller
and Seller agreed to transfer to the Company the specified equity securities of all companies in the Life Sciences Portfolio at set prices
at various future dates. The transfer dates would vary among the Life Sciences Portfolio companies as the Transaction Agreement gives
the Company the exclusive right to determine when to call for transfer of each security, and because each Life Sciences Portfolio company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific terms
and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase equity securities
in each public and private company at a specified price on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with the Transaction Agreement, the Company transferred
the total purchase price of &#163;223.9 million into an escrow account. Upon the transfer of equity securities in the Life Sciences Portfolio
to the Company, the associated funds were released from the escrow account to Seller based on the consideration amount assigned to the
equity securities for such Life Sciences Portfolio company in the Transaction Agreement. As of December 31, 2020, all of the equity securities
in the Life Sciences Portfolio were transferred to the Company pursuant to the Transaction Agreement. The Company has sold a portion of
the equity securities of such Life Sciences Portfolio while retaining an interest in a number of operating businesses, including a controlling
interest in one of the companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For accounting purposes, the total purchase price of the Life Sciences
Portfolio was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their quoted
market price. The fair values of the private company securities were estimated based on recent financing transactions and secondary market
transactions and factoring in a discount for the illiquidity of these securities. As of September 30, 2021 and December 31, 2020, the
fair value of the Life Sciences Portfolio equity securities, excluding the equity method investment discussed below, was $354.6 million
and $248.1 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in the Life
Sciences Portfolio are recorded as unrealized gains or losses in the consolidated statements of operations. In late September 2021, the
Company sold one security which resulted in a gain of $18.6 million. The proceeds of that sale were settled and received in early October
2021, and therefore the Company recorded a $21.5 million other receivable as included in the consolidated balance sheet as of September
30, 2021. Accordingly, this trade date receivable from the sale of equity securities has been reflected as a noncash investing activity
in the consolidated statement of cash flows for the nine months ended September 30, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_237_zRgaqUW5hbV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zJAF1ggK1Ped" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zRk0csJKNPhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_238_zuWVUoIQt2Rd" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zsirDsaaV7Wk" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zejvcoUzo4a9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three and nine months ended September 30, 2021 and 2020, the
consolidated statements of operations reflected the following from the Life Sciences Portfolio:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zxL2We0nCSN5" summary="xdx: Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BE_zKXQW0rympAg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of unrealized gains or losses</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of equity securities</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_zMEUkkqcH3d6" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-07-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63,907</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-07-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">84,299</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,180</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-01-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83,230</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zuJEfw7epRQj" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-07-012021-09-30_custom_EquitySecuritesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-07-012020-09-30_custom_EquitySecuritesDerivativeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,651</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zdgMTswNPWpe" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-01-012021-09-30_custom_EquitySecuritesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-01-012020-09-30_custom_EquitySecuritesDerivativeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,542</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities forward contract</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zdxfROMNNJX2" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-07-012021-09-30_custom_EquitySecuritesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-07-012020-09-30_custom_EquitySecuritesForwardContractMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">74,662</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zw18vjWcmTk" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2021-01-012021-09-30_custom_EquitySecuritesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_ztucdF4aE139" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" contextRef="From2020-01-012020-09-30_custom_EquitySecuritesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain (loss)
    on sale of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zNqcMfNxvUZ1" title="Loss on sale of trading security" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,112</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RealizedInvestmentGainsLosses_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_pn3n3" title="Loss on sale of trading security" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,908</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_znTGs2UIlfOe" title="Loss on sale of trading security" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,167</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zrfTas6FX2Qf" title="Loss on sale of trading security" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RealizedInvestmentGainsLosses" contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,202</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Gain
    on sale of prepaid investment and derivative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zQb3u7swTyr6" title="Gain on sale of prepaid investment and derivative" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative" contextRef="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivativey_pn3n3_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zmnv5aeeFWa6" title="Gain on sale of prepaid investment and derivativey" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivativey" contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_z7nIFl2ff16c" title="Gain on sale of prepaid investment and derivative" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative" contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zqCCa3FwKtGh" title="Gain on sale of prepaid investment and derivative" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative" contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_ztnyFAXHjkh" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2021-07-012021-09-30_custom_LFFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101,019</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_LFFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,041</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--GainLossOnInvestments_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2021-01-012021-09-30_custom_LFFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164,347</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_LFFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99,415</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">As part of the Company&#8217;s
acquisition of equity securities in the Life Sciences Portfolio, the Company acquired a majority interest in the equity securities of
MalinJ1 (63.9%), which were transferred to the Company on December 3, 2020. The acquisition of the MalinJ1 securities was accounted for
as an asset acquisition as there was a change of control of MalinJ1 and substantially all of the fair value of the assets acquired was
concentrated in a single identifiable asset, an investment in Viamet Pharmaceuticals Holdings, LLC (&#8220;Viamet&#8221;). As such, the
cost basis of the MalinJ1 securities was used to allocate to the Viamet investment, the single identifiable asset, and no goodwill was
recognized. The Company through its consolidation of MalinJ1 accounts for the Viamet investment under the equity method as MalinJ1 owns
41.0% of outstanding shares of Viamet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:InvestmentHoldingsTextBlock"><p id="xdx_80C_eus-gaap--InvestmentHoldingsTextBlock_zKzfd8qQ8iSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. <span id="xdx_827_z2hL1KiZKkxl">INVESTMENT AT FAIR VALUE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2016 and 2017, Acacia made certain investments in Veritone.
As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone common stock and warrants to purchase
a total of 1,120,432 shares of Veritone common stock at an exercise price of $13.61 per share expiring between 2020 and 2027. During the
nine months ended September 30, 2020, Acacia sold all remaining 298,450 shares Veritone common stock and recorded a realized loss of $3.3
million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2020, Acacia exercised 154,312
warrants, and recognized a realized gain of $554,000 on the sale of common stock. During the nine months ended September 30,
2021, Acacia exercised all remaining 156,720 warrants, and recognized a realized gain of $3.6 million on the sale of common stock. The
Company no longer has an investment in Veritone common stock and warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in Veritone
are recorded as unrealized gains or losses in the consolidated statements of operations. For the three and nine months ended September
30, 2021 and 2020, the consolidated statements of operations reflected the following:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:GainLossOnInvestmentsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_zb8KfomJmqyl" summary="xdx: Disclosure - INVESTMENT AT FAIR VALUE (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zeRXAGEneIue" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of gain on investments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of investment, warrants</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zHWFPxmYQpCk" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-07-012021-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zBALI1iOvgBk" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,081</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zyACk9VbfrKh" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-01-012021-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,752</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Change in fair value of investment" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of investment, common stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2aYF2y3cM6c" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-07-012021-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zfSP8TYgl9Xk" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zy9OuX3Ssi01" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2021-01-012021-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,479</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on sale
    of investment, warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zw1VJthNG0oi" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2021-07-012021-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zu11xIn4bKyc" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2021-01-012021-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,591</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Loss
    on sale of investment, common stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zpanvTIk1fGf" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2c64wloIrl1" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z08tvJcl3vQ6" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2021-01-012021-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zxbeb8UKZ8W3" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,316</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized (loss) gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20210701__20210930_z7p5QeItbWLd" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_iN_pn3n3_di_c20200701__20200930_zwv5wA4AXM9f" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,081</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--GainLossOnInvestments_c20210101__20210930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">942</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_234_z7qyvbHhOTsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zM9obh7rEzn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zIsbvmxD29pi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_23A_ze4CPXSwBdDf" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zOFRmtu5zSK7" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zqq0s95tI0b8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:PatentsNetOfAccumulatedAmortizationTextBlock"><p id="xdx_809_ecustom--PatentsNetOfAccumulatedAmortizationTextBlock_zTpxf0aZQPNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. <span id="xdx_826_zij6bxuAdYCi">PATENTS, NET OF ACCUMULATED AMORTIZATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s only identifiable intangible assets as of September
30, 2021 and December 31, 2020 are patents and patent rights. Patent-related accumulated amortization totaled $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20210930_zWMfi9WnMjRl" title="Accumulated amortization"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">291.6</ix:nonFraction></span> million and $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20201231_zDLvRdd58j29" title="Accumulated amortization"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">319.9</ix:nonFraction></span>
million as of September 30, 2021 and December 31, 2020, respectively. Acacia&#8217;s patents have remaining estimated economic useful
lives ranging from twenty-six to fifty-two months. The weighted average remaining estimated economic useful life of Acacia&#8217;s patents
is approximately four years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the scheduled annual aggregate amortization
expense as of September 30, 2021:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zUT140DEdHl3" summary="xdx: Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)" style="border-collapse: collapse; width: 40%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zuiqmEMygJp9" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of intangible assets</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210930_zz4FFSJwI0E1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJix_ze9vNrN0UJf9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,612</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJix_zTiA3MPpqzjk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,448</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJix_zFlxBGuOz923" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,381</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJix_zEvY4MqUajF2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,005</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJix_z3cmojYdLkNi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2025</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,630</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJix_zmEDNRUUDwe3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">750</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJix_znHIRvRyAwCj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Patents,
    net&#160;&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,826</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the nine months ended September 30, 2021, Acacia accrued patent
and patent rights acquisition costs totaling $<span id="xdx_90F_ecustom--AccruedPatentAcquisitionCosts_iI_pn3n3_dm_c20210930_zMIyiWiJNvVf" title="Accrued patent acquisition costs"><ix:nonFraction name="ACTG:AccruedPatentAcquisitionCosts" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">13.0</ix:nonFraction></span> million, of which $<span id="xdx_90C_eus-gaap--OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_dm_c20210930_z11shg8Vq3Af" title="Accrued patent acquisition costs due within a year"><ix:nonFraction name="us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">8.0</ix:nonFraction></span> million is due December 1, 2021 and $<span id="xdx_908_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_pn3n3_dm_c20210930_zJcRlYw3UMz7" title="Accrued patent acquisition costs due within 2 years"><ix:nonFraction name="us-gaap:OtherCommitmentDueInNextTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">5.0</ix:nonFraction></span> million is due February
18, 2023. Such amounts are included in accrued patent investment costs and other long-term liabilities in the consolidated balance sheet
as of September 30, 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="ACTG:StarboardInvestmentTextBlock"><p id="xdx_803_ecustom--StarboardInvestmentTextBlock_zziu1Lyfzex3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. <span id="xdx_821_zMcYgilkxbti">STARBOARD INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Redeemable Convertible Preferred Stock&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, the Company entered into a Securities Purchase
Agreement with Starboard Value LP (&#8220;Starboard&#8221;) and certain funds and accounts affiliated with, or managed by, Starboard (collectively,
the &#8220;Buyers&#8221;) pursuant to which the Company issued (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20191101__20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-11-012019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span> shares of Series A Redeemable Convertible Preferred Stock with
a par value of $0.001 per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_pdd" title="Warrants issued, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares of
the Company&#8217;s common stock to the Buyers. The Securities Purchase Agreement also established the terms of certain senior secured
notes and additional Series B Warrants which may be issued to Starboard in the future. On June 4, 2020, the Company entered into a Supplemental
Agreement, as defined below under &#8220;Senior Secured Notes&#8221;, with certain contractual agreements affecting the Series A Redeemable
Convertible Preferred Stock, reflected below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii) the conversion
price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.65</ix:nonFraction></span> (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable Convertible Preferred
Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible Preferred Stock into shares
of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#8217;s common stock equals or
exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions of the common stock have been
met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders have the option to redeem all or a portion of the Series A
Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August 15,
2022, provided that there is not outstanding at least $50.0 million aggregate principal of senior secured notes to the Buyers pursuant
to the Securities Purchase Agreement at the time of the redemption. Holders also have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have
the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control
or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&#8217;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_23A_zUxWj7UjF4vf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zRXhuT0kGwhl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zzTgtFIPG9hc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_23A_z853YwhjykS4" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zW5UmdDecmzj" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zQCQNxy7GTNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company may redeem all, and not less than all, of the Series A
Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August 15, 2022,
provided that there is not outstanding at least $50.0 million aggregate principal of the senior secured notes at the time of the redemption,
and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed
at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any Series A Redeemable Convertible Preferred Stock remains outstanding
on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In all redemption scenarios, the redemption price for the Series A
Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on the redemption
scenario, the redemption price may also include a make-whole amount or stated premium as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When the Company issues Notes, the Holder may exchange the Series A
Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Redeemable Convertible Preferred Stock accrues cumulative
dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of the approved investment in June 2020, the dividend
rate increased to 8.0% on the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering
event occurs before an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. In
connection with the approved investment in June 2020, the Company and the Buyers agreed that the dividend rate on the Series A Redeemable
Convertible Preferred Stock would accrue at 3.0% so long as no triggering event occurs and the Company maintains $35.0 million in escrow.
Series A Redeemable Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to
common stockholders. No accrued and unpaid dividends as of September 30, 2021. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Upon consummation of the approved acquisition in October 2021, the
dividend rate increased to 8.0% on the stated value. Refer to Note 11 for additional information related to the subsequent period acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of the Series A Redeemable Convertible Preferred Stock have
the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible Preferred
Stock will also be entitled to a separate class vote with respect to amendments to the Company&#8217;s organizational documents that generally
have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon liquidation of the Company, holders of Series A Redeemable Convertible
Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior to any distribution
to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid dividends or (ii) the amount
that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted into common stock immediately
prior to the liquidation event at the then effective conversion price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company determined that certain features of the Series A Redeemable
Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled together as a single,
compound embedded derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2019, total proceeds received and transaction costs incurred
from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkNsLZ672zWc" title="Proceeds from issuance of preferred stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35.0</ix:nonFraction></span> million and $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zs75OjSbOHoc" title="Payment of stock issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between
the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A
Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series A Warrants,
embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and $8.9 million, respectively.
Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and the Series A Warrants on the same
basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible Preferred Stock were treated as a discount
to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23A_z8gB7spzQxO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zzmV4REM4kE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z4xkbH7fiyx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_231_zquLsPqhsdNh" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23B_zLXIvBqGIRH4" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zeuGAQNxaPF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise on November
15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company accretes the
instrument to its redemption value using the effective interest method and recognizes any changes against additional paid in capital in
the absence of retained earnings. Accretion for the three and nine months ended September 30, 2021 was $<span id="xdx_908_eus-gaap--AccretionExpense_pn3p0_c20210701__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zKHVd9iYmgRc" title="Accretion expense"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">991,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AccretionExpense_pn3n3_dm_c20210101__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkyTiXbW3UI5" title="Accretion expense"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">2.8</ix:nonFraction></span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers and a Governance Agreement with Starboard
and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights
with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with
the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint
Jonathan Sagal as a director of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to
the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets,
(v) appoint certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following features of the Series A Redeemable Convertible Preferred
Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative: (i) the right
of the holders to redeem the shares (the &#8220;put option&#8221;), (ii) the right of the holders to receive common stock upon conversion
of the shares (the &#8220;conversion option&#8221;), (iii) the right of the Company to redeem the shares (the &#8220;call option&#8221;),
and (iv) the change in dividend rate upon consummation of an approved investment or a triggering event (the &#8220;contingent dividend
rate feature&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These features are required to be accounted for separately from the
Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related to the debt-like
host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are bundled together and are
accounted for as a single, compound embedded derivative liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, we have recorded an embedded derivative liability representing
the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value at each period
end with changes in fair value recorded other income or (expense) in the &#8220;Change in fair value of the Series A and B warrants and
embedded derivatives&#8221; financial statement line item of the consolidated statements of operations. As of September 30, 2021 and December
31, 2020, the fair value of the Series A embedded derivative liabilities was $<span id="xdx_90C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zwK8Z9P5ipT5" title="Fair value of embedded derivative"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">41.4</ix:nonFraction></span> million and $<span id="xdx_90A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20201231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkMfyAsve7Ig" title="Fair value of embedded derivative"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">26.7</ix:nonFraction></span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, in connection with the issuance of the Series
A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrants to acquire up to purchase 5 million shares
of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at any time during a period of eight years
beginning on the instrument&#8217;s issuance date of the Series A Warrants. The fair value of the Series A Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zVduOVdhfJW3" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.8</ix:nonFraction></span> million upon
issuance. The Series A Warrants will be recognized at fair value at each reporting period until exercised, with changes in fair value
recognized in other income or (expense) in the consolidated statements of operations. As of September 30, 2021 and December 31, 2020,
the fair value of the Series A Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zmkROtM85Gnb" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">18.5</ix:nonFraction></span> million and $<span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zDSBS5WvWmKa"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">6.6</ix:nonFraction></span> million, respectively. As of September 30, 2021, the Series A Warrants
have <span id="xdx_907_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zFNzS50Vw9Uc" title="Warrants exercised"><ix:nonFraction name="ACTG:WarrantsExercisedShares" contextRef="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Warrants are classified as a liability in accordance with
ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series B Warrants </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities Purchase
Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_dm_c20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zv5GbrN3S5a7" title="Warrants issued, shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="3" unitRef="Shares">100</ix:nonFraction></span> million shares of the Company&#8217;s
common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i) $5.25 per share, if exercising
by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65 per share, if exercising by cancellation
of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200201__20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zMyMexkZuAig" title="Proceeds from issuance of preferred stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2020-02-012020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.6</ix:nonFraction></span> million. The Series B Warrants
expire on November 15, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_237_zFfp2JTMWSV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zeXdl7xBiDN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zPMSJKZdTclj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div id="xdx_23A_zXOCjN2YQCvg" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zORT0aHFkWKe" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zHkGUrLRoVW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the issuance of the Notes on June 4, 2020, the terms
of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the payment of cash,
rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November 15, 2027. 31,506,849
of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their
original terms. As of September 30, 2021, the Series B Warrants have <span id="xdx_900_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zbleMgenLO05" title="Warrants exercised"><ix:nonFraction name="ACTG:WarrantsExercisedShares" contextRef="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series B Warrants will be recognized at fair value at each reporting
period until exercised, with changes in fair value recognized in other income or (expense) in the consolidated statements of operations.
As of September 30, 2021 and December 31, 2020, the fair value of the Series B Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zVvHHwpTRnP8" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">229.6</ix:nonFraction></span> million and $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zDr0DS4EoiC7" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">52.3</ix:nonFraction></span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series B Warrants are classified as a liability in accordance with
ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Secured Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Securities Purchase Agreement dated November 18, 2019
with Starboard and the Buyers, on June 4, 2020, the Company issued $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zri2UsNCqTqe" title="Proceeds from issuance of debt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">115.0</ix:nonFraction></span> million in Notes to the Buyers. Also on June 4, 2020, in connection
with the issuance of the Notes, the Company entered into a Supplemental Agreement with Starboard (the &#8220;Supplemental Agreement&#8221;),
pursuant to which the Company agreed to redeem $<span id="xdx_905_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeptemberRedemptionMember_zLsTwy9lCgs" title="Repayment of debt"><ix:nonFraction name="ACTG:RedemptionOfSecuredNotes" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeptemberRedemptionMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">80.0</ix:nonFraction></span> million aggregate principal amount of the Notes by September 30, 2020, and $<span id="xdx_903_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--DecemberRedemptionMember_zXgD1ONnFORb" title="Repayment of debt"><ix:nonFraction name="ACTG:RedemptionOfSecuredNotes" contextRef="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_DecemberRedemptionMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35.0</ix:nonFraction></span>
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid by December
31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zei6ZnSUFmb6" title="Debt stated interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.00</ix:nonFraction></span>% per annum, and in an event of default, the
interest rate is increased to <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zYIcyIroiFtl" title="Debt stated interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.00</ix:nonFraction></span>% per annum. The Notes include certain financial and non-financial covenants. Additionally, all or
any portion of the principal amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation
in payment of the exercise price upon the exercise of Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into an Exchange Agreement (the
&#8220;Exchange Agreement&#8221;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned subsidiary
of the Company (&#8220;Merton&#8221;) and Starboard, on behalf of itself and on behalf of certain funds and accounts under its management,
including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal
amount for new senior notes (the &#8220;New Notes&#8221;) issued by Merton having an aggregate outstanding original principal amount of
$<span id="xdx_900_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_pn3n3_dm_c20200101__20200630__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zkA8NOn0ZtN2" title="Notes exchanged"><ix:nonFraction name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" contextRef="From2020-01-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">115.0</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The New Notes bear interest at a rate of 6.00% per annum and had a
maturity date of December 31, 2020. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of the Company
and Merton and non-recourse equity pledges of each of the Company&#8217;s material subsidiaries. Pursuant to the Exchange Agreement, the
New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes of the Securities Purchase Agreement, (ii) are deemed to be &#8220;June
2020 Approved Investment Notes&#8221; for purposes of the Supplemental Agreement, and with the Company agreeing to redeem $80 million
principal amount of the New Notes by September 30, 2020 and $35 million principal amount of the New Notes by December 31, 2020, and (iii)
are deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of the New
Notes will also satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#8217;s
Series A Convertible Preferred Stock, par value $0.001 per share. The New Notes will not be deemed to be &#8220;Notes&#8221; for the purposes
of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the New Notes are to be settled within twelve months pursuant
to their terms, they are classified as current liabilities in the consolidated balance sheets. The Company capitalized $<span id="xdx_907_eus-gaap--DeferredFinanceCostsGross_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zwG59JrVgGCh" title="Capitalized lender fees"><ix:nonFraction name="us-gaap:DeferredFinanceCostsGross" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.6</ix:nonFraction></span> million in
lender fees and $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zWS0zSted7" title="Unamortized discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long-term deferred debt issuance costs and are included in other non-current assets in the consolidated balance sheets, and will be
amortized to interest expense until November 15, 2027, the maturity date of Series A Redeemable Convertible Preferred Stock. The $0.5
million issuance costs are recognized as a discount on the Notes and will be amortized to interest expense over the contractual life of
the Notes. There was $3.1 million and $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zrmbQ1F2oYF7" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">863,000</ix:nonFraction></span> accrued and unpaid interest on the New Notes as of September 30, 2021 and December 31,
2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 29, 2021, the Company redeemed $<span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zUtTeJV7zK22" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">50.0</ix:nonFraction></span> million of the New
Notes and on March 31, 2021, the Company reissued $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zqP8l3s0DDs3" title="Proceeds from issuance of debt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">50.0</ix:nonFraction></span> million of the New Notes. On June 30, 2021, the Company issued $30.0 million in
additional New Notes (the &#8220;June 2021 Merton Notes&#8221;) and amended the maturity date of the New Notes to <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zy1M9PDT01d3" title="Debt maturity date"><ix:nonNumeric contextRef="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">October 15, 2021</ix:nonNumeric></span>. On
September 30, 2021, the Company issued $35.0 million in additional New Notes (the &#8220;September 2021 Merton Notes&#8221;) and amended
the maturity date of the New Notes to December 1, 2021. The June and September 2021 Merton Notes cannot be used to exercise Series B Warrants
issued to Starboard Value. The total principal amount outstanding of New Notes as of September 30, 2021 and December 31, 2020 was $<span id="xdx_901_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20210930__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_z5xPYi3ltAVg"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-09-30_custom_NewNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">180.0</ix:nonFraction></span>
million and $<span id="xdx_907_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20201231__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_zCmJBAeei48k"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2020-12-31_custom_NewNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">115.0</ix:nonFraction></span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23A_zDrL36Fs4V0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zNW0Sarvb4W1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zXR6dvaTqIQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 23 -->
    <div id="xdx_23A_z0UfHJkfHh22" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_235_zr1we3urToE6" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zh0x1lZTrQD3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Modifications to Series A Redeemable Convertible Preferred Stock
and Series B Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The June 4, 2020 Supplemental Agreement also provided for (i) a waiver
of increased dividends under the original terms of the Series A Redeemable Convertible Preferred Stock that would have otherwise accrued
due to the Company&#8217;s use of the $35.0 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series A
Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified through the
issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the payment of the lower
exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding, at any time until
the expiration of the Series B Warrants on November 15, 2027. 31,506,849 of the Series B Warrants are subject to this adjustment with
the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We analyzed the amendments to the terms of the Series A Redeemable
Convertible Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a
modification on a prospective basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The incremental fair value of the Series B Warrants associated with
the modification of their terms in connection with the issuance of the Notes was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEOtlWdTPO0c" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. As of September 30, 2021, $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEyeYmxPGXi2" title="Amortization of discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.2</ix:nonFraction></span> million was amortized
to interest expense and $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAjLlS0B38dd" title="Unamortized discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">151,000</ix:nonFraction></span> is remaining to be amortized until the maturity date of December 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zpKhLwp8QjW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. <span id="xdx_828_zCMtKAoIWlh7">FAIR VALUE MEASUREMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is
defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 1 - <i>Observable Inputs</i>:&#160;&#160;Quoted prices in active markets for identical investments;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 2 - <i>Pricing Models with Significant Observable Inputs</i>:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 3 - <i>Unobservable Inputs</i>:&#160;&#160;Unobservable inputs reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Management estimates include certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair value of derivatives and certain investments.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whenever possible, the Company is required to use observable market
inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls
is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of
a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs
used to measure fair value may fall into different levels of the fair value hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia holds the following types of financial instruments at September
30, 2021 and December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities at Fair Value. </i>Equity securities includes
investments in public company common stock and are recorded at fair value based on the quoted market price of each share on the valuation
date. The fair value of these securities are within Level 1 of the valuation hierarchy. Equity investments that do not have regular market
pricing, but for which fair value can be determined based on other data values or market prices, are recorded at fair value within Level
2 of the valuation hierarchy. At September 30, 2021, our Level 2 equity securities include an investment measured with an applied pricing
model that includes significant observable inputs to the public company common stock value. The fair value of the Level 2 equity securities
investment as of September 30, 2021 was estimated based on a discount of 7.5 percent determined using the following significant inputs
to the pricing model: expected term of restriction of 6 months and volatility of approximately 45 percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_234_zafmaTlvVOKa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zIUmsSxVFaLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 24 -->
    <div id="xdx_23A_zDXOUwKIZsU1" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_z9BAQRcl7m34" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zEdXfkmqsNF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investments at Fair Value - Common Stock and Warrants. </i>Acacia&#8217;s
equity investment in Veritone common stock was recorded at fair value based on the quoted market price of Veritone&#8217;s common stock
on the applicable valuation date (Level 1). Warrants were recorded at fair value, as based on the Black-Scholes option-pricing model (Level
2). Refer to Note 4 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Warrants. </i>Series A Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in estimate with regard to
the calculation of the volatility assumption used in the Black Scholes option-pricing model. As a result, the Series A Warrants are now
measured as Level 3 as opposed to Level 2 as measured previously. The fair value of the Series A Warrants as of September 30, 2021 was
estimated based on the following significant assumptions: volatility of 30 percent, risk-free rate of 1.16 percent, term of 6.04 years
and a dividend yield of 0 percent.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series B Warrants. </i>Series B Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in methodology used to an
acceptable Black-Scholes option-pricing model from a Monte Carlo valuation technique used to value the Series B Warrants as of December
31, 2020. The fair value of the Series B Warrants as of September 30, 2021 was estimated based on the following significant assumptions:
(1) volatility of 30 percent, risk-free rate of 1.17 percent, term of 6.13 years and a dividend yield of 0 percent, and (2) volatility
of 25 percent, risk-free rate of 0.08 percent, term of 0.90 years and a dividend yield of 0 percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Embedded Derivative Liability. </i>Embedded derivatives that are
required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company
in 2019 (Level 3). The binomial model utilizes the Tsiveriotis and Fernandes implementation in which a convertible instrument is split
into two separate components within a single lattice framework: a cash-only component which is subject to the selected risk-adjusted discount
rate and an equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value
of our common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up
in rates), and (vi) event probabilities of the various conversion and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The volatility of the Company&#8217;s common stock is estimated by
analyzing the Company&#8217;s historical volatility, implied volatility of publicly traded stock options, and the Company&#8217;s current
asset composition and financial leverage. The selected volatility, as described below, represents a haircut from the Company&#8217;s actual
realized historical volatility. A volatility haircut is a concept used to describe a commonly observed occurrence in which the volatility
implied by market prices involving options, warrants, and convertible debt is lower than historical actual realized volatility. The assumed
base case term used in the valuation model is the period remaining until November 15, 2027, the Series A Redeemable Convertible Preferred
Stock maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term equal to the expected
term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s valuation of the embedded
derivative at September 30, 2021 are as follows: volatility of 30 percent, risk-free rate of 1.20 percent, term of 6.13 years, discount
rate of 9.40 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative is sensitive to these assumptions
and changes in these assumptions could result in a materially different fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:exclude><p id="xdx_23B_z8EFTWfep5Bc" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zzZRA2wJfkJl" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zPNdCCnrhQE4" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_zyXrrSGl0AR1" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_z2R0ZEGVJ1F5" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zoqA3AU27NK" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial assets and liabilities measured at fair value on a recurring
basis were as follows:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_pn3n3_z5kmnjed5E3k" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span id="xdx_8BC_zDbtPuaj44Q3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of financial assets and liabilities at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Assets</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities at fair value</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,280</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">267,840</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zZVGoE48BD8" title="Fair value of assets" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">387,120</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,280</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">267,840</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFd2v3vOBIX9" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">387,120</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,103</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_z12hfjlqUkOg" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zNn5o9jioYY8" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,103</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1363">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,752</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zN4HkkyX1IZh" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,752</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,103</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,752</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2Rk1i7V7BS7" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">111,855</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1XPiKQebxPi" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0h2bMhasRM8" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,527</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,527</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zGptlAREhr5b" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zbUAXEhdiYoe" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,411</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,411</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zszAV4gWLbAf" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3llNtszR3bb" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229,637</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229,637</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRePaEdnRYff" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zulGZMy3unc2" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">289,575</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">289,575</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxBmcUIyZc3b" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6jzNfrJFBzl" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zFozVzESS9Mg" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ztuwH6r7aNWe" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,728</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" title="Fair value of assets" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,728</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z1HETD3mtmD2" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3Hr5U8tBAhk" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,341</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,341</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zK9m32J7ly9a" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79,069</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Fair value of assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85,709</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AC_zPROrwdnk37i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following tables set forth a summary of the changes in the estimated
fair value of the Company&#8217;s Level 3 liabilities, which are measured at fair value on a recurring basis:<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zJtwOdyWcwLg" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B2_zIPeRQjNeech" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of changes in fair value Level 3 liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br />
    Warrant <br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br />
    Embedded<br />
    Derivative<br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br />
    Warrant<br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2021</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zSPzxpg6DGq4" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zujtjgtXKbQ1" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,728</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_znuUhmeXlKqa" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,341</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zSR2lyFjgLFi" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79,069</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br /></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zlQZnye4JgA7" title="Transfers into Level 3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zGrY5yXshLu2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhyJh3RikVw3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1455">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHYe0aNOPkd7" title="Transfers into Level 3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,640</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zXhrft1TTTZ" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,824</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zcWTPiOMsHl8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,463</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z0J95BCXdmh8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">178,198</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlebWdggdMs7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204,485</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2021</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGFuWMIvIS17" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,464</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwX7uhS4u3Fd" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,191</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z9mgILvYsVA6" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">230,539</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOxnHuGUb8xj" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">290,194</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zFbBIGc4Y8K4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zaWhKZtdHvw1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">220</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zYGjpF1DHtc6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">902</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zioDjYCWSYN8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2021-07-012021-09-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">619</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2021</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGzvcijAnNYf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,527</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zk1RCguf9FSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,411</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zPpqonDA4Ft2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229,637</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zro8i4u4bx5c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-09-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">289,575</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: bottom"><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br />
    Warrant <br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br />
    Embedded<br />
    Derivative<br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br />
    Warrant<br />
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2020</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zp9cRBopGs62" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,568</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zDpoRIa5BQc3" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,974</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z84jGZDL2Lpa" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1479">&#8211;</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqmsElSo18Sc" title="Derivative liability, beginning balance" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,542</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br /></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zzraf0BsSHQ" title="Transfers into Level 3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z0hxfQQe1KUk" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1484">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zGFOHDDByka8" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,929</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2734OILGBl9" title="Transfers into Level 3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" contextRef="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,929</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zOu2doI0EZ87" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,384</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zzGpS86ipsdl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,539</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ze9KisgH5gpg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,361</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKhFU982rY3f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67,284</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2020</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zmbMqnh9IrR5" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,952</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrg6VIxa6VV3" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,513</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z8qoSeDp3adl" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58,290</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGoptiET9TH" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-06-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94,755</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zA2rM9qQmwK6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,348</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zXyzG31qtlfb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,831</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhrd7tO3fLT3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,493</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlXHxnpiqD0c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" contextRef="From2020-07-012020-09-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,672</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2020</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zNOVurYjPAue" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwGjuEo589wc" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ziAHBWp4jxia" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,797</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLHn752plRSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">74,083</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"></p>


</ix:nonNumeric><p id="xdx_8A2_zZbK9lJySAu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with U.S. GAAP, from time to time, the Company measures
certain assets at fair value on a nonrecurring basis. The Company reviews the carrying value of equity securities without readily determinable
fair value, equity method investments and patents on a quarterly basis for indications of impairment, and other long-lived assets at least
annually. When indications of potential impairment are identified, the Company may be required to determine the fair value of those assets
and record an adjustment for the carrying amount in excess of the fair value determined. Any fair value determination would be based on
valuation approaches, which are appropriate under the circumstances and utilize Level 2 and Level 3 measurements as required.</p>

<ix:exclude><p id="xdx_231_zzSDwqRFobWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zBMY2qdVocK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zawLlTbnXgB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 26 -->
    <div id="xdx_23F_zrpz4So6HkKh" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23C_zT210h0Nrgwi" style="break-before: page; margin-top: 6pt">&#160;</div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zMJf5hRJr95d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0fkI4SvQ047" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. <span id="xdx_821_zefBAmB1niW6">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Facility Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company primarily leases office facilities under operating lease
arrangements that will end in various years through July 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 7, 2019, we entered into a building lease agreement (the &#8220;New
Lease&#8221;) with Jamboree Center 4 LLC (the &#8220;Landlord&#8221;). Pursuant to the New Lease, we have leased approximately 8,293 square
feet of office space in Irvine, California. The New Lease commenced on August 1, 2019. The term of the New Lease is 60 months from the
commencement date, provides for annual rent increases, and does not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 7, 2020, we entered into a building lease agreement (the
&#8220;New York Office Lease&#8221;) with Sage Realty Corporation (the &#8220;New York Office Landlord&#8221;). Pursuant to the New York
Office Lease, we have leased approximately 4,000 square feet of office space for our corporate headquarters in New York, New York. The
New York Office Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides
for annual rent increases, and does not provide us the right to early terminate or extend our lease terms. During August 2021, we entered
into a first amendment of the New York Office Lease, to commence for a period of three years upon landlords&#8217; substantial completion
of adequate substitution space, as defined. To date, the substitution space is not ready for use, accordingly the term extension has not
begun.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Operating lease costs were $<span id="xdx_906_eus-gaap--OperatingLeaseCost_pn3p0_c20210701__20210930_zrjiEKtJyBD6" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">155,000</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--OperatingLeaseCost_pn3p0_c20200701__20200930_z51rOJ1fpYu6" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">174,000</ix:nonFraction></span> for the three months
ended September 30, 2021 and 2020, respectively, and $<span id="xdx_905_eus-gaap--OperatingLeaseCost_pn3p0_c20210101__20210930_zmM3AphN5NRj" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">457,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3p0_c20200101__20200930_zitkPtxlCxo9" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">459,000</ix:nonFraction></span> for the nine months ended September 30, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below presents aggregate future minimum payments due under
the New Lease and the New York Office Lease discussed above, reconciled to long-term lease liabilities and short-term lease liabilities
(included in accrued expenses and other current liabilities) included in the consolidated balance sheet as of September 30, 2021:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zYQioXzgu3R7" summary="xdx: Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)" style="border-collapse: collapse; width: 40%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B9_z9otGpxq51zf" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of future minimum operating lease payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_495_20210930_zPhAs40X9ILd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Operating
    Leases</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maOLFMPzNL8_zxCD2Hqv0Pk3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 26%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">149</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maOLFMPzNL8_zCUrJidv2kK1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">370</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maOLFMPzNL8_zY8NTYWvgYui" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">364</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maOLFMPzNL8_zET1tgSv8Ts2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_d0_maOLFMPzNL8_zoCNEil6fSRl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" contextRef="AsOf2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtOLFMPzNL8_zJT3wzL1sCs2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total minimum
    payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,101</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zW62Da70zQqh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    short-term lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">430</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term
    lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_231_z2Zm697ECx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zAHasferoWXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 27 -->
    <div id="xdx_23B_zKA11REdrUT4" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_232_zXrWGMqLZWN4" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zMJlj4uAsNCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the investment in certain patents and patent rights,
certain of Acacia&#8217;s operating subsidiaries executed related agreements which grant to the former owners of the respective patents
or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated
as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries may retain the services of law
firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities.
These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees,
settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of Acacia&#8217;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#8217;s operating subsidiaries&#8217;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated
statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural
aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries
or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia is subject to claims, counterclaims and legal actions that arise
in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if
any, will not have a material effect on Acacia&#8217;s consolidated financial position, results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2017, the Federal Court of Canada allowed a counterclaim
for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions LLC in amounts that are included
in the 2021 and 2020 accrual balances discussed below. During the three months ended September 30, 2021, the Company made approximately
$1.0 million in settlement payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 6, 2019, Slingshot Technologies, LLC, or Slingshot, filed
a lawsuit in Delaware Chancery Court against the Company and Acacia Research Group, LLC, or collectively, the Acacia Entities, Monarch
Networking Solutions LLC (&#8220;Monarch&#8221;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd., or Transpacific.
Slingshot alleges that the Acacia Entities and Monarch misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities and Monarch by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive
option to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. On March 15, 2021, the court issued orders granting Monarch&#8217;s
motion to dismiss for lack of personal jurisdiction and Ms. Wolanyk&#8217;s motion to dismiss for lack of subject matter jurisdiction.
The remaining parties then commenced discovery, and have since served initial written requests and responses, and notices of the depositions
of the parties&#8217; corporate designees. The Acacia Entities maintain that Slingshot&#8217;s allegations are baseless, that the Acacia
Entities neither had access to nor used Slingshot&#8217;s information in acquiring the portfolio, that the Acacia Entities acquired the
portfolio as a result of the independent efforts of its IP licensing group, and that Slingshot suffered no damages given its exclusive
option to purchase the portfolio had already ended and it has proven itself incapable of closing on the portfolio purchase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the three months ended September 30, 2021 and 2020, there were
no operating expenses related to settlement and contingency accruals. During the nine months ended September 30, 2021, we incurred $338,000
in operating expenses for settlement and contingency accruals. During the nine months ended September 30, 2020, operating expenses included
a net income for settlement offset by contingency accruals totaling $<span id="xdx_908_ecustom--NetIncomeForSettlementOffsetByContingencyAccruals_pn3p0_c20200101__20200930_zhd1bgFna53j" title="Income from settlement"><ix:nonFraction name="ACTG:NetIncomeForSettlementOffsetByContingencyAccruals" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">308,000</ix:nonFraction></span>, net of prior accruals. At September 30, 2021 and December
31, 2020, our contingency accrual balance was $<span id="xdx_906_eus-gaap--LossContingencyAccrualAtCarryingValue_c20210930_pn3p0" title="Contingency accruals"><ix:nonFraction name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">587,000</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20201231_zy4230WGNSOa" title="Contingency accruals"><ix:nonFraction name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_239_z7YhDUb8KZN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zAkbKoqnSGP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zE2I3gGxAgO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 28 -->
    <div id="xdx_233_zR1mhQk4ZtC2" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zDmkxNuR4gZd" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zuaVt0y9lxU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_znZoqUbX7sf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>9. <span id="xdx_829_zJ9CaZ4j8l59">STOCKHOLDERS&#8217; EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Repurchases of Common Stock </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 5, 2019, Acacia&#8217;s Board of Directors approved a stock
repurchase program, which authorized the purchase of up to $<span id="xdx_901_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_zpuRECaiCtIa"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2019-08-05_custom_StockRepurchaseProgramMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">10.0</ix:nonFraction>
</span>million of the Company&#8217;s common stock through open market purchases, through block trades, through 10b5-1 plans, or by means
of private purchases, from time to time, through July 31, 2020. Stock repurchases for the periods presented, all of which were purchased
as part of a publicly announced plan or program, were as follows:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:AcceleratedShareRepurchasesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_zRhwhpin0KBh" summary="xdx: Disclosure -  STOCKHOLDERS&apos; EQUITY (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B6_zqWEq4Bw0Jrj" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of repurchased shares</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total
    Number<br /> of Shares<br /> Purchased</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Average<br />
    Price<br /> paid per<br /> Share</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Approximate<br />
    Dollar<br /> Value of Shares<br />
    that<br /> May Yet be<br />
    Purchased<br /> under the<br />
    Program</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Plan
    Expiration Date</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">March
    20, 2020 - March 31, 2020</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--TreasuryStockSharesAcquired_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares repurchased" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">576,898</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Average price paid per share" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.28</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" title="Approximate value of shares that may yet be purchased" style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ApproximateValueOfSharesThatMayYetBePurchased" contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">8,686,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 13%; font-size: 10pt; text-align: center"><span id="xdx_902_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1jSPqRNZTKh" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember" format="ixt:datemonthdayyearen" name="us-gaap:StockRepurchaseProgramExpirationDate">July
    31, 2020</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">April
    1, 2020 - April 23, 2020</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares repurchased" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,107,639</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Average price paid per share" style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.42</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" title="Approximate value of shares that may yet be purchased" style="padding-bottom: 1pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ApproximateValueOfSharesThatMayYetBePurchased" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">6,001,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"><span id="xdx_901_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2duEkvoJjWk" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:datemonthdayyearen" name="us-gaap:StockRepurchaseProgramExpirationDate">July
    31, 2020</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    repurchases in 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Number of shares repurchased" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,684,537</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Average price paid per share" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.37</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In determining whether or not to repurchase any shares of Acacia&#8217;s
common stock, Acacia&#8217;s Board of Directors consider such factors, among others, as the impact of the repurchase on Acacia&#8217;s
cash position, as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s capital. Acacia
has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding
share count and enhance stockholder value.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tax Benefits Preservation Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 12, 2019, Acacia&#8217;s Board of Directors announced that
it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#8220;Plan&#8221;). Our stockholders ratified the adoption
of the Plan in July 2019. The purpose of the Plan is to protect the Company&#8217;s ability to utilize potential tax assets, such as net
operating loss carryforwards and tax credits to offset potential future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Plan is designed to reduce the likelihood that the Company will
experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more of the Company&#8217;s
outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement of the adoption of the
Plan, beneficially own more than 4.9% of the Company&#8217;s then-outstanding shares of the Company&#8217;s common stock from acquiring
additional shares of the Company&#8217;s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will
prevent the Company from experiencing an ownership change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the adoption of the Plan, Acacia&#8217;s Board of
Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#8217;s common stock
to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right would initially entitle
the holder to purchase one one-thousandth of a share of the Company&#8217;s Series B Junior Participating Preferred Stock, $0.001 par
value for a purchase price of $12.00. On March 15, 2021 the rights expired pursuant to their terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has a provision in its Amended and Restated Certificate
of Incorporation, as amended (the &#8220;Charter Provision&#8221;) which generally prohibits transfers of its common stock that could
result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#8217;s ability to utilize
potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income. The Charter
Provision was approved by the Company&#8217;s stockholders on July 15, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<ix:exclude><p id="xdx_230_zdBmIZqfRJed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zRqPOAid5Sve" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zsUzDRCKt7Ga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 29 -->
    <div id="xdx_23A_zxSuPveXIl11" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zSnYSAwKkDJf" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zTGkSpJtdFUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zkerc449FzF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. <span id="xdx_824_zzJEAzxtxPYd">INCOME/LOSS PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zgbXg2sOefXg" summary="xdx: Disclosure - INCOME/LOSS PER SHARE (Details)" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span id="xdx_8B9_zVrmlA3L6504" style="font: 10pt Times New Roman, Times, Serif; display: none">Calculation
    of basic and diluted net loss per share</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20210701__20210930_zpblr4UDGed6" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49E_20200701__20200930_z7qOwCUpQKp1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210101__20210930_zFBF3yU6vn4f" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20200101__20200930_z5QXqKuQujHd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands, except share and per share information)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Numerator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 44%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to Acacia Research Corporation</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89,604</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,507</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di_zytxWlyW6E8c" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Dividend
    on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">262</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">785</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di_zykUE09mVaKh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Accretion
    of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">991</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">733</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,762</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zuHjVJ4perMi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Undistributed
    earnings allocated to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,367</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,619</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,204</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,984</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,529</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">59,054</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,838</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DividendOnSeriesRedeemableConvertiblePreferredStock_d0_zvQN6GcEwcpj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Dividend on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_d0_z5ju7nq3fJL6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Accretion of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">733</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_d0_zBu9eOfBc129" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A redeemable convertible preferred stock embedded derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-07-012021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,831</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-01-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ChangeInFairValueOfSeriesWarrants_d0_zHLx0s1KWuw1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of dilutive Series B warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">902</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,557</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1633">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,557</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_ecustom--InterestExpenseAssociatedWithStarboardNotesNetOfTax_zOXosm3OcbC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Interest expense associated with Starboard Notes, net of tax</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,536</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,889</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1638">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,889</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_d0_zz2ju8XPbY3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Undistributed earnings allocated to participating securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,367</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,619</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,204</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_d0_zIrNoG0YtTlk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Reallocation
    of undistributed earnings to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,877</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">296</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,645</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_ecustom--NetIncomeLossAvailableToCommonStockholderDiluted_zIr9KIFNSS4h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:NetIncomeLossAvailableToCommonStockholderDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">80,171</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:NetIncomeLossAvailableToCommonStockholderDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,205</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="ACTG:NetIncomeLossAvailableToCommonStockholderDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">59,054</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="ACTG:NetIncomeLossAvailableToCommonStockholderDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,381</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Denominator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,949,504</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,467,885</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,759,873</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,949,706</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB_zEk8nkeJ0rCd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Potentially
    dilutive common shares:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKkMuV7VIDVa" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zETSzCWfjRT5" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">9,589,041</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKirbQ2Yoor5" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKnaiHzRzR8" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Restricted
    stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zJF7f4mvOp0l" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30_custom_RestrictedStockUnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">798,356</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zMkU0EdviRii" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">728,936</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zOJu5omQ8n8g" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-09-30_custom_RestrictedStockUnitsMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zYRXlPFFIb9j" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">598,328</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Stock
    options</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zeaYyeQPthn" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30_custom_EmployeeStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">35,815</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zkUd73Hfl71h" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">21,624</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zPgEbZO4A6se" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-09-30_custom_EmployeeStockOptionsMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zaVQrUnVwe71" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zDzc4FbOzBkl" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">2,019,724</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z7WoPzAd95ti" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">310,367</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zZnhIcNFlxh6" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-09-30_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zUvgbSo8UNFj" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">103,456</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zW9XGGHHTqMk" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-07-012021-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">41,278,103</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zINAkGS70pp8" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">31,506,849</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ziIjUwWeiJv1" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2021-01-012021-09-30_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zPAZ0GYoyFfi" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">10,502,283</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zzeKVIBoiv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">93,081,502</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,624,702</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">48,759,873</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">60,153,773</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Basic
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.49</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.63</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.21</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.51</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Diluted
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.86</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.32</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.21</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.36</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_iB_zAA51t9fyYb9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Anti-dilutive
    potential common shares excluded from the computation of diluted net income (loss) per common share:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity-based
    incentive awards</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zjonp0WplYTk" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">398,168</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zo9B1P8eBkx7" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">191,312</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zpCE74DNTtRh" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">2,230,624</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zUHZgQbwXMX1" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">310,083</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zAvEczJmdNx8" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_custom_SeriesAWarrantsMember50317218" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zjhYgVn24X8j" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember50317234" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zSFBrX3kdS6e" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-09-30_custom_SeriesAWarrantsMember50317250" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">5,000,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zhX75AYVh6T4" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember50317265" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_z2xXFsqBcTB" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30_custom_SeriesBWarrantsMember50317281" format="ixt:zerodash" decimals="-3" scale="3" unitRef="Shares">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zLiFotOF4Xf5" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember50317296" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">68,493,151</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_znuuZyWd7Af8" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-09-30_custom_SeriesBWarrantsMember50317312" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">100,000,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zY6ZhpOBfTl" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember50317328" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">68,493,151</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930_zfPhf3MEWAYh" title="Antidilutive shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">398,168</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930_zhxNnhzLXLXd" title="Antidilutive shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">68,684,463</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930_zpdjGBzpfpm3" title="Antidilutive shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">107,230,624</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930_z70wa1rdKsb4" title="Antidilutive shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">68,803,234</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zQvSRAB0ruI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. <span id="xdx_82F_z4hFLwyCzOZ2">SUBSEQUENT EVENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 8, 2021, the Company acquired all of the outstanding stock
of a leading printing technology company, for a cash purchase price of $37.0 million, which includes an initial $33.0 million cash payment
and a $4.0 million working capital adjustment. The business services a diverse group of customers that operate across healthcare, food
and beverage, manufacturing and logistics, and other sectors. The acquisition triggered the release of $35.0 million held in escrow (refer
to Note 2 &#8220;Long-Term Restricted Cash&#8221; for additional information).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_814_zC2HTS8m8qB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br />
</p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq10"></span><b>Item 2. Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>The following discussion and analysis of our financial condition
and results of operations should be read together with our unaudited condensed consolidated financial statements and the related notes
included in Part I, Item1 of this Quarterly Report on Form10-Q for the three and nine months ended September 30, 2021, or this Report.
This discussion and analysis contains forward-looking statements that are based on our current expectations and reflect our plans, estimates
and anticipated future financial performance. See the section of this Report entitled &#8220;Cautionary Statement Regarding Forward-Looking
Statements&#8221; for additional information. These statements involve numerous risks and uncertainties. Our actual results may differ
materially from those expressed or implied by these forward-looking statements as a result of many factors, including those set forth
in &#8220;Risk Factors&#8221; in Part II, Item1A. of this Report.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia Research Corporation (the &#8220;Company,&#8221; &#8220;we,&#8221;
&#8220;us,&#8221; or &#8220;our&#8221;) acquires businesses and operating assets that we believe to be undervalued and where we believe
we can leverage our resources and skill sets to realize and unlock value. We leverage our (i) access to flexible capital that can be deployed
unconditionally, (ii) expertise in corporate governance and operational restructuring, (iii) willingness to invest in out of favor industries
and businesses that suffer from a complexity discount and untangle complex, multi-factor situations, and (iv) expertise and relationships
in certain sectors, to complete strategic acquisitions of businesses, divisions, and/or assets with a focus on mature technology, healthcare,
industrial and certain financial segments. We seek to identify opportunities where we believe we are advantaged buyers, where we can avoid
structured sale processes and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price
due to our unique capabilities, relationships, or expertise, or where we believe the target would be worth more to us than to other buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We operate our business based on three key principles of People, Process
and Performance and have built a management team with identified expertise in Research, Execution and Operation of our targeted acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We utilized these skill sets and resources to acquire a portfolio of
equity securities of public and private life science businesses, or the &#8220;Life Sciences Portfolio&#8221;, in June 2020. As of September
30, 2021, we have monetized a portion of the portfolio while retaining an interest in a number of operating businesses, including a controlling
interest in one of the companies in the portfolio. Further, some of the businesses in which we continue to hold an interest generate revenues
through the receipt of royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We also operate our legacy business of investing in intellectual property,
or IP, and related absolute return assets and engaging in the licensing and enforcement of patented technologies. We partner with inventors
and patent owners, from small entities to large corporations, applying our legal and technology expertise to patent assets to unlock the
financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and
application, and facilitating efficiency in connection with the monetization of patent assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We generate revenues and related cash flows from the granting of IP
rights for the use of patented technologies that our operating subsidiaries control or own. We assist patent owners with the prosecution
and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented
technologies through the filing of patent infringement litigation. Currently, on a consolidated basis, our operating subsidiaries own
or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies
used in a variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have established a proven track record of licensing and enforcement
success with over 1,600 license agreements executed to date, across nearly 200 patent portfolio licensing and enforcement programs. To
date, we have generated gross licensing revenue of approximately $1.7 billion, and have returned $828.7 million to our patent partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>COVID-19 Pandemic</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#8217;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and
Economic Security Act (&#8220;CARES Act&#8221;) was signed into law on March 27, 2020. The CARES Act, among other things, includes tax
provisions relating to refundable payroll tax credits, deferment of employer&#8217;s social security payments, net operating loss utilization
and carryback periods and modifications to the net interest deduction limitations. The CARES Act has not had a material impact on the
Company&#8217;s income tax provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 27, 2020, the President of the United States signed the
Consolidated Appropriations Act, 2021 (&#8220;Consolidated Appropriations Act&#8221;) into law. The Consolidated Appropriations Act is
intended to enhance and expand certain provisions of the CARES Act, allows for the deductions of expenses related to the Payroll Protection
Program funds received by companies, and provides an update to meals and entertainment expensing for 2021. The Consolidated Appropriations
Act did not have a material impact to the Company&#8217;s income tax provision for 2020. The Company will continue to evaluate the impact
of the Consolidated Appropriations Act on its financial position, results of operations and cash flows, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 11, 2021 the United States enacted the American Rescue Plan
Act of 2021. This Act includes various income and payroll tax measures. The Company does not expect a material impact of the American
Rescue Plan on its consolidated financial statements and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Summary</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Overview</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our operating activities during the periods presented were focused
on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent licensing
and enforcement programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Licensing and Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Patent Litigation Trial Dates and Related Trials</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of the date of this report, our operating subsidiaries have nine
pending patent infringement cases with scheduled trial dates in the next twelve months. Patent infringement trials are components of our
overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us.
Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the trials may
occur according to the court&#8217;s scheduling calendar at a specific point in time. A court may change previously scheduled trial dates.
In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent assets and typically for
reasons that are beyond our control. While scheduled trial dates provide an indication of the timing of possible future revenue generating
opportunities for us, the trials themselves and the immediately preceding periods represent the possible future revenue generating opportunities.
These future opportunities can result in varying outcomes. In fact, it is difficult to predict the outcome of patent enforcement litigation
at the trial level and outcomes can be unfavorable. It can be difficult to understand complex patented technologies, and as a result,
this may lead to a higher rate of unfavorable litigation outcomes. Moreover, in the event of a favorable outcome, there is, in our experience,
a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive
and time consuming, resulting in increased costs and a potential for delayed or foregone revenue opportunities in the event of modification
or reversal of favorable outcomes. Although we diligently pursue enforcement litigation, we cannot predict with reliability the decisions
made by juries and trial courts. Please refer to Part II, Item 1A. &#8220;Risk Factors&#8221; for additional information regarding trials,
patent litigation and related risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Litigation and Licensing Expense</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expect patent-related legal expenses to continue to fluctuate from
period to period based on the factors summarized herein, in connection with future trial dates, international enforcement, strategic patent
portfolio prosecution and our current and future patent portfolio investment, prosecution, licensing and enforcement activities. The pursuit
of enforcement actions in connection with our licensing and enforcement programs can involve certain risks and uncertainties, including
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs, could increase our operating costs and decrease our profit generating opportunities;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e., markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above could harm our operating results and our financial position.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investments in Patent Portfolios</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to our licensing, enforcement and overall business, neither
we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents,
inventions and companies that own IP through our relationships with inventors, universities, research institutions, technology companies
and others. If our operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then we
may not be able to identify new technology-based patent opportunities for sustainable revenue and /or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our current or future relationships may not provide the volume or quality
of technologies necessary to sustain our licensing, enforcement and overall business. In some cases, universities and other technology
sources compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research
in exchange for the exclusive right to commercialize resulting inventions. These and other strategies employed by potential partners may
reduce the number of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current
relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse
effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Portfolio Intake </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One of the significant challenges in our industry continues to be quality
patent intake due to the challenges and complexity associated with the current patent environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, we acquired one new
patent portfolio consisting of Wi-Fi 6 standard essential patents. The patents and patent rights acquired during the nine months ended
September 30, 2021 have estimated economic useful lives of approximately five years. In fiscal year 2020, we acquired five patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Starboard Securities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2019, as part of its strategy to grow, the Company began evaluating
a wide range of strategic opportunities that culminated in the strategic investment in the Company by certain funds and accounts, or the
Buyers, affiliated with, or managed by, Starboard Value LP, or Starboard. On November 18, 2019, the Company entered into a Securities
Purchase Agreement with Starboard and the Buyers, or the Securities Purchase Agreement, pursuant to which the Buyers purchased (i) 350,000
shares of the Company&#8217;s newly designated Series A Convertible Preferred Stock, or Series A Preferred Stock, at an aggregate purchase
price of $35.0 million, and warrants to purchase up to 5 million shares of the Company&#8217;s common stock, or Series A Warrants. The
Securities Purchase Agreements also established the terms of certain senior secured notes, or Notes, and additional warrants, or the Series
B Warrants, which may be issued to the Buyers in the future. Refer to Notes 2 and 6 to the consolidated financial statements elsewhere
herein for additional information related to the Series A Preferred Stock, Series A Warrants and Series B Warrants. In connection with
the Buyer&#8217;s investment, Starboard was granted certain corporate governance rights, including the right to appoint Jonathan Sagal,
Managing Director of Starboard, as a director of the Company and recommend two additional directors for appointment to our Board of Directors.
The investment by the Buyers is referred to herein as the &#8220;Starboard Investment,&#8221; and the Series A Preferred Stock, Series
A Warrants and Series B Warrants are referred to herein as, collectively, the &#8220;Starboard Securities.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 14, 2020, the Company&#8217;s stockholders approved, for
purposes of Nasdaq Rules 5635(b) and 5635(d), as applicable, (i) the voting of the Series A Preferred Stock on an as-converted basis and
(ii) the issuance of the maximum number of shares of common stock issuable in connection with the potential future (A) conversion of the
Series A Preferred Stock and (B) exercise of the Series A and Series B Warrants, in each case, without giving effect to the exchange cap
set forth in the Series A Preferred Stock Certificate of Designations and in the Series A Warrants, issued pursuant to the Securities
Purchase Agreement dated November 18, 2019. Refer to Note 6 to the consolidated financial statements elsewhere herein for additional information.
The Company&#8217;s stockholders also approved an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation to
increase the total number of authorized shares of common stock by 200 million shares, from 100 million shares to 300 million shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities Purchase
Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to 100 million shares of the Company&#8217;s
common stock at an exercise price of either (i) $5.25 per share, if exercising by cash payment, or (ii) $3.65 per share, if exercising
by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase price of $4.6 million. Refer
to Note 6 to the consolidated financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Securities Purchase Agreement with Starboard
and the Buyers, on June 4, 2020, the Company issued $115.0 million in Notes to the Buyers. Also on June 4, 2020, in connection with the
issuance of the Notes, the Company entered into a Supplemental Agreement with Starboard, or the Supplemental Agreement, through which,
the Company agreed to redeem $80.0 million aggregate principal amount of the Notes by September 30, 2020, and $35.0 million aggregate
principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid by December 31, 2020. Per
the Supplemental Agreement, interest is payable semiannually at a rate of 6.00% per annum, and in an event of default, the interest rate
is increased to 10.00% per annum. The Notes outlined certain financial and non-financial covenants. Additionally, all or any portion of
the principal amount outstanding under the Notes may, at the election of the holders, be surrendered to the Company for cancellation in
payment of the exercise price upon the exercise of the Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into an Exchange Agreement, or
the Exchange Agreement, with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company,
or Merton, and Starboard, on behalf of itself and on behalf of the Buyers, including the holders of the Notes. Pursuant to the Exchange
Agreement, the holders of the Notes exchanged the entire outstanding principal amount of the Notes for new senior notes, or the New Notes,
issued by Merton and having an aggregate outstanding original principal amount of $115.0 million. The New Notes bear interest at a rate
of 6.00% per annum and had a maturity date of December 31, 2020. The New Notes are fully guaranteed by the Company and are secured by
an all-assets pledge of the Company and Merton and non-recourse equity pledges of each of the Company&#8217;s material subsidiaries. Pursuant
to the Exchange Agreement, the New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes of the Securities Purchase Agreement, (ii)
are deemed to be &#8220;June 2020 Approved Investment Notes&#8221; for purposes of the Supplemental Agreement, and with the Company agreeing
to redeem $80.0 million principal amount of the New Notes by September 30, 2020 and $35.0 million principal amount of the New Notes by
December 31, 2020, and (iii) are deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be tendered
pursuant to a Note Cancellation under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery
of notes in the form of the New Notes will satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations
of the Company&#8217;s Series A Convertible Preferred Stock, par value $0.001 per share. The New Notes will not be deemed to be &#8220;Notes&#8221;
for the purposes of the Registration Rights Agreement, dated as of November 18, 2019, by and between the Company, Starboard and the Buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 29, 2021, the Company redeemed $50.0 million of the New
Notes and on March 31, 2021, the Company reissued $50.0 million of the New Notes. On June 30, 2021, the Company issued $30.0 million in
additional New Notes (the &#8220;June 2021 Merton Notes&#8221;) and amended the maturity date of the New Notes to October 15, 2021. On
September 30, 2021, the Company issued $35.0 million in additional New Notes (the &#8220;September 2021 Merton Notes&#8221;) and amended
the maturity date of the New Notes to December 1, 2021. The June and September 2021 Merton Notes cannot be used to exercise Series B Warrants
issued to Starboard Value. The total principal amount outstanding of New Notes as of September 30, 2021 and December 31, 2020 was $180.0
million and $115.0 million, respectively. Refer to Note 6 to the consolidated financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities Portfolio Investment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 3, 2020, the Company entered into an Option Agreement with
Seller to purchase equity securities in the Life Sciences Portfolio, for an aggregate purchase price of &#163;223.9 million, approximately
$277.5 million at the exchange rate on April 3, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2020, the Company executed the Transaction Agreement between
Link Fund Solutions Limited, or Link, Seller, and the Company. Pursuant to the Transaction Agreement, the Company will purchase from Seller
and Seller will transfer to the Company the specified equity securities of all companies in the Life Sciences Portfolio at set prices
at various future dates. In accordance with the Transaction Agreement, the Company transferred the total purchase price of &#163;223.9
million into an escrow account. Upon the transfer of equity securities in the Life Sciences Portfolio to the Company, the associated funds
were released from the escrow account to Seller based on the consideration amount assigned to the equity securities for such Life Sciences
Portfolio company in the Transaction Agreement. As of December 31, 2020, all of the equity securities in the Life Sciences Portfolio were
transferred to the Company pursuant to the Transaction Agreement. Refer to Note 3 to the consolidated financial statements elsewhere herein
for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Operating Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our revenues historically have fluctuated quarterly, and can vary significantly,
based on a number of factors including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">fluctuations in the total number of agreements executed each period;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the relative maturity of licensing programs during the applicable periods; &#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the willingness of prospective licensees to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as such infringement cases approached a court determined trial date; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management does not attempt to manage for smooth sequential periodic
growth in revenues from period to period, and therefore, periodic results can be uneven. Unlike most operating businesses and industries,
licensing revenues not generated in a current period are not necessarily foregone but, depending on whether negotiations, litigation or
both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be pushed into subsequent
fiscal periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues for the nine months ended September 30, 2021 and 2020 included
fees from the following technology licensing and enforcement programs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: middle">
    <td style="width: 2%">&#8226;</td>
    <td style="text-align: left; width: 47%; vertical-align: top">Bone Wedge technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 2%">&#8226;</td>
    <td style="text-align: left; width: 47%; vertical-align: top">Wireless Mesh Networking technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td></tr>
  <tr style="vertical-align: middle">
    <td>&#8226;</td>
    <td style="text-align: left; vertical-align: top">Flash Memory technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#8226;</td>
    <td style="text-align: left; vertical-align: top">MIPI DSI technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(2)</sup></span></td></tr>
  <tr style="vertical-align: middle">
    <td>&#8226;</td>
    <td style="text-align: left; vertical-align: top">Internet search, advertising and cloud computing technology <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#8226;</td>
    <td style="text-align: left; vertical-align: top">Semiconductor and Memory-Related technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(2)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Speech codecs used in wireless and wireline systems technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td>
    <td style="vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Super Resolutions Microscopy technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(2)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Wireless Infrastructure and User Equipment technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td style="vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Video Conferencing technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(2)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Networking and Security technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td style="vertical-align: middle">&#160;</td>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="text-align: left; vertical-align: top">Internet radio ad placement<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(2)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: left; vertical-align: top">__________________________</td>
    <td style="vertical-align: bottom; background-color: white">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="4" style="vertical-align: middle"><sup>(1)</sup> <span style="font: normal 400 10pt Times New Roman, Times, Serif">Licensing and enforcement program generating revenue in 2021.</span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="4" style="vertical-align: middle"><sup>(2)</sup> <span style="font: normal 400 10pt Times New Roman, Times, Serif">Licensing and enforcement program generating revenue in 2020.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consolidated Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Summary for the Three and Nine Months Ended September 30, 2021 and
2020</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage change
    values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,582</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">19,466</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(17,884</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(92%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">24,785</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">25,399</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(614</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Operating costs and expenses</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">14,304</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">22,248</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(7,944</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(36%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">41,539</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,498</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,041</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">8%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(12,722</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2,782</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(9,940</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">357%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(16,754</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(13,099</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(3,655</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">28%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Other income (expense)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">102,337</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">41,213</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">61,124</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">148%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(37,316</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">45,047</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(82,363</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(183%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Income (loss) before income taxes</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">89,615</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,431</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">51,184</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">133%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(54,070</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">31,948</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(86,018</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(269%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Income tax (expense) benefit</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(11</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(83</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">72</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(87%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(531</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,257</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1,788</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(142%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income (loss) attributable to Acacia Research Corporation</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">89,604</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">51,256</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">134%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(55,507</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">33,205</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(88,712</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(267%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><br />
</i></b></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations &#8211; Three months ended September 30,
2021 compared with the three months ended September 30, 2020</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues decreased $17.9 million to $1.6 million for the three months
ended September 30, 2021, as compared to $19.5 million in the comparable prior year quarter, primarily due to a decrease in revenues from
licensing and enforcement programs during the quarter. New agreements executed were flat quarter over quarter. Refer to &#8220;<i>Investments
in Patent Portfolios&#8221; </i>above for additional information regarding the impact of portfolio acquisition trends on current and future
licensing and enforcement related revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income before income taxes was $89.6 million for the three months ended
September 30, 2021, as compared to $38.4 million for the three months ended September 30, 2020. The net change was comprised of the change
in revenues described above and other changes in operating expenses and other income (expense) as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Paid-up revenue decreased $18.3 million primarily due to a decrease in average
revenue per agreement executed during the quarter, offset by an increase of $401,000 in recurring revenue that provides for quarterly
sales-based license fees. Refer to Note 2 to the consolidated financial statements elsewhere herein for additional information regarding
certain sales-based revenue contracts that provide for the payment of quarterly license fees based on quarterly sales of applicable product
units by licensees.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Inventor royalties and contingent legal fees, on a combined basis, decreased
$11.8 million, from $12.4 million to $565,000, primarily due to the net decrease in revenues described above.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Litigation and licensing expenses - patents decreased $219,000, from $1.0 million
to $782,000, primarily due to a net decrease in litigation support and third-party technical consulting expenses associated with ongoing
litigation.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Amortization of patents expense increased $1.4 million, from $1.2 million to
$2.6 million, due to an increase in scheduled amortization resulting from the new portfolios acquired in 2021.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses, excluding non-cash stock compensation,
increased $2.8 million, from $7.2 million to $10.0 million, primarily due to higher corporate, general and administrative costs related
to legal and other business development expenses, and to a lesser extent from non-recurring employee severance costs, personnel cost
and board fees.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Net non-cash stock compensation expense decreased $188,000, from $488,000 to
$300,000, primarily due to forfeitures in the third quarter partially offset by higher expense from stock grants issued to employees
and the Board of Directors in 2021.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">There was no unrealized gain or loss on our fair value investment for the three
months ended September 30, 2021, as compared to an unrealized loss of $3.1 million for the three months ended September 30, 2020. There
was no realized gain or loss on our fair value investment for the three months ended September 30, 2021 and 2020. Refer to Note 4 to
the consolidated financial statements elsewhere herein for additional information.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Unrealized gain from the fair value measurements of the Series A and Series
B warrants and the embedded derivative decreased to $619,000 for the three months ended September 30, 2021, as compared to an unrealized
gain of $20.7 million for the three months ended September 30, 2020. Refer to Note 6 to the consolidated financial statements elsewhere
herein for additional information regarding the Starboard Securities.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Unrealized gain from equity securities increased to $66.5 million for the three
months ended September 30, 2021, as compared to an unrealized gain of $20.5 million for the three months ended September 30, 2020. The
current period unrealized gain primarily relates to one Life Sciences Portfolio company&#8217;s valuation increase in connection with
its initial public offering. Refer to Notes 2 and 3 to the consolidated financial statements elsewhere herein for additional information
regarding our investment in equity securities.</span></td></tr>
</table>


<p style="font: 10pt Symbol; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Symbol; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Symbol; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Symbol; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Symbol; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Realized gain from the sale of our equity securities increased to $37.7 million
for the three months ended September 30, 2021, as compared to a gain of $2.7 million for the three months ended September 30, 2020. The
current period realized gain primarily relates to the partial sale of two Life Sciences Portfolio securities. Refer to Notes 2 and 3
to the consolidated financial statements elsewhere herein for additional information regarding our investment in equity securities.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We incurred losses on foreign currency exchange of $17,000 and $48,000 during
the three months ended September 30, 2021 and 2020, respectively.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We incurred interest expense of $2.5 million during the three months ended September
30, 2021 from the Notes issued in 2020 and 2021, as compared to $2.4 million during the three months ended September 30, 2020. Refer
to Note 6 to the consolidated financial statements elsewhere herein for additional information regarding the Starboard Senior Secured
Notes.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Interest income and other increased to $76,000 for the three months ended September
30, 2021 from $10,000 for the three months ended September 30, 2020. Refer to Note 2 to the consolidated financial statements elsewhere
herein for additional information regarding our cash and cash equivalents and investments in equity securities.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations &#8211; Nine months ended September 30,
2021 compared with the nine months ended September 30, 2020</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues decreased $614,000 to $24.8 million for the nine months ended
September 30, 2021, as compared to $25.4 million in the comparable prior year, primarily due to a decrease in revenues from licensing
and enforcement programs generating revenue during the period. Refer to &#8220;<i>Investments in Patent Portfolios&#8221; </i>above for
additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Loss before income taxes was $54.1 million for the nine months ended
September 30, 2021, as compared to income before income taxes of $31.9 million for the nine months ended September 30, 2020. The net change
was comprised of the change in revenues described above and other changes in operating expenses and other income (expense) as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Paid-up revenue decreased $1.4 million primarily due to a decrease in average
revenue per agreement executed during the period, offset by an increase of $753,000 in recurring revenue that provides for quarterly
sales-based license fees. Refer to Note 2 to the consolidated financial statements elsewhere herein for additional information regarding
certain sales-based revenue contracts that provide for the payment of quarterly license fees based on quarterly sales of applicable product
units by licensees.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Inventor royalties and contingent legal fees, on a combined basis, decreased
$7.1 million, from $13.7 million to $6.6 million, primarily due to a higher percentage of revenues generated during the nine months ended
September 30, 2021 having no inventor royalty obligations.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Litigation and licensing expenses - patents increased $1.4 million, from $3.5
million to $4.9 million, primarily due to a net increase in litigation support and third-party technical consulting expenses associated
with ongoing litigation.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Amortization of patents expense increased $3.6 million, from $3.5 million to
$7.1 million, due to an increase in scheduled amortization resulting from the new portfolios acquired in 2020 and 2021.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Other patent portfolio income for the nine months ended September 30, 2020 was
$308,000 due to the reversal of previously recorded expenses for settlement and contingency accruals.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">General and administrative expenses, excluding non-cash stock compensation,
increased $4.9 million, from $16.8 million to $21.7 million, primarily due to higher corporate, general and administrative costs related
to legal and other business development expenses, personnel cost and board fees, and to a lesser extent from increased variable performance-based
compensation costs.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Net non-cash stock compensation expense increased $36,000, from $1.2 million
to $1.3 million, primarily due to stock grants issued to employees and the Board of Directors in 2021, partially offset by forfeitures
for terminated employees.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We recognized an unrealized loss of $2.8 million on our fair value investment
for the nine months ended September 30, 2021, as compared to an unrealized gain of $3.7 million for the nine months ended September 30,
2020. There was a realized gain of $3.6 million on our fair value investment for the nine months ended September 30, 2021, as compared
to a realized loss of $2.8 million for the nine months ended September 30, 2020. Refer to Note 4 to the consolidated financial statements
elsewhere herein for additional information.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We incurred an unrealized net loss of $203.9 million from the fair value measurements
of the Series A and Series B warrants and the embedded derivative for the nine months ended September 30, 2021, as compared to an unrealized
loss of $46.6 million for the nine months ended September 30, 2020. Refer to Note 6 to the consolidated financial statements elsewhere
herein for additional information regarding the Starboard Securities.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Unrealized gain from equity securities increased to $115.5 million for the nine
months ended September 30, 2021, as compared to an unrealized gain of $99.4 million for the nine months ended September 30, 2020. The
current period unrealized gain primarily relates to one Life Sciences Portfolio company&#8217;s valuation increase in connection with
its initial public offering. Refer to Notes 2 and 3 to the consolidated financial statements elsewhere herein for additional information
regarding our investment equity securities.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Realized gain from the sale of our equity securities increased to $53.1 million
for the nine months ended September 30, 2021, as compared to a loss of $4.3 million for the nine months ended September 30, 2020. The
current period realized gain primarily relates to the sale of three Life Sciences Portfolio securities. Refer to Notes 2 and 3 to the
consolidated financial statements elsewhere herein for additional information regarding our investment in equity securities.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Earnings on equity investment in joint venture was $2.7 million for the nine
months ended September 30, 2021. Refer to Note 3 to the consolidated financial statements elsewhere herein for additional information
regarding our equity method investment.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We incurred losses on foreign currency exchange of $193,000 and $4.9 million
during the nine months ended September 30, 2021 and 2020, respectively.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">We incurred interest expense of $5.6 million during the nine months ended September
30, 2021 from the Notes issued in 2020 and 2021, as compared to $3.2 million during the nine months ended September 30, 2020. Refer to
Note 6 to the consolidated financial statements elsewhere herein for additional information regarding the Starboard Senior Secured Notes.</span></td></tr>

<tr style="vertical-align: top">
    <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td><span style="font-family: Symbol">&#183;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Interest income and other decreased to $135,000 for the nine months ended September
30, 2021 from $811,000 for the nine months ended September 30, 2020, mainly due to a decrease in interest income from our former investment
in debt securities, which was sold in 2020. Refer to Note 2 to the consolidated financial statements elsewhere herein for additional
information regarding our cash and cash equivalents and investments in equity securities.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenues</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue for the periods presented included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Revenues (in thousands, except percentage
change values)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,582</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">19,466</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(17,884</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(92%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">24,785</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">25,399</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(614</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">New agreements executed</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">16</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">11</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">5</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">45%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Licensing and enforcement programs generating revenues</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">5</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(40%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">7</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">8</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(13%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Licensing and enforcement programs with initial revenues</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(100%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">50%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">New patent portfolios</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(75%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods presented herein, the majority of the revenue agreements
executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain IP Rights for patented technology
rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of
the underlying patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Note 2 to the consolidated financial statements elsewhere
herein for additional information regarding our revenue arrangements and related concentrations for the periods presented herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to &#8220;<i>Investments in Patent Portfolios</i>&#8221; above
for information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cost of Revenues</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Fees Expense</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage change
    values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 20%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">Inventor royalties</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">280</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">5,772</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(5,492</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(95%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">823</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,843</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(6,020</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(88%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 8pt">Contingent legal fees</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">285</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,609</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(6,324</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(96%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">5,735</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,855</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1,120</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(16%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">565</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">12,381</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(11,816</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(95%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,558</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">13,698</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(7,140</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(52%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended September 30, 20201, inventor royalties
and contingent legal fees, on a combined basis, decreased $11.8 million, or 95%. For the nine months ended September 30, 20201, inventor
royalties and contingent legal fees, on a combined basis, decreased $7.1 million, or 52%. Inventor royalties and contingent legal fee
expenses fluctuate from period to period based on the amount of revenues recognized each period, the terms and conditions of agreements
executed each period and the mix of specific patent portfolios, with varying economic terms and obligations, generating revenues each
period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Litigation and Licensing Expenses - Patents and Amortization of
Patents</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage change
    values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Litigation and licensing expenses - patents</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">782</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(219</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(22%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,881</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,497</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,384</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">40%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">Amortization of patents</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,612</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,174</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,438</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">122%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,086</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,522</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,564</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">101%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,394</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,175</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,219</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">56%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">11,967</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,019</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,948</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">70%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended September 30, 2021, litigation and licensing
expenses-patents decreased $219,000, or 22%. For the nine months ended September 30, 2021, litigation and licensing expenses-patents increased
$1.4 million, or 40%. The changes were due to fluctuations in litigation support and third-party technical consulting expenses during
the periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended September 30, 2021, amortization expense
increased $1.4 million, or 122%. For the nine months ended September 30, 2021, amortization expense increased $3.6 million, or 101%. These
increases were due to new patents acquired in 2020 and 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Operating Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General and Administrative Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage change
    values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">General and administrative expenses</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">10,045</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,204</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,841</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">39%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">21,735</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">16,846</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,889</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">29%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Non-cash stock compensation expense</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">300</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">488</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(188</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(39%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,279</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,243</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">36</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Total
    general and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">10,345</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,692</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,653</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">34%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">23,014</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">18,089</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,925</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">27%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of the main drivers of the change in general and administrative
expenses for the periods presented, is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"> Three Months Ended</td><td style="text-align: center; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="text-align: center; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021 vs. 2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021 vs. 2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-style: italic">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Personnel costs and board fees</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">415</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">1,563</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Variable performance-based compensation costs</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(172</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">268</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Corporate, general and administrative costs</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,111</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,973</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Non-cash stock compensation expense</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(188</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">36</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Non-recurring employee severance costs</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">487</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">85</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total change in general and administrative expenses</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,653</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,925</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The increases in personnel cost and board fees for the periods presented
were primarily due to an increase in headcount and related costs. The changes in variable performance-based compensation costs were primarily
due to fluctuations in performance-based compensation accruals. The increases in corporate, general and administrative costs were primarily
due to higher legal and business development related expenses. The decrease in non-cash stock compensation expense for the three months
ended September 30, 2021, was primarily due to forfeitures in the third quarter partially offset by higher expense from stock grants issued
to employees and the Board of Directors in 2021. Non-recurring employee severance costs fluctuate based on the severance arrangements
of terminated employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Income (Expense)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our equity investments in Veritone, the Life Sciences Portfolio and
other equity securities are recorded at fair value at each balance sheet date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our quarterly results included no unrealized or realized gain or loss
on our fair value investment in Veritone for the three months ended September 30, 2021, as compared to an unrealized loss of $3.1 million
for the three months ended September 30, 2020. Our year-to-date results included an unrealized loss of $2.8 million on our fair value
investment in Veritone for the nine months ended September 30, 2021, as compared to an unrealized gain of $3.7 million for the nine months
ended September 30, 2020. There was a realized gain of $3.6 million on our equity investment in Veritone for the nine months ended September
30, 2021, as compared to a realized loss of $2.8 million for the nine months ended September 30, 2020. Refer to Note 4 to the consolidated
financial statements elsewhere herein for additional information regarding our investment in Veritone.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our quarterly results included an unrealized gain from equity securities
of $66.5 million for the three months ended September 30, 2021, as compared to an unrealized gain of $20.5 million for the three months
ended September 30, 2020. Realized gain from the sale of our equity securities increased to $37.7 million for the three months ended September
30, 2021, as compared to a gain of $2.7 million for the three months ended September 30, 2020. Our year-to-date results included an unrealized
gain from equity securities of $115.5 million for the nine months ended September 30, 2021, as compared to an unrealized gain of $99.4
million for the nine months ended September 30, 2020. Realized gain from the sale of our equity securities increased to $53.1 million
for the nine months ended September 30, 2021, as compared to a loss of $4.3 million for the nine months ended September 30, 2020. Refer
to Notes 2 and 3 to the consolidated financial statements elsewhere herein for additional information regarding our investment in the
Life Sciences Portfolio and other equity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-indent: -10pt; width: 20%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">Income tax (expense) benefit</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(11</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(83</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">72</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(87%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(531</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,257</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1,788</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(142%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">Effective tax rate</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(4%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The provision for income taxes is determined using an effective tax
rate. For the three and nine months ended September 30, 2021, the Company&#8217;s estimated annual effective tax rates were lower than
the U.S. federal statutory rate primarily due to the change in valuation allowance, as well as state income taxes. The effective tax rate
may be subject to fluctuations during the year as new information is obtained which may affect the assumptions used to estimate the effective
tax rate, including factors such as expected utilization of net operating loss carryforwards, changes in or the interpretation of tax
laws in jurisdictions where the Company conducts business, the Company&#8217;s expansion into new states or foreign countries, and the
amount of valuation allowances against deferred tax assets. For the nine months ended September 30, 2020, the Company recorded a benefit
for income taxes of which primarily reflects the impact of state taxes and foreign tax withholding or refund incurred on revenue agreements
executed with third-party licensees domiciled in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company recognizes deferred tax assets and liabilities for temporary
differences between the financial reporting basis and the tax basis of its assets and liabilities along with net operating loss and tax
credit carryforwards. The Company records a valuation allowance against its deferred tax assets to reduce the net carrying value to an
amount it believes is more likely than not to be realized. When the Company establishes or reduces the valuation allowance against its
deferred tax assets, the provision for income taxes will increase or decrease, respectively, in the period such determination is made.
For the nine months ended September 30, 2021, the Company has recorded a full valuation allowance against its deferred tax assets as they
are not expected to be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 27, 2020, the United States enacted the CARES Act which provides
certain income tax benefits including the ability to carryback federal NOLs generated in 2018 through 2020 for an extended five-year period
and increased the limitation for the deduction of interest expense from 30 percent to 50 percent of modified taxable income. The CARES
Act also provides other economic benefits such as allowing employers to defer payment of the employer&#8217;s portion of payroll taxes
for 2020 and a refundable employee retention credit of up to $5,000 per eligible employee wages. The Company did not realize benefits
from the provisions of the CARES Act including the extended NOL carryback period, the payroll tax deferral, and the employee retention
credit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 27, 2020, the United States enacted the Consolidated Appropriations
Act which extended many of the benefits of the CARES Act that were scheduled to expire. The Company does not expect a material impact
of Consolidated Appropriations Act on its consolidated financial statements and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 11, 2021 the United States enacted the American Rescue Plan
Act of 2021. These Acts includes various income and payroll tax measures. The Company does not expect a material impact of the American
Rescue Plan on its consolidated financial statements and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 29, 2020, the state of California passed Assembly Bill 85 which
suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;D credit usage for the same period (for
credit usages in excess of $5.0 million). The Company anticipates a California income tax liability for 2021, however it is not expected
to materially impact the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our primary sources of liquidity are cash and cash equivalents on hand
generated from our operating activities, and as deemed appropriate by management from our Senior Secured Notes (discussed below under
the caption &#8220;Starboard Investment and Senior Secured Notes&#8221;). Our management believes that our cash and cash equivalent balances,
anticipated cash flows from operations and proceeds from our Senior Secured Notes will be sufficient to meet our cash requirements through
at least twelve months from the date of this report and for the foreseeable future. We may, however, encounter unforeseen difficulties
that may deplete our capital resources more rapidly than anticipated, including those set forth under Part II, Item 1A, &#8220;Risk Factors&#8221;.
Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing. However, additional
funding may not be available to us on favorable terms, or at all. The capital and credit markets have experienced extreme volatility and
disruption in recent years, and the volatility and impact of the disruption may continue. At times during this period, the volatility
and disruption has reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and credit
capacity for certain issuers, and the commercial paper markets may not be a reliable source of short-term financing for us. If we fail
to obtain additional financing when needed, we may not be able to execute our business plans and our business, conducted by our operating
subsidiaries, may suffer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of our operating subsidiaries are often required to engage
in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries&#8217; patent enforcement
actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority,
regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such
enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney&#8217;s
fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash, Cash Equivalents and Investments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our consolidated cash, cash equivalents, equity securities at fair
value, and long-term restricted cash totaled $640.5 million at September 30, 2021, compared to $309.6 million at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The net change in cash, cash equivalents and restricted cash for the
periods presented was comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Net cash (used in) provided by:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Operating activities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(7,602</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">5,549</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Investing activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(3,219</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(9,815</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Financing activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">64,417</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">109,471</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Increase in cash and cash equivalents and restricted cash</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">53,596</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">105,205</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b></b></span><span style="font: 10pt Times New Roman, Times, Serif"><i>Cash Flows from Operating Activities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash receipts from licensees for the nine months ended September 30,
2021 decreased to $24.9 million, as compared to $25.6 million in the comparable 2020 period, mainly due to the timing on cash collected
from accounts receivables in prior year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash outflows from operations for the nine months ended September 30,
2021 increased to $7.6 million, as compared to a $5.5 million cash inflow in the comparable 2020 period, primarily due to our higher net
loss (discussed above under the caption &#8220;Results of Operations &#8211; Nine months ended September 30, 2021 compared with the nine
months ended September 30, 2020&#8221;) and a gain on sale of equity securities, partially offset by the net changes in fair value of
Series A and B warrants, embedded derivatives and equity securities and to a lesser extent the changes in working capital cash flows.
Refer to &#8220;Working Capital&#8221; below for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Flows from Investing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash flows from investing activities and related changes were comprised
of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Patent acquisition</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(13,000</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(13,780</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Sale of investment at fair value</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,591</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,460</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Purchases of equity securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(57,978</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(33,800</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Maturities and sales of equity securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">64,235</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">316,746</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Purchases of prepaid investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(276,275</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative and forward contract acquisition cost</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(3,989</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(67</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(177</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash used in investing activities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(3,219</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(9,815</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Flows from Financing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash flows from financing activities and related changes were comprised
of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Repurchase of common stock</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(3,998</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Issuance of Senior Secured Notes, net of lender fee</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">65,000</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">110,437</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Senior Secured Notes issuance costs paid to other parties</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(496</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Dividend on Series A Redeemable Convertible Preferred Stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(785</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,120</td><td style="font-size: 10pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,600</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Proceeds from exercise of stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">202</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">48</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Paydown of Senior Secured Notes - short-term</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(50,000</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Reissuance of Senior Secured Notes - short-term</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">50,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash provided by financing activities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">64,417</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">109,471</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Starboard Investment and Senior Secured Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, the Company entered into the Securities Purchase
Agreement with Starboard and the Buyers pursuant to which the Buyers purchased (i) 350,000 shares of Series A Preferred Stock at an aggregate
purchase price of $35.0 million, and Series A Warrants to purchase up to 5 million shares of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities Purchase
Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to 100 million shares of the Company&#8217;s
common stock at an exercise price of either (i) $5.25 per share, if exercising by cash payment, or (ii) $3.65 per share, if exercising
by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase price of $4.6 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2020, pursuant to the Securities Purchase Agreement dated
November 2019, the Company issued $115.0 million in Notes to the Buyer. Per the Supplemental Agreement, interest is payable semiannually
at a rate of 6.00% per annum, and in an event of default, the interest rate is increased to 10.00% per annum. In connection with the issuance
of the Notes, the terms of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through
the payment of cash, rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November
15, 2027. 31,506,849 of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series B Warrants
continuing under their original terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into the Exchange Agreement with
Merton and Starboard, on behalf of itself and on behalf of certain funds and accounts under its management, including the holders of the
Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal amount for New Notes issued
by Merton having an aggregate outstanding original principal amount of $115.0 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 29, 2021, the Company redeemed $50.0 million of the New
Notes and on March 31, 2021, the Company reissued $50.0 million of the New Notes. On June 30, 2021, the Company issued $30.0 million in
additional New Notes (the &#8220;June 2021 Merton Notes&#8221;) and amended the maturity date of the New Notes to October 15, 2021. On
September 30, 2021, the Company issued $35.0 million in additional New Notes (the &#8220;September 2021 Merton Notes&#8221;) and amended
the maturity date of the New Notes to December 1, 2021. The June and September 2021 Merton Notes cannot be used to exercise Series B Warrants
issued to Starboard Value. The total principal amount outstanding of New Notes as of September 30, 2021 and December 31, 2020 was $180.0
million and $115.0 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Notes 2 and 6 to the consolidated financial statements elsewhere
herein for additional information related to the Starboard Securities and Senior Secured Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Working Capital</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Working capital at September 30, 2021 increased to $465.0 million,
as compared to $332.9 million at December 31, 2020. Accounts receivable from licensees decreased to $412,000 at September 30, 2021, compared
to $506,000 at December 31, 2020. Accounts payable, accrued expenses and accrued compensation increased to $11.8 million at September
30, 2021, from $7.0 million at December 31, 2020. Royalties and contingent legal fees payable decreased to $1.8 million at September 30,
2021, from $2.2 million at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The royalties and contingent legal fees payable are generally scheduled
to be paid in the subsequent quarter upon our receipt of the related fee payments from licensees, in accordance with the underlying contractual
arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Critical Accounting Policies and Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our unaudited interim condensed consolidated financial statements have
been prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of these condensed
consolidated statements requires management to make assumptions, judgments and estimates that can have a significant impact on amounts
reported in these condensed consolidated financial statements. We base our assumptions, judgments and estimates on historical experience
and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these
estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make
changes accordingly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Securities and Exchange Commission (&#8220;SEC&#8221;) has defined
a company&#8217;s critical accounting policies as the ones that are most important to the portrayal of a company&#8217;s financial condition
and results of operations, and which require a company to make its most difficult and subjective judgments. A summary of significant accounting
policies and a description of accounting policies that are considered critical may be found in the audited consolidated financial statements
and notes thereto and under the caption &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
- Critical Accounting Policies&#8221; included in our Annual Report. In addition, as set forth in Note 2 (under the caption &#8220;Use
of Estimates&#8221;) to the consolidated financial statements included in this report, certain accounting policies were identified during
the current period, based on activities occurring during the current period, as critical and requiring significant judgments and estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Adopted Accounting Pronouncements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Note 2 (under the caption &#8220;Recent Accounting Pronouncements&#8221;)
to the consolidated financial statements included in this report for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2021, we did not have any relationships with any
unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities,
which would have been established to facilitate any off-balance sheet arrangements or for any other contractually specified purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq11"></span><b>Item 3. Quantitative and Qualitative Disclosures about Market Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The primary objective of our short-term investment activities is to
preserve principal while concurrently maximizing the income we receive from our equity securities at fair value without significantly
increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that a change
in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity markets, with respect
to market risk, may cause the principal amount or market value of the equity securities at fair value to fluctuate. For example, if we
hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest rate later rises, the
current value of the principal amount of our investment may decline. To minimize these risks in the future, we intend to maintain our
portfolio of cash equivalents and equity securities at fair value in a variety of securities, including commercial paper, money market
funds, government and non-government debt securities, certificates of deposit and equity securities. In general, money market funds are
not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100 basis
point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected to have a material
impact on the value of such money market funds. Declines in interest rates over time will, however, reduce our interest income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2020, we sold all of our investment in debt securities, comprised
of AAA rated money market funds that invested in first-tier only securities, which primarily included domestic commercial paper, securities
issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations and fully collateralized repurchase agreements, and
direct investments in short-term, highly liquid, investment grade, U.S. government and corporate securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investment Risk</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are exposed to investment risks related to changes in the underlying
financial condition of certain of our equity investments in technology companies. The fair value of these investments can be significantly
impacted by the risk of adverse changes in securities markets generally, as well as risks related to the performance of the companies
whose securities we have invested in, risks associated with specific industries, and other factors. These investments are subject to significant
fluctuations in fair value due to the volatility of the securities markets and of the underlying businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2021 and December 31, 2020, the carrying value
of our common stock and warrants in public and private companies was $424.8 million and $285.8 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Foreign Currency Exchange Risk</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we do not have any material foreign operations, we are also
exposed to market risks related to fluctuations in foreign currency exchange rates between the U.S. dollar, and the British Pound and
Euro currency exchange rates, primarily related to revenue agreements with licensees domiciled in foreign jurisdictions and certain equity
security investments. A hypothetical 10% change in exchange rates related to our at risk foreign denominated equity securities would have
approximately a $32.4 million effect on our financial position and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq12"></span><b>Item 4. Controls and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(i). Evaluation of Disclosure Controls and Procedures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the supervision and with the participation of our management,
including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures,
as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on this evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that, as of September 30, 2021, our disclosure controls and procedures were effective to ensure that the information
required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure,
and that such information is recorded, processed, summarized and reported within the time periods prescribed by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(ii). Changes in Internal Control Over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no changes in our internal control over financial reporting
that occurred during our last fiscal quarter (the quarter ended September 30, 2021) that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(iii). Inherent Limitations on Effectiveness of Controls</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management, including our Chief Executive Officer and Chief Financial
Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error
and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the
control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there are resource constraints,
and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems,
no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues
and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about
the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls
may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="septq13"></span>PART II--OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq14"></span><b>Item 1. Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the ordinary course of business, we are the subject of, or party
to, various pending or threatened legal actions, including various counterclaims in connection with our patent enforcement activities.
We believe that any liability arising from these actions will not have a material adverse effect on our consolidated financial position,
results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our operating subsidiaries are often required to engage in litigation
to enforce their patents and patent rights. Certain of our operating subsidiaries are parties to ongoing patent enforcement related litigation,
alleging infringement by third-parties of certain of the patented technologies owned or controlled by our operating subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with any of our patent enforcement actions, it is possible
that a defendant may claim and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local
court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court
may issue monetary sanctions against us or our operating subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s),
which could be material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and
our financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We spend a significant amount of our financial and management resources
to pursue our current litigation matters. We believe that these litigation matters and others that we may in the future determine to pursue
could continue for years and continue to consume significant financial and management resources. The counterparties to our litigation
are sometimes large, well-financed companies with substantially greater resources than us. We cannot assure you that any of our current
or future litigation matters will result in a favorable outcome for us. In addition, in part due to the appeals process and other legal
processes, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the
ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may
be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other
adverse effects which could encumber our ability to effectively and efficiently monetize our assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 6, 2019, Slingshot Technologies, LLC, or Slingshot, filed
a lawsuit in Delaware Chancery Court against the Company and Acacia Research Group, LLC, or collectively, the Acacia Entities, Monarch
Networking Solutions LLC (&#8220;Monarch&#8221;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd., or Transpacific.
Slingshot alleges that the Acacia Entities and Monarch misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities and Monarch by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive
option to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. On March 15, 2021, the court issued orders granting Monarch&#8217;s
motion to dismiss for lack of personal jurisdiction and Ms. Wolanyk&#8217;s motion to dismiss for lack of subject matter jurisdiction.
The remaining parties then commenced discovery, and have since served initial written requests and responses, and notices of the depositions
of the parties&#8217; corporate designees. The Acacia Entities maintain that Slingshot&#8217;s allegations are baseless, that the Acacia
Entities neither had access to nor used Slingshot&#8217;s information in acquiring the portfolio, that the Acacia Entities acquired the
portfolio as a result of the independent efforts of its IP licensing group, and that Slingshot suffered no damages given its exclusive
option to purchase the portfolio had already ended and it has proven itself incapable of closing on the portfolio purchase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the three months ended September 30, 2021 and 2020, there were
no operating expenses related to settlement and contingency accruals. During the nine months ended September 30, 2021, we incurred $338,000
in operating expenses for settlement and contingency accruals. During the nine months ended September 30, 2020, operating expenses included
a net income for settlement offset by contingency accruals totaling $308,000, net of prior accruals. At September 30, 2021 and December
31, 2020, our contingency accrual balance was $587,000 and $1.3 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq15"></span><b>Item 1A. Risk Factors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investment in our common stock involves risks. Before making an
investment decision, you should carefully consider all of the information in this Quarterly Report on Form 10-Q, including in the section
entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part I, Item 2,
as well as our consolidated financial statements and the accompanying notes thereto. In addition, you should carefully consider the risks
and uncertainties described below, and in the section entitled &#8220;Risk Factors&#8221; in Part I, Item 1A of our Annual Report, as
well as in our other public filings with the SEC. If any of the identified risks are realized, our business, financial condition, operating
results and prospects could be materially and adversely affected. In that case, the trading price of our common stock may decline, and
you could lose all or part of your investment. In addition, other risks of which we are currently unaware, or which we do not currently
view as material, could have a material adverse effect on our business, financial condition, operating results and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">Risks related to COVID-19</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The COVID-19 pandemic could have a material adverse effect on
our operations, the operations of our business partners, and the global economy as a whole.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ongoing COVID-19 pandemic, and governmental and societal responses
thereto, have had a severe impact on recent global economic and market conditions, including significant disruption of, and volatility
in, financial markets, global supply chain, and the institution of social distancing and shelter-in-place requirements that have resulted
in temporary closures of many businesses, lost revenues, and increased unemployment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These conditions could adversely impact our operations, as well as
the operations of our licensees and other business partners. <span style="background-color: white">With regard to the COVID-19 pandemic,
we do not expect the current situation to present direct risks to our business. Our cash is held in major financial institutions primarily
in government instruments. Our business is fully able to operate in a socially distanced and/or remote capacity and in accordance with
applicable laws, policies, and best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery
and business continuity policies that have been revised to account for a long-term remote work contingency such as this. </span>While
governmental authorities have taken measures to provide economic assistance to individual households and businesses, stabilize the markets,
and support economic growth, the ultimate success of these measures is unknown and they may not be sufficient to mitigate fully the negative
impact of the ongoing pandemic. <span style="background-color: white">However, the ongoing pandemic may present risks that we do not currently
consider material or risks that may evolve quickly that could have a materially adverse effect on our business, financial condition, operating
results, and/or prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq16"></span><b>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq17"></span><b>Item 3. Defaults Upon Senior Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq18"></span><b>Item 4. Mine Safety Disclosures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq19"></span><b>Item 5. Other Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During August 2021, we entered into a first amendment of an office
lease, to commence for a period of three years upon landlords&#8217; substantial completion of adequate substitution space, as defined.
To date, the substitution space is not ready for use, accordingly the term extension has not begun. Refer to Note 8 to the consolidated
financial statements elsewhere herein for additional information. This agreement is filed herewith, refer to Part II, Item 6, &#8220;Exhibits&#8221;
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="septq20"></span><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 6. Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 15%"><span style="font: 10pt Times New Roman, Times, Serif"><b>EXHIBIT<br />
 <span style="text-decoration: underline">NUMBER</span></b></span></td>
    <td style="width: 85%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">EXHIBIT</span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.1</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Form of Note (incorporated by reference to Exhibit 10.1)</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
    <td style="vertical-align: bottom"><a href="https://www.sec.gov/Archives/edgar/data/934549/000168316821004728/acacia_ex1001.htm"><span style="font-size: 10pt">Fourth Supplemental Agreement, dated as of September 30, 2021, between Starboard Value, L.P., Acacia Research Corporation, Merton Acquisition Holdco LLC and certain other direct and indirect subsidiaries of the Company</span></a> <span style="font-size: 10pt">(incorporated by reference to the Current Report on Form 8-K filed on October 6, 2021)</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.2#</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt"><a href="acacia_ex1002.htm">First Amendment of Lease, dated as of August 5, 2021, between Sage Realty Corporation and Acacia Research Corporation</a> (filed herewith pursuant to Part II, Item 5)</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">31.1#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3101.htm">Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">31.2#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3102.htm">Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">32.1*#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3201.htm">Certification of Principal Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">32.2*#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3202.htm">Certification of Principal Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">The following financial statements from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders' Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">104#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________________</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 20px"><span style="font: 10pt Times New Roman, Times, Serif">#</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Filed herewith.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 20px"><span style="font: 10pt Times New Roman, Times, Serif">*</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, shall not be deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the Registrant&#8217;s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b>ACACIA RESEARCH CORPORATION</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">/s/ Clifford Press&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">By: <b>Clifford Press</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>President and Chief Executive Officer</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>(Principal Executive Officer and Duly Authorized Signatory)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">/s/ Richard Rosenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">By: <b>Richard Rosenstein</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>Chief Financial Officer</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>(Principal Financial Officer)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 51; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>acacia_ex1002.htm
<DESCRIPTION>FIRST AMENDMENT OF LEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FIRST AMENDMENT OF LEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>THIS FIRST AMENDMENT OF LEASE </B>(this &ldquo;First
Amendment of Lease&rdquo;), dated as of the 5th day of August, 2021 (the&ldquo;Effective Date&rdquo;), between SAGE REALTY CORPORATION,
a New York corporation having an office at 767 Third Avenue, New York, New York 10017, as agent for the owner of the building hereinafter
mentioned (&ldquo;Landlord&rdquo;), and ACACIA RESEARCH CORPORATION, a Delaware corporation authorized to do business in New York State,
having an office at 767 Third Avenue, New York, New York 10017 (&ldquo;Tenant&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>W I T N E S S E T H</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>WHEREAS, </B>Landlord and Tenant entered into
an Indenture of Lease, dated as of January 7, 2020 (the &ldquo;Lease&rdquo;), pursuant to which Landlord leases to Tenant, and Tenant
hires from Landlord, a portion of the sixth (6<SUP>th</SUP>) floor (the &ldquo;Existing Premises&rdquo;) in the building known as 767
Third Avenue, New York, New York 10017 (the &ldquo;Building&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WHEREAS, </B>Landlord and
Tenant desire to amend the Lease to provide, among other things, for a substitution of the Existing Premises and for an extension of the
term of the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><B>NOW, THEREFORE, </B>for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">1.&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined Terms.</U></B> All capitalized terms used herein shall have the same meaning ascribed to them in the Lease, unless otherwise
herein indicated, or unless the context hereof shall otherwise require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">2.&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Extension of Term</U></B>. Effective as of the date <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hereof,
the Term is hereby extended to the last day of the month in which the three (3) year and one (1) month anniversary of the Substitution
Space Commencement Date (as such term is defined below) occurs. Said date shall hereafter be deemed the &ldquo;Expiration Date&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">3<B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Substitution
Space</U></B><U>.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the
date of Substantial Completion of Landlord&rsquo;s Substitution Space Work (as such terms are defined below) (the
&ldquo;Substitution Space Commencement Date&rdquo;), that portion of the sixth (6<SUP>th</SUP>) floor of the Building as shown by
diagonal lines on <U>Schedule A</U> attached hereto (the &ldquo;Substitution Space&rdquo;), including all fixtures and equipment
which as of the Substitution Space Commencement Date or during the Term of the Lease are attached thereto or become a part thereof,
shall be substituted in lieu of the Existing Premises, and from and after such date the Substitution Space shall be deemed to be the
&ldquo;Premises&rdquo; for all purposes under the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On or before the date that is five (5) days from and after the Substitution Space Commencement Date (the &ldquo;Surrender Date&rdquo;),
Tenant shall vacate and surrender the Existing Premises to Landlord broom clean, free of all tenancies and Tenant&rsquo;s personal property,
and otherwise in the condition required by the Lease upon the Expiration Date. From and after the later to occur of the Substitution Space
Commencement Date and the actual date Tenant surrenders the Existing Premises to Landlord in accordance with the Lease, Tenant shall have
no further responsibility with respect to the Existing Premises, provided, however, notwithstanding such surrender, Tenant shall be and
remain liable for all obligations relating to the Existing Premises which expressly survive the expiration of the Term of the Lease and
for all obligations relating to the Existing Premises arising prior to the Substitution Space Commencement Date, including, without limitation,
any and all Fixed Rent and additional rent due and owing for the Existing Premises, whether or not theretofore billed, for the period
through and including the day immediately preceding the Substitution Space Commencement Date, and Tenant's failure to pay any such sums
and/or deliver the Existing Premises to Landlord as herein required shall be deemed a default entitling Landlord to all remedies provided
for in the Lease or otherwise available at law. Tenant acknowledges that Tenant&rsquo;s failure to surrender the Existing Premises to
Landlord upon the Surrender Date pursuant to this paragraph will cause substantial damage to Landlord and shall be deemed a holdover governed
by Article 16B of the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 7 herein, the taking of possession by Tenant of the Substitution Space for occupancy by Tenant
shall be deemed an acceptance of same by Tenant. Such taking of possession shall also be conclusive evidence, as against Tenant,
that the Substitution Space and the Building of which the same form a part were in good and satisfactory condition (subject to
Landlord&rsquo;s obligation to remedy any latent defects discovered in the Substitution Space and reported to Landlord within six
(6) months of the Substitution Space Commencement Date) at the time of such occupancy and that the Substitution Space were
substantially as shown on <U>Schedule A.</U> The foregoing provisions shall not be construed to modify Landlord&rsquo;s repair,
maintenance and replacement obligations set forth in the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
Landlord shall be unable to give possession of the Substitution Space on the date anticipated herein for any reason whatsoever,
Landlord shall not be subject to any liability, nor shall the validity of the Lease and this First Amendment of Lease, nor the
obligations of Tenant hereunder be thereby affected <FONT STYLE="font-size: 10pt">(except as may be otherwise expressly set forth
herein). The parties hereto expressly negate the provisions of Section 223-a of the Real Property Law and agree that such
Section shall be inapplicable hereto. Tenant agrees that the provisions of this paragraph are intended to constitute &quot;an
express provision to the contrary&quot; within the meaning of said Section 223-a. Notwithstanding anything to the contrary contained
herein, i</FONT>n the event that Landlord shall be unable to give possession of the Substitution Space to Tenant with
Landlord&rsquo;s Work substantially complete on or prior to the date that is one hundred twenty (120) days from and after the later
of (x) the date on which Tenant has selected its paint and carpet colors for the Substitution Space, and (y) the Effective Date (the
&ldquo;Completion Date&rdquo;) (subject to extension for a period of up to three (3) months in the aggregate by reason of force
majeure [set forth immediately below]), Tenant shall be granted, in addition to the Initial Abatement (as defined below) an
abatement of Fixed Rent hereunder in an amount equal to one (1) day of Fixed Rent for each day after the Completion Date that the
Substitution Space Commencement Date does not occur. Force majeure shall mean any delay in Landlord&rsquo;s substantial completion
of Landlord&rsquo;s Substitution Space Work caused by labor trouble, governmental controls, acts of God, or any other cause beyond
Landlord&rsquo;s reasonable control, provided that Landlord&rsquo;s lack of funds shall not be deemed to be a force majeure
event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Fixed
Rent</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;From and after the Substitution Space Commencement
Date, Section 1C of the Lease amended such that the annual Fixed Rent shall be as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$258,525.00
during the period beginning on the Substitution Space Commencement Date and continuing through the last day of the month in which occurs
the date which immediately precedes the first (1<SUP>st</SUP>) anniversary of the Substitution Space Commencement Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$263,396.76
during the period beginning on the first day of the month immediately following the month in which occurs the date which immediately
precedes the first (1<SUP>st</SUP>) anniversary of the Substitution Space Commencement Date and continuing through the last day of the
month in which occurs the date which immediately precedes the second (2<SUP>nd</SUP>) anniversary of the Substitution Space Commencement
Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$268,365.96
during the period beginning on the first day of the month immediately following the month in which occurs the date which immediately
precedes the second (2<SUP>nd</SUP>) anniversary of the Substitution Space Commencement Date and continuing through the last day of the
month in which occurs the date which immediately precedes the third (3<SUP>rd</SUP>) anniversary of the Substitution Space Commencement
Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 120pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$273,434.53 during the period beginning on the first day of the month immediately following the month in which occurs the date which
immediately precedes the third (3<SUP>rd</SUP>) anniversary of the Substitution Space Commencement Date and continuing through the Expiration
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything herein to the contrary
notwithstanding, provided that this First Amendment of Lease and the Lease shall be in full force and effect and Tenant shall not then
be in default hereunder or thereunder beyond any applicable notice and cure periods, the Fixed Rent attributable to the Substitution Space
shall abate at the rate of $20,299.00 per month for the first (1<SUP>st</SUP>) month following the Substitution Space Commencement Date
(the &ldquo;Initial Abatement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Real
Estate Taxes</U></B>. From and after the <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substitution Space
Commencement Date, Article 5 of the Lease shall also be amended as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subparagraphs
(I) of Section 5A shall be amended and restated in their entirety as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&ldquo;I. The term &ldquo;Base Tax Year&rdquo;
as hereinafter set forth for the determination of real estate tax escalation shall mean calendar year 2021 <U>(i.e.,</U> Real Estate
Taxes, as hereinafter defined, for the Base Tax Year shall be the average of Real Estate Taxes for the period commencing on July 1, 2020,
and ending on June 30, 2021, and Real Estate Taxes for the period commencing on July 1, 2021, and ending on June 30, 2022).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">II. The term &ldquo;the Percentage&rdquo; shall
mean 1.55%.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">6.&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Electric</U></B><U>.
</U>From and after the Substitution Space Commencement Date, Section 5C of the Lease is hereby amended to delete &ldquo;$1,075.21&rdquo;
and replace it with &ldquo;$1,244.75&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">7<B>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Landlord&rsquo;s
Substitution Space Work</U></B><U>.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant hereby acknowledges
that, except as provided in Section 4B above and Section 7B below, Landlord is not required to perform any work, furnish any materials,
or give Tenant any rent credit or work allowance or any sum of money in connection with this First Amendment of Lease and the Substitution
Space, and Tenant is taking the same &ldquo;as-is&rdquo; as of the Substitution Space Commencement Date. The foregoing provisions shall
not be construed to modify Landlord&rsquo;s repair, maintenance and replacement obligations set forth in the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With reasonable promptness
after the date hereof, Landlord agrees to perform the following work in the Substitution Space at Landlord&rsquo;s sole cost and expense
in accordance with the Building standard (collectively, &ldquo;Landlord's Substitution Space Work&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-align: justify; text-indent: 0in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;install new carpet in the Substitution Space with carpet selected by Tenant from the Building-standard carpet options;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-align: justify; text-indent: 0in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; install new Building standard ceiling tiles throughout the Substitution Space; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 120pt; text-align: justify; text-indent: 0in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paint the Substitution Space one coat and one color, with the color selected by Tenant from the Building-standard color chart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this
First Amendment of Lease, the Substitution Space shall be deemed substantially completed (herein, &quot;Substantial Completion&quot;
or &quot;Substantially Completed&quot;) on the date when Landlord's Substitution Space Work has been substantially completed, notwithstanding
the fact that minor changes or insubstantial details of construction, mechanical adjustment or decoration remain to be completed (any
such items, &ldquo;punchlist items&rdquo;), provided Tenant's use and occupancy of the Substitution Space is not thereby materially affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.05in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Extension Option</U></B><U>.
</U>The following new Article 27 is hereby added to the Lease at the end of Article 26:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<U>ARTICLE 27: TENANT&rsquo;S EXTENSION OPTION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provided (i) this Lease shall then be in full force and effect, (ii) Tenant shall not then be in default hereunder beyond any applicable
notice or grace period as of the date of Tenant&rsquo;s exercise of the extension option described herein (which conditions regarding
default may be waived by Landlord in its sole discretion), and (iii) named Tenant herein and/or any of its affiliates that are permitted
to occupy the Premises (and their respective employees, agents and visitors) shall be in actual occupancy of the Premises as of the date
of Tenant&rsquo;s exercise of the extension option described herein and as of the day which would otherwise be the first day of the Extension
Term, Tenant shall have the right, at its option, to extend the Term for a single two (2) year period (the &ldquo;Extension Term&rdquo;).
The Extension Term shall commence on the day immediately following the original Expiration Date and shall expire on the last day of the
month in which occurs the date which immediately precedes the second (2<SUP>nd</SUP>) anniversary of such date unless the Extension Term
shall sooner end pursuant to any of the terms, covenants or conditions of this Lease or pursuant to law. Tenant shall give Landlord written
notice of Tenant&rsquo;s intention to exercise such option on or before the date which is nine (9) months prior to the then-scheduled
Expiration Date, the time of exercise being of the essence, and upon the giving of such notice, this Lease and the Term shall be extended
without execution or delivery of any other or further documents, with the same force and effect as if the Extension Term had originally
been included in the Term and the Expiration Date shall thereupon be deemed to be the last day of the Extension Term. All of the terms,
covenants and conditions of this Lease shall continue in full force and effect during the Extension Term, including items of additional
rent and escalation which shall remain payable on the terms herein set forth, except that (i) the Fixed Rent shall be as determined in
accordance with Section 27B of this Article, (ii) the Base Tax Year shall be revised to the fiscal tax year in which the Extension Term
commences and (iii) Tenant shall have no further right to extend the Term pursuant to this Article. Tenant shall accept the Premises
in its then present &ldquo;as-is&rdquo; condition on the commencement of Extension Term and Landlord shall have no obligation to perform
any work or give Tenant any work allowance, offset or rent credit in connection with the Extension Term. The foregoing provisions shall
not be construed to modify Landlord&rsquo;s repair, maintenance and replacement obligations set forth in the Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Fixed
Rent payable by Tenant for the Premises during the Extension Term shall be the fair market rental value of the Premises taking into consideration
all relevant factors (fair market rental value taking into account the foregoing is hereinafter referred to as the &ldquo;FMRV&rdquo;).
The FMRV shall be determined in accordance with the following procedure:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.75in"></TD><TD STYLE="width: 0.7in">1.</TD><TD>Immediately after the exercise by Tenant of its option under Section 27A above, Landlord and Tenant shall use their good faith efforts
to agree upon the FMRV. In the event Landlord and Tenant cannot reach agreement within fifteen (15) Business Days after the date of Tenant&rsquo;s
notice of exercise of its option, Landlord and Tenant shall each select a reputable, independent, qualified, licensed real estate broker
having an office in New York County and familiar with the rentals then being charged in the Building and in comparable buildings (respectively,
&ldquo;Landlord&rsquo;s Broker&rdquo; and &ldquo;Tenant&rsquo;s Broker&rdquo;) who shall confer promptly after their selection by Landlord
and Tenant and shall use their good faith efforts to agree upon the FMRV. If Landlord&rsquo;s Broker and Tenant&rsquo;s Broker cannot
reach agreement within sixty (60) days after the date of Tenant&rsquo;s notice of exercise of its option, then within ten (10) days thereafter,
they shall designate a third reputable, independent, qualified, licensed real estate broker having an office in New York County (the &ldquo;Independent
Broker&rdquo;). Upon the failure of Landlord&rsquo;s Broker and Tenant&rsquo;s Broker to agree upon the designation of the Independent
Broker, then the Independent Broker shall be appointed by a Justice of the Supreme Court of the State of New York upon ten (10) days&rsquo;
notice, or by any other court in New York County having jurisdiction and exercising
functions similar to those exercised by the Supreme Court of the State of New York. Concurrently with such appointment, Landlord&rsquo;s
Broker and Tenant&rsquo;s Broker shall each submit a letter to the Independent Broker, with a copy to Landlord and Tenant, setting forth
such broker&rsquo;s estimate of the FMRV (respectively, &ldquo;Landlord&rsquo;s Broker&rsquo;s Letter&rdquo; and &ldquo;Tenant&rsquo;s
Broker&rsquo;s Letter&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.75in">&nbsp;</TD>
  <TD STYLE="width: 0.7in">2.</TD>
  <TD>In the event the FMRV set forth in Landlord&rsquo;s Broker&rsquo;s Letter and Tenant&rsquo;s Broker&rsquo;s Letter shall differ by $2.50
or less per square foot for each year during the Extension Term, then the FMRV shall not be determined by the Independent Broker, and
the FMRV shall be the average of the FMRV set forth in Landlord&rsquo;s Broker&rsquo;s Letter and Tenant&rsquo;s Broker&rsquo;s Letter.
In the event the FMRV set forth in Landlord&rsquo;s Broker&rsquo;s Letter and Tenant&rsquo;s Broker&rsquo;s Letter shall differ by more
than $2.50 per square foot per annum for any year during the Extension Term, the Independent Broker shall conduct such investigations
and hearings as he may deem appropriate and shall, within sixty (60) days after the date of his designation, choose either the rental
set forth in Landlord&rsquo;s Broker&rsquo;s Letter or Tenant&rsquo;s Broker&rsquo;s Letter to be the FMRV during the Extension Term
and such choice shall be binding upon Landlord and Tenant. Landlord and Tenant shall each pay the fees and expenses of its respective
broker. The fees and expenses of the Independent Broker shall be shared equally by Landlord and Tenant.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event the Extension
Term shall commence prior to determination of the Fixed Rent during the Extension Term as herein provided, then the Fixed Rent to be
paid by Tenant to Landlord until such determination has been made shall be the Fixed Rent for the twelve (12) month period immediately
preceding the commencement of the Extension Term. After such determination has been made for the Fixed Rent during the Extension Term,
any excess rental for the Extension Term theretofore paid by Tenant to Landlord shall be credited by Landlord against the next ensuing
monthly Fixed Rent payable by Tenant to Landlord and any deficiency in Fixed Rent due from Tenant to Landlord during the Extension Term
shall be paid within fifteen (15) days after written demand.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Termination
Option</U></B><U>.</U> The following new Article 28 is hereby added to the Lease at the end of Article 27:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;<U>ARTICLE 28: TENANT&rsquo;S TERMINATION OPTION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the provisions of Section 28B hereof, Tenant shall have the option to cancel and terminate this Lease (The &ldquo;Termination Option&rdquo;)
effective as of the last day of the month that is nineteen (19) months after the Substitution Space Commencement Date (such date is herein
referred to as the &ldquo;Early Termination Date&rdquo;) by written notice (&ldquo;Tenant&rsquo;s Termination Notice&rdquo;) delivered
to Landlord no later than nine (9) months prior to such Early Termination Date, time being of the essence as to the giving of Tenant&rsquo;s
Termination Notice. Within fifteen (15) days after receipt of Tenant&rsquo;s Termination Notice, Landlord shall deliver to Tenant a statement
setting forth the amount of the Termination Payment (hereinafter defined) that will be due from Tenant in order to exercise such Termination
Option, along with reasonable supporting documentation of the amount of the same. Within fifteen (15) days of receipt of such statement
(and such supporting documentation), Tenant shall deliver to Landlord an unendorsed official bank check drawn on a bank which is a member
of the New York City Clearing House Association or a wire transfer of funds to an account designated by Landlord in an amount equal to
the Termination Payment. Upon timely delivery of Tenant&rsquo;s Termination Notice and the Termination Payment, this Lease will expire
on the Early Termination Date as if such date were the Expiration Date set forth herein and Tenant shall vacate the Premises on or before
the Early Termination Date leaving the same in the condition otherwise required upon the expiration or sooner termination of this Lease.
As used herein, the term &ldquo;Termination Payment&rdquo; shall mean an amount equal to the sum of (a) the unamortized costs (on a straight
line basis over the period from the Substitution Space Commencement Date through the Expiration Date, as extended hereby) of any brokerage
fees paid, the actual out-of-pocket cost of Landlord&rsquo;s Substitution Space Work, and any legal fees related to the negotiation of
this First Amendment of Lease, plus (b) one month (1) of the then current monthly Fixed Rent payment (less the Electric Charge) and monthly
Tenant&rsquo;s Tax Payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
effectiveness of the foregoing option is expressly conditioned upon there not being any uncured default by Tenant beyond any applicable
notice or grace periods hereunder at the time of the exercise of said option and at the time of termination (unless Landlord, in its
sole discretion, elects to waive such condition). The Termination Payment shall be paid by Tenant and received by Landlord as consideration
for the privilege of termination when, as, and if Tenant exercises the said option to terminate this Lease, as aforesaid.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignment
Subletting</U></B><U>.</U> From and after the Effective Date, Article 11 of the Lease shall be deleted and replaced with the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 100pt; text-align: justify">&ldquo;Tenant will not by operation of law or
otherwise, assign, mortgage or otherwise encumber this Lease, nor the estate and Term hereby granted, nor sublet or permit the Premises
or any part thereof to be used by others without Landlord&rsquo;s prior written consent, which consent shall not be unreasonably withheld,
conditioned or delayed. For the purposes of this Lease, any sale, transfer or assignment of any of fifty percent (50%) or more of the
stock of a corporate Tenant or any transfer in the control of Tenant by operation of law or otherwise shall be deemed an assignment.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">11.<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tenant
Work</U></B><U>.</U> Landlord hereby acknowledges and agrees that Tenant may (x) install a variable speed fan by the overhead compressor
and (y) relocate the thermostat located in the Demised Premises to a location approved by Landlord (with Tenant acknowledging that Landlord
has determined that there is no reason to relocate the thermostat); provided, however, that (i) Tenant shall perform all such work in
accordance with the terms and provisions of the Lease, (ii) Tenant shall deliver to Landlord plans for such work, which must be approved
by Landlord (such approval not to be unreasonably withheld, conditioned or delayed) prior to performing such work and (iii) Tenant shall
be responsible all costs associated with the foregoing work and shall be responsible for all maintenance, repair and replacement of the
relocated thermostat, fan and associated systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">12.&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto agree that Sage Realty Corporation and Jones Lang LaSalle (collectively, the &ldquo;Brokers&rdquo;), were the only
brokers who negotiated and brought about this transaction, and Landlord agrees to pay the Brokers a commission therefor as per separate
agreement. Tenant represents and warrants that it has not dealt with any broker other than the Brokers, and Tenant agrees to indemnify
and save Landlord harmless from and against any claims made by other brokers claiming to have dealt with Tenant. Landlord represents and
warrants that it has not dealt with any broker other than the Brokers, and Landlord agrees to indemnify and save Tenant harmless from
and against any claims made by the Brokers or other brokers claiming to have dealt with Landlord.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tenant warrants and represents that, to its actual knowledge, as of the date hereof, Landlord has performed all of its obligations under
the Lease. Landlord warrants and represents that, to its actual knowledge, as of the date hereof, Tenant has performed all of its obligations
under the Lease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
It is expressly understood and agreed that, pursuant to this First Amendment of Lease, the Term of the Lease is only extended until the
date which is three (3) years and one (1) month following the Substitution Space Commencement Date. Except as otherwise set forth in Article
27 of the Lease, any further extension of the Term of the Lease if the parties hereafter shall agree to same shall require a written agreement
between the parties hereto and any such agreement shall not be binding upon Landlord or Tenant unless same is fully executed and unconditionally
delivered by Landlord and Tenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as modified by this First Amendment of Lease, the Lease and each of the covenants, terms and conditions set forth therein are and
shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Lease may be signed by facsimile signature or electronic mail in portable document format and may be executed in counterparts, all
such counterparts shall constitute the same agreement, and the signature of any party to any counterpart shall be deemed a signature to,
and may be attached to, any other counterparts provided, however, that original signed pages shall be sent by the parties to each other
promptly thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signatures appear on following page.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>IN WITNESS WHEREOF, </B>Landlord
and Tenant have respectively executed this First Amendment of Lease as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SAGE REALTY CORPORATION, as Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By:<U>/s/ Jonathan Kaufman Iger</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:Jonathan Kaufman Iger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: CEO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 9pt Sans-Serif; color: Red"><B></B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ACACIA
RESEARCH CORPORATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <U>/s/ Richard Rosenstein</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:Richard Rosenstein </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title: Chief Financial officer</P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSTITUTION SPACE FLOOR PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Sans-Serif; font-size: 9pt; color: Red"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[See attached]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex1002_image1.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>acacia_ex3101.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Clifford Press, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. I have reviewed this Quarterly Report on Form
10-Q of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2. Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">4. The registrant&rsquo;s other certifying officer and I
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and
the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</FONT></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>/s/ Clifford Press &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Clifford Press</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>President and Chief Executive Officer</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Principal Executive Officer)</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>acacia_ex3102.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Richard Rosenstein, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. I have reviewed this Quarterly Report on Form
10-Q of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2. Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">4. The registrant&rsquo;s other certifying officer and I
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period
in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and
the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</FONT></TD>
    <TD STYLE="width: 50%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Richard Rosenstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Richard Rosenstein</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Financial Officer</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Principal Financial Officer)</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>acacia_ex3201.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report of Acacia
Research Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly period ended September 30, 2021, as filed with the Securities
and Exchange Commission on November 15, 2021 (the &ldquo;Report&rdquo;), I, Clifford Press, President and Chief Executive Officer of the
Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350,
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By: <U>/s/ Clifford Press&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clifford Press</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President and Chief Executive Officer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(Principal Executive Officer)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report pursuant
to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed
by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.
This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>acacia_ex3202.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report of Acacia
Research Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly period ended September 30, 2021, as filed with the Securities
and Exchange Commission on November 15, 2021 (the &ldquo;Report&rdquo;), I, Richard Rosenstein, Chief Financial Officer of the Company,
hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: November 15, 2021</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By: <U>/s/ Richard Rosenstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Rosenstein</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(Principal Financial Officer)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report pursuant
to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed
by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section.
This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities
Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex1002_image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1002_image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'H G\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[\'_ !H_X63XA_O6G_?@_P"-'UVGY_<'U"MY?>>R9%&17C?_  LGQ#_>M/\
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MKV'O7CWQ,_Y&[_MUC_FU<F-_A?,[,!_&^\X^BBBO(/;"BBB@ HHH[T %%%%
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MY^3[HSTS[8J)45&-[]_P*6(<I62[?BCGZ***P.D**** "BBB@ HHHH ****
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M\HO^_P"G^-'_  KWQ)_SY1?]_P!/\:]LP*,"CZC3\Q_VA5\ON/$_^%>^)/\
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MZ?XT?\*]\2?\^47_ '_3_&O;,"C H^I4^[#^T*OE]QXG_P *]\2?\^47_?\
M3_&C_A7OB3_GRB_[_I_C7MF!1@4?4J?=A_:%7R^X\3_X5[XD_P"?*+_O^G^-
M'_"O?$G_ #Y1?]_T_P :]LP*,"CZE3[L/[0J^7W'B?\ PKWQ)_SY1?\ ?]/\
M:/\ A7OB3_GRB_[_ *?XU[9@48%'U*GW8?VA5\ON/$_^%>^)/^?*+_O^G^-'
M_"O?$G_/E%_W_3_&O;,"C H^I4^[#^T*OE]QXG_PKWQ)_P ^47_?]/\ &C_A
M7OB3_GRB_P"_Z?XU[9@48%'U*GW8?VA5\ON/$_\ A7OB3_GRB_[_ *?XT?\
M"O?$G_/E%_W_ $_QKVS HP*/J5/NP_M"KY?<>)_\*]\2?\^47_?]/\:/^%>^
M)/\ GRB_[_I_C7MF!1@4?4J?=A_:%7R^X\3_ .%>^)/^?*+_ +_I_C1_PKWQ
M)_SY1?\ ?]/\:]LP*,"CZE3[L/[0J^7W'B?_  KWQ)_SY1?]_P!/\:/^%>^)
M/^?*+_O^G^->V8%&!1]2I]V']H5?+[CQ/_A7OB3_ )\HO^_Z?XT?\*]\2?\
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MXU[9@48%'U*GW8?VA5\ON/$_^%>^)/\ GRB_[_I_C1_PKWQ)_P ^47_?]/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9$7#2MO<Y^\< 9_( ?@* )A1110 4444 %%%% !1110 4444 %%%% !1110
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M (U77Q 7!9;"?;DC)91T./7UH VJ*QCKK@\Z?/UQ]Y?Q[]J/[>?_ *!T_P!
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M4_V>'_GE'_WP*9=?=C_ZZ"K':@"+[/#_ ,\H_P#O@4?9X?\ GE'_ -\"I:*
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M*_-G .1W]N?3HWMV=H9*0S6S$DPOA3G/RM\PY[\'K0!JT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5CX_XG]QGT@_]GK8K'_YCUQQ_#!_[/0!KCI2T44
M%%%% !1110 4444 %%%% !1110 4444 5[K[L?\ UT%6.U5[K[L?_7058[4
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MH **** "L?\ YCUQ_NP?^SUL5CX_XG]P?]F#^;T ; Z4444 %%&:* "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/_ ,QZXX_A@_\ 9ZV*Q_\ F/7'^[!_[/0!L4444 ,E_P!4_./E-,,$>TGY
MNG]\_P"-2, RE3T(Q47V?C'FR_\ ?5 $D?\ JU^@I](H"@ = ,4M !1110 4
M444 %&*** "BBB@"O=?=C_ZZ"K':J]U]V/\ ZZ"K':@ HHHH **** "BBB@
MHHHH **** "BBB@ K&M1_HYY(_>/U[_.>X]/7M6S6/:?ZE@.,2.3GY?XSSGU
MQT/X&@"8X&!M)QGC'3VQ_3OU%!SG@^GS9S^/_P!?OT-!QC)(QUZ$<#^@_,4$
M'..>N""/7KQWSZ=#U'- "'ICT'(_S_\ K%+SGDG.>HQ_G)_(T=>>W49[>G_Z
M^W0T#)8C'/(Z9^H_^M^(H 3H.>"0.<X!]\]>.Q[=#0<X^F<#;T]MO?W'XCM2
MG)YSW X.2,^_]>AHSCE< XSUP#ST)]!^:_2@".3_ %L7/\?<^Q_SGOT/-/Y
MZ9'\O_K#\UQZ=&R;%0O(<*O))XQ^ ]<\COU%-MV=XP6!4$@QDGYL$=3Z'L#^
M!YH E'!]>O/!S[?CZ=#U%(,@=>.._P"N[^1_ TI./3CJ!TX_I[=1VXI,9]<Y
MQGJ?\.?R/UH 9-_Q[2Y_YYM@;<8XZ8]NOMVXIFCY&IZ@"/X8>X.?E//'^33I
MS_HTK9PWEDG!P#QCKU_'MT--T<8U+4.H&(N,8['MVH V:*** "BBB@ HHHH
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M$-JMHSALG[5"\B@8/9>1]?K6MVKG_%HM&TU5OKB2*V#&21$E5/."J3Y9W##
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M%% !1110 4444 %1M!"S%FB0L>I*CFI** &I&D8PB*HZ\#%.HHH KW7W8_\
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M'H/]D_Y]NE23C_1I5(!^1A@CVST_F/Q%1Z1_R$K_ #UV0]\_PGOWH V:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "N=\7:E;:7IT=S=3I"@<Y=KPV^0%)*JPZL<8 .![
M\5T58WB*6Z@T\SVL=PYBR\GV>9(V"@$GE@0>G2@"'PI<P7NE-<V]U!<K),Q9
MX+EKA00 ,>8WWB,#H,=JWZR]%%T+5Q>I.DWFDD32K(V,#NH Q[8K4H *Q_\
MF/7'^[!_[/6Q6.#_ ,3ZXX/W8/\ V>@#8HHHH **** "BBB@ HHHH ***,T
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MD679$$90NXCD$@'U[?S4^U6,G'3.,]NA],=/PZ'J*AZ7OI\@P2??@Y_K^!H
M3[0&@,D9^;.W!'\9X*E?7U'?J*E0[D5NF<-UZ>G/]?P-1R0QY>4#YMN" 3C\
MO;\QVXQ2Q%C''\J_=&"#UX^G?\C0 _'&#V&.GY\?TZCMQ2G)SZDY(&"<G].?
MR/UI,MG 4<C/#$9'J#C/'3/;O2;B'5&4#<"!QP3Z8^G./J10!!=P/+LDC/\
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M]^F_PI\HS&P]C33*N" KY_W#_A0!("&&1TI:9&,(H]A3Z "C-%4+YW28%2Y
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MMEIEO9Y9 6D8?-(QR6J[B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I&^Z?I2TC?=/TH HG_CUD_P"O=?Y-3)]#T^XNI+I[8&>0
M;6D#E6QQW!XZ#]?6G,P%J^2!FW7'Y&GSW30NBK\^\XR.QZ]@?UQ0!37PQHZ,
MS)81C><N.<-R3R._6K?E&%U=T+1Q#$849V# YYY)]_2K!? /[T?I5:*Y:=)@
MQ";<J"1U/?KC_#WH FDN0J)Y:L[R#Y5']?0>],$$<XS>00/(G!)4$>O&>U4
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MJ9Z[1C-/HH KR0&2<2"1E^7;@ '//N*/LQ_Y[O\ ]\I_A5BB@"NL!24/YC,
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M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T
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MD1M,LF[/).16K30,=J=6B5D9MW=PHHHIB"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH QM4\*Z'K<Z3ZGI5K=RH-JO*F3CTSW'M6I;P16MND$,:1
M11J%1$4!5 Z  =!4M% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>actg-20210930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOamJ2aPty552yYkxvmR5fck6LysqWFS1xiLTlXI2AZQN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ACTG="http://acaciaresearch.com/20210930" elementFormDefault="qualified" targetNamespace="http://acaciaresearch.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://acaciaresearch.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" id="UnauditedCondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" id="UnauditedCondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" id="UnauditedCondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" id="UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity">
	  <link:definition>00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" id="EquitySecuritiesPortfolioInvestment">
	  <link:definition>00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentAtFairValue" id="InvestmentAtFairValue">
	  <link:definition>00000010 - Disclosure - INVESTMENT AT FAIR VALUE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" id="PatentsNetOfAccumulatedAmortization">
	  <link:definition>00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StarboardInvestment" id="StarboardInvestment">
	  <link:definition>00000012 - Disclosure - STARBOARD INVESTMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueMeasurements" id="FairValueMeasurements">
	  <link:definition>00000013 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomelossPerShare" id="IncomelossPerShare">
	  <link:definition>00000016 - Disclosure - INCOME/LOSS PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SubsequentEvent" id="SubsequentEvent">
	  <link:definition>00000017 - Disclosure - SUBSEQUENT EVENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" id="DescriptionOfBusinessAndBasisOfPresentationPolicies">
	  <link:definition>00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" id="EquitySecuritiesPortfolioInvestmentTables">
	  <link:definition>00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueTables" id="InvestmentAtFairValueTables">
	  <link:definition>00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" id="PatentsNetOfAccumulatedAmortizationTables">
	  <link:definition>00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
	  <link:definition>00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
	  <link:definition>00000026 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomelossPerShareTables" id="IncomelossPerShareTables">
	  <link:definition>00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" id="SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" id="SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails">
	  <link:definition>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" id="EquitySecuritiesPortfolioInvestmentDetails">
	  <link:definition>00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" id="EquitySecuritiesPortfolioInvestmentDetailsNarrative">
	  <link:definition>00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" id="InvestmentAtFairValueDetails">
	  <link:definition>00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" id="PatentsNetOfAccumulatedAmortizationDetails">
	  <link:definition>00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" id="PatentsNetOfAccumulatedAmortizationDetailsNarrative">
	  <link:definition>00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" id="StarboardInvestmentDetailsNarrative">
	  <link:definition>00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" id="FairValueMeasurementsDetails-FairValueOnRecurringBasis">
	  <link:definition>00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" id="FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3">
	  <link:definition>00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
	  <link:definition>00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
	  <link:definition>00000042 - Disclosure -  STOCKHOLDERS' EQUITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000043 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomelossPerShareDetails" id="IncomelossPerShareDetails">
	  <link:definition>00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="ACTG_SeriesARedeemableConvertiblePreferredStockMember" name="SeriesARedeemableConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PaidUpRevenueAgreementsMember" name="PaidUpRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RecurringRevenueAgreementsMember" name="RecurringRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicenseeMember" name="OneLicenseeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TwoLicenseeMember" name="TwoLicenseeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ThreeLicenseeMember" name="ThreeLicenseeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee2Member" name="OneLicensee2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee3Member" name="OneLicensee3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ForeignLicenseeMember" name="ForeignLicenseeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritesLfFundPublicSecuritiesMember" name="EquitySecuritesLfFundPublicSecuritiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesOtherEquityMember" name="EquitySecuritiesOtherEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_BlackScholesMethodMember" name="BlackScholesMethodMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RSAsMember" name="RSAsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OptionAgreementMember" name="OptionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PortfolioCompaniesMember" name="PortfolioCompaniesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritesLfFundSecuritiesMember" name="EquitySecuritesLfFundSecuritiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritesDerivativeMember" name="EquitySecuritesDerivativeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritesForwardContractMember" name="EquitySecuritesForwardContractMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesLFFundTradingSecurityMember" name="EquitySecuritiesLFFundTradingSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_LFFundSecuritiesMember" name="LFFundSecuritiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantInvestmentMember" name="WarrantInvestmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_CommonStockInvestmentMember" name="CommonStockInvestmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StarboardValueMember" name="StarboardValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesARedeemableConvertibleStockMember" name="SeriesARedeemableConvertibleStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsMember" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeniorSecuredNotesMember" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeptemberRedemptionMember" name="SeptemberRedemptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DecemberRedemptionMember" name="DecemberRedemptionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_MertonMember" name="MertonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NewNotesMember" name="NewNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" name="SeriesAEmbeddedDerivativeLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAWarrantsLiabilityMember" name="SeriesAWarrantsLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsLiabilityMember" name="SeriesBWarrantsLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StockRepurchaseProgramMember" name="StockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmployeeStockOptionsMember" name="EmployeeStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquityBasedIncentiveAwardsMember" name="EquityBasedIncentiveAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" name="EquitySecuritiesWithoutReadilyDeterminableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquityMethodInvestmentsCurrent" name="EquityMethodInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RoyaltiesAndContingentLegalFeesPayable" name="RoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccruedPatentInvestmentCostsCurrent" name="AccruedPatentInvestmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DerivativeLiabilitiesNoncurrent1" name="DerivativeLiabilitiesNoncurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ContingentLegalFees" name="ContingentLegalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_LitigationAndLicensingExpensesPatents" name="LitigationAndLicensingExpensesPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetPortfolioIncomeLoss" name="NetPortfolioIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfEquitySecurities" name="ChangeInFairValueOfEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EarningsOnEquityInvestmentInJointVenture" name="EarningsOnEquityInvestmentInJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InterestIncomeExpenseAndOther" name="InterestIncomeExpenseAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" name="NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" name="AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" name="IssuanceOfCommonStockForVestingOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" name="IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" name="IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" name="IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" name="ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_UnrealizedGainLossOnDerivatives1" name="UnrealizedGainLossOnDerivatives1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" name="GainOnSaleOfPrepaidInvestmentAndDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" name="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PurchasesOfPrepaidInvestment" name="PurchasesOfPrepaidInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" name="EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" name="SeniorSecuredNotesIssuanceCostsPaidToOtherParties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NoncashInvestingActivitesAbstract" name="NoncashInvestingActivitesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3" name="TradeDateReceivableFromSaleOfEquitySecuritiesNote3" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PatentAcquisitionInExchangeOfNotesReceivable" name="PatentAcquisitionInExchangeOfNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PatentAcquisitionAccruedLiabilityShortTerm" name="PatentAcquisitionAccruedLiabilityShortTerm" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PatentAcquisitionAccruedLiabilityLongTerm" name="PatentAcquisitionAccruedLiabilityLongTerm" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AcquisitionOfPrepaidInvestmentSecurities" name="AcquisitionOfPrepaidInvestmentSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" name="DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_BusinessDescriptionTextBlock" name="BusinessDescriptionTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" name="DisclosurePatentsNetOfAccumulatedAmortizationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PatentsNetOfAccumulatedAmortizationTextBlock" name="PatentsNetOfAccumulatedAmortizationTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DisclosureStarboardInvestmentAbstract" name="DisclosureStarboardInvestmentAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StarboardInvestmentTextBlock" name="StarboardInvestmentTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DescriptionOfBusinessPolicyTextBlock" name="DescriptionOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_BasisOfAccountingPoliesPolicyTextBlock" name="BasisOfAccountingPoliesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_Covid19PandemicAndCaresActPolicyTextBlock" name="Covid19PandemicAndCaresActPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SegmentReportingPolicyTextBlock" name="SegmentReportingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EstimatesPolicytextBlock" name="EstimatesPolicytextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PatentPortfolioOperationsPolicyTextBlock" name="PatentPortfolioOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ConcentrationsPolicyTextBlock" name="ConcentrationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RelatedPartyTransactionsPolicyTextBlock" name="RelatedPartyTransactionsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesAtFairValuePolicyTextBlock" name="EquitySecuritiesAtFairValuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ImpairmentOfInvestmentPolicyTextBlock" name="ImpairmentOfInvestmentPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAandBWarrantsPolicyTextBlock" name="SeriesAandBWarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NumberOfPatentPortfoliosAcquired" name="NumberOfPatentPortfoliosAcquired" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" name="GainOnSaleOfPrepaidInvestmentAndDerivativey" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccruedPatentAcquisitionCosts" name="AccruedPatentAcquisitionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsExercisedShares" name="WarrantsExercisedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RedemptionOfSecuredNotes" name="RedemptionOfSecuredNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetIncomeForSettlementOffsetByContingencyAccruals" name="NetIncomeForSettlementOffsetByContingencyAccruals" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" name="ApproximateValueOfSharesThatMayYetBePurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" name="DividendOnSeriesRedeemableConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" name="AccretionOfSeriesRedeemableConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" name="ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesWarrants" name="ChangeInFairValueOfSeriesWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" name="ChangeInFairValueOfDilutiveSeriesBWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" name="InterestExpenseAssociatedWithStarboardNotesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" name="NetIncomeLossAvailableToCommonStockholderDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" name="EarningsPerShareBasicAndDilutedDeniminatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>actg-20210930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:href="actg-20210930.xsd#InvestmentAtFairValue" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortization" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestment" xlink:href="actg-20210930.xsd#StarboardInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurements" xlink:href="actg-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShare" xlink:href="actg-20210930.xsd#IncomelossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvent" xlink:href="actg-20210930.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:href="actg-20210930.xsd#InvestmentAtFairValueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:href="actg-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20210930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:href="actg-20210930.xsd#IncomelossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:href="actg-20210930.xsd#InvestmentAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#StarboardInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20210930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:href="actg-20210930.xsd#IncomelossPerShareDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaapEquitySecuritiesFvNi" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEquitySecuritiesFvNi" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_ACTGEquitySecuritiesWithoutReadilyDeterminableFairValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_ACTGEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityMethodInvestmentsCurrent" xlink:label="loc_ACTGEquityMethodInvestmentsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_ACTGEquityMethodInvestmentsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaapOtherInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccruedPatentInvestmentCostsCurrent" xlink:label="loc_ACTGAccruedPatentInvestmentCostsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ACTGAccruedPatentInvestmentCostsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="loc_ACTGDerivativeLiabilitiesNoncurrent1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ACTGDerivativeLiabilitiesNoncurrent1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfEquitySecurities" xlink:label="loc_ACTGChangeInFairValueOfEquitySecurities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ACTGChangeInFairValueOfEquitySecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsOnEquityInvestmentInJointVenture" xlink:label="loc_ACTGEarningsOnEquityInvestmentInJointVenture" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ACTGEarningsOnEquityInvestmentInJointVenture" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestIncomeExpenseAndOther" xlink:label="loc_ACTGInterestIncomeExpenseAndOther" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ACTGInterestIncomeExpenseAndOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="loc_ACTGUnrealizedGainLossOnDerivatives1" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGUnrealizedGainLossOnDerivatives1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfEquitySecurities" xlink:label="loc_ACTGChangeInFairValueOfEquitySecurities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGChangeInFairValueOfEquitySecurities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PurchasesOfPrepaidInvestment" xlink:label="loc_ACTGPurchasesOfPrepaidInvestment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ACTGPurchasesOfPrepaidInvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:label="loc_ACTGEquitySecuritiesDerivativeAndForwardContractAcquisitionCost" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ACTGEquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:label="loc_ACTGSeniorSecuredNotesIssuanceCostsPaidToOtherParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ACTGSeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:title="00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:title="00000010 - Disclosure - INVESTMENT AT FAIR VALUE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:title="00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestment" xlink:title="00000012 - Disclosure - STARBOARD INVESTMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurements" xlink:title="00000013 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShare" xlink:title="00000016 - Disclosure - INCOME/LOSS PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvent" xlink:title="00000017 - Disclosure - SUBSEQUENT EVENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:title="00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:title="00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:title="00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:title="00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:title="00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:title="00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:title="00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:title="00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:title="00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:title="00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:title="00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:title="00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:title="00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000042 - Disclosure -  STOCKHOLDERS&apos; EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:title="00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>actg-20210930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:href="actg-20210930.xsd#InvestmentAtFairValue" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortization" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestment" xlink:href="actg-20210930.xsd#StarboardInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurements" xlink:href="actg-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShare" xlink:href="actg-20210930.xsd#IncomelossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvent" xlink:href="actg-20210930.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:href="actg-20210930.xsd#InvestmentAtFairValueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:href="actg-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20210930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:href="actg-20210930.xsd#IncomelossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:href="actg-20210930.xsd#InvestmentAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#StarboardInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20210930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:href="actg-20210930.xsd#IncomelossPerShareDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_50" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" xlink:label="loc_ACTGNetIncomeIncludingNoncontrollingInterestsInSubsidiaries_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNetIncomeIncludingNoncontrollingInterestsInSubsidiaries_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" xlink:label="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnits_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" xlink:label="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" xlink:label="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" xlink:label="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares_80" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:title="00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:title="00000010 - Disclosure - INVESTMENT AT FAIR VALUE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:title="00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestment" xlink:title="00000012 - Disclosure - STARBOARD INVESTMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurements" xlink:title="00000013 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShare" xlink:title="00000016 - Disclosure - INCOME/LOSS PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvent" xlink:title="00000017 - Disclosure - SUBSEQUENT EVENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:title="00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:title="00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:title="00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:title="00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:title="00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundPublicSecuritiesMember" xlink:label="loc_ACTGEquitySecuritesLfFundPublicSecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesLfFundPublicSecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesOtherEquityMember" xlink:label="loc_ACTGEquitySecuritiesOtherEquityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesOtherEquityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaapEquitySecuritiesFvNiCost_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiCost_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="loc_us-gaapEquityMethodInvestmentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentsFairValueDisclosure_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicenseeMember" xlink:label="loc_ACTGOneLicenseeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicenseeMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_TwoLicenseeMember" xlink:label="loc_ACTGTwoLicenseeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGTwoLicenseeMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ThreeLicenseeMember" xlink:label="loc_ACTGThreeLicenseeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGThreeLicenseeMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicensee2Member_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicensee3Member_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ForeignLicenseeMember" xlink:label="loc_ACTGForeignLicenseeMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGForeignLicenseeMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BlackScholesMethodMember" xlink:label="loc_ACTGBlackScholesMethodMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGBlackScholesMethodMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RSAsMember" xlink:label="loc_ACTGRSAsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGRSAsMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NonQualifiedStockOptionsMember" xlink:label="loc_ACTGNonQualifiedStockOptionsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGNonQualifiedStockOptionsMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfLongtermInvestments_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfLongtermInvestments_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_310" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_310" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_310" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensation_310" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_310" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_310" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_310" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:title="00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaapMarketableSecuritiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaapMarketableSecuritiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapMarketableSecuritiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundSecuritiesMember" xlink:label="loc_ACTGEquitySecuritesLfFundSecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesLfFundSecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesDerivativeMember" xlink:label="loc_ACTGEquitySecuritesDerivativeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesDerivativeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesForwardContractMember" xlink:label="loc_ACTGEquitySecuritesForwardContractMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesForwardContractMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesLFFundTradingSecurityMember" xlink:label="loc_ACTGEquitySecuritiesLFFundTradingSecurityMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesLFFundTradingSecurityMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LFFundSecuritiesMember" xlink:label="loc_ACTGLFFundSecuritiesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGLFFundSecuritiesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGainLoss_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGainLoss_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="loc_us-gaapRealizedInvestmentGainsLosses_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapRealizedInvestmentGainsLosses_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivativey_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivativey_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_210" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:title="00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OptionAgreementMember" xlink:label="loc_ACTGOptionAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGOptionAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="loc_ACTGPortfolioCompaniesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGPortfolioCompaniesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:title="00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaapInvestmentHoldingsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaapInvestmentHoldingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapInvestmentHoldingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaapGainOnSaleOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainOnSaleOfInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:title="00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:title="00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:title="00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_MertonMember" xlink:label="loc_ACTGMertonMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGMertonMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeptemberRedemptionMember" xlink:label="loc_ACTGSeptemberRedemptionMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeptemberRedemptionMember_170" xlink:type="arc" order="173" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DecemberRedemptionMember" xlink:label="loc_ACTGDecemberRedemptionMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGDecemberRedemptionMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="loc_ACTGSeniorSecuredNotesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotesMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NewNotesMember" xlink:label="loc_ACTGNewNotesMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGNewNotesMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAccretionExpense_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_300" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_300" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ACTGWarrantsExercisedShares_300" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_300" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RedemptionOfSecuredNotes" xlink:label="loc_ACTGRedemptionOfSecuredNotes_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ACTGRedemptionOfSecuredNotes_300" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_300" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent_300" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsGross_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsGross_300" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_300" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_300" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt_300" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_300" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLongTermDebt_300" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_300" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:title="00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapEquitySecuritiesMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember_120" xlink:type="arc" order="124" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_200" xlink:type="arc" order="204" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_240" xlink:type="arc" order="244" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_280" xlink:type="arc" order="284" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_530" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:title="00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesAWarrantsLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsLiabilityMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesBWarrantsLiabilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsLiabilityMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_410" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_410" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000042 - Disclosure -  STOCKHOLDERS&apos; EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="loc_us-gaapEquityClassOfTreasuryStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="loc_us-gaapClassOfTreasuryStockTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapClassOfTreasuryStockTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:title="00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="loc_ACTGEmployeeStockOptionsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmployeeStockOptionsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="loc_ACTGEquityBasedIncentiveAwardsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGEquityBasedIncentiveAwardsMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapNetIncomeLoss_370" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact_370" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_370" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_370" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_370" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGDividendOnSeriesRedeemableConvertiblePreferredStock_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGDividendOnSeriesRedeemableConvertiblePreferredStock_370" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock_370" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_370" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="loc_ACTGChangeInFairValueOfSeriesWarrants_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesWarrants_370" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants_370" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" xlink:label="loc_ACTGInterestExpenseAssociatedWithStarboardNotesNetOfTax_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGInterestExpenseAssociatedWithStarboardNotesNetOfTax_370" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_370" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_370" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" xlink:label="loc_ACTGNetIncomeLossAvailableToCommonStockholderDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGNetIncomeLossAvailableToCommonStockholderDiluted_370" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_370" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_370" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_370" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_370" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_370" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_370" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" xlink:label="loc_ACTGAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_370" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_370" xlink:type="arc" order="23" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>actg-20210930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="us-gaap_RedeemablePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockMember" xlink:to="us-gaap_RedeemablePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemablePreferredStockMember_lbl" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="ACTG_PaidUpRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PaidUpRevenueAgreementsMember" xlink:to="ACTG_PaidUpRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PaidUpRevenueAgreementsMember_lbl" xml:lang="en-US">Paid Up Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="ACTG_RecurringRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RecurringRevenueAgreementsMember" xlink:to="ACTG_RecurringRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RecurringRevenueAgreementsMember_lbl" xml:lang="en-US">Recurring Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicenseeMember" xlink:label="ACTG_OneLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicenseeMember" xlink:to="ACTG_OneLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicenseeMember_lbl" xml:lang="en-US">One Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_TwoLicenseeMember" xlink:label="ACTG_TwoLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TwoLicenseeMember" xlink:to="ACTG_TwoLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TwoLicenseeMember_lbl" xml:lang="en-US">Two Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ThreeLicenseeMember" xlink:label="ACTG_ThreeLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ThreeLicenseeMember" xlink:to="ACTG_ThreeLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ThreeLicenseeMember_lbl" xml:lang="en-US">Three Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee2Member" xlink:label="ACTG_OneLicensee2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee2Member" xlink:to="ACTG_OneLicensee2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee2Member_lbl" xml:lang="en-US">One Licensee 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee3Member" xlink:label="ACTG_OneLicensee3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee3Member" xlink:to="ACTG_OneLicensee3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee3Member_lbl" xml:lang="en-US">One Licensee 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ForeignLicenseeMember" xlink:label="ACTG_ForeignLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignLicenseeMember" xlink:to="ACTG_ForeignLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ForeignLicenseeMember_lbl" xml:lang="en-US">Foreign Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundPublicSecuritiesMember" xlink:label="ACTG_EquitySecuritesLfFundPublicSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritesLfFundPublicSecuritiesMember" xlink:to="ACTG_EquitySecuritesLfFundPublicSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritesLfFundPublicSecuritiesMember_lbl" xml:lang="en-US">Equity Securites Lf Fund Public Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesOtherEquityMember" xlink:label="ACTG_EquitySecuritiesOtherEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesOtherEquityMember" xlink:to="ACTG_EquitySecuritiesOtherEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesOtherEquityMember_lbl" xml:lang="en-US">Equity Securities Other Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BlackScholesMethodMember" xlink:label="ACTG_BlackScholesMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_BlackScholesMethodMember" xlink:to="ACTG_BlackScholesMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_BlackScholesMethodMember_lbl" xml:lang="en-US">Black Scholes Method [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="ACTG_RestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RestrictedStockUnitsMember" xlink:to="ACTG_RestrictedStockUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RestrictedStockUnitsMember_lbl" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RSAsMember" xlink:label="ACTG_RSAsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RSAsMember" xlink:to="ACTG_RSAsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RSAsMember_lbl" xml:lang="en-US">R S As [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NonQualifiedStockOptionsMember" xlink:label="ACTG_NonQualifiedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonQualifiedStockOptionsMember" xlink:to="ACTG_NonQualifiedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US">Non Qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OptionAgreementMember" xlink:label="ACTG_OptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OptionAgreementMember" xlink:to="ACTG_OptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OptionAgreementMember_lbl" xml:lang="en-US">Option Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="ACTG_PortfolioCompaniesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioCompaniesMember" xlink:to="ACTG_PortfolioCompaniesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PortfolioCompaniesMember_lbl" xml:lang="en-US">Portfolio Companies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundSecuritiesMember" xlink:label="ACTG_EquitySecuritesLfFundSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritesLfFundSecuritiesMember" xlink:to="ACTG_EquitySecuritesLfFundSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritesLfFundSecuritiesMember_lbl" xml:lang="en-US">Equity Securites Lf Fund Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesDerivativeMember" xlink:label="ACTG_EquitySecuritesDerivativeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritesDerivativeMember" xlink:to="ACTG_EquitySecuritesDerivativeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritesDerivativeMember_lbl" xml:lang="en-US">Equity Securites Derivative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesForwardContractMember" xlink:label="ACTG_EquitySecuritesForwardContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritesForwardContractMember" xlink:to="ACTG_EquitySecuritesForwardContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritesForwardContractMember_lbl" xml:lang="en-US">Equity Securites Forward Contract [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesLFFundTradingSecurityMember" xlink:label="ACTG_EquitySecuritiesLFFundTradingSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesLFFundTradingSecurityMember" xlink:to="ACTG_EquitySecuritiesLFFundTradingSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesLFFundTradingSecurityMember_lbl" xml:lang="en-US">Equity Securities L F Fund Trading Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LFFundSecuritiesMember" xlink:label="ACTG_LFFundSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LFFundSecuritiesMember" xlink:to="ACTG_LFFundSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_LFFundSecuritiesMember_lbl" xml:lang="en-US">L F Fund Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantInvestmentMember" xlink:label="ACTG_WarrantInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantInvestmentMember" xlink:to="ACTG_WarrantInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantInvestmentMember_lbl" xml:lang="en-US">Warrant Investment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="ACTG_CommonStockInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CommonStockInvestmentMember" xlink:to="ACTG_CommonStockInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_CommonStockInvestmentMember_lbl" xml:lang="en-US">Common Stock Investment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StarboardValueMember" xlink:label="ACTG_StarboardValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StarboardValueMember" xlink:to="ACTG_StarboardValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StarboardValueMember_lbl" xml:lang="en-US">Starboard Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="ACTG_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsMember" xlink:to="ACTG_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertibleStockMember" xlink:to="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="ACTG_SeriesBWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsMember" xlink:to="ACTG_SeriesBWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="ACTG_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SecuritiesPurchaseAgreementMember" xlink:to="ACTG_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="ACTG_SeniorSecuredNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeniorSecuredNotesMember" xlink:to="ACTG_SeniorSecuredNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeniorSecuredNotesMember_lbl" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeptemberRedemptionMember" xlink:label="ACTG_SeptemberRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeptemberRedemptionMember" xlink:to="ACTG_SeptemberRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeptemberRedemptionMember_lbl" xml:lang="en-US">September Redemption [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DecemberRedemptionMember" xlink:label="ACTG_DecemberRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DecemberRedemptionMember" xlink:to="ACTG_DecemberRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DecemberRedemptionMember_lbl" xml:lang="en-US">December Redemption [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_MertonMember" xlink:label="ACTG_MertonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_MertonMember" xlink:to="ACTG_MertonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_MertonMember_lbl" xml:lang="en-US">Merton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NewNotesMember" xlink:label="ACTG_NewNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NewNotesMember" xlink:to="ACTG_NewNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NewNotesMember_lbl" xml:lang="en-US">New Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember" xlink:label="us-gaap_AssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsMember" xlink:to="us-gaap_AssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsMember_lbl" xml:lang="en-US">Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xml:lang="en-US">Equity Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember" xlink:label="us-gaap_LiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityMember" xlink:to="us-gaap_LiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityMember_lbl" xml:lang="en-US">Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:to="ACTG_SeriesAEmbeddedDerivativeLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAEmbeddedDerivativeLiabilityMember_lbl" xml:lang="en-US">Series A Embedded Derivative Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsLiabilityMember" xlink:label="ACTG_SeriesAWarrantsLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsLiabilityMember" xlink:to="ACTG_SeriesAWarrantsLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAWarrantsLiabilityMember_lbl" xml:lang="en-US">Series A Warrants Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="ACTG_SeriesBWarrantsLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsLiabilityMember" xlink:to="ACTG_SeriesBWarrantsLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsLiabilityMember_lbl" xml:lang="en-US">Series B Warrants Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="us-gaap_ShareRepurchaseProgramAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramAxis" xlink:to="us-gaap_ShareRepurchaseProgramAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="ACTG_StockRepurchaseProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StockRepurchaseProgramMember" xlink:to="ACTG_StockRepurchaseProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StockRepurchaseProgramMember_lbl" xml:lang="en-US">Stock Repurchase Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="ACTG_EmployeeStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmployeeStockOptionsMember" xlink:to="ACTG_EmployeeStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmployeeStockOptionsMember_lbl" xml:lang="en-US">Employee Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="ACTG_EquityBasedIncentiveAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquityBasedIncentiveAwardsMember" xlink:to="ACTG_EquityBasedIncentiveAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquityBasedIncentiveAwardsMember_lbl" xml:lang="en-US">Equity Based Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNi" xlink:to="us-gaap_EquitySecuritiesFvNi_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xml:lang="en-US">Equity securities at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue_lbl" xml:lang="en-US">Equity securities without readily determinable fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityMethodInvestmentsCurrent" xlink:label="ACTG_EquityMethodInvestmentsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquityMethodInvestmentsCurrent" xlink:to="ACTG_EquityMethodInvestmentsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquityMethodInvestmentsCurrent_lbl" xml:lang="en-US">Investment securities - equity method investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestments" xlink:label="us-gaap_OtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestments_lbl" xml:lang="en-US">Investment at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivable (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xml:lang="en-US">Long-term restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Patents, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Leased right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccruedPatentInvestmentCostsCurrent" xlink:label="ACTG_AccruedPatentInvestmentCostsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccruedPatentInvestmentCostsCurrent" xlink:to="ACTG_AccruedPatentInvestmentCostsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccruedPatentInvestmentCostsCurrent_lbl" xml:lang="en-US">Accrued patent investment costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="us-gaap_SecuredDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtCurrent" xlink:to="us-gaap_SecuredDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebtCurrent_lbl" xml:lang="en-US">Senior Secured Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Series A warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Series A embedded derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="ACTG_DerivativeLiabilitiesNoncurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DerivativeLiabilitiesNoncurrent1" xlink:to="ACTG_DerivativeLiabilitiesNoncurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DerivativeLiabilitiesNoncurrent1_lbl" xml:lang="en-US">Series B warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Long-term lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="us-gaap_PreferredStockRedemptionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionAmount" xlink:to="us-gaap_PreferredStockRedemptionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionAmount_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2021 and December 31, 2020; aggregate liquidation preference of $35,000 as of September 30, 2021 and December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,591,852 and 49,279,453 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost, 4,604,365 shares as of September 30, 2021 and December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Acacia Research Corporation stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, liquidation preference</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenueAbstract_lbl" xml:lang="en-US">Patent portfolio operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ContingentLegalFees" xlink:label="ACTG_ContingentLegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ContingentLegalFees" xlink:to="ACTG_ContingentLegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ContingentLegalFees_lbl" xml:lang="en-US">Contingent legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="ACTG_LitigationAndLicensingExpensesPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LitigationAndLicensingExpensesPatents" xlink:to="ACTG_LitigationAndLicensingExpensesPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_LitigationAndLicensingExpensesPatents_lbl" xml:lang="en-US">Litigation and licensing expenses - patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Other patent portfolio income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Patent portfolio expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="ACTG_NetPortfolioIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ACTG_NetPortfolioIncomeLoss_lbl" xml:lang="en-US">Net patent portfolio (loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Change in fair value of investment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="us-gaap_GainLossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfInvestments_lbl" xml:lang="en-US">Gain (loss) on sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of the Series A and B warrants and embedded derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="us-gaap_GainLossOnSaleOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfEquitySecurities" xlink:label="ACTG_ChangeInFairValueOfEquitySecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfEquitySecurities" xlink:to="ACTG_ChangeInFairValueOfEquitySecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfEquitySecurities_lbl" xml:lang="en-US">Change in fair value of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_lbl" xml:lang="en-US">Gain (loss) on sale of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsOnEquityInvestmentInJointVenture" xlink:label="ACTG_EarningsOnEquityInvestmentInJointVenture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsOnEquityInvestmentInJointVenture" xlink:to="ACTG_EarningsOnEquityInvestmentInJointVenture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EarningsOnEquityInvestmentInJointVenture_lbl" xml:lang="en-US">Earnings on equity investment in joint venture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Loss on foreign currency exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense on Senior Secured Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestIncomeExpenseAndOther" xlink:label="ACTG_InterestIncomeExpenseAndOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InterestIncomeExpenseAndOther" xlink:to="ACTG_InterestIncomeExpenseAndOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InterestIncomeExpenseAndOther_lbl" xml:lang="en-US">Interest income and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income (loss) before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax (expense) benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net income (loss) including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net income attributable to noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss) attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic net income (loss) per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net income (loss) per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Weighted average number of shares outstanding - Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance at beginning, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net income attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" xlink:label="ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" xlink:to="ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries_lbl" xml:lang="en-US">Net (loss) income including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_lbl" xml:lang="en-US">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="us-gaap_DividendsPreferredStockStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStockStock_lbl" xml:lang="en-US">Dividend on Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" xlink:label="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" xlink:to="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits_lbl" xml:lang="en-US">Issuance of common stock for vesting of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" xlink:label="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" xlink:to="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares_lbl" xml:lang="en-US">Issuance of common stock for vesting of restricted stock units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" xlink:label="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" xlink:to="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures_lbl" xml:lang="en-US">Issuance of common stock for unvested restricted stock awards, net of forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" xlink:label="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" xlink:to="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares_lbl" xml:lang="en-US">Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense for share-based awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of common stock, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance at ending, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Net (loss) income including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash (used in) provided by operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Change in fair value of investment, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="us-gaap_GainLossOnSaleOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfInvestments_2_lbl" xml:lang="en-US">(Gain) loss on sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discount and issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xml:lang="en-US">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of Series A warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_UnrealizedGainLossOnDerivatives1" xlink:to="ACTG_UnrealizedGainLossOnDerivatives1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1_lbl" xml:lang="en-US">Change in fair value of Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Non-cash stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_lbl" xml:lang="en-US">Loss on foreign currency exchange</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfEquitySecurities" xlink:to="ACTG_ChangeInFairValueOfEquitySecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_ChangeInFairValueOfEquitySecurities_2_lbl" xml:lang="en-US">Change in fair value of equity securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2_lbl" xml:lang="en-US">(Gain) loss on sale of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:to="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Earnings on equity investment in joint venture, net of distributions received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Patent acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_lbl" xml:lang="en-US">Sale of investment at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchases of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Maturities and sales of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PurchasesOfPrepaidInvestment" xlink:label="ACTG_PurchasesOfPrepaidInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PurchasesOfPrepaidInvestment" xlink:to="ACTG_PurchasesOfPrepaidInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PurchasesOfPrepaidInvestment_lbl" xml:lang="en-US">Purchases of prepaid investment</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:label="ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:to="ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost_lbl" xml:lang="en-US">Equity securities derivative and forward contract acquisition cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Issuance of Senior Secured Notes, net of lender fee</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:label="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:to="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties_lbl" xml:lang="en-US">Senior Secured Notes issuance costs paid to other parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividends_lbl" xml:lang="en-US">Dividend on Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US">Paydown of Senior Secured Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xml:lang="en-US">Reissuance of Senior Secured Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Increase in cash and cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental schedule of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidInterest" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidInterest" xlink:to="us-gaap_IncreaseDecreaseInPrepaidInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInterest_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NoncashInvestingActivitesAbstract" xlink:label="ACTG_NoncashInvestingActivitesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NoncashInvestingActivitesAbstract" xlink:to="ACTG_NoncashInvestingActivitesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NoncashInvestingActivitesAbstract_lbl" xml:lang="en-US">Noncash investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3" xlink:label="ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3" xlink:to="ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3_lbl" xml:lang="en-US">Trade date receivable from sale of equity securities (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionInExchangeOfNotesReceivable" xlink:label="ACTG_PatentAcquisitionInExchangeOfNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PatentAcquisitionInExchangeOfNotesReceivable" xlink:to="ACTG_PatentAcquisitionInExchangeOfNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PatentAcquisitionInExchangeOfNotesReceivable_lbl" xml:lang="en-US">Patent acquisition in exchange of notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionAccruedLiabilityShortTerm" xlink:label="ACTG_PatentAcquisitionAccruedLiabilityShortTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PatentAcquisitionAccruedLiabilityShortTerm" xlink:to="ACTG_PatentAcquisitionAccruedLiabilityShortTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PatentAcquisitionAccruedLiabilityShortTerm_lbl" xml:lang="en-US">Patent acquisition accrued liability - short-term</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionAccruedLiabilityLongTerm" xlink:label="ACTG_PatentAcquisitionAccruedLiabilityLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PatentAcquisitionAccruedLiabilityLongTerm" xlink:to="ACTG_PatentAcquisitionAccruedLiabilityLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PatentAcquisitionAccruedLiabilityLongTerm_lbl" xml:lang="en-US">Patent acquisition accrued liability - long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:label="ACTG_AcquisitionOfPrepaidInvestmentSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:to="ACTG_AcquisitionOfPrepaidInvestmentSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AcquisitionOfPrepaidInvestmentSecurities_lbl" xml:lang="en-US">Acquisition of prepaid investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract_lbl" xml:lang="en-US">Description Of Business And Basis Of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BusinessDescriptionTextBlock" xlink:label="ACTG_BusinessDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_BusinessDescriptionTextBlock" xlink:to="ACTG_BusinessDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_BusinessDescriptionTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">EQUITY SECURITIES PORTFOLIO INVESTMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="us-gaap_InvestmentHoldingsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTextBlock" xlink:to="us-gaap_InvestmentHoldingsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTextBlock_lbl" xml:lang="en-US">INVESTMENT AT FAIR VALUE</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:label="ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract_lbl" xml:lang="en-US">Patents Net Of Accumulated Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentsNetOfAccumulatedAmortizationTextBlock" xlink:label="ACTG_PatentsNetOfAccumulatedAmortizationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PatentsNetOfAccumulatedAmortizationTextBlock" xlink:to="ACTG_PatentsNetOfAccumulatedAmortizationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PatentsNetOfAccumulatedAmortizationTextBlock_lbl" xml:lang="en-US">PATENTS, NET OF ACCUMULATED AMORTIZATION</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureStarboardInvestmentAbstract" xlink:label="ACTG_DisclosureStarboardInvestmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DisclosureStarboardInvestmentAbstract" xlink:to="ACTG_DisclosureStarboardInvestmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DisclosureStarboardInvestmentAbstract_lbl" xml:lang="en-US">Starboard Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StarboardInvestmentTextBlock" xlink:label="ACTG_StarboardInvestmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StarboardInvestmentTextBlock" xlink:to="ACTG_StarboardInvestmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StarboardInvestmentTextBlock_lbl" xml:lang="en-US">STARBOARD INVESTMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">INCOME/LOSS PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENT</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:label="ACTG_DescriptionOfBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:to="ACTG_DescriptionOfBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DescriptionOfBusinessPolicyTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BasisOfAccountingPoliesPolicyTextBlock" xlink:label="ACTG_BasisOfAccountingPoliesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_BasisOfAccountingPoliesPolicyTextBlock" xlink:to="ACTG_BasisOfAccountingPoliesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_BasisOfAccountingPoliesPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_Covid19PandemicAndCaresActPolicyTextBlock" xlink:label="ACTG_Covid19PandemicAndCaresActPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_Covid19PandemicAndCaresActPolicyTextBlock" xlink:to="ACTG_Covid19PandemicAndCaresActPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_Covid19PandemicAndCaresActPolicyTextBlock_lbl" xml:lang="en-US">COVID-19 Pandemic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting Principles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SegmentReportingPolicyTextBlock" xlink:label="ACTG_SegmentReportingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SegmentReportingPolicyTextBlock" xlink:to="ACTG_SegmentReportingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SegmentReportingPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EstimatesPolicytextBlock" xlink:label="ACTG_EstimatesPolicytextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EstimatesPolicytextBlock" xlink:to="ACTG_EstimatesPolicytextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EstimatesPolicytextBlock_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentPortfolioOperationsPolicyTextBlock" xlink:label="ACTG_PatentPortfolioOperationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PatentPortfolioOperationsPolicyTextBlock" xlink:to="ACTG_PatentPortfolioOperationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PatentPortfolioOperationsPolicyTextBlock_lbl" xml:lang="en-US">Patent Portfolio Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ConcentrationsPolicyTextBlock" xlink:label="ACTG_ConcentrationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ConcentrationsPolicyTextBlock" xlink:to="ACTG_ConcentrationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ConcentrationsPolicyTextBlock_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RelatedPartyTransactionsPolicyTextBlock" xlink:label="ACTG_RelatedPartyTransactionsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RelatedPartyTransactionsPolicyTextBlock" xlink:to="ACTG_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RelatedPartyTransactionsPolicyTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesAtFairValuePolicyTextBlock" xlink:label="ACTG_EquitySecuritiesAtFairValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesAtFairValuePolicyTextBlock" xlink:to="ACTG_EquitySecuritiesAtFairValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesAtFairValuePolicyTextBlock_lbl" xml:lang="en-US">Equity Securities at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_lbl" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Equity Method Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ImpairmentOfInvestmentPolicyTextBlock" xlink:label="ACTG_ImpairmentOfInvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ImpairmentOfInvestmentPolicyTextBlock" xlink:to="ACTG_ImpairmentOfInvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ImpairmentOfInvestmentPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Long-Term Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAandBWarrantsPolicyTextBlock" xlink:label="ACTG_SeriesAandBWarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAandBWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesAandBWarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAandBWarrantsPolicyTextBlock_lbl" xml:lang="en-US">Series A and B Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="us-gaap_DerivativesEmbeddedDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesEmbeddedDerivatives" xlink:to="us-gaap_DerivativesEmbeddedDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesEmbeddedDerivatives_lbl" xml:lang="en-US">Embedded derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US">Schedule of equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xml:lang="en-US">Schedule of unrealized gains or losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xml:lang="en-US">Schedule of gain on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of financial assets and liabilities at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of changes in fair value Level 3 liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xml:lang="en-US">Schedule of repurchased shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Calculation of basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xml:lang="en-US">Number of new patent portfolios acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="us-gaap_EquitySecuritiesFvNiCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiCost" xlink:to="us-gaap_EquitySecuritiesFvNiCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiCost_lbl" xml:lang="en-US">Equity securities - cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="us-gaap_EquityMethodInvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="us-gaap_EquityMethodInvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Equity securities at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfLongtermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfLongtermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfLongtermInvestments_lbl" xml:lang="en-US">Proceeds from sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="us-gaap_LossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossOnSaleOfInvestments_lbl" xml:lang="en-US">Loss on sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:to="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xml:lang="en-US">Assumptions used for derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Option Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US">Option Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average grant-date fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="us-gaap_MarketableSecuritiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTable" xlink:to="us-gaap_MarketableSecuritiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesTable_lbl" xml:lang="en-US">Marketable Securities [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="us-gaap_MarketableSecuritiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesLineItems_lbl" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xml:lang="en-US">Change in fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xml:lang="en-US">Loss on sale of trading security</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:to="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_2_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" xlink:to="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivativey</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Payment to acquire equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTable_lbl" xml:lang="en-US">Investment Holdings [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsLineItems_lbl" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xml:lang="en-US">Change in fair value of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_4_lbl" xml:lang="en-US">Change in fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="us-gaap_GainOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainOnSaleOfInvestments" xlink:to="us-gaap_GainOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainOnSaleOfInvestments_lbl" xml:lang="en-US">Gain on sale of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LossOnSaleOfInvestments_2_lbl" xml:lang="en-US">Loss on sale of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnInvestments_2_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">Remainder of 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Patents, net&#160;&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccruedPatentAcquisitionCosts" xlink:label="ACTG_AccruedPatentAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccruedPatentAcquisitionCosts" xlink:to="ACTG_AccruedPatentAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccruedPatentAcquisitionCosts_lbl" xml:lang="en-US">Accrued patent acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Accrued patent acquisition costs due within a year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentDueInNextTwelveMonths_lbl" xml:lang="en-US">Accrued patent acquisition costs due within 2 years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from issuance of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of stock issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xml:lang="en-US">Fair value of embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantsExercisedShares" xlink:label="ACTG_WarrantsExercisedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsExercisedShares_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt_2_lbl" xml:lang="en-US">Proceeds from issuance of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RedemptionOfSecuredNotes" xlink:label="ACTG_RedemptionOfSecuredNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RedemptionOfSecuredNotes" xlink:to="ACTG_RedemptionOfSecuredNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RedemptionOfSecuredNotes_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt stated interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xml:lang="en-US">Notes exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xml:lang="en-US">Capitalized lender fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Unamortized discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RepaymentsOfSecuredDebt_2_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long-term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Fair value of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Derivative liability, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xml:lang="en-US">Transfers into Level 3</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_lbl" xml:lang="en-US">Remainder of 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Less: short-term lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease costs, net of sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeForSettlementOffsetByContingencyAccruals" xlink:label="ACTG_NetIncomeForSettlementOffsetByContingencyAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetIncomeForSettlementOffsetByContingencyAccruals" xlink:to="ACTG_NetIncomeForSettlementOffsetByContingencyAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetIncomeForSettlementOffsetByContingencyAccruals_lbl" xml:lang="en-US">Income from settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xml:lang="en-US">Contingency accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xml:lang="en-US">Average price paid per share</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramExpirationDate" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xml:lang="en-US">Stock Repurchase Program Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="us-gaap_ClassOfTreasuryStockTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Numerator:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income (loss) attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Dividend on Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xml:lang="en-US">Accretion of Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_lbl" xml:lang="en-US">Undistributed earnings allocated to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" xlink:label="ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" xlink:to="ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Add: Dividend on Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:to="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Add: Accretion of Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="ACTG_ChangeInFairValueOfSeriesWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesWarrants" xlink:to="ACTG_ChangeInFairValueOfSeriesWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesWarrants_lbl" xml:lang="en-US">Less: Change in fair value of Series A warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:to="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_lbl" xml:lang="en-US">Less: Change in fair value of dilutive Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" xlink:label="ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" xlink:to="ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax_lbl" xml:lang="en-US">Add: Interest expense associated with Starboard Notes, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl" xml:lang="en-US">Add: Undistributed earnings allocated to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl" xml:lang="en-US">Reallocation of undistributed earnings to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" xlink:label="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" xlink:to="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xml:lang="en-US">Denominator:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_lbl" xml:lang="en-US">Potentially dilutive common shares:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xml:lang="en-US">Potentially dilutive common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net income (loss) per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" xlink:label="ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" xlink:to="ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_lbl" xml:lang="en-US">Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_doc" xml:lang="en-US">Accretion of Series A Convertible Preferred Stock to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_doc" xml:lang="en-US">Number of patent portfolios acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccruedPatentAcquisitionCosts" xlink:to="ACTG_AccruedPatentAcquisitionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccruedPatentAcquisitionCosts_doc" xml:lang="en-US">Accrued patent acquisition costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsExercisedShares_doc" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xml:lang="en-US">Denominator [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetPortfolioIncomeLoss_2_lbl" xml:lang="en-US">NetPortfolioIncomeLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_2_lbl" xml:lang="en-US">Interest Expense, Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue_3_lbl" xml:lang="en-US">AccretionOfSeriesConvertiblePreferredStockToRedemptionValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_2_lbl" xml:lang="en-US">ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_UnrealizedGainLossOnDerivatives1" xlink:to="ACTG_UnrealizedGainLossOnDerivatives1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1_2_lbl" xml:lang="en-US">UnrealizedGainLossOnDerivatives1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:to="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative_3_lbl" xml:lang="en-US">GainOnSaleOfPrepaidInvestmentAndDerivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_2_lbl" xml:lang="en-US">IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:to="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties_2_lbl" xml:lang="en-US">SeniorSecuredNotesIssuanceCostsPaidToOtherParties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividends_2_lbl" xml:lang="en-US">Payments of Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSecuredDebt_3_lbl" xml:lang="en-US">Repayments of Secured Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_2_lbl" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="us-gaap_EquityMethodInvestmentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsFairValueDisclosure_2_lbl" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xml:lang="en-US">Preferred Stock, Accretion of Redemption Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" xlink:to="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetIncomeLossAvailableToCommonStockholderDiluted_2_lbl" xml:lang="en-US">NetIncomeLossAvailableToCommonStockholderDiluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>actg-20210930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20210930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:href="actg-20210930.xsd#InvestmentAtFairValue" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortization" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestment" xlink:href="actg-20210930.xsd#StarboardInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurements" xlink:href="actg-20210930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20210930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShare" xlink:href="actg-20210930.xsd#IncomelossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvent" xlink:href="actg-20210930.xsd#SubsequentEvent" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:href="actg-20210930.xsd#InvestmentAtFairValueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:href="actg-20210930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20210930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:href="actg-20210930.xsd#IncomelossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20210930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20210930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:href="actg-20210930.xsd#InvestmentAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:href="actg-20210930.xsd#PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:href="actg-20210930.xsd#StarboardInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:href="actg-20210930.xsd#FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20210930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20210930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:href="actg-20210930.xsd#IncomelossPerShareDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaapEquitySecuritiesFvNi" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapEquitySecuritiesFvNi" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_ACTGEquitySecuritiesWithoutReadilyDeterminableFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_ACTGEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityMethodInvestmentsCurrent" xlink:label="loc_ACTGEquityMethodInvestmentsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_ACTGEquityMethodInvestmentsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestments" xlink:label="loc_us-gaapOtherInvestments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccruedPatentInvestmentCostsCurrent" xlink:label="loc_ACTGAccruedPatentInvestmentCostsCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ACTGAccruedPatentInvestmentCostsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="loc_ACTGDerivativeLiabilitiesNoncurrent1" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ACTGDerivativeLiabilitiesNoncurrent1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaapCostOfRevenueAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfEquitySecurities" xlink:label="loc_ACTGChangeInFairValueOfEquitySecurities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_ACTGChangeInFairValueOfEquitySecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsOnEquityInvestmentInJointVenture" xlink:label="loc_ACTGEarningsOnEquityInvestmentInJointVenture" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_ACTGEarningsOnEquityInvestmentInJointVenture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestIncomeExpenseAndOther" xlink:label="loc_ACTGInterestIncomeExpenseAndOther" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_ACTGInterestIncomeExpenseAndOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries" xlink:label="loc_ACTGNetIncomeIncludingNoncontrollingInterestsInSubsidiaries" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNetIncomeIncludingNoncontrollingInterestsInSubsidiaries" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesConvertiblePreferredStockToRedemptionValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits" xlink:label="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnits" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" xlink:label="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" xlink:label="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" xlink:label="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGIssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="loc_ACTGUnrealizedGainLossOnDerivatives1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGUnrealizedGainLossOnDerivatives1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfEquitySecurities" xlink:label="loc_ACTGChangeInFairValueOfEquitySecurities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGChangeInFairValueOfEquitySecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PurchasesOfPrepaidInvestment" xlink:label="loc_ACTGPurchasesOfPrepaidInvestment" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_ACTGPurchasesOfPrepaidInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:label="loc_ACTGEquitySecuritiesDerivativeAndForwardContractAcquisitionCost" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_ACTGEquitySecuritiesDerivativeAndForwardContractAcquisitionCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:label="loc_ACTGSeniorSecuredNotesIssuanceCostsPaidToOtherParties" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ACTGSeniorSecuredNotesIssuanceCostsPaidToOtherParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidInterest" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidInterest" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NoncashInvestingActivitesAbstract" xlink:label="loc_ACTGNoncashInvestingActivitesAbstract" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGNoncashInvestingActivitesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3" xlink:label="loc_ACTGTradeDateReceivableFromSaleOfEquitySecuritiesNote3" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGNoncashInvestingActivitesAbstract" xlink:to="loc_ACTGTradeDateReceivableFromSaleOfEquitySecuritiesNote3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionInExchangeOfNotesReceivable" xlink:label="loc_ACTGPatentAcquisitionInExchangeOfNotesReceivable" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGPatentAcquisitionInExchangeOfNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionAccruedLiabilityShortTerm" xlink:label="loc_ACTGPatentAcquisitionAccruedLiabilityShortTerm" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGPatentAcquisitionAccruedLiabilityShortTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentAcquisitionAccruedLiabilityLongTerm" xlink:label="loc_ACTGPatentAcquisitionAccruedLiabilityLongTerm" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGPatentAcquisitionAccruedLiabilityLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:label="loc_ACTGAcquisitionOfPrepaidInvestmentSecurities" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGAcquisitionOfPrepaidInvestmentSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BusinessDescriptionTextBlock" xlink:label="loc_ACTGBusinessDescriptionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_ACTGBusinessDescriptionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment" xlink:title="00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValue" xlink:title="00000010 - Disclosure - INVESTMENT AT FAIR VALUE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="loc_us-gaapInvestmentHoldingsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapInvestmentHoldingsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization" xlink:title="00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:label="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentsNetOfAccumulatedAmortizationTextBlock" xlink:label="loc_ACTGPatentsNetOfAccumulatedAmortizationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_ACTGPatentsNetOfAccumulatedAmortizationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestment" xlink:title="00000012 - Disclosure - STARBOARD INVESTMENT">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureStarboardInvestmentAbstract" xlink:label="loc_ACTGDisclosureStarboardInvestmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StarboardInvestmentTextBlock" xlink:label="loc_ACTGStarboardInvestmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureStarboardInvestmentAbstract" xlink:to="loc_ACTGStarboardInvestmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurements" xlink:title="00000013 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000015 - Disclosure - STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShare" xlink:title="00000016 - Disclosure - INCOME/LOSS PER SHARE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvent" xlink:title="00000017 - Disclosure - SUBSEQUENT EVENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:label="loc_ACTGDescriptionOfBusinessPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_ACTGDescriptionOfBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BasisOfAccountingPoliesPolicyTextBlock" xlink:label="loc_ACTGBasisOfAccountingPoliesPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_ACTGBasisOfAccountingPoliesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_Covid19PandemicAndCaresActPolicyTextBlock" xlink:label="loc_ACTGCovid19PandemicAndCaresActPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_ACTGCovid19PandemicAndCaresActPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SegmentReportingPolicyTextBlock" xlink:label="loc_ACTGSegmentReportingPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGSegmentReportingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EstimatesPolicytextBlock" xlink:label="loc_ACTGEstimatesPolicytextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGEstimatesPolicytextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PatentPortfolioOperationsPolicyTextBlock" xlink:label="loc_ACTGPatentPortfolioOperationsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGPatentPortfolioOperationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ConcentrationsPolicyTextBlock" xlink:label="loc_ACTGConcentrationsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGConcentrationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RelatedPartyTransactionsPolicyTextBlock" xlink:label="loc_ACTGRelatedPartyTransactionsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGRelatedPartyTransactionsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesAtFairValuePolicyTextBlock" xlink:label="loc_ACTGEquitySecuritiesAtFairValuePolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGEquitySecuritiesAtFairValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:label="loc_us-gaapEquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ImpairmentOfInvestmentPolicyTextBlock" xlink:label="loc_ACTGImpairmentOfInvestmentPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGImpairmentOfInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAandBWarrantsPolicyTextBlock" xlink:label="loc_ACTGSeriesAandBWarrantsPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGSeriesAandBWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="loc_us-gaapDerivativesEmbeddedDerivatives" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesEmbeddedDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="loc_us-gaapStockholdersEquityPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables" xlink:title="00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueTables" xlink:title="00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaapGainLossOnInvestmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapGainLossOnInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables" xlink:title="00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:label="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsTables" xlink:title="00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000026 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="loc_us-gaapAcceleratedShareRepurchasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAcceleratedShareRepurchasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareTables" xlink:title="00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:label="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="loc_ACTGNumberOfPatentPortfoliosAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract" xlink:to="loc_ACTGNumberOfPatentPortfoliosAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundPublicSecuritiesMember" xlink:label="loc_ACTGEquitySecuritesLfFundPublicSecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesLfFundPublicSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesOtherEquityMember" xlink:label="loc_ACTGEquitySecuritiesOtherEquityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesOtherEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaapEquitySecuritiesFvNiCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:label="loc_us-gaapEquityMethodInvestmentsFairValueDisclosure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicenseeMember" xlink:label="loc_ACTGOneLicenseeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_TwoLicenseeMember" xlink:label="loc_ACTGTwoLicenseeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGTwoLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ThreeLicenseeMember" xlink:label="loc_ACTGThreeLicenseeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGThreeLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicensee2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGOneLicensee3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ForeignLicenseeMember" xlink:label="loc_ACTGForeignLicenseeMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ACTGForeignLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_BlackScholesMethodMember" xlink:label="loc_ACTGBlackScholesMethodMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGBlackScholesMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RSAsMember" xlink:label="loc_ACTGRSAsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGRSAsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NonQualifiedStockOptionsMember" xlink:label="loc_ACTGNonQualifiedStockOptionsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGNonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:label="loc_us-gaapProceedsFromSaleOfLongtermInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfLongtermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails" xlink:title="00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable" xlink:label="loc_us-gaapMarketableSecuritiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems" xlink:label="loc_us-gaapMarketableSecuritiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapMarketableSecuritiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesLfFundSecuritiesMember" xlink:label="loc_ACTGEquitySecuritesLfFundSecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesLfFundSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesDerivativeMember" xlink:label="loc_ACTGEquitySecuritesDerivativeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesDerivativeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritesForwardContractMember" xlink:label="loc_ACTGEquitySecuritesForwardContractMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritesForwardContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquitySecuritiesLFFundTradingSecurityMember" xlink:label="loc_ACTGEquitySecuritiesLFFundTradingSecurityMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesLFFundTradingSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_LFFundSecuritiesMember" xlink:label="loc_ACTGLFFundSecuritiesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGLFFundSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGainLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="loc_us-gaapRealizedInvestmentGainsLosses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapRealizedInvestmentGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey" xlink:label="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivativey" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_ACTGGainOnSaleOfPrepaidInvestmentAndDerivativey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesLineItems" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative" xlink:title="00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_OptionAgreementMember" xlink:label="loc_ACTGOptionAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGOptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="loc_ACTGPortfolioCompaniesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGPortfolioCompaniesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentAtFairValueDetails" xlink:title="00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaapInvestmentHoldingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapInvestmentHoldingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaapInvestmentHoldingsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentHoldingsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaapGainOnSaleOfInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails" xlink:title="00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:label="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative" xlink:title="00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:label="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccruedPatentAcquisitionCosts" xlink:label="loc_ACTGAccruedPatentAcquisitionCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_ACTGAccruedPatentAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapOtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:label="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosurePatentsNetOfAccumulatedAmortizationAbstract" xlink:to="loc_us-gaapOtherCommitmentDueInNextTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative" xlink:title="00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DisclosureStarboardInvestmentAbstract" xlink:label="loc_ACTGDisclosureStarboardInvestmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGDisclosureStarboardInvestmentAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_MertonMember" xlink:label="loc_ACTGMertonMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGMertonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeptemberRedemptionMember" xlink:label="loc_ACTGSeptemberRedemptionMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeptemberRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DecemberRedemptionMember" xlink:label="loc_ACTGDecemberRedemptionMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGDecemberRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="loc_ACTGSeniorSecuredNotesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NewNotesMember" xlink:label="loc_ACTGNewNotesMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGNewNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ACTGWarrantsExercisedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RedemptionOfSecuredNotes" xlink:label="loc_ACTGRedemptionOfSecuredNotes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_ACTGRedemptionOfSecuredNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="loc_us-gaapDeferredFinanceCostsGross" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis" xlink:title="00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3" xlink:title="00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesAWarrantsLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesBWarrantsLiabilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeForSettlementOffsetByContingencyAccruals" xlink:label="loc_ACTGNetIncomeForSettlementOffsetByContingencyAccruals" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_ACTGNetIncomeForSettlementOffsetByContingencyAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000042 - Disclosure -  STOCKHOLDERS&apos; EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="loc_us-gaapClassOfTreasuryStockTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfTreasuryStockTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="loc_us-gaapEquityClassOfTreasuryStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapEquityClassOfTreasuryStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomelossPerShareDetails" xlink:title="00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="loc_ACTGEmployeeStockOptionsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmployeeStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="loc_ACTGEquityBasedIncentiveAwardsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGEquityBasedIncentiveAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGDividendOnSeriesRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGDividendOnSeriesRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="loc_ACTGChangeInFairValueOfSeriesWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax" xlink:label="loc_ACTGInterestExpenseAssociatedWithStarboardNotesNetOfTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGInterestExpenseAssociatedWithStarboardNotesNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_NetIncomeLossAvailableToCommonStockholderDiluted" xlink:label="loc_ACTGNetIncomeLossAvailableToCommonStockholderDiluted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGNetIncomeLossAvailableToCommonStockholderDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20210930.xsd#ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" xlink:label="loc_ACTGAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>acacia_i10q-93021_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ACTG="http://acaciaresearch.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="actg-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2021-11-08</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ThreeLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ThreeLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:TwoLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesOtherEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_RSAsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:RSAsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquitySecuritesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquitySecuritesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesLFFundTradingSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_LFFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_LFFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_LFFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_LFFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:LFFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-11-012019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-18</endDate>
        </period>
    </context>
    <context id="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-18</instant>
        </period>
    </context>
    <context id="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-18</instant>
        </period>
    </context>
    <context id="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-19</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-25</instant>
        </period>
    </context>
    <context id="From2020-02-012020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-25</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-04</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeptemberRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeptemberRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_DecemberRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:DecemberRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_NewNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:NewNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_NewNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:NewNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-08-05_custom_StockRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-05</instant>
        </period>
    </context>
    <context id="From2020-09-202020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-20</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-23_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-23</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesAWarrantsMember50317218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember50317234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesAWarrantsMember50317250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember50317265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_SeriesBWarrantsMember50317281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember50317296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_SeriesBWarrantsMember50317312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember50317328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>ACTG:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-09-30">0000934549</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-09-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-09-30">2021</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-07-012021-09-30"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0478"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0486"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0539"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0555"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0617"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0625"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0638"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0641"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0646"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnits
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0656"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0659"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0660"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0661"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0670"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0671"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0679"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      id="xdx2ixbrl1363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      id="xdx2ixbrl1454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      id="xdx2ixbrl1455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      id="xdx2ixbrl1479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      id="xdx2ixbrl1484"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl1633"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl1638"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2021-01-01to2021-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-09-30">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-09-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-09-30">1-37721</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-09-30">Acacia Research Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-09-30">95-4405754</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-09-30">767 THIRD AVENUE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-09-30">SUITE 602</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-09-30">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-09-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-09-30">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-09-30">(949)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-09-30">480-8300</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-09-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-09-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-11-08" decimals="INF" unitRef="Shares">49591852</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">217957000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">165546000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">761000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">0</us-gaap:RestrictedCash>
    <us-gaap:EquitySecuritiesFvNi contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">387120000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">109103000</us-gaap:EquitySecuritiesFvNi>
    <ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5816000</ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue>
    <ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">143257000</ACTG:EquitySecuritiesWithoutReadilyDeterminableFairValue>
    <ACTG:EquityMethodInvestmentsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">31840000</ACTG:EquityMethodInvestmentsCurrent>
    <ACTG:EquityMethodInvestmentsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">30673000</ACTG:EquityMethodInvestmentsCurrent>
    <us-gaap:OtherInvestments contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">0</us-gaap:OtherInvestments>
    <us-gaap:OtherInvestments contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2752000</us-gaap:OtherInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">412000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">506000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">21539000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">3986000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">5832000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">669431000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">457669000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">35424000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">35000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">39826000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">16912000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">671000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">951000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4482000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">4988000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">749834000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">515520000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">2196000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">1019000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5586000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">3707000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">4019000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2265000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1793000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">2162000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <ACTG:AccruedPatentInvestmentCostsCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">8000000</ACTG:AccruedPatentInvestmentCostsCurrent>
    <ACTG:AccruedPatentInvestmentCostsCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">0</ACTG:AccruedPatentInvestmentCostsCurrent>
    <us-gaap:SecuredDebtCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">182855000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">115663000</us-gaap:SecuredDebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">204449000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">124816000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">18527000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">6640000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">41411000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">26728000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <ACTG:DerivativeLiabilitiesNoncurrent1 contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">229637000</ACTG:DerivativeLiabilitiesNoncurrent1>
    <ACTG:DerivativeLiabilitiesNoncurrent1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">52341000</ACTG:DerivativeLiabilitiesNoncurrent1>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">671000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">951000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5591000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">591000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">500286000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">212067000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">100</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">100</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2021-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2020-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">13686000</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">10924000</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">49591852</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">49591852</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">49279453</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">49279453</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">50000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">49000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">4604365</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">4604365</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">43270000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">43270000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">649349000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">651416000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">-382215000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-326708000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">223914000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">281487000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">11948000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">11042000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">235862000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">292529000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">749834000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">515520000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">19466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">24785000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">25399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RoyaltyExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">280000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">5772000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">823000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">6843000</us-gaap:RoyaltyExpense>
    <ACTG:ContingentLegalFees
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">285000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">6609000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5735000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">6855000</ACTG:ContingentLegalFees>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">782000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1001000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">4881000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3497000</ACTG:LitigationAndLicensingExpensesPatents>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">2612000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1174000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">7086000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3522000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">308000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">3959000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">14556000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">18525000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">20409000</us-gaap:CostOfGoodsAndServicesSold>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-2377000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4910000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">6260000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">4990000</ACTG:NetPortfolioIncomeLoss>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">10345000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">7692000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">23014000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">18089000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-12722000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-2782000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-16754000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-13099000</us-gaap:OperatingIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-3081000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-2752000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3704000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3591000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-2762000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">619000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20672000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-203866000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-46612000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">66502000</ACTG:ChangeInFairValueOfEquitySecurities>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20488000</ACTG:ChangeInFairValueOfEquitySecurities>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">115509000</ACTG:ChangeInFairValueOfEquitySecurities>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">99449000</ACTG:ChangeInFairValueOfEquitySecurities>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">37688000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2737000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">53124000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-4272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <ACTG:EarningsOnEquityInvestmentInJointVenture
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:EarningsOnEquityInvestmentInJointVenture>
    <ACTG:EarningsOnEquityInvestmentInJointVenture
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:EarningsOnEquityInvestmentInJointVenture>
    <ACTG:EarningsOnEquityInvestmentInJointVenture
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2737000</ACTG:EarningsOnEquityInvestmentInJointVenture>
    <ACTG:EarningsOnEquityInvestmentInJointVenture
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:EarningsOnEquityInvestmentInJointVenture>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-17000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-48000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-193000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-4938000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InterestExpenseDebt
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">2531000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2410000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5601000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3178000</us-gaap:InterestExpenseDebt>
    <ACTG:InterestIncomeExpenseAndOther
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">76000</ACTG:InterestIncomeExpenseAndOther>
    <ACTG:InterestIncomeExpenseAndOther
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">10000</ACTG:InterestIncomeExpenseAndOther>
    <ACTG:InterestIncomeExpenseAndOther
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">135000</ACTG:InterestIncomeExpenseAndOther>
    <ACTG:InterestIncomeExpenseAndOther
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">811000</ACTG:InterestIncomeExpenseAndOther>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">102337000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">41213000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-37316000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">45047000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">89615000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38431000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-54070000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">31948000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">11000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">83000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">531000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-1257000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">89604000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-54601000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">906000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">89604000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-55507000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">72984</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">30529</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-59054</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">24838</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">1.49</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.63</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.21</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.51</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">48949504</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">48467885</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">48759873</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">48949706</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">80171000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">29204000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-59054000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">21380000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">93081502</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">90624702</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">48759873</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">60153773</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">12695000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49616602</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650194000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-471819000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11948000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">147103000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">89604000</ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">89604000</ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">-991000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">991000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">991000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">262000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">262000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">108000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">108000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-54750</ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">13686000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49591852</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">649349000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-382215000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11948000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">235862000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">9400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49306137</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650843000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-444799000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">164656000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">-734000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">734000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">734000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">467000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:DividendsPreferredStockStock>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-26684</ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">10134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49279453</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-406451000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">202291000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">10924000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49279453</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">651416000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-326708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11042000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">292529000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-55507000</ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-012021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">906000</ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries>
    <ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-54601000</ACTG:NetIncomeIncludingNoncontrollingInterestsInSubsidiaries>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">-2762000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">2762000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2762000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">785000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">785000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">60000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">201000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">202000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">28834</ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">223565</ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1279000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1279000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">13686000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49591852</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">649349000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-382215000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">11948000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">235862000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">8089000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">50370987</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">652003000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-439656000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">174958000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">-2045000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">2045000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">2045000</ACTG:AccretionOfSeriesConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1119000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1119000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">48000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14354</ACTG:IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares>
    <ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">565316</ACTG:IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-1684537</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">3998000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3999000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">10134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49279453</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-406451000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">202291000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-54601000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-2752000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3704000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3591000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-2762000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">7198000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3609000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">460000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">955000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-14683000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-7708000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-11887000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-2036000</us-gaap:UnrealizedGainLossOnDerivatives>
    <ACTG:UnrealizedGainLossOnDerivatives1
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-177296000</ACTG:UnrealizedGainLossOnDerivatives1>
    <ACTG:UnrealizedGainLossOnDerivatives1
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-36867000</ACTG:UnrealizedGainLossOnDerivatives1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1279000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:ShareBasedCompensation>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-193000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-4938000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">115509000</ACTG:ChangeInFairValueOfEquitySecurities>
    <ACTG:ChangeInFairValueOfEquitySecurities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">99449000</ACTG:ChangeInFairValueOfEquitySecurities>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">53124000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-4272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-0</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">2845000</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">907000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-94000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-248000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2345000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-1038000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">7002000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">614000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-369000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">12052000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-7602000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">5549000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">13000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">13780000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">3591000</us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1460000</us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">57978000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33800000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">64235000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">316746000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <ACTG:PurchasesOfPrepaidInvestment
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:PurchasesOfPrepaidInvestment>
    <ACTG:PurchasesOfPrepaidInvestment
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-276275000</ACTG:PurchasesOfPrepaidInvestment>
    <ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost>
    <ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-3989000</ACTG:EquitySecuritiesDerivativeAndForwardContractAcquisitionCost>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">67000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">177000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-3219000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-9815000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">3998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">65000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">110437000</us-gaap:ProceedsFromIssuanceOfDebt>
    <ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-0</ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties>
    <ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">496000</ACTG:SeniorSecuredNotesIssuanceCostsPaidToOtherParties>
    <us-gaap:PaymentsOfDividends
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">785000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1120000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">202000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">50000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">50000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">64417000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">109471000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">53596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">105205000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">200546000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">92359000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">254142000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">197564000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncreaseDecreaseInPrepaidInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2340000</us-gaap:IncreaseDecreaseInPrepaidInterest>
    <us-gaap:IncreaseDecreaseInPrepaidInterest
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInPrepaidInterest>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">9000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">164000</us-gaap:IncomeTaxesPaid>
    <ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">21539000</ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3>
    <ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:TradeDateReceivableFromSaleOfEquitySecuritiesNote3>
    <ACTG:PatentAcquisitionInExchangeOfNotesReceivable
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">4000000</ACTG:PatentAcquisitionInExchangeOfNotesReceivable>
    <ACTG:PatentAcquisitionInExchangeOfNotesReceivable
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:PatentAcquisitionInExchangeOfNotesReceivable>
    <ACTG:PatentAcquisitionAccruedLiabilityShortTerm
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">8000000</ACTG:PatentAcquisitionAccruedLiabilityShortTerm>
    <ACTG:PatentAcquisitionAccruedLiabilityShortTerm
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:PatentAcquisitionAccruedLiabilityShortTerm>
    <ACTG:PatentAcquisitionAccruedLiabilityLongTerm
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">5000000</ACTG:PatentAcquisitionAccruedLiabilityLongTerm>
    <ACTG:PatentAcquisitionAccruedLiabilityLongTerm
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:PatentAcquisitionAccruedLiabilityLongTerm>
    <ACTG:AcquisitionOfPrepaidInvestmentSecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AcquisitionOfPrepaidInvestmentSecurities>
    <ACTG:AcquisitionOfPrepaidInvestmentSecurities
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">231480000</ACTG:AcquisitionOfPrepaidInvestmentSecurities>
    <ACTG:BusinessDescriptionTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_808_ecustom--BusinessDescriptionTextBlock_zLQd26KmL4Da" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;1. &lt;span id="xdx_823_zVPOKEhMhwLg"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--DescriptionOfBusinessPolicyTextBlock_znfMED2mVuqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_861_z58pdAAvzUra"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;As used herein, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d;
&#x201c;Acacia&#x201d; and the &#x201c;Company&#x201d; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled
operating subsidiaries, and/or where applicable, its management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia was incorporated on January 25, 1993 under the laws of the State
of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia acquires businesses and operating assets that the Company believes
to be undervalued and where the Company believes it can leverage its resources and skill sets to realize and unlock value. The Company
intends to leverage its (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and
operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount
and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions
of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. Acacia
seeks to identify opportunities where the Company believes it is an advantaged buyer, where the Company can avoid structured sale processes
and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to the Company&#x2019;s
unique capabilities, relationships, or expertise, or where Acacia believes the target would be worth more to the Company than to other
buyers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia operates its business based on three key principles of People,
Process and Performance and has built a management team with identified expertise in Research, Execution and Operation of the Company&#x2019;s
targeted acquisitions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia, through its operating subsidiaries, also currently engages
in its legacy business of investing in, licensing and enforcing patented technologies. Acacia&#x2019;s operating subsidiaries partner with
inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented
inventions. In recent years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships
developed as a leader in the intellectual property (&#x201c;IP&#x201d;) industry to pursue these opportunities. In some cases, these opportunities
will complement and/or supplement Acacia&#x2019;s primary licensing and enforcement business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s operating subsidiaries generate revenues and related
cash flows from the granting of IP rights (hereinafter, &#x201c;IP Rights&#x201d;) for the use of patented technologies that its operating
subsidiaries control or own. Acacia&#x2019;s operating subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through
the filing of patent infringement litigation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s operating subsidiaries are principals in the licensing
and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia&#x2019;s
operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through
its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#x2019;s operating subsidiaries
are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based
opportunities for sustainable revenue and/or revenue growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the nine months ended September 30, 2021, Acacia obtained
control of one &lt;span id="xdx_90D_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20210101__20210930_zFPmsscH2NBj" style="display: none" title="Number of new patent portfolios acquired"&gt;1&lt;/span&gt;
new patent portfolio. During fiscal year 2020, Acacia obtained control of five &lt;span id="xdx_907_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20200101__20201231_z0DlQoQ7KXz8" style="display: none" title="Number of new patent portfolios acquired"&gt;5&lt;/span&gt; new patent portfolios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--BasisOfAccountingPoliesPolicyTextBlock_zTkfyraUtA34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_865_zJRRpXQOfCwi"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial statements
include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;)
for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information
and note disclosures required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly
reporting requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). These interim unaudited condensed consolidated financial
statements and notes hereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2020, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March 29, 2021, as well as in our other
public filings with the SEC. The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring
nature which, in the opinion of management, are necessary for a fair statement of Acacia&#x2019;s consolidated financial position as of
September 30, 2021, and results of its operations and its cash flows for the interim periods presented. The consolidated results of operations
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal
year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Certain prior period amounts in the consolidated financial statements
have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated
results of operations or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--Covid19PandemicAndCaresActPolicyTextBlock_zazWKBu653X5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_869_zJQM5ugWaLIa"&gt;COVID-19 Pandemic&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#x2019;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.&lt;/p&gt;

</ACTG:BusinessDescriptionTextBlock>
    <ACTG:DescriptionOfBusinessPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84A_ecustom--DescriptionOfBusinessPolicyTextBlock_znfMED2mVuqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_861_z58pdAAvzUra"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;As used herein, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d;
&#x201c;Acacia&#x201d; and the &#x201c;Company&#x201d; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled
operating subsidiaries, and/or where applicable, its management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia was incorporated on January 25, 1993 under the laws of the State
of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia acquires businesses and operating assets that the Company believes
to be undervalued and where the Company believes it can leverage its resources and skill sets to realize and unlock value. The Company
intends to leverage its (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and
operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount
and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions
of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. Acacia
seeks to identify opportunities where the Company believes it is an advantaged buyer, where the Company can avoid structured sale processes
and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to the Company&#x2019;s
unique capabilities, relationships, or expertise, or where Acacia believes the target would be worth more to the Company than to other
buyers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia operates its business based on three key principles of People,
Process and Performance and has built a management team with identified expertise in Research, Execution and Operation of the Company&#x2019;s
targeted acquisitions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia, through its operating subsidiaries, also currently engages
in its legacy business of investing in, licensing and enforcing patented technologies. Acacia&#x2019;s operating subsidiaries partner with
inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented
inventions. In recent years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships
developed as a leader in the intellectual property (&#x201c;IP&#x201d;) industry to pursue these opportunities. In some cases, these opportunities
will complement and/or supplement Acacia&#x2019;s primary licensing and enforcement business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s operating subsidiaries generate revenues and related
cash flows from the granting of IP rights (hereinafter, &#x201c;IP Rights&#x201d;) for the use of patented technologies that its operating
subsidiaries control or own. Acacia&#x2019;s operating subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through
the filing of patent infringement litigation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s operating subsidiaries are principals in the licensing
and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia&#x2019;s
operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through
its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#x2019;s operating subsidiaries
are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based
opportunities for sustainable revenue and/or revenue growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the nine months ended September 30, 2021, Acacia obtained
control of one &lt;span id="xdx_90D_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20210101__20210930_zFPmsscH2NBj" style="display: none" title="Number of new patent portfolios acquired"&gt;1&lt;/span&gt;
new patent portfolio. During fiscal year 2020, Acacia obtained control of five &lt;span id="xdx_907_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20200101__20201231_z0DlQoQ7KXz8" style="display: none" title="Number of new patent portfolios acquired"&gt;5&lt;/span&gt; new patent portfolios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</ACTG:DescriptionOfBusinessPolicyTextBlock>
    <ACTG:NumberOfPatentPortfoliosAcquired
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Integer">1</ACTG:NumberOfPatentPortfoliosAcquired>
    <ACTG:NumberOfPatentPortfoliosAcquired
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Integer">5</ACTG:NumberOfPatentPortfoliosAcquired>
    <ACTG:BasisOfAccountingPoliesPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_846_ecustom--BasisOfAccountingPoliesPolicyTextBlock_zTkfyraUtA34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_865_zJRRpXQOfCwi"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial statements
include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;)
for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information
and note disclosures required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly
reporting requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). These interim unaudited condensed consolidated financial
statements and notes hereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2020, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March 29, 2021, as well as in our other
public filings with the SEC. The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring
nature which, in the opinion of management, are necessary for a fair statement of Acacia&#x2019;s consolidated financial position as of
September 30, 2021, and results of its operations and its cash flows for the interim periods presented. The consolidated results of operations
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal
year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Certain prior period amounts in the consolidated financial statements
have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated
results of operations or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

</ACTG:BasisOfAccountingPoliesPolicyTextBlock>
    <ACTG:Covid19PandemicAndCaresActPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84E_ecustom--Covid19PandemicAndCaresActPolicyTextBlock_zazWKBu653X5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_869_zJQM5ugWaLIa"&gt;COVID-19 Pandemic&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#x2019;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.&lt;/p&gt;

</ACTG:Covid19PandemicAndCaresActPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zxLzCpbkUtD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;2. &lt;span id="xdx_82F_zUjdVBQzojDh"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1ORXFzaCLxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zDJple5wwSO8"&gt;Accounting Principles&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The consolidated financial statements and accompanying notes are prepared
on the accrual basis of accounting in accordance with U.S. GAAP.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zZGNypmCv9a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zfiRWS9j1Ysd"&gt;Principles of Consolidation&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited consolidated financial statements include
the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Noncontrolling interests in Acacia&#x2019;s majority-owned and controlled
operating subsidiaries (&#x201c;noncontrolling interests&#x201d;) are separately presented as a component of stockholders&#x2019; equity.
Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated
statements of operations. Refer to the accompanying Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders&#x2019;
Equity for total noncontrolling interests.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In 2020, in connection with the transaction with Link Fund Solutions
Limited, which is more fully described in Note 3, the Company acquired equity securities of Malin J1 Limited (&#x201c;MalinJ1&#x201d;).
MalinJ1 is included in the Company&#x2019;s consolidated financial statements because the Company, through its interest in the equity securities
of MalinJ1, has the ability to control the operations and activities of MalinJ1. Viamet HoldCo LLC, a Delaware limited liability company
and wholly-owned subsidiary of Acacia, is the majority shareholder of MalinJ1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;A wholly-owned subsidiary of Acacia is the general partner of the Acacia
Intellectual Property Fund, L.P. (the &#x201c;Acacia IP Fund&#x201d;), which was formed in August 2010. The Acacia IP Fund has been included
in the Company&#x2019;s consolidated financial statements since 2010, as Acacia&#x2019;s wholly-owned subsidiary, the general partner of
Acacia IP Fund, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia IP Fund was terminated as of
December 31, 2017 and dissolved in 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--SegmentReportingPolicyTextBlock_zADk5K4ldVx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_zeJga3udMrb8"&gt;Segment Reporting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia uses the management approach, which designates the internal
organization that is used by management for making operating decisions and assessing performance as the basis of Acacia&#x2019;s reportable
segments. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--EstimatesPolicytextBlock_z7iuQVnnEnC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_865_zSX0sSXVwUHk"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described
herein, the accounting policies associated with revenue recognition, the valuation of the equity instruments, the valuation of Series
A redeemable convertible preferred stock (the &#x201c;Series A Redeemable Convertible Preferred Stock&#x201d;), embedded derivatives, Series
A warrants (the &#x201c;Series A Warrants&#x201d;), Series B warrants (the &#x201c;Series B Warrants&#x201d;), stock-based compensation expense,
impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income
taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zp4pqpx2Pche" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86F_z0axyN6kaGS5"&gt;Revenue Recognition&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenue is recognized upon transfer of control (i.e., by the granting)
of promised bundled IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they
exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition
criteria have been met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the periods presented, revenue contracts executed by the Company
primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain
IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based revenue contracts,
the majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on quarterly
sales of applicable product units by licensees (&#x201c;Recurring Revenue Agreements&#x201d;). Revenues may also include court ordered settlements
or awards related to our patent portfolio or sales of our patent portfolio. IP Rights granted included the following, as applicable: (i)
the grant of a non-exclusive, future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue,
(iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were generally
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for
as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to grant combined items
to which the promised IP Rights are inputs and (ii) the Company's promise to grant each individual IP right described above to the customer
is not separately identifiable from other promises to grant IP Rights in the contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Since the promised IP Rights are not individually distinct, the Company
combined each individual IP Right in the contract into a bundle of IP Rights that is distinct, and accounted for all of the IP Rights
promised in the contract as a single performance obligation. The IP Rights granted were &#x201c;functional IP rights&#x201d; that have significant
standalone functionality. Acacia&#x2019;s subsequent activities do not substantively change that functionality and do not significantly
affect the utility of the IP to which the licensee has rights. Acacia&#x2019;s operating subsidiaries have no further obligation with respect
to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support
or services. The contracts provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon
execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process
is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition
criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 15-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are
generally non-refundable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the
amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently
resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later
of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been
allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenues from contracts with significant financing components (either
explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash
for the IP Rights when they are granted to the licensee. In determining the transaction price, the Company adjusts the promised amount
of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount
of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between
when the entity grants promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In general, the Company is required to make certain judgments and estimates
in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in
the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct
from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating
the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and
estimating revenues recognized at a point in time for sales-based royalties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Revenues
were comprised of the following for the periods presented:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Disaggregation
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Paid-up
    revenue agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,385&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;23,110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,477&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recurring
    Revenue Agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,675&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;922&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,466&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,399&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AE_z9c4bc72xOyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&lt;b/&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Refer to &#x201c;&lt;i&gt;Inventor Royalties and
Contingent Legal Expenses&lt;/i&gt;&#x201d; below for information on related direct costs of revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--PatentPortfolioOperationsPolicyTextBlock_zt9WnCalrHff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_869_zqjcrZxcdwW3"&gt;Patent Portfolio Operations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Cost of revenues include the costs and expenses incurred in connection
with Acacia&#x2019;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, patent maintenance
and prosecution costs, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent
counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related
investment costs. These costs are included under the caption &#x201c;Patent portfolio operations&#x201d; in the consolidated statements
of operations.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Inventor royalties are expensed in the consolidated statements of operations
in the period that the related revenues are recognized. Patent costs, including any upfront advances paid to patent owners by Acacia&#x2019;s
operating subsidiaries, that are recoverable from future net revenues are amortized over the estimated economic useful life of the related
patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period
recovered and included in amortization expense in the consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Contingent legal fees are expensed in the consolidated statements of
operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers,
no contingent legal fees are paid; however, Acacia&#x2019;s operating subsidiaries may be liable for certain out of pocket legal costs
incurred pursuant to the underlying legal services agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Inventor royalty and contingent legal agreements generally provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments
are received from licensees by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--ConcentrationsPolicyTextBlock_zdCisWyLDcGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86D_z629mh8x2Fg3"&gt;Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, equity securities and accounts receivable. Acacia places its cash equivalents and equity securities
primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in
deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Four licensees individually accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z08Z9l632Sma" title="Concentration risk percentage"&gt;32&lt;/span&gt;%, &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z3sOv6LAIQUd" title="Concentration risk percentage"&gt;25&lt;/span&gt;%, &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zxTh9mIiCwge" title="Concentration risk percentage"&gt;22&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zLScaSSvNJK9" title="Concentration risk percentage"&gt;13&lt;/span&gt;% of
revenues recognized during the three months ended September 30, 2021, and one licensee accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z30FpxRpeW0k" title="Concentration risk percentage"&gt;98&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2020. Three licensees individually accounted for &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_znyPUuufBOm3" title="Concentration risk percentage"&gt;50&lt;/span&gt;%, &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zx39kZPTH5Yd" title="Concentration risk percentage"&gt;19&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zENUWIIMvvqc" title="Concentration risk percentage"&gt;12&lt;/span&gt;% of revenues recognized during the
nine months ended September 30, 2021, and two licensees accounted for &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee3Member_z2vQAS6oMQnh" title="Concentration risk percentage"&gt;75&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z7RGndZS4Sr1" title="Concentration risk percentage"&gt;9&lt;/span&gt;% of revenues recognized during the nine months ended September
30, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company does not have any material foreign operations. Based on
the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for the three
and nine months ended September 30, 2021, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zXbwkFsoK2F8" title="Concentration risk percentage"&gt;8&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_z9U13b52KX1g" title="Concentration risk percentage"&gt;15&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions.
For the three and nine months ended September 30, 2020, &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zzAcapFYsMyg" title="Concentration risk percentage"&gt;0.1&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zdyx2eenqfSb" title="Concentration risk percentage"&gt;5&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Two licensees represented &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zlW1ntM3cEX8" title="Concentration risk percentage"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zPMhqdsSsote"&gt;100&lt;/span&gt;&lt;/span&gt;% of accounts receivable at September
30, 2021. Two licensees individually represented approximately &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zg6fPuOeDpqc" title="Concentration risk percentage"&gt;62&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zVRo2X70XVZk" title="Concentration risk percentage"&gt;21&lt;/span&gt;% of accounts receivable at December 31, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--RelatedPartyTransactionsPolicyTextBlock_zUtnhFN0ysLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zZ9svsDlVKPl"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2019, the Company purchased shares of common stock of Drive
Shack, Inc. (&#x201c;Drive Shack&#x201d;) for an aggregate purchase price of $2.4 million. At the time, Drive Shack and Clifford Press,
Chief Executive Officer and director of Acacia, were related parties as Mr. Press was a board member of Drive Shack until June 2021. The
market value of the investment was $1.4 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company
sold its investment receiving proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromSaleOfLongtermInvestments_pn3n3_dm_c20210101__20210930_z8wZGQ7XLEvl" title="Proceeds from sale of investment"&gt;1.8 &lt;/span&gt;million and recognized a loss of $&lt;span id="xdx_909_eus-gaap--LossOnSaleOfInvestments_pn3p0_c20210101__20210930_zbEpXupgctJj" title="Loss on sale of investment"&gt;515,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znBggoYpGtE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zApTIkBILrjc"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia considers all highly liquid, equity securities with original
maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#x2019;s cash equivalents are
comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic
commercial paper and securities issued or guaranteed by the U.S. government or its agencies. Acacia&#x2019;s cash equivalents are measured
at fair value using observable inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_845_ecustom--EquitySecuritiesAtFairValuePolicyTextBlock_zKwKzjxaIxTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86A_zMr6TNNWWq8h"&gt;Equity Securities at Fair Value &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investments in equity securities are reported at fair value on a recurring
basis, with related realized and unrealized gains and losses in the value of such securities recorded in the consolidated statements of
operations in other income or (expense). Dividend income is included in the consolidated statements of operations in other income or (expense).
Refer to Note 7 for additional information related to fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity securities at fair value for the periods presented were comprised
of the following:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Security
    Type&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;62,042&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;288,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;348,738&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;35,178&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;38,382&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;97,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;291,797&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity securities
    - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;32,765&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;72,689&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(583&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;104,871&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,086&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,410&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;36,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;74,099&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,847&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A6_zpdhH9K9HW7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_zA5jIua165jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_862_ztj8KnAgfmB2"&gt;Equity Securities Without Readily Determinable Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For equity securities that do not have readily determinable fair value,
the Company elected to report them under the measurement alternative. They are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The
fair values of the private company securities were estimated based on recent financing transactions and secondary market transactions
and factoring in any adjustments for illiquidity or preference of these securities. Changes in fair value are reported in the consolidated
statements of operations in other income or (expense). Refer to Note 3 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--EquityMethodInvestmentsPolicy_zEKMmci1k7Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_862_zLpxVmZXnVai"&gt;Equity Method Investments &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity investments in common stock and in-substance common stock without
readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted
for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees
in earnings on equity investment in joint venture in the consolidated statements of operations. Refer to Note 3 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_znHRNqpxtPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_zSHlKiT5CP7b"&gt;Investment at Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On an individual investment basis, Acacia may elect to account for
investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of
the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under the equity
method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and
warrants). We elected the fair value method for our investment in Veritone, Inc. (&#x201c;Veritone&#x201d;) upon acquisition of the investment.
Since March 2021, we have no more investment in Veritone stocks and warrants. Refer to Note 4 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











&lt;p id="xdx_847_ecustom--ImpairmentOfInvestmentPolicyTextBlock_zRWgCZILRST4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86F_z8aUtYt7Lw5e"&gt;Impairment of Investments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative
evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates,
among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zLoyDWm9Wmw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_z2TQncf3udej"&gt;Long-Term Restricted Cash &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Restricted cash relates primarily to the proceeds received from the
issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account (refer to Note 6). The amounts are to
be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii)
the conversion of Series A Redeemable Convertible Preferred Stock into common stock. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Refer to Note 11 for additional information related to the subsequent
period acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zuh4nTi8mO3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zoKMVuQnHAik"&gt;Patents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Patents include the cost of patents or patent rights acquired from
third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over
their remaining economic useful lives. Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zruaHSR5TAmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86A_zpvZ1zkYyGje"&gt;Impairment of Long-lived Assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not
be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying
amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#x2019;s carrying value over its fair
value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If
quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value
of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Fair value is generally estimated using the &#x201c;Income Approach,&#x201d;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic useful
life. Estimates of future after-tax cash flows are converted to present value through &#x201c;discounting,&#x201d; including an estimated
rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based
on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are
based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license
fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#x2019;s licensing and
enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status
and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent
information that could impact future net cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--SeriesAandBWarrantsPolicyTextBlock_zuTOJOxjyock" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86C_zVQjbnwmj3A4"&gt;Series A and B Warrants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The fair value of the Series A and B Warrants are estimated using a
Black-Scholes option-pricing model. Refer to Notes 6 and 7 for additional information related to the Series A and B Warrants and their
fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--DerivativesEmbeddedDerivatives_zRArdVHPPach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_zIbQuddiHXx5"&gt;Embedded derivatives&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Embedded derivatives that are required to be bifurcated from their
host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded
derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019. Refer to Notes 6 and 7 for additional
information related to the embedded derivatives and their fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











&lt;p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zAgIWGu5eFW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zIEBNkgpHQm3"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. Refer to Note 7 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zLIMZCIP7dyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_z8pF6IErMmu4"&gt;Treasury Stock&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Repurchases of the Company&#x2019;s outstanding common stock are accounted
for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive
retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital and
reflected as treasury stock in the consolidated balance sheets. Refer to Note 9 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvPvcmTx8j3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86D_zIGubIqJW9Il"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The compensation cost for all stock-based awards is measured at the
grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#x2019;s requisite
service period (generally the vesting period of the equity award) which is generally one to three years. The fair value of restricted
stock awards (&#x201c;RSAs&#x201d;) and restricted stock units (&#x201c;RSUs&#x201d;) are determined by the product of the number of shares
or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the
date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;RSUs granted in September 2019 with market-based vesting conditions
vest based upon the Company achieving specified stock price targets over a three-year period. The effect of a market condition is reflected
in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized
with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition
is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique, that resulted in a fair value of $1.42 per
unit, included: estimated risk-free interest rate of &lt;span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;1.38 percent&lt;/span&gt;; term of &lt;span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z0Hir3knAOO2" title="Assumptions used for derivatives"&gt;3.00 years&lt;/span&gt;; expected volatility of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;38 percent&lt;/span&gt;; and expected
dividend yield of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues.
The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations
regarding dividend payments. During the nine months ended September 30, 2021, &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfsoNSr2NIc5" title="Option Forfeited"&gt;450,000&lt;/span&gt; RSUs were forfeited, leaving &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkA1kLOVQEc" title="Option Forfeited"&gt;450,000&lt;/span&gt; units with
market-based vesting conditions outstanding and unvested at period end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the nine months ended September 30, 2021, the Company granted
&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zJ99UTGtC3i7" title="Weighted Average Grant"&gt;324,401&lt;/span&gt; RSAs at a weighted average grant-date fair value of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zXdwiRqa7Bg2" title="Weighted average grant-date fair value"&gt;5.56 &lt;/span&gt;per share, &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3I4cREBWCte"&gt;473,000&lt;/span&gt; RSUs at a weighted average grant-date fair value
of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsbs1hsoSqb" title="Weighted average grant-date fair value"&gt;5.86&lt;/span&gt; per unit and &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEBfRxUcHaa6"&gt;393,750&lt;/span&gt; non-qualified stock options at a grant-date fair value of $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zogY04uAPWJa"&gt;1.79&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Stock-based compensation is reported in the consolidated statements
of operations in general and administrative expenses. Total stock-based compensation for the three and nine months ended September 30,
2021 was $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_pn3p0_c20210701__20210930_zmrcwGz6Jdza" title="Stock-based compensation"&gt;300,000&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210101__20210930_pn3p0" title="Stock-based compensation"&gt;1,279,000&lt;/span&gt;, respectively. Total unrecognized stock-based compensation expense as of September 30, 2021 was $&lt;span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20210930_pn3p0" title="Unrecognized stock-based compensation expense"&gt;5,952,000&lt;/span&gt;,
which will be amortized over a weighted average remaining vesting period of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930_zdmyqOeYYNDb" title="Weighted-average remaining vesting period"&gt;2.20&lt;/span&gt; years. Total stock-based compensation for the three and
nine months ended September 30, 2020 was $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930_pn3p0" title="Stock-based compensation"&gt;488,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200930_pn3p0" title="Stock-based compensation"&gt;1,243,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Profits Interest Units (&#x201c;PIUs&#x201d;) were accounted for in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10, &#x201c;Compensation - Stock Compensation.&#x201d; The vesting conditions
did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the PIUs were classified as
liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion of the requisite service period
rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#x2019;s requisite service period (generally
the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended
September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period. The Company has a purchase
option to purchase the vested PIUs that are not otherwise forfeited after termination of continuous service. The exercise price of the
purchase option is the fair market value of the PIUs on the date of termination of continuous service. The individuals holding PIUs are
no longer employed by the Company. Included in other long-term liabilities in the consolidated balance sheets as of September 30, 2021
and December 31, 2020, the PIUs totaled $591,000, which was their fair value as of December 31, 2018 after termination of service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhkUQWPPd5J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86C_za3TxTxZzFm3"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Income taxes are accounted for using an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been
recognized in Acacia&#x2019;s consolidated financial statements or consolidated income tax returns. A valuation allowance is established
to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that
there is uncertainty regarding future realization of such assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The provision for income taxes for interim periods is determined using
an estimate of Acacia&#x2019;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant
period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative
adjustment is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company&#x2019;s effective tax rates were &lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210701__20210930_z11XD73sdRb4" title="Effective tax rate"&gt;0&lt;/span&gt;% and (&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210930_zpSd4wOSJbW3" title="Effective tax rate"&gt;1&lt;/span&gt;%) for the three
and nine months ended September 30, 2021, respectively, and &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200701__20200930_zgvk1NgPLcZh" title="Effective tax rate"&gt;0&lt;/span&gt;% and (&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20200930_z9kHwwZ0ewu9" title="Effective tax rate"&gt;4&lt;/span&gt;%) for the three and nine months ended September 30, 2020, respectively.
Tax expense/benefit for the periods presented primarily reflects the impact of state taxes and foreign tax withholding (or refund) incurred
on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. The Company has recorded a full valuation
allowance against our net deferred tax assets as of September 30, 2021 and December 31, 2020. These assets primarily consist of foreign
tax credits, capital loss carryforwards and net operating loss carryforwards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZXOl0XkMU5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_zviHK9QTSmF9"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December of 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes.&#x201d; The update removed certain exceptions to the general principles in Topic 740 in U.S. GAAP. The Company adopted the update
on January 1, 2021. The adoption of the update did not have a material effect on the Company&#x2019;s financial position, results of operations
or financial statement disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Not Yet Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In June 2016, the FASB issued ASU No. 2016-13, &#x201c;Financial Instruments&#x2014;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d; to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset,
including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected
credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019,
the FASB issued ASU No. 2019-04, &#x201c;Codification Improvements to Topic 326, Financial Instruments&#x2014;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments,&#x201d; to clarify the inclusion of recoveries of trade receivables previously
written off when estimating an allowance for credit losses. The amendments in these updates will currently be effective for the Company
on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments in these updates
may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity,&#x201d; to simplify the accounting for convertible
instruments by eliminating large sections of the existing guidance in this area. It also eliminates several triggers for derivative accounting,
including a requirement to settle certain contracts by delivering registered shares. This update reduces the number of accounting models
for convertible instruments, revises the derivatives scope exception, and provides targeted improvements for earnings per share. Upon
adoption, companies have the option to apply a modified or full retrospective transition approach. The amendments in this update will
currently be effective for the Company on January 1, 2024, with early adoption permitted. Management is currently evaluating the impact
that the amendments in this update may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In October 2021, the FASB issued ASU No. 2021-08, &#x201c;Business Combinations
(Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,&#x201d; to require that an acquirer
recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with &#x201c;Revenue from
Contracts with Customers (Topic 606).&#x201d; At the acquisition date, an acquirer should account for the related revenue contracts in
accordance with Topic 606 as if it had originated the contracts. The amendments in this update should be applied prospectively and will
be effective for the Company on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the
amendments in this update may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1ORXFzaCLxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zDJple5wwSO8"&gt;Accounting Principles&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The consolidated financial statements and accompanying notes are prepared
on the accrual basis of accounting in accordance with U.S. GAAP.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zZGNypmCv9a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zfiRWS9j1Ysd"&gt;Principles of Consolidation&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited consolidated financial statements include
the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Noncontrolling interests in Acacia&#x2019;s majority-owned and controlled
operating subsidiaries (&#x201c;noncontrolling interests&#x201d;) are separately presented as a component of stockholders&#x2019; equity.
Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated
statements of operations. Refer to the accompanying Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders&#x2019;
Equity for total noncontrolling interests.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In 2020, in connection with the transaction with Link Fund Solutions
Limited, which is more fully described in Note 3, the Company acquired equity securities of Malin J1 Limited (&#x201c;MalinJ1&#x201d;).
MalinJ1 is included in the Company&#x2019;s consolidated financial statements because the Company, through its interest in the equity securities
of MalinJ1, has the ability to control the operations and activities of MalinJ1. Viamet HoldCo LLC, a Delaware limited liability company
and wholly-owned subsidiary of Acacia, is the majority shareholder of MalinJ1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;A wholly-owned subsidiary of Acacia is the general partner of the Acacia
Intellectual Property Fund, L.P. (the &#x201c;Acacia IP Fund&#x201d;), which was formed in August 2010. The Acacia IP Fund has been included
in the Company&#x2019;s consolidated financial statements since 2010, as Acacia&#x2019;s wholly-owned subsidiary, the general partner of
Acacia IP Fund, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia IP Fund was terminated as of
December 31, 2017 and dissolved in 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <ACTG:SegmentReportingPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_844_ecustom--SegmentReportingPolicyTextBlock_zADk5K4ldVx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_zeJga3udMrb8"&gt;Segment Reporting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia uses the management approach, which designates the internal
organization that is used by management for making operating decisions and assessing performance as the basis of Acacia&#x2019;s reportable
segments. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:SegmentReportingPolicyTextBlock>
    <ACTG:EstimatesPolicytextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84C_ecustom--EstimatesPolicytextBlock_z7iuQVnnEnC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_865_zSX0sSXVwUHk"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described
herein, the accounting policies associated with revenue recognition, the valuation of the equity instruments, the valuation of Series
A redeemable convertible preferred stock (the &#x201c;Series A Redeemable Convertible Preferred Stock&#x201d;), embedded derivatives, Series
A warrants (the &#x201c;Series A Warrants&#x201d;), Series B warrants (the &#x201c;Series B Warrants&#x201d;), stock-based compensation expense,
impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income
taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:EstimatesPolicytextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zp4pqpx2Pche" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86F_z0axyN6kaGS5"&gt;Revenue Recognition&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenue is recognized upon transfer of control (i.e., by the granting)
of promised bundled IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they
exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition
criteria have been met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the periods presented, revenue contracts executed by the Company
primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain
IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based revenue contracts,
the majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on quarterly
sales of applicable product units by licensees (&#x201c;Recurring Revenue Agreements&#x201d;). Revenues may also include court ordered settlements
or awards related to our patent portfolio or sales of our patent portfolio. IP Rights granted included the following, as applicable: (i)
the grant of a non-exclusive, future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue,
(iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were generally
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for
as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to grant combined items
to which the promised IP Rights are inputs and (ii) the Company's promise to grant each individual IP right described above to the customer
is not separately identifiable from other promises to grant IP Rights in the contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Since the promised IP Rights are not individually distinct, the Company
combined each individual IP Right in the contract into a bundle of IP Rights that is distinct, and accounted for all of the IP Rights
promised in the contract as a single performance obligation. The IP Rights granted were &#x201c;functional IP rights&#x201d; that have significant
standalone functionality. Acacia&#x2019;s subsequent activities do not substantively change that functionality and do not significantly
affect the utility of the IP to which the licensee has rights. Acacia&#x2019;s operating subsidiaries have no further obligation with respect
to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support
or services. The contracts provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon
execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process
is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition
criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 15-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are
generally non-refundable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the
amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently
resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later
of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been
allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenues from contracts with significant financing components (either
explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash
for the IP Rights when they are granted to the licensee. In determining the transaction price, the Company adjusts the promised amount
of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount
of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between
when the entity grants promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In general, the Company is required to make certain judgments and estimates
in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in
the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct
from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating
the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and
estimating revenues recognized at a point in time for sales-based royalties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Revenues
were comprised of the following for the periods presented:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Disaggregation
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Paid-up
    revenue agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,385&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;23,110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,477&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recurring
    Revenue Agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,675&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;922&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,466&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,399&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AE_z9c4bc72xOyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&lt;b/&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Refer to &#x201c;&lt;i&gt;Inventor Royalties and
Contingent Legal Expenses&lt;/i&gt;&#x201d; below for information on related direct costs of revenues.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Disaggregation
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Paid-up
    revenue agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,100&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,385&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;23,110&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,477&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recurring
    Revenue Agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;81&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,675&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;922&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;19,466&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,399&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">19385000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">23110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">24477000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">482000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">81000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">1675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">19466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">24785000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">25399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ACTG:PatentPortfolioOperationsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_847_ecustom--PatentPortfolioOperationsPolicyTextBlock_zt9WnCalrHff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_869_zqjcrZxcdwW3"&gt;Patent Portfolio Operations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Cost of revenues include the costs and expenses incurred in connection
with Acacia&#x2019;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, patent maintenance
and prosecution costs, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent
counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related
investment costs. These costs are included under the caption &#x201c;Patent portfolio operations&#x201d; in the consolidated statements
of operations.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Inventor royalties are expensed in the consolidated statements of operations
in the period that the related revenues are recognized. Patent costs, including any upfront advances paid to patent owners by Acacia&#x2019;s
operating subsidiaries, that are recoverable from future net revenues are amortized over the estimated economic useful life of the related
patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period
recovered and included in amortization expense in the consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Contingent legal fees are expensed in the consolidated statements of
operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers,
no contingent legal fees are paid; however, Acacia&#x2019;s operating subsidiaries may be liable for certain out of pocket legal costs
incurred pursuant to the underlying legal services agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Inventor royalty and contingent legal agreements generally provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments
are received from licensees by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

</ACTG:PatentPortfolioOperationsPolicyTextBlock>
    <ACTG:ConcentrationsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_845_ecustom--ConcentrationsPolicyTextBlock_zdCisWyLDcGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86D_z629mh8x2Fg3"&gt;Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, equity securities and accounts receivable. Acacia places its cash equivalents and equity securities
primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in
deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Four licensees individually accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z08Z9l632Sma" title="Concentration risk percentage"&gt;32&lt;/span&gt;%, &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z3sOv6LAIQUd" title="Concentration risk percentage"&gt;25&lt;/span&gt;%, &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zxTh9mIiCwge" title="Concentration risk percentage"&gt;22&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zLScaSSvNJK9" title="Concentration risk percentage"&gt;13&lt;/span&gt;% of
revenues recognized during the three months ended September 30, 2021, and one licensee accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z30FpxRpeW0k" title="Concentration risk percentage"&gt;98&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2020. Three licensees individually accounted for &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_znyPUuufBOm3" title="Concentration risk percentage"&gt;50&lt;/span&gt;%, &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zx39kZPTH5Yd" title="Concentration risk percentage"&gt;19&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zENUWIIMvvqc" title="Concentration risk percentage"&gt;12&lt;/span&gt;% of revenues recognized during the
nine months ended September 30, 2021, and two licensees accounted for &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee3Member_z2vQAS6oMQnh" title="Concentration risk percentage"&gt;75&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z7RGndZS4Sr1" title="Concentration risk percentage"&gt;9&lt;/span&gt;% of revenues recognized during the nine months ended September
30, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company does not have any material foreign operations. Based on
the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for the three
and nine months ended September 30, 2021, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zXbwkFsoK2F8" title="Concentration risk percentage"&gt;8&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_z9U13b52KX1g" title="Concentration risk percentage"&gt;15&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions.
For the three and nine months ended September 30, 2020, &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zzAcapFYsMyg" title="Concentration risk percentage"&gt;0.1&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zdyx2eenqfSb" title="Concentration risk percentage"&gt;5&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Two licensees represented &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zlW1ntM3cEX8" title="Concentration risk percentage"&gt;&lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zPMhqdsSsote"&gt;100&lt;/span&gt;&lt;/span&gt;% of accounts receivable at September
30, 2021. Two licensees individually represented approximately &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zg6fPuOeDpqc" title="Concentration risk percentage"&gt;62&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zVRo2X70XVZk" title="Concentration risk percentage"&gt;21&lt;/span&gt;% of accounts receivable at December 31, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:ConcentrationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee3Member"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoLicenseeMember"
      decimals="INF"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.62</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <ACTG:RelatedPartyTransactionsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_842_ecustom--RelatedPartyTransactionsPolicyTextBlock_zUtnhFN0ysLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zZ9svsDlVKPl"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2019, the Company purchased shares of common stock of Drive
Shack, Inc. (&#x201c;Drive Shack&#x201d;) for an aggregate purchase price of $2.4 million. At the time, Drive Shack and Clifford Press,
Chief Executive Officer and director of Acacia, were related parties as Mr. Press was a board member of Drive Shack until June 2021. The
market value of the investment was $1.4 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company
sold its investment receiving proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromSaleOfLongtermInvestments_pn3n3_dm_c20210101__20210930_z8wZGQ7XLEvl" title="Proceeds from sale of investment"&gt;1.8 &lt;/span&gt;million and recognized a loss of $&lt;span id="xdx_909_eus-gaap--LossOnSaleOfInvestments_pn3p0_c20210101__20210930_zbEpXupgctJj" title="Loss on sale of investment"&gt;515,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

</ACTG:RelatedPartyTransactionsPolicyTextBlock>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1800000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">515000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znBggoYpGtE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_864_zApTIkBILrjc"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia considers all highly liquid, equity securities with original
maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#x2019;s cash equivalents are
comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic
commercial paper and securities issued or guaranteed by the U.S. government or its agencies. Acacia&#x2019;s cash equivalents are measured
at fair value using observable inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <ACTG:EquitySecuritiesAtFairValuePolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_845_ecustom--EquitySecuritiesAtFairValuePolicyTextBlock_zKwKzjxaIxTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86A_zMr6TNNWWq8h"&gt;Equity Securities at Fair Value &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investments in equity securities are reported at fair value on a recurring
basis, with related realized and unrealized gains and losses in the value of such securities recorded in the consolidated statements of
operations in other income or (expense). Dividend income is included in the consolidated statements of operations in other income or (expense).
Refer to Note 7 for additional information related to fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity securities at fair value for the periods presented were comprised
of the following:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Security
    Type&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;62,042&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;288,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;348,738&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;35,178&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;38,382&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;97,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;291,797&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity securities
    - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;32,765&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;72,689&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(583&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;104,871&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,086&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,410&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;36,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;74,099&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,847&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8A6_zpdhH9K9HW7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ACTG:EquitySecuritiesAtFairValuePolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Security
    Type&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Gain&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gross&lt;br/&gt;
    Unrealized&lt;br/&gt; Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;62,042&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;288,508&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,812&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;348,738&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;35,178&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,289&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(85&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;38,382&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;97,220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;291,797&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,897&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity securities
    - Life Sciences Portfolio (Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;32,765&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;72,689&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(583&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;104,871&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities - other equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,086&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,410&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,264&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;4,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;36,851&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;74,099&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,847&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">62042000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">288508000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">1812000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="AsOf2021-09-30_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">348738000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">35178000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">3289000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">85000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="AsOf2021-09-30_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">38382000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">97220000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">291797000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1897000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">387120000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">32765000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">72689000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2020-01-012020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">583000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_custom_EquitySecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">104871000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">4086000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">1410000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2020-01-012020-12-31_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">1264000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="AsOf2020-12-31_custom_EquitySecuritiesOtherEquityMember"
      decimals="-3"
      unitRef="USD">4232000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">36851000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">74099000</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">1847000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">109103000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84E_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_zA5jIua165jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_862_ztj8KnAgfmB2"&gt;Equity Securities Without Readily Determinable Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For equity securities that do not have readily determinable fair value,
the Company elected to report them under the measurement alternative. They are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The
fair values of the private company securities were estimated based on recent financing transactions and secondary market transactions
and factoring in any adjustments for illiquidity or preference of these securities. Changes in fair value are reported in the consolidated
statements of operations in other income or (expense). Refer to Note 3 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_844_eus-gaap--EquityMethodInvestmentsPolicy_zEKMmci1k7Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_862_zLpxVmZXnVai"&gt;Equity Method Investments &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity investments in common stock and in-substance common stock without
readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted
for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees
in earnings on equity investment in joint venture in the consolidated statements of operations. Refer to Note 3 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_znHRNqpxtPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_zSHlKiT5CP7b"&gt;Investment at Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On an individual investment basis, Acacia may elect to account for
investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of
the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under the equity
method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and
warrants). We elected the fair value method for our investment in Veritone, Inc. (&#x201c;Veritone&#x201d;) upon acquisition of the investment.
Since March 2021, we have no more investment in Veritone stocks and warrants. Refer to Note 4 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:InvestmentPolicyTextBlock>
    <ACTG:ImpairmentOfInvestmentPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_847_ecustom--ImpairmentOfInvestmentPolicyTextBlock_zRWgCZILRST4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86F_z8aUtYt7Lw5e"&gt;Impairment of Investments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative
evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates,
among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:ImpairmentOfInvestmentPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_847_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zLoyDWm9Wmw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_z2TQncf3udej"&gt;Long-Term Restricted Cash &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Restricted cash relates primarily to the proceeds received from the
issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account (refer to Note 6). The amounts are to
be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii)
the conversion of Series A Redeemable Convertible Preferred Stock into common stock. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Refer to Note 11 for additional information related to the subsequent
period acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zuh4nTi8mO3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zoKMVuQnHAik"&gt;Patents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Patents include the cost of patents or patent rights acquired from
third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over
their remaining economic useful lives. Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zruaHSR5TAmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86A_zpvZ1zkYyGje"&gt;Impairment of Long-lived Assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not
be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying
amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#x2019;s carrying value over its fair
value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If
quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value
of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Fair value is generally estimated using the &#x201c;Income Approach,&#x201d;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic useful
life. Estimates of future after-tax cash flows are converted to present value through &#x201c;discounting,&#x201d; including an estimated
rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based
on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are
based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license
fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#x2019;s licensing and
enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status
and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent
information that could impact future net cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <ACTG:SeriesAandBWarrantsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84C_ecustom--SeriesAandBWarrantsPolicyTextBlock_zuTOJOxjyock" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86C_zVQjbnwmj3A4"&gt;Series A and B Warrants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The fair value of the Series A and B Warrants are estimated using a
Black-Scholes option-pricing model. Refer to Notes 6 and 7 for additional information related to the Series A and B Warrants and their
fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:SeriesAandBWarrantsPolicyTextBlock>
    <us-gaap:DerivativesEmbeddedDerivatives contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84F_eus-gaap--DerivativesEmbeddedDerivatives_zRArdVHPPach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_zIbQuddiHXx5"&gt;Embedded derivatives&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Embedded derivatives that are required to be bifurcated from their
host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded
derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019. Refer to Notes 6 and 7 for additional
information related to the embedded derivatives and their fair value measurements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:DerivativesEmbeddedDerivatives>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zAgIWGu5eFW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_867_zIEBNkgpHQm3"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. Refer to Note 7 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zLIMZCIP7dyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_866_z8pF6IErMmu4"&gt;Treasury Stock&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Repurchases of the Company&#x2019;s outstanding common stock are accounted
for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive
retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital and
reflected as treasury stock in the consolidated balance sheets. Refer to Note 9 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvPvcmTx8j3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86D_zIGubIqJW9Il"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The compensation cost for all stock-based awards is measured at the
grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#x2019;s requisite
service period (generally the vesting period of the equity award) which is generally one to three years. The fair value of restricted
stock awards (&#x201c;RSAs&#x201d;) and restricted stock units (&#x201c;RSUs&#x201d;) are determined by the product of the number of shares
or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the
date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;RSUs granted in September 2019 with market-based vesting conditions
vest based upon the Company achieving specified stock price targets over a three-year period. The effect of a market condition is reflected
in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized
with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition
is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique, that resulted in a fair value of $1.42 per
unit, included: estimated risk-free interest rate of &lt;span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;1.38 percent&lt;/span&gt;; term of &lt;span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z0Hir3knAOO2" title="Assumptions used for derivatives"&gt;3.00 years&lt;/span&gt;; expected volatility of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;38 percent&lt;/span&gt;; and expected
dividend yield of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues.
The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations
regarding dividend payments. During the nine months ended September 30, 2021, &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfsoNSr2NIc5" title="Option Forfeited"&gt;450,000&lt;/span&gt; RSUs were forfeited, leaving &lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkA1kLOVQEc" title="Option Forfeited"&gt;450,000&lt;/span&gt; units with
market-based vesting conditions outstanding and unvested at period end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the nine months ended September 30, 2021, the Company granted
&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zJ99UTGtC3i7" title="Weighted Average Grant"&gt;324,401&lt;/span&gt; RSAs at a weighted average grant-date fair value of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zXdwiRqa7Bg2" title="Weighted average grant-date fair value"&gt;5.56 &lt;/span&gt;per share, &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3I4cREBWCte"&gt;473,000&lt;/span&gt; RSUs at a weighted average grant-date fair value
of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsbs1hsoSqb" title="Weighted average grant-date fair value"&gt;5.86&lt;/span&gt; per unit and &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEBfRxUcHaa6"&gt;393,750&lt;/span&gt; non-qualified stock options at a grant-date fair value of $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zogY04uAPWJa"&gt;1.79&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Stock-based compensation is reported in the consolidated statements
of operations in general and administrative expenses. Total stock-based compensation for the three and nine months ended September 30,
2021 was $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_pn3p0_c20210701__20210930_zmrcwGz6Jdza" title="Stock-based compensation"&gt;300,000&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210101__20210930_pn3p0" title="Stock-based compensation"&gt;1,279,000&lt;/span&gt;, respectively. Total unrecognized stock-based compensation expense as of September 30, 2021 was $&lt;span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20210930_pn3p0" title="Unrecognized stock-based compensation expense"&gt;5,952,000&lt;/span&gt;,
which will be amortized over a weighted average remaining vesting period of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930_zdmyqOeYYNDb" title="Weighted-average remaining vesting period"&gt;2.20&lt;/span&gt; years. Total stock-based compensation for the three and
nine months ended September 30, 2020 was $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930_pn3p0" title="Stock-based compensation"&gt;488,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200930_pn3p0" title="Stock-based compensation"&gt;1,243,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Profits Interest Units (&#x201c;PIUs&#x201d;) were accounted for in accordance
with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10, &#x201c;Compensation - Stock Compensation.&#x201d; The vesting conditions
did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the PIUs were classified as
liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion of the requisite service period
rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#x2019;s requisite service period (generally
the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended
September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period. The Company has a purchase
option to purchase the vested PIUs that are not otherwise forfeited after termination of continuous service. The exercise price of the
purchase option is the fair market value of the PIUs on the date of termination of continuous service. The individuals holding PIUs are
no longer employed by the Company. Included in other long-term liabilities in the consolidated balance sheets as of September 30, 2021
and December 31, 2020, the PIUs totaled $591,000, which was their fair value as of December 31, 2018 after termination of service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">1.38 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">3.00 years</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">38 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2021-01-012021-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesMethodMember_custom_RestrictedStockUnitsMember">0 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      unitRef="Shares">450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      unitRef="USD">450000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_RSAsMember"
      decimals="INF"
      unitRef="USDPShares">324401</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_RSAsMember"
      decimals="INF"
      unitRef="USDPShares">5.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="USDPShares">473000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="USDPShares">5.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">393750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">1.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">1279000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5952000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-01to2021-09-30">P2Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">488000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhkUQWPPd5J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_86C_za3TxTxZzFm3"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Income taxes are accounted for using an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been
recognized in Acacia&#x2019;s consolidated financial statements or consolidated income tax returns. A valuation allowance is established
to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that
there is uncertainty regarding future realization of such assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The provision for income taxes for interim periods is determined using
an estimate of Acacia&#x2019;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant
period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative
adjustment is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company&#x2019;s effective tax rates were &lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210701__20210930_z11XD73sdRb4" title="Effective tax rate"&gt;0&lt;/span&gt;% and (&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210930_zpSd4wOSJbW3" title="Effective tax rate"&gt;1&lt;/span&gt;%) for the three
and nine months ended September 30, 2021, respectively, and &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200701__20200930_zgvk1NgPLcZh" title="Effective tax rate"&gt;0&lt;/span&gt;% and (&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20200930_z9kHwwZ0ewu9" title="Effective tax rate"&gt;4&lt;/span&gt;%) for the three and nine months ended September 30, 2020, respectively.
Tax expense/benefit for the periods presented primarily reflects the impact of state taxes and foreign tax withholding (or refund) incurred
on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. The Company has recorded a full valuation
allowance against our net deferred tax assets as of September 30, 2021 and December 31, 2020. These assets primarily consist of foreign
tax credits, capital loss carryforwards and net operating loss carryforwards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">0.01</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Pure">0.04</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZXOl0XkMU5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span id="xdx_860_zviHK9QTSmF9"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Recently Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December of 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2019-12, &#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes.&#x201d; The update removed certain exceptions to the general principles in Topic 740 in U.S. GAAP. The Company adopted the update
on January 1, 2021. The adoption of the update did not have a material effect on the Company&#x2019;s financial position, results of operations
or financial statement disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Not Yet Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In June 2016, the FASB issued ASU No. 2016-13, &#x201c;Financial Instruments&#x2014;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#x201d; to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset,
including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected
credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019,
the FASB issued ASU No. 2019-04, &#x201c;Codification Improvements to Topic 326, Financial Instruments&#x2014;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments,&#x201d; to clarify the inclusion of recoveries of trade receivables previously
written off when estimating an allowance for credit losses. The amendments in these updates will currently be effective for the Company
on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments in these updates
may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In August 2020, the FASB issued ASU No. 2020-06, &#x201c;Debt&#x2014;Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity,&#x201d; to simplify the accounting for convertible
instruments by eliminating large sections of the existing guidance in this area. It also eliminates several triggers for derivative accounting,
including a requirement to settle certain contracts by delivering registered shares. This update reduces the number of accounting models
for convertible instruments, revises the derivatives scope exception, and provides targeted improvements for earnings per share. Upon
adoption, companies have the option to apply a modified or full retrospective transition approach. The amendments in this update will
currently be effective for the Company on January 1, 2024, with early adoption permitted. Management is currently evaluating the impact
that the amendments in this update may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In October 2021, the FASB issued ASU No. 2021-08, &#x201c;Business Combinations
(Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,&#x201d; to require that an acquirer
recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with &#x201c;Revenue from
Contracts with Customers (Topic 606).&#x201d; At the acquisition date, an acquirer should account for the related revenue contracts in
accordance with Topic 606 as if it had originated the contracts. The amendments in this update should be applied prospectively and will
be effective for the Company on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the
amendments in this update may have on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zsvFU5CLq6Uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;3. &lt;span id="xdx_823_zq6fDjbnU4I3"&gt;EQUITY SECURITIES PORTFOLIO INVESTMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On April 3, 2020, the Company entered into an Option Agreement with
LF Equity Income Fund (&#x201c;Seller&#x201d;), which included general terms through which the Company was provided the option to purchase
life sciences equity securities in a portfolio of public and private companies (&#x201c;Life Sciences Portfolio&#x201d;) for an aggregate
purchase price of &#xa3;223.9 million, approximately $&lt;span id="xdx_90F_eus-gaap--PaymentsToAcquireInvestments_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zwMDlfL5mK6e" title="Payment to acquire equity securities"&gt;277.5&lt;/span&gt; million at the exchange rate on April 3, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On June 4, 2020, the Company executed the Transaction Agreement between
Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the Company agreed to purchase from Seller
and Seller agreed to transfer to the Company the specified equity securities of all companies in the Life Sciences Portfolio at set prices
at various future dates. The transfer dates would vary among the Life Sciences Portfolio companies as the Transaction Agreement gives
the Company the exclusive right to determine when to call for transfer of each security, and because each Life Sciences Portfolio company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific terms
and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase equity securities
in each public and private company at a specified price on a future date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In accordance with the Transaction Agreement, the Company transferred
the total purchase price of &#xa3;223.9 million into an escrow account. Upon the transfer of equity securities in the Life Sciences Portfolio
to the Company, the associated funds were released from the escrow account to Seller based on the consideration amount assigned to the
equity securities for such Life Sciences Portfolio company in the Transaction Agreement. As of December 31, 2020, all of the equity securities
in the Life Sciences Portfolio were transferred to the Company pursuant to the Transaction Agreement. The Company has sold a portion of
the equity securities of such Life Sciences Portfolio while retaining an interest in a number of operating businesses, including a controlling
interest in one of the companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For accounting purposes, the total purchase price of the Life Sciences
Portfolio was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their quoted
market price. The fair values of the private company securities were estimated based on recent financing transactions and secondary market
transactions and factoring in a discount for the illiquidity of these securities. As of September 30, 2021 and December 31, 2020, the
fair value of the Life Sciences Portfolio equity securities, excluding the equity method investment discussed below, was $354.6 million
and $248.1 million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in the fair value of Acacia&#x2019;s investment in the Life
Sciences Portfolio are recorded as unrealized gains or losses in the consolidated statements of operations. In late September 2021, the
Company sold one security which resulted in a gain of $18.6 million. The proceeds of that sale were settled and received in early October
2021, and therefore the Company recorded a $21.5 million other receivable as included in the consolidated balance sheet as of September
30, 2021. Accordingly, this trade date receivable from the sale of equity securities has been reflected as a noncash investing activity
in the consolidated statement of cash flows for the nine months ended September 30, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the three and nine months ended September 30, 2021 and 2020, the
consolidated statements of operations reflected the following from the Life Sciences Portfolio:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zxL2We0nCSN5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BE_zKXQW0rympAg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of unrealized gains or losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change
    in fair value of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_zMEUkkqcH3d6" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;84,299&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;112,180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;83,230&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of equity securities derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zuJEfw7epRQj" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,651&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zdgMTswNPWpe" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;17,542&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of equity securities forward contract&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zdxfROMNNJX2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(74,662&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zw18vjWcmTk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_ztucdF4aE139" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain (loss)
    on sale of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zNqcMfNxvUZ1" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;37,112&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RealizedInvestmentGainsLosses_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_znTGs2UIlfOe" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zrfTas6FX2Qf" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(4,202&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain
    on sale of prepaid investment and derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zQb3u7swTyr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivativey_pn3n3_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zmnv5aeeFWa6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivativey"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,845&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_z7nIFl2ff16c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zqCCa3FwKtGh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,845&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    realized and unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_ztnyFAXHjkh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;101,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,041&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnInvestments_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;164,347&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;99,415&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="background-color: white"&gt;As part of the Company&#x2019;s
acquisition of equity securities in the Life Sciences Portfolio, the Company acquired a majority interest in the equity securities of
MalinJ1 (63.9%), which were transferred to the Company on December 3, 2020. The acquisition of the MalinJ1 securities was accounted for
as an asset acquisition as there was a change of control of MalinJ1 and substantially all of the fair value of the assets acquired was
concentrated in a single identifiable asset, an investment in Viamet Pharmaceuticals Holdings, LLC (&#x201c;Viamet&#x201d;). As such, the
cost basis of the MalinJ1 securities was used to allocate to the Viamet investment, the single identifiable asset, and no goodwill was
recognized. The Company through its consolidation of MalinJ1 accounts for the Viamet investment under the equity method as MalinJ1 owns
41.0% of outstanding shares of Viamet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember"
      decimals="-3"
      unitRef="USD">277500000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zxL2We0nCSN5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BE_zKXQW0rympAg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of unrealized gains or losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change
    in fair value of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_zMEUkkqcH3d6" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;84,299&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;112,180&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;83,230&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of equity securities derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zuJEfw7epRQj" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,651&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zdgMTswNPWpe" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;17,542&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of equity securities forward contract&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zdxfROMNNJX2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(74,662&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zw18vjWcmTk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_ztucdF4aE139" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain (loss)
    on sale of equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zNqcMfNxvUZ1" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;37,112&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RealizedInvestmentGainsLosses_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_znTGs2UIlfOe" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zrfTas6FX2Qf" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(4,202&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain
    on sale of prepaid investment and derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zQb3u7swTyr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivativey_pn3n3_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zmnv5aeeFWa6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivativey"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,845&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_z7nIFl2ff16c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zqCCa3FwKtGh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,845&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    realized and unrealized gain&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_ztnyFAXHjkh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;101,019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,041&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnInvestments_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;164,347&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;99,415&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-07-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">63907000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">84299000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">112180000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">83230000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-07-012021-09-30_custom_EquitySecuritesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritesDerivativeMember"
      decimals="-3"
      unitRef="USD">10651000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritesDerivativeMember"
      decimals="-3"
      unitRef="USD">17542000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-07-012021-09-30_custom_EquitySecuritesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritesForwardContractMember"
      decimals="-3"
      unitRef="USD">-74662000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">37112000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">1908000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">52167000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">-4202000</us-gaap:RealizedInvestmentGainsLosses>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative
      contextRef="From2021-07-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">0</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivativey
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">2845000</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivativey>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative
      contextRef="From2021-01-012021-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">0</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative>
    <ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundTradingSecurityMember"
      decimals="-3"
      unitRef="USD">2845000</ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative>
    <us-gaap:GainLossOnInvestments
      contextRef="From2021-07-012021-09-30_custom_LFFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">101019000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_LFFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">25041000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2021-01-012021-09-30_custom_LFFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">164347000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_LFFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">99415000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentHoldingsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--InvestmentHoldingsTextBlock_zKzfd8qQ8iSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;4. &lt;span id="xdx_827_z2hL1KiZKkxl"&gt;INVESTMENT AT FAIR VALUE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2016 and 2017, Acacia made certain investments in Veritone.
As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone common stock and warrants to purchase
a total of 1,120,432 shares of Veritone common stock at an exercise price of $13.61 per share expiring between 2020 and 2027. During the
nine months ended September 30, 2020, Acacia sold all remaining 298,450 shares Veritone common stock and recorded a realized loss of $3.3
million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the nine months ended September 30, 2020, Acacia exercised 154,312
warrants, and recognized a realized gain of $554,000 on the sale of common stock. During the nine months ended September 30,
2021, Acacia exercised all remaining 156,720 warrants, and recognized a realized gain of $3.6 million on the sale of common stock. The
Company no longer has an investment in Veritone common stock and warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in the fair value of Acacia&#x2019;s investment in Veritone
are recorded as unrealized gains or losses in the consolidated statements of operations. For the three and nine months ended September
30, 2021 and 2020, the consolidated statements of operations reflected the following:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_zb8KfomJmqyl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENT AT FAIR VALUE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B4_zeRXAGEneIue" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of gain on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change
    in fair value of investment, warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zHWFPxmYQpCk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zBALI1iOvgBk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,081&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zyACk9VbfrKh" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of investment, common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2aYF2y3cM6c" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zfSP8TYgl9Xk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zy9OuX3Ssi01" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,479&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain on sale
    of investment, warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zw1VJthNG0oi" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zu11xIn4bKyc" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,591&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Loss
    on sale of investment, common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zpanvTIk1fGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2c64wloIrl1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z08tvJcl3vQ6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zxbeb8UKZ8W3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    realized and unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20210701__20210930_z7p5QeItbWLd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_iN_pn3n3_di_c20200701__20200930_zwv5wA4AXM9f" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,081&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GainLossOnInvestments_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;942&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:InvestmentHoldingsTextBlock>
    <us-gaap:GainLossOnInvestmentsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_zb8KfomJmqyl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENT AT FAIR VALUE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B4_zeRXAGEneIue" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of gain on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change
    in fair value of investment, warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zHWFPxmYQpCk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zBALI1iOvgBk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,081&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zyACk9VbfrKh" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Change in
    fair value of investment, common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2aYF2y3cM6c" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zfSP8TYgl9Xk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zy9OuX3Ssi01" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,479&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Gain on sale
    of investment, warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zw1VJthNG0oi" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zu11xIn4bKyc" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,591&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Loss
    on sale of investment, common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zpanvTIk1fGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2c64wloIrl1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z08tvJcl3vQ6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zxbeb8UKZ8W3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,316&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    realized and unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20210701__20210930_z7p5QeItbWLd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_iN_pn3n3_di_c20200701__20200930_zwv5wA4AXM9f" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,081&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GainLossOnInvestments_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;839&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;942&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-07-012021-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">3081000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-01-012021-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">2752000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">225000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-07-012021-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2021-01-012021-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">3479000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2021-07-012021-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2021-01-012021-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">3591000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">554000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2021-01-012021-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">3316000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">3081000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">839000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">942000</us-gaap:GainLossOnInvestments>
    <ACTG:PatentsNetOfAccumulatedAmortizationTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_809_ecustom--PatentsNetOfAccumulatedAmortizationTextBlock_zTpxf0aZQPNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;5. &lt;span id="xdx_826_zij6bxuAdYCi"&gt;PATENTS, NET OF ACCUMULATED AMORTIZATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s only identifiable intangible assets as of September
30, 2021 and December 31, 2020 are patents and patent rights. Patent-related accumulated amortization totaled $&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20210930_zWMfi9WnMjRl" title="Accumulated amortization"&gt;291.6&lt;/span&gt; million and $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20201231_zDLvRdd58j29" title="Accumulated amortization"&gt;319.9&lt;/span&gt;
million as of September 30, 2021 and December 31, 2020, respectively. Acacia&#x2019;s patents have remaining estimated economic useful
lives ranging from twenty-six to fifty-two months. The weighted average remaining estimated economic useful life of Acacia&#x2019;s patents
is approximately four years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table presents the scheduled annual aggregate amortization
expense as of September 30, 2021:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zUT140DEdHl3" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zuiqmEMygJp9" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210930_zz4FFSJwI0E1" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For&#160;the&#160;years&#160;ending&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJix_ze9vNrN0UJf9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remainder
    of 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,612&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJix_zTiA3MPpqzjk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,448&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJix_zFlxBGuOz923" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,381&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJix_zEvY4MqUajF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJix_z3cmojYdLkNi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,630&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJix_zmEDNRUUDwe3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;750&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJix_znHIRvRyAwCj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="color: rgb(238,238,238); font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Patents,
    net&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;39,826&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the nine months ended September 30, 2021, Acacia accrued patent
and patent rights acquisition costs totaling $&lt;span id="xdx_90F_ecustom--AccruedPatentAcquisitionCosts_iI_pn3n3_dm_c20210930_zMIyiWiJNvVf" title="Accrued patent acquisition costs"&gt;13.0&lt;/span&gt; million, of which $&lt;span id="xdx_90C_eus-gaap--OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_dm_c20210930_z11shg8Vq3Af" title="Accrued patent acquisition costs due within a year"&gt;8.0&lt;/span&gt; million is due December 1, 2021 and $&lt;span id="xdx_908_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_pn3n3_dm_c20210930_zJcRlYw3UMz7" title="Accrued patent acquisition costs due within 2 years"&gt;5.0&lt;/span&gt; million is due February
18, 2023. Such amounts are included in accrued patent investment costs and other long-term liabilities in the consolidated balance sheet
as of September 30, 2021, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ACTG:PatentsNetOfAccumulatedAmortizationTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">291600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">319900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zUT140DEdHl3" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zuiqmEMygJp9" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210930_zz4FFSJwI0E1" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For&#160;the&#160;years&#160;ending&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="4" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJix_ze9vNrN0UJf9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remainder
    of 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,612&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJix_zTiA3MPpqzjk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,448&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJix_zFlxBGuOz923" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,381&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJix_zEvY4MqUajF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,005&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJix_z3cmojYdLkNi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,630&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJix_zmEDNRUUDwe3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;750&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJix_znHIRvRyAwCj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="color: rgb(238,238,238); font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Patents,
    net&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;39,826&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">2612000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">10448000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">10381000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">9005000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">6630000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">750000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">39826000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <ACTG:AccruedPatentAcquisitionCosts contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">13000000.0</ACTG:AccruedPatentAcquisitionCosts>
    <us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">8000000.0</us-gaap:OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">5000000.0</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <ACTG:StarboardInvestmentTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_803_ecustom--StarboardInvestmentTextBlock_zziu1Lyfzex3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;6. &lt;span id="xdx_821_zMcYgilkxbti"&gt;STARBOARD INVESTMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Series A Redeemable Convertible Preferred Stock&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On November 18, 2019, the Company entered into a Securities Purchase
Agreement with Starboard Value LP (&#x201c;Starboard&#x201d;) and certain funds and accounts affiliated with, or managed by, Starboard (collectively,
the &#x201c;Buyers&#x201d;) pursuant to which the Company issued (i) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20191101__20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Stock issued"&gt;350,000&lt;/span&gt; shares of Series A Redeemable Convertible Preferred Stock with
a par value of $0.001 per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_pdd" title="Warrants issued, shares"&gt;5,000,000&lt;/span&gt; shares of
the Company&#x2019;s common stock to the Buyers. The Securities Purchase Agreement also established the terms of certain senior secured
notes and additional Series B Warrants which may be issued to Starboard in the future. On June 4, 2020, the Company entered into a Supplemental
Agreement, as defined below under &#x201c;Senior Secured Notes&#x201d;, with certain contractual agreements affecting the Series A Redeemable
Convertible Preferred Stock, reflected below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii) the conversion
price of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Conversion price"&gt;3.65&lt;/span&gt; (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable Convertible Preferred
Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible Preferred Stock into shares
of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#x2019;s common stock equals or
exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions of the common stock have been
met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Holders have the option to redeem all or a portion of the Series A
Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August 15,
2022, provided that there is not outstanding at least $50.0 million aggregate principal of senior secured notes to the Buyers pursuant
to the Securities Purchase Agreement at the time of the redemption. Holders also have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have
the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control
or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&#x2019;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company may redeem all, and not less than all, of the Series A
Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August 15, 2022,
provided that there is not outstanding at least $50.0 million aggregate principal of the senior secured notes at the time of the redemption,
and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed
at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;If any Series A Redeemable Convertible Preferred Stock remains outstanding
on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In all redemption scenarios, the redemption price for the Series A
Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on the redemption
scenario, the redemption price may also include a make-whole amount or stated premium as described above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;When the Company issues Notes, the Holder may exchange the Series A
Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Series A Redeemable Convertible Preferred Stock accrues cumulative
dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of the approved investment in June 2020, the dividend
rate increased to 8.0% on the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering
event occurs before an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. In
connection with the approved investment in June 2020, the Company and the Buyers agreed that the dividend rate on the Series A Redeemable
Convertible Preferred Stock would accrue at 3.0% so long as no triggering event occurs and the Company maintains $35.0 million in escrow.
Series A Redeemable Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to
common stockholders. No accrued and unpaid dividends as of September 30, 2021. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Upon consummation of the approved acquisition in October 2021, the
dividend rate increased to 8.0% on the stated value. Refer to Note 11 for additional information related to the subsequent period acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Holders of the Series A Redeemable Convertible Preferred Stock have
the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible Preferred
Stock will also be entitled to a separate class vote with respect to amendments to the Company&#x2019;s organizational documents that generally
have an adverse effect on the Series A Redeemable Convertible Preferred Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Upon liquidation of the Company, holders of Series A Redeemable Convertible
Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior to any distribution
to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid dividends or (ii) the amount
that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted into common stock immediately
prior to the liquidation event at the then effective conversion price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company determined that certain features of the Series A Redeemable
Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled together as a single,
compound embedded derivative.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During 2019, total proceeds received and transaction costs incurred
from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkNsLZ672zWc" title="Proceeds from issuance of preferred stock"&gt;35.0&lt;/span&gt; million and $&lt;span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zs75OjSbOHoc" title="Payment of stock issuance costs"&gt;1.3&lt;/span&gt; million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between
the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A
Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series A Warrants,
embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and $8.9 million, respectively.
Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and the Series A Warrants on the same
basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible Preferred Stock were treated as a discount
to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise on November
15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company accretes the
instrument to its redemption value using the effective interest method and recognizes any changes against additional paid in capital in
the absence of retained earnings. Accretion for the three and nine months ended September 30, 2021 was $&lt;span id="xdx_908_eus-gaap--AccretionExpense_pn3p0_c20210701__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zKHVd9iYmgRc" title="Accretion expense"&gt;991,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AccretionExpense_pn3n3_dm_c20210101__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkyTiXbW3UI5" title="Accretion expense"&gt;2.8&lt;/span&gt; million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers and a Governance Agreement with Starboard
and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights
with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with
the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint
Jonathan Sagal as a director of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to
the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets,
(v) appoint certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following features of the Series A Redeemable Convertible Preferred
Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative: (i) the right
of the holders to redeem the shares (the &#x201c;put option&#x201d;), (ii) the right of the holders to receive common stock upon conversion
of the shares (the &#x201c;conversion option&#x201d;), (iii) the right of the Company to redeem the shares (the &#x201c;call option&#x201d;),
and (iv) the change in dividend rate upon consummation of an approved investment or a triggering event (the &#x201c;contingent dividend
rate feature&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;These features are required to be accounted for separately from the
Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related to the debt-like
host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are bundled together and are
accounted for as a single, compound embedded derivative liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Accordingly, we have recorded an embedded derivative liability representing
the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value at each period
end with changes in fair value recorded other income or (expense) in the &#x201c;Change in fair value of the Series A and B warrants and
embedded derivatives&#x201d; financial statement line item of the consolidated statements of operations. As of September 30, 2021 and December
31, 2020, the fair value of the Series A embedded derivative liabilities was $&lt;span id="xdx_90C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zwK8Z9P5ipT5" title="Fair value of embedded derivative"&gt;41.4&lt;/span&gt; million and $&lt;span id="xdx_90A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20201231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkMfyAsve7Ig" title="Fair value of embedded derivative"&gt;26.7&lt;/span&gt; million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Series A Warrants&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On November 18, 2019, in connection with the issuance of the Series
A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrants to acquire up to purchase 5 million shares
of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at any time during a period of eight years
beginning on the instrument&#x2019;s issuance date of the Series A Warrants. The fair value of the Series A Warrants was $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zVduOVdhfJW3" title="Fair value of warrants"&gt;4.8&lt;/span&gt; million upon
issuance. The Series A Warrants will be recognized at fair value at each reporting period until exercised, with changes in fair value
recognized in other income or (expense) in the consolidated statements of operations. As of September 30, 2021 and December 31, 2020,
the fair value of the Series A Warrants was $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zmkROtM85Gnb" title="Fair value of warrants"&gt;18.5&lt;/span&gt; million and $&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zDSBS5WvWmKa"&gt;6.6&lt;/span&gt; million, respectively. As of September 30, 2021, the Series A Warrants
have &lt;span id="xdx_907_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zFNzS50Vw9Uc" title="Warrants exercised"&gt;no&lt;/span&gt;t been exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Series A Warrants are classified as a liability in accordance with
ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Series B Warrants &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On February 25, 2020, pursuant to the terms of the Securities Purchase
Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_dm_c20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zv5GbrN3S5a7" title="Warrants issued, shares"&gt;100&lt;/span&gt; million shares of the Company&#x2019;s
common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i) $5.25 per share, if exercising
by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65 per share, if exercising by cancellation
of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase price of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200201__20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zMyMexkZuAig" title="Proceeds from issuance of preferred stock"&gt;4.6&lt;/span&gt; million. The Series B Warrants
expire on November 15, 2027.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In connection with the issuance of the Notes on June 4, 2020, the terms
of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the payment of cash,
rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November 15, 2027. 31,506,849
of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their
original terms. As of September 30, 2021, the Series B Warrants have &lt;span id="xdx_900_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zbleMgenLO05" title="Warrants exercised"&gt;no&lt;/span&gt;t been exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Series B Warrants will be recognized at fair value at each reporting
period until exercised, with changes in fair value recognized in other income or (expense) in the consolidated statements of operations.
As of September 30, 2021 and December 31, 2020, the fair value of the Series B Warrants was $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zVvHHwpTRnP8" title="Fair value of warrants"&gt;229.6&lt;/span&gt; million and $&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zDr0DS4EoiC7" title="Fair value of warrants"&gt;52.3&lt;/span&gt; million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Series B Warrants are classified as a liability in accordance with
ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Senior Secured Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Pursuant to the Securities Purchase Agreement dated November 18, 2019
with Starboard and the Buyers, on June 4, 2020, the Company issued $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zri2UsNCqTqe" title="Proceeds from issuance of debt"&gt;115.0&lt;/span&gt; million in Notes to the Buyers. Also on June 4, 2020, in connection
with the issuance of the Notes, the Company entered into a Supplemental Agreement with Starboard (the &#x201c;Supplemental Agreement&#x201d;),
pursuant to which the Company agreed to redeem $&lt;span id="xdx_905_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeptemberRedemptionMember_zLsTwy9lCgs" title="Repayment of debt"&gt;80.0&lt;/span&gt; million aggregate principal amount of the Notes by September 30, 2020, and $&lt;span id="xdx_903_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--DecemberRedemptionMember_zXgD1ONnFORb" title="Repayment of debt"&gt;35.0&lt;/span&gt;
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid by December
31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zei6ZnSUFmb6" title="Debt stated interest rate"&gt;6.00&lt;/span&gt;% per annum, and in an event of default, the
interest rate is increased to &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zYIcyIroiFtl" title="Debt stated interest rate"&gt;10.00&lt;/span&gt;% per annum. The Notes include certain financial and non-financial covenants. Additionally, all or
any portion of the principal amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation
in payment of the exercise price upon the exercise of Series B Warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On June 30, 2020, the Company entered into an Exchange Agreement (the
&#x201c;Exchange Agreement&#x201d;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned subsidiary
of the Company (&#x201c;Merton&#x201d;) and Starboard, on behalf of itself and on behalf of certain funds and accounts under its management,
including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal
amount for new senior notes (the &#x201c;New Notes&#x201d;) issued by Merton having an aggregate outstanding original principal amount of
$&lt;span id="xdx_900_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_pn3n3_dm_c20200101__20200630__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zkA8NOn0ZtN2" title="Notes exchanged"&gt;115.0&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The New Notes bear interest at a rate of 6.00% per annum and had a
maturity date of December 31, 2020. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of the Company
and Merton and non-recourse equity pledges of each of the Company&#x2019;s material subsidiaries. Pursuant to the Exchange Agreement, the
New Notes (i) are deemed to be &#x201c;Notes&#x201d; for purposes of the Securities Purchase Agreement, (ii) are deemed to be &#x201c;June
2020 Approved Investment Notes&#x201d; for purposes of the Supplemental Agreement, and with the Company agreeing to redeem $80 million
principal amount of the New Notes by September 30, 2020 and $35 million principal amount of the New Notes by December 31, 2020, and (iii)
are deemed to be &#x201c;Notes&#x201d; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of the New
Notes will also satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#x2019;s
Series A Convertible Preferred Stock, par value $0.001 per share. The New Notes will not be deemed to be &#x201c;Notes&#x201d; for the purposes
of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Because the New Notes are to be settled within twelve months pursuant
to their terms, they are classified as current liabilities in the consolidated balance sheets. The Company capitalized $&lt;span id="xdx_907_eus-gaap--DeferredFinanceCostsGross_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zwG59JrVgGCh" title="Capitalized lender fees"&gt;4.6&lt;/span&gt; million in
lender fees and $&lt;span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zWS0zSted7" title="Unamortized discount"&gt;0.5&lt;/span&gt; million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long-term deferred debt issuance costs and are included in other non-current assets in the consolidated balance sheets, and will be
amortized to interest expense until November 15, 2027, the maturity date of Series A Redeemable Convertible Preferred Stock. The $0.5
million issuance costs are recognized as a discount on the Notes and will be amortized to interest expense over the contractual life of
the Notes. There was $3.1 million and $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zrmbQ1F2oYF7" title="Accrued interest"&gt;863,000&lt;/span&gt; accrued and unpaid interest on the New Notes as of September 30, 2021 and December 31,
2020, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On January 29, 2021, the Company redeemed $&lt;span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zUtTeJV7zK22" title="Repayment of debt"&gt;50.0&lt;/span&gt; million of the New
Notes and on March 31, 2021, the Company reissued $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zqP8l3s0DDs3" title="Proceeds from issuance of debt"&gt;50.0&lt;/span&gt; million of the New Notes. On June 30, 2021, the Company issued $30.0 million in
additional New Notes (the &#x201c;June 2021 Merton Notes&#x201d;) and amended the maturity date of the New Notes to &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zy1M9PDT01d3" title="Debt maturity date"&gt;October 15, 2021&lt;/span&gt;. On
September 30, 2021, the Company issued $35.0 million in additional New Notes (the &#x201c;September 2021 Merton Notes&#x201d;) and amended
the maturity date of the New Notes to December 1, 2021. The June and September 2021 Merton Notes cannot be used to exercise Series B Warrants
issued to Starboard Value. The total principal amount outstanding of New Notes as of September 30, 2021 and December 31, 2020 was $&lt;span id="xdx_901_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20210930__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_z5xPYi3ltAVg"&gt;180.0&lt;/span&gt;
million and $&lt;span id="xdx_907_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20201231__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_zCmJBAeei48k"&gt;115.0&lt;/span&gt; million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Modifications to Series A Redeemable Convertible Preferred Stock
and Series B Warrants&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The June 4, 2020 Supplemental Agreement also provided for (i) a waiver
of increased dividends under the original terms of the Series A Redeemable Convertible Preferred Stock that would have otherwise accrued
due to the Company&#x2019;s use of the $35.0 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series A
Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified through the
issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the payment of the lower
exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding, at any time until
the expiration of the Series B Warrants on November 15, 2027. 31,506,849 of the Series B Warrants are subject to this adjustment with
the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;We analyzed the amendments to the terms of the Series A Redeemable
Convertible Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a
modification on a prospective basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The incremental fair value of the Series B Warrants associated with
the modification of their terms in connection with the issuance of the Notes was $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEOtlWdTPO0c" title="Fair value of warrants"&gt;1.3&lt;/span&gt; million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. As of September 30, 2021, $&lt;span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEyeYmxPGXi2" title="Amortization of discount"&gt;1.2&lt;/span&gt; million was amortized
to interest expense and $&lt;span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAjLlS0B38dd" title="Unamortized discount"&gt;151,000&lt;/span&gt; is remaining to be amortized until the maturity date of December 1, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ACTG:StarboardInvestmentTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-11-012019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">5000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2019-11-18_custom_StarboardValueMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">3.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">35000000.0</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2020-05-192021-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">1300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:AccretionExpense
      contextRef="From2021-07-012021-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">991000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2021-01-012021-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">2800000</us-gaap:AccretionExpense>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2021-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">41400000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-12-31_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">26700000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2019-11-18_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">4800000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">18500000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">6600000</us-gaap:WarrantsAndRightsOutstanding>
    <ACTG:WarrantsExercisedShares
      contextRef="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</ACTG:WarrantsExercisedShares>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2020-02-012020-02-25_custom_StarboardValueMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <ACTG:WarrantsExercisedShares
      contextRef="From2021-01-012021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</ACTG:WarrantsExercisedShares>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2021-09-30_custom_StarboardValueMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">229600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2020-12-31_custom_StarboardValueMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">52300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">115000000.0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <ACTG:RedemptionOfSecuredNotes
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeptemberRedemptionMember"
      decimals="-3"
      unitRef="USD">80000000.0</ACTG:RedemptionOfSecuredNotes>
    <ACTG:RedemptionOfSecuredNotes
      contextRef="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_DecemberRedemptionMember"
      decimals="-3"
      unitRef="USD">35000000.0</ACTG:RedemptionOfSecuredNotes>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="INF"
      unitRef="Pure">0.0600</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="INF"
      unitRef="Pure">0.1000</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent
      contextRef="From2020-01-012020-06-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">115000000.0</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">500000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">863000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">50000000.0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember"
      decimals="-3"
      unitRef="USD">50000000.0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-01-012021-01-29_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_MertonMember">2021-10-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-09-30_custom_NewNotesMember"
      decimals="-3"
      unitRef="USD">180000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2020-12-31_custom_NewNotesMember"
      decimals="-3"
      unitRef="USD">115000000.0</us-gaap:LongTermDebt>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">1300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-01-012021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">1200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2021-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">151000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zpKhLwp8QjW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;7. &lt;span id="xdx_828_zCMtKAoIWlh7"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is
defined as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 96px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level 1 - &lt;i&gt;Observable Inputs&lt;/i&gt;:&#160;&#160;Quoted prices in active markets for identical investments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 96px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level 2 - &lt;i&gt;Pricing Models with Significant Observable Inputs&lt;/i&gt;:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 96px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level 3 - &lt;i&gt;Unobservable Inputs&lt;/i&gt;:&#160;&#160;Unobservable inputs reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Management estimates include certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs, including the entity&#x2019;s own assumptions in determining the fair value of derivatives and certain investments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Whenever possible, the Company is required to use observable market
inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls
is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of
a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs
used to measure fair value may fall into different levels of the fair value hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia holds the following types of financial instruments at September
30, 2021 and December 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Equity Securities at Fair Value. &lt;/i&gt;Equity securities includes
investments in public company common stock and are recorded at fair value based on the quoted market price of each share on the valuation
date. The fair value of these securities are within Level 1 of the valuation hierarchy. Equity investments that do not have regular market
pricing, but for which fair value can be determined based on other data values or market prices, are recorded at fair value within Level
2 of the valuation hierarchy. At September 30, 2021, our Level 2 equity securities include an investment measured with an applied pricing
model that includes significant observable inputs to the public company common stock value. The fair value of the Level 2 equity securities
investment as of September 30, 2021 was estimated based on a discount of 7.5 percent determined using the following significant inputs
to the pricing model: expected term of restriction of 6 months and volatility of approximately 45 percent.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Investments at Fair Value - Common Stock and Warrants. &lt;/i&gt;Acacia&#x2019;s
equity investment in Veritone common stock was recorded at fair value based on the quoted market price of Veritone&#x2019;s common stock
on the applicable valuation date (Level 1). Warrants were recorded at fair value, as based on the Black-Scholes option-pricing model (Level
2). Refer to Note 4 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Series A Warrants. &lt;/i&gt;Series A Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in estimate with regard to
the calculation of the volatility assumption used in the Black Scholes option-pricing model. As a result, the Series A Warrants are now
measured as Level 3 as opposed to Level 2 as measured previously. The fair value of the Series A Warrants as of September 30, 2021 was
estimated based on the following significant assumptions: volatility of 30 percent, risk-free rate of 1.16 percent, term of 6.04 years
and a dividend yield of 0 percent.&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Series B Warrants. &lt;/i&gt;Series B Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in methodology used to an
acceptable Black-Scholes option-pricing model from a Monte Carlo valuation technique used to value the Series B Warrants as of December
31, 2020. The fair value of the Series B Warrants as of September 30, 2021 was estimated based on the following significant assumptions:
(1) volatility of 30 percent, risk-free rate of 1.17 percent, term of 6.13 years and a dividend yield of 0 percent, and (2) volatility
of 25 percent, risk-free rate of 0.08 percent, term of 0.90 years and a dividend yield of 0 percent.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Embedded Derivative Liability. &lt;/i&gt;Embedded derivatives that are
required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company
in 2019 (Level 3). The binomial model utilizes the Tsiveriotis and Fernandes implementation in which a convertible instrument is split
into two separate components within a single lattice framework: a cash-only component which is subject to the selected risk-adjusted discount
rate and an equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value
of our common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up
in rates), and (vi) event probabilities of the various conversion and redemption scenarios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The volatility of the Company&#x2019;s common stock is estimated by
analyzing the Company&#x2019;s historical volatility, implied volatility of publicly traded stock options, and the Company&#x2019;s current
asset composition and financial leverage. The selected volatility, as described below, represents a haircut from the Company&#x2019;s actual
realized historical volatility. A volatility haircut is a concept used to describe a commonly observed occurrence in which the volatility
implied by market prices involving options, warrants, and convertible debt is lower than historical actual realized volatility. The assumed
base case term used in the valuation model is the period remaining until November 15, 2027, the Series A Redeemable Convertible Preferred
Stock maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term equal to the expected
term of the conversion and early redemption options. The significant assumptions utilized in the Company&#x2019;s valuation of the embedded
derivative at September 30, 2021 are as follows: volatility of 30 percent, risk-free rate of 1.20 percent, term of 6.13 years, discount
rate of 9.40 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative is sensitive to these assumptions
and changes in these assumptions could result in a materially different fair value measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Financial assets and liabilities measured at fair value on a recurring
basis were as follows:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_pn3n3_z5kmnjed5E3k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8BC_zDbtPuaj44Q3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of financial assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;119,280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;267,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zZVGoE48BD8" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;119,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;267,840&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFd2v3vOBIX9" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity securities
    at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_z12hfjlqUkOg" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zNn5o9jioYY8" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Investment
    at fair value - warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zN4HkkyX1IZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2Rk1i7V7BS7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;111,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1XPiKQebxPi" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0h2bMhasRM8" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zGptlAREhr5b" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zbUAXEhdiYoe" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zszAV4gWLbAf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3llNtszR3bb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRePaEdnRYff" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zulGZMy3unc2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxBmcUIyZc3b" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6jzNfrJFBzl" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zFozVzESS9Mg" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ztuwH6r7aNWe" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z1HETD3mtmD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3Hr5U8tBAhk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zK9m32J7ly9a" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,069&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;85,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AC_zPROrwdnk37i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following tables set forth a summary of the changes in the estimated
fair value of the Company&#x2019;s Level 3 liabilities, which are measured at fair value on a recurring basis:&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zJtwOdyWcwLg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B2_zIPeRQjNeech" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of changes in fair value Level 3 liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A &lt;br/&gt;
    Warrant &lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A&lt;br/&gt;
    Embedded&lt;br/&gt;
    Derivative&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B&lt;br/&gt;
    Warrant&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zSPzxpg6DGq4" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zujtjgtXKbQ1" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_znuUhmeXlKqa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zSR2lyFjgLFi" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,069&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transfers
    to Level 3&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zlQZnye4JgA7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zGrY5yXshLu2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhyJh3RikVw3" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHYe0aNOPkd7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zXhrft1TTTZ" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,824&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zcWTPiOMsHl8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,463&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z0J95BCXdmh8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;178,198&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlebWdggdMs7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGFuWMIvIS17" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,464&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwX7uhS4u3Fd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z9mgILvYsVA6" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;230,539&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOxnHuGUb8xj" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,194&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zFbBIGc4Y8K4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zaWhKZtdHvw1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zYGjpF1DHtc6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zioDjYCWSYN8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(619&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at September 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGzvcijAnNYf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zk1RCguf9FSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zPpqonDA4Ft2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zro8i4u4bx5c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A &lt;br/&gt;
    Warrant &lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A&lt;br/&gt;
    Embedded&lt;br/&gt;
    Derivative&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B&lt;br/&gt;
    Warrant&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at January 1, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zp9cRBopGs62" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zDpoRIa5BQc3" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;17,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z84jGZDL2Lpa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1479"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqmsElSo18Sc" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,542&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transfers
    to Level 3&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zzraf0BsSHQ" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z0hxfQQe1KUk" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zGFOHDDByka8" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2734OILGBl9" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zOu2doI0EZ87" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,384&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zzGpS86ipsdl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,539&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ze9KisgH5gpg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,361&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKhFU982rY3f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zmbMqnh9IrR5" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,952&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrg6VIxa6VV3" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z8qoSeDp3adl" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGoptiET9TH" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,755&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zA2rM9qQmwK6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zXyzG31qtlfb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,831&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhrd7tO3fLT3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(15,493&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlXHxnpiqD0c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(20,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at September 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zNOVurYjPAue" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwGjuEo589wc" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ziAHBWp4jxia" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;42,797&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLHn752plRSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;74,083&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;


&lt;p id="xdx_8A2_zZbK9lJySAu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In accordance with U.S. GAAP, from time to time, the Company measures
certain assets at fair value on a nonrecurring basis. The Company reviews the carrying value of equity securities without readily determinable
fair value, equity method investments and patents on a quarterly basis for indications of impairment, and other long-lived assets at least
annually. When indications of potential impairment are identified, the Company may be required to determine the fair value of those assets
and record an adjustment for the carrying amount in excess of the fair value determined. Any fair value determination would be based on
valuation approaches, which are appropriate under the circumstances and utilize Level 2 and Level 3 measurements as required.&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_pn3n3_z5kmnjed5E3k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8BC_zDbtPuaj44Q3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of financial assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity
    securities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;119,280&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;267,840&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zZVGoE48BD8" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;119,280&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;267,840&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFd2v3vOBIX9" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;387,120&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity securities
    at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_z12hfjlqUkOg" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zNn5o9jioYY8" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Investment
    at fair value - warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1363"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zN4HkkyX1IZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;109,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2Rk1i7V7BS7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;111,855&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30, 2021:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1XPiKQebxPi" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0h2bMhasRM8" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zGptlAREhr5b" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zbUAXEhdiYoe" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zszAV4gWLbAf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3llNtszR3bb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRePaEdnRYff" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zulGZMy3unc2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;December
    31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxBmcUIyZc3b" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6jzNfrJFBzl" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series A
    embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zFozVzESS9Mg" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ztuwH6r7aNWe" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z1HETD3mtmD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3Hr5U8tBAhk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zK9m32J7ly9a" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,069&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;85,709&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">119280000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">267840000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">387120000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">119280000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">267840000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">387120000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">109103000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_EquitySecuritiesMember"
      decimals="-3"
      unitRef="USD">109103000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">2752000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">2752000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">109103000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">2752000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">111855000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">18527000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">18527000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">41411000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">41411000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">229637000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">229637000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">289575000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2021-09-30_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">289575000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">6640000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">6640000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">26728000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">26728000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">52341000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">52341000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">6640000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">79069000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-12-31_us-gaap_LiabilityMember_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">85709000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zJtwOdyWcwLg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B2_zIPeRQjNeech" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of changes in fair value Level 3 liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A &lt;br/&gt;
    Warrant &lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A&lt;br/&gt;
    Embedded&lt;br/&gt;
    Derivative&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B&lt;br/&gt;
    Warrant&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at January 1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zSPzxpg6DGq4" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zujtjgtXKbQ1" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;26,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_znuUhmeXlKqa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;52,341&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zSR2lyFjgLFi" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;79,069&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transfers
    to Level 3&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zlQZnye4JgA7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zGrY5yXshLu2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhyJh3RikVw3" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHYe0aNOPkd7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zXhrft1TTTZ" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,824&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zcWTPiOMsHl8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,463&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z0J95BCXdmh8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;178,198&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlebWdggdMs7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204,485&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGFuWMIvIS17" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,464&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwX7uhS4u3Fd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z9mgILvYsVA6" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;230,539&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOxnHuGUb8xj" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;290,194&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zFbBIGc4Y8K4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zaWhKZtdHvw1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;220&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zYGjpF1DHtc6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zioDjYCWSYN8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(619&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at September 30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGzvcijAnNYf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;18,527&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zk1RCguf9FSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,411&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zPpqonDA4Ft2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;229,637&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zro8i4u4bx5c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;289,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A &lt;br/&gt;
    Warrant &lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A&lt;br/&gt;
    Embedded&lt;br/&gt;
    Derivative&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B&lt;br/&gt;
    Warrant&lt;br/&gt;
    Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at January 1, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zp9cRBopGs62" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;3,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zDpoRIa5BQc3" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;17,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z84jGZDL2Lpa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1479"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqmsElSo18Sc" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,542&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Transfers
    to Level 3&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zzraf0BsSHQ" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z0hxfQQe1KUk" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zGFOHDDByka8" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2734OILGBl9" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zOu2doI0EZ87" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,384&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zzGpS86ipsdl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,539&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ze9KisgH5gpg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,361&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKhFU982rY3f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,284&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance at June 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zmbMqnh9IrR5" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,952&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrg6VIxa6VV3" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z8qoSeDp3adl" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;58,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGoptiET9TH" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,755&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remeasurement
    to fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zA2rM9qQmwK6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zXyzG31qtlfb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,831&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhrd7tO3fLT3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(15,493&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlXHxnpiqD0c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(20,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at September 30, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zNOVurYjPAue" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwGjuEo589wc" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;25,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ziAHBWp4jxia" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;42,797&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLHn752plRSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;74,083&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;


</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">26728000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">52341000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">79069000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">6640000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">6640000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">11824000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">14463000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">178198000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-01-012021-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">204485000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">18464000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">41191000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">230539000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">290194000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">63000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">220000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-07-012021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">-902000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2021-07-012021-09-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">-619000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">18527000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">41411000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">229637000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-09-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">289575000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">3568000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">17974000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">21542000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">5929000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">5929000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">3384000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">11539000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">52361000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-01-012020-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">67284000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">6952000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">29513000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">58290000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-06-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">94755000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">-1348000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">-3831000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-07-012020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">-15493000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
      contextRef="From2020-07-012020-09-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">-20672000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">25682000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">42797000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">74083000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0fkI4SvQ047" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;8. &lt;span id="xdx_821_zefBAmB1niW6"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Facility Leases&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company primarily leases office facilities under operating lease
arrangements that will end in various years through July 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On June 7, 2019, we entered into a building lease agreement (the &#x201c;New
Lease&#x201d;) with Jamboree Center 4 LLC (the &#x201c;Landlord&#x201d;). Pursuant to the New Lease, we have leased approximately 8,293 square
feet of office space in Irvine, California. The New Lease commenced on August 1, 2019. The term of the New Lease is 60 months from the
commencement date, provides for annual rent increases, and does not provide us the right to early terminate or extend our lease terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On January 7, 2020, we entered into a building lease agreement (the
&#x201c;New York Office Lease&#x201d;) with Sage Realty Corporation (the &#x201c;New York Office Landlord&#x201d;). Pursuant to the New York
Office Lease, we have leased approximately 4,000 square feet of office space for our corporate headquarters in New York, New York. The
New York Office Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides
for annual rent increases, and does not provide us the right to early terminate or extend our lease terms. During August 2021, we entered
into a first amendment of the New York Office Lease, to commence for a period of three years upon landlords&#x2019; substantial completion
of adequate substitution space, as defined. To date, the substitution space is not ready for use, accordingly the term extension has not
begun.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Operating lease costs were $&lt;span id="xdx_906_eus-gaap--OperatingLeaseCost_pn3p0_c20210701__20210930_zrjiEKtJyBD6" title="Operating lease costs, net of sublease income"&gt;155,000&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--OperatingLeaseCost_pn3p0_c20200701__20200930_z51rOJ1fpYu6" title="Operating lease costs, net of sublease income"&gt;174,000&lt;/span&gt; for the three months
ended September 30, 2021 and 2020, respectively, and $&lt;span id="xdx_905_eus-gaap--OperatingLeaseCost_pn3p0_c20210101__20210930_zmM3AphN5NRj" title="Operating lease costs, net of sublease income"&gt;457,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3p0_c20200101__20200930_zitkPtxlCxo9" title="Operating lease costs, net of sublease income"&gt;459,000&lt;/span&gt; for the nine months ended September 30, 2021 and 2020, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The table below presents aggregate future minimum payments due under
the New Lease and the New York Office Lease discussed above, reconciled to long-term lease liabilities and short-term lease liabilities
(included in accrued expenses and other current liabilities) included in the consolidated balance sheet as of September 30, 2021:&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zYQioXzgu3R7" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B9_z9otGpxq51zf" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210930_zPhAs40X9ILd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
    Leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maOLFMPzNL8_zxCD2Hqv0Pk3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 26%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remainder
    of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maOLFMPzNL8_zCUrJidv2kK1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;370&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maOLFMPzNL8_zY8NTYWvgYui" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maOLFMPzNL8_zET1tgSv8Ts2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;218&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_d0_maOLFMPzNL8_zoCNEil6fSRl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtOLFMPzNL8_zJT3wzL1sCs2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total minimum
    payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,101&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zW62Da70zQqh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    short-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(430&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In connection with the investment in certain patents and patent rights,
certain of Acacia&#x2019;s operating subsidiaries executed related agreements which grant to the former owners of the respective patents
or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated
as a result of licensing and otherwise enforcing the respective patents or patent portfolios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia&#x2019;s operating subsidiaries may retain the services of law
firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities.
These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees,
settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Patent Enforcement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Certain of Acacia&#x2019;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#x2019;s operating subsidiaries&#x2019;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated
statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural
aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries
or award attorney&#x2019;s fees and/or expenses to a defendant(s), which could be material.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Acacia is subject to claims, counterclaims and legal actions that arise
in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if
any, will not have a material effect on Acacia&#x2019;s consolidated financial position, results of operations or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In December 2017, the Federal Court of Canada allowed a counterclaim
for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions LLC in amounts that are included
in the 2021 and 2020 accrual balances discussed below. During the three months ended September 30, 2021, the Company made approximately
$1.0 million in settlement payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On September 6, 2019, Slingshot Technologies, LLC, or Slingshot, filed
a lawsuit in Delaware Chancery Court against the Company and Acacia Research Group, LLC, or collectively, the Acacia Entities, Monarch
Networking Solutions LLC (&#x201c;Monarch&#x201d;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd., or Transpacific.
Slingshot alleges that the Acacia Entities and Monarch misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities and Monarch by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#x2019;s exclusive
option to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. On March 15, 2021, the court issued orders granting Monarch&#x2019;s
motion to dismiss for lack of personal jurisdiction and Ms. Wolanyk&#x2019;s motion to dismiss for lack of subject matter jurisdiction.
The remaining parties then commenced discovery, and have since served initial written requests and responses, and notices of the depositions
of the parties&#x2019; corporate designees. The Acacia Entities maintain that Slingshot&#x2019;s allegations are baseless, that the Acacia
Entities neither had access to nor used Slingshot&#x2019;s information in acquiring the portfolio, that the Acacia Entities acquired the
portfolio as a result of the independent efforts of its IP licensing group, and that Slingshot suffered no damages given its exclusive
option to purchase the portfolio had already ended and it has proven itself incapable of closing on the portfolio purchase.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;During the three months ended September 30, 2021 and 2020, there were
no operating expenses related to settlement and contingency accruals. During the nine months ended September 30, 2021, we incurred $338,000
in operating expenses for settlement and contingency accruals. During the nine months ended September 30, 2020, operating expenses included
a net income for settlement offset by contingency accruals totaling $&lt;span id="xdx_908_ecustom--NetIncomeForSettlementOffsetByContingencyAccruals_pn3p0_c20200101__20200930_zhd1bgFna53j" title="Income from settlement"&gt;308,000&lt;/span&gt;, net of prior accruals. At September 30, 2021 and December
31, 2020, our contingency accrual balance was $&lt;span id="xdx_906_eus-gaap--LossContingencyAccrualAtCarryingValue_c20210930_pn3p0" title="Contingency accruals"&gt;587,000&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20201231_zy4230WGNSOa" title="Contingency accruals"&gt;1.3&lt;/span&gt; million, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">155000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">174000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">457000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">459000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zYQioXzgu3R7" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B9_z9otGpxq51zf" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_495_20210930_zPhAs40X9ILd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
    Leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maOLFMPzNL8_zxCD2Hqv0Pk3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 26%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remainder
    of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;149&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maOLFMPzNL8_zCUrJidv2kK1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;370&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maOLFMPzNL8_zY8NTYWvgYui" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;364&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maOLFMPzNL8_zET1tgSv8Ts2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;218&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_d0_maOLFMPzNL8_zoCNEil6fSRl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtOLFMPzNL8_zJT3wzL1sCs2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total minimum
    payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,101&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zW62Da70zQqh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    short-term lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(430&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-term
    lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;671&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">149000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">370000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">364000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">218000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">1101000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">430000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">671000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <ACTG:NetIncomeForSettlementOffsetByContingencyAccruals
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">308000</ACTG:NetIncomeForSettlementOffsetByContingencyAccruals>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">587000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">1300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_znZoqUbX7sf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;9. &lt;span id="xdx_829_zJ9CaZ4j8l59"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Repurchases of Common Stock &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On August 5, 2019, Acacia&#x2019;s Board of Directors approved a stock
repurchase program, which authorized the purchase of up to $&lt;span id="xdx_901_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_zpuRECaiCtIa"&gt;10.0
&lt;/span&gt;million of the Company&#x2019;s common stock through open market purchases, through block trades, through 10b5-1 plans, or by means
of private purchases, from time to time, through July 31, 2020. Stock repurchases for the periods presented, all of which were purchased
as part of a publicly announced plan or program, were as follows:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_zRhwhpin0KBh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  STOCKHOLDERS' EQUITY (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B6_zqWEq4Bw0Jrj" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of repurchased shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    Number&lt;br/&gt; of Shares&lt;br/&gt; Purchased&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;br/&gt;
    Price&lt;br/&gt; paid per&lt;br/&gt; Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Approximate&lt;br/&gt;
    Dollar&lt;br/&gt; Value of Shares&lt;br/&gt;
    that&lt;br/&gt; May Yet be&lt;br/&gt;
    Purchased&lt;br/&gt; under the&lt;br/&gt;
    Program&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Plan
    Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;March
    20, 2020 - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TreasuryStockSharesAcquired_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;576,898&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.28&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="width: 11%; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;8,686,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-size: 10pt; text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1jSPqRNZTKh" style="font: 10pt Times New Roman, Times, Serif"&gt;July
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;April
    1, 2020 - April 23, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,107,639&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,001,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_901_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2duEkvoJjWk" style="font: 10pt Times New Roman, Times, Serif"&gt;July
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    repurchases in 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,684,537&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In determining whether or not to repurchase any shares of Acacia&#x2019;s
common stock, Acacia&#x2019;s Board of Directors consider such factors, among others, as the impact of the repurchase on Acacia&#x2019;s
cash position, as well as Acacia&#x2019;s capital needs and whether there is a better alternative use of Acacia&#x2019;s capital. Acacia
has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding
share count and enhance stockholder value.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Tax Benefits Preservation Plan&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On March 12, 2019, Acacia&#x2019;s Board of Directors announced that
it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#x201c;Plan&#x201d;). Our stockholders ratified the adoption
of the Plan in July 2019. The purpose of the Plan is to protect the Company&#x2019;s ability to utilize potential tax assets, such as net
operating loss carryforwards and tax credits to offset potential future taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Plan is designed to reduce the likelihood that the Company will
experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more of the Company&#x2019;s
outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement of the adoption of the
Plan, beneficially own more than 4.9% of the Company&#x2019;s then-outstanding shares of the Company&#x2019;s common stock from acquiring
additional shares of the Company&#x2019;s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will
prevent the Company from experiencing an ownership change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In connection with the adoption of the Plan, Acacia&#x2019;s Board of
Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#x2019;s common stock
to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right would initially entitle
the holder to purchase one one-thousandth of a share of the Company&#x2019;s Series B Junior Participating Preferred Stock, $0.001 par
value for a purchase price of $12.00. On March 15, 2021 the rights expired pursuant to their terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company has a provision in its Amended and Restated Certificate
of Incorporation, as amended (the &#x201c;Charter Provision&#x201d;) which generally prohibits transfers of its common stock that could
result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#x2019;s ability to utilize
potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income. The Charter
Provision was approved by the Company&#x2019;s stockholders on July 15, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;











</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2019-08-05_custom_StockRepurchaseProgramMember"
      decimals="-3"
      unitRef="USD">10000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:AcceleratedShareRepurchasesTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_zRhwhpin0KBh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  STOCKHOLDERS' EQUITY (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B6_zqWEq4Bw0Jrj" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
    of repurchased shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    Number&lt;br/&gt; of Shares&lt;br/&gt; Purchased&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;br/&gt;
    Price&lt;br/&gt; paid per&lt;br/&gt; Share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Approximate&lt;br/&gt;
    Dollar&lt;br/&gt; Value of Shares&lt;br/&gt;
    that&lt;br/&gt; May Yet be&lt;br/&gt;
    Purchased&lt;br/&gt; under the&lt;br/&gt;
    Program&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Plan
    Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 44%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;March
    20, 2020 - March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--TreasuryStockSharesAcquired_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;576,898&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.28&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="width: 11%; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;8,686,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-size: 10pt; text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1jSPqRNZTKh" style="font: 10pt Times New Roman, Times, Serif"&gt;July
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;April
    1, 2020 - April 23, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,107,639&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.42&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,001,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_901_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2duEkvoJjWk" style="font: 10pt Times New Roman, Times, Serif"&gt;July
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
    repurchases in 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,684,537&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right" title="Average price paid per share"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">576898</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">2.28</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <ACTG:ApproximateValueOfSharesThatMayYetBePurchased
      contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">8686000</ACTG:ApproximateValueOfSharesThatMayYetBePurchased>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="From2020-09-202020-09-30_us-gaap_CommonStockMember">2020-07-31</us-gaap:StockRepurchaseProgramExpirationDate>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1107639</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">2.42</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <ACTG:ApproximateValueOfSharesThatMayYetBePurchased
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">6001000</ACTG:ApproximateValueOfSharesThatMayYetBePurchased>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember">2020-07-31</us-gaap:StockRepurchaseProgramExpirationDate>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1684537</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">2.37</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zkerc449FzF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;10. &lt;span id="xdx_824_zzJEAzxtxPYd"&gt;INCOME/LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zgbXg2sOefXg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME/LOSS PER SHARE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span id="xdx_8B9_zVrmlA3L6504" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Calculation
    of basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20210701__20210930_zpblr4UDGed6" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20200701__20200930_z7qOwCUpQKp1" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210101__20210930_zFBF3yU6vn4f" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20200101__20200930_z5QXqKuQujHd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands, except share and per share information)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; width: 44%; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to Acacia Research Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;89,604&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;38,348&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(55,507&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;33,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di_zytxWlyW6E8c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend
    on Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(262&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(467&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(785&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di_zykUE09mVaKh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accretion
    of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(991&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(733&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,762&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zuHjVJ4perMi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Undistributed
    earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(15,367&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(6,619&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;72,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;30,529&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(59,054&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,838&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DividendOnSeriesRedeemableConvertiblePreferredStock_d0_zvQN6GcEwcpj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Dividend on Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;467&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_d0_z5ju7nq3fJL6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Accretion of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;733&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_d0_zBu9eOfBc129" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of Series A redeemable convertible preferred stock embedded derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,831&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ChangeInFairValueOfSeriesWarrants_d0_zHLx0s1KWuw1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of Series A warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of dilutive Series B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(902&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,557&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,557&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestExpenseAssociatedWithStarboardNotesNetOfTax_zOXosm3OcbC4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Interest expense associated with Starboard Notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,536&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1638"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_d0_zz2ju8XPbY3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Undistributed earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;15,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,619&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_d0_zIrNoG0YtTlk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Reallocation
    of undistributed earnings to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(8,877&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(296&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--NetIncomeLossAvailableToCommonStockholderDiluted_zIr9KIFNSS4h" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;80,171&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;29,205&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(59,054&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,381&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,949,504&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,467,885&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,759,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,949,706&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB_zEk8nkeJ0rCd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Potentially
    dilutive common shares:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKkMuV7VIDVa" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zETSzCWfjRT5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,589,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKirbQ2Yoor5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKnaiHzRzR8" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted
    stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zJF7f4mvOp0l" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;798,356&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zMkU0EdviRii" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;728,936&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zOJu5omQ8n8g" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zYRXlPFFIb9j" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;598,328&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zeaYyeQPthn" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;35,815&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zkUd73Hfl71h" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zPgEbZO4A6se" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zaVQrUnVwe71" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zDzc4FbOzBkl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,019,724&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z7WoPzAd95ti" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;310,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zZnhIcNFlxh6" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zUvgbSo8UNFj" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;103,456&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zW9XGGHHTqMk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,278,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zINAkGS70pp8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;31,506,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ziIjUwWeiJv1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zPAZ0GYoyFfi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,502,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zzeKVIBoiv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;93,081,502&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;90,624,702&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,759,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;60,153,773&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
    net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.63&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.51&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted
    net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_iB_zAA51t9fyYb9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Anti-dilutive
    potential common shares excluded from the computation of diluted net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity-based
    incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zjonp0WplYTk" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;398,168&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zo9B1P8eBkx7" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;191,312&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zpCE74DNTtRh" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,230,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zUHZgQbwXMX1" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;310,083&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zAvEczJmdNx8" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zjhYgVn24X8j" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zSFBrX3kdS6e" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zhX75AYVh6T4" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_z2xXFsqBcTB" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zLiFotOF4Xf5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,493,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_znuuZyWd7Af8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zY6ZhpOBfTl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,493,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930_zfPhf3MEWAYh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;398,168&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930_zhxNnhzLXLXd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,684,463&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930_zpdjGBzpfpm3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;107,230,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930_z70wa1rdKsb4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,803,234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zgbXg2sOefXg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME/LOSS PER SHARE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span id="xdx_8B9_zVrmlA3L6504" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Calculation
    of basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20210701__20210930_zpblr4UDGed6" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49E_20200701__20200930_z7qOwCUpQKp1" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210101__20210930_zFBF3yU6vn4f" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20200101__20200930_z5QXqKuQujHd" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Nine
    Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(In
    thousands, except share and per share information)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; width: 44%; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to Acacia Research Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;89,604&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;38,348&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(55,507&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;33,205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di_zytxWlyW6E8c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend
    on Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(262&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(467&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(785&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,118&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di_zykUE09mVaKh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accretion
    of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(991&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(733&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,762&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(2,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zuHjVJ4perMi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Undistributed
    earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(15,367&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(6,619&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;72,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;30,529&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(59,054&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;24,838&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DividendOnSeriesRedeemableConvertiblePreferredStock_d0_zvQN6GcEwcpj" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Dividend on Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;467&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_d0_z5ju7nq3fJL6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Accretion of Series A redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;733&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_d0_zBu9eOfBc129" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of Series A redeemable convertible preferred stock embedded derivative&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,831&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ChangeInFairValueOfSeriesWarrants_d0_zHLx0s1KWuw1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of Series A warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;63&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1,348&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Less:
    Change in fair value of dilutive Series B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(902&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,557&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(5,557&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestExpenseAssociatedWithStarboardNotesNetOfTax_zOXosm3OcbC4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Interest expense associated with Starboard Notes, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,536&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1638"&gt;&#x2013;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_d0_zz2ju8XPbY3j" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Add:
    Undistributed earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;15,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;6,619&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_d0_zIrNoG0YtTlk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Reallocation
    of undistributed earnings to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(8,877&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(296&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(3,645&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--NetIncomeLossAvailableToCommonStockholderDiluted_zIr9KIFNSS4h" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Net
    income (loss) attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;80,171&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;29,205&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(59,054&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,381&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,949,504&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,467,885&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,759,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,949,706&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB_zEk8nkeJ0rCd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Potentially
    dilutive common shares:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKkMuV7VIDVa" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zETSzCWfjRT5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;9,589,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKirbQ2Yoor5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKnaiHzRzR8" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Restricted
    stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zJF7f4mvOp0l" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;798,356&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zMkU0EdviRii" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;728,936&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zOJu5omQ8n8g" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zYRXlPFFIb9j" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;598,328&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zeaYyeQPthn" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;35,815&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zkUd73Hfl71h" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;21,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zPgEbZO4A6se" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zaVQrUnVwe71" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zDzc4FbOzBkl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,019,724&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z7WoPzAd95ti" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;310,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zZnhIcNFlxh6" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zUvgbSo8UNFj" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;103,456&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zW9XGGHHTqMk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;41,278,103&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zINAkGS70pp8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;31,506,849&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ziIjUwWeiJv1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zPAZ0GYoyFfi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;10,502,283&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zzeKVIBoiv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;93,081,502&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;90,624,702&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;48,759,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;60,153,773&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
    net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;1.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.63&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.51&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted
    net income (loss) per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(1.21&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;0.36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_iB_zAA51t9fyYb9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Anti-dilutive
    potential common shares excluded from the computation of diluted net income (loss) per common share:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equity-based
    incentive awards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zjonp0WplYTk" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;398,168&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zo9B1P8eBkx7" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;191,312&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zpCE74DNTtRh" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;2,230,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zUHZgQbwXMX1" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;310,083&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    A warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zAvEczJmdNx8" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zjhYgVn24X8j" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zSFBrX3kdS6e" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zhX75AYVh6T4" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Series
    B warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_z2xXFsqBcTB" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zLiFotOF4Xf5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,493,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_znuuZyWd7Af8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;100,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zY6ZhpOBfTl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,493,151&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 2.5pt; text-indent: -5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930_zfPhf3MEWAYh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;398,168&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930_zhxNnhzLXLXd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,684,463&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930_zpdjGBzpfpm3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;107,230,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930_z70wa1rdKsb4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;68,803,234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">89604000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-55507000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">262000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">785000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">991000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">733000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">2762000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">2045000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-15367000</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-6619000</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-5204000</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">72984000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">30529000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-59054000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">24838000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock>
    <ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock>
    <ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock>
    <ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:DividendOnSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">733000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-3831000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">63000</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-1348000</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-1348000</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-902000</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-5557000</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-5557000</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1536000</ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax>
    <ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1889000</ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax>
    <ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">1889000</ACTG:InterestExpenseAssociatedWithStarboardNotesNetOfTax>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">15367000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">6619000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">5204000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-8877000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-296000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">-3645000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <ACTG:NetIncomeLossAvailableToCommonStockholderDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">80171000</ACTG:NetIncomeLossAvailableToCommonStockholderDiluted>
    <ACTG:NetIncomeLossAvailableToCommonStockholderDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">29205000</ACTG:NetIncomeLossAvailableToCommonStockholderDiluted>
    <ACTG:NetIncomeLossAvailableToCommonStockholderDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="-3"
      unitRef="USD">-59054000</ACTG:NetIncomeLossAvailableToCommonStockholderDiluted>
    <ACTG:NetIncomeLossAvailableToCommonStockholderDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="-3"
      unitRef="USD">21381000</ACTG:NetIncomeLossAvailableToCommonStockholderDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">48949504</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">48467885</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">48759873</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">48949706</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">9589041</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">798356</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">728936</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-09-30_custom_RestrictedStockUnitsMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">598328</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">35815</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">21624</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-09-30_custom_EmployeeStockOptionsMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">2019724</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">310367</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-09-30_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">103456</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-07-012021-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">41278103</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">31506849</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2021-01-012021-09-30_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">10502283</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">93081502</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">90624702</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">48759873</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">60153773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">1.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">398168</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">191312</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">2230624</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">310083</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_custom_SeriesAWarrantsMember50317218"
      decimals="-3"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember50317234"
      decimals="-3"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-09-30_custom_SeriesAWarrantsMember50317250"
      decimals="INF"
      unitRef="Shares">5000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember50317265"
      decimals="-3"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30_custom_SeriesBWarrantsMember50317281"
      decimals="-3"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember50317296"
      decimals="INF"
      unitRef="Shares">68493151</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-09-30_custom_SeriesBWarrantsMember50317312"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember50317328"
      decimals="INF"
      unitRef="Shares">68493151</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">398168</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">68684463</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">107230624</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">68803234</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zQvSRAB0ruI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;11. &lt;span id="xdx_82F_z4hFLwyCzOZ2"&gt;SUBSEQUENT EVENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On October 8, 2021, the Company acquired all of the outstanding stock
of a leading printing technology company, for a cash purchase price of $37.0 million, which includes an initial $33.0 million cash payment
and a $4.0 million working capital adjustment. The business services a diverse group of customers that operate across healthcare, food
and beverage, manufacturing and logistics, and other sectors. The acquisition triggered the release of $35.0 million held in escrow (refer
to Note 2 &#x201c;Long-Term Restricted Cash&#x201d; for additional information).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956505944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acacia
Research Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000934549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4405754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">767 THIRD AVENUE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">480-8300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,591,852<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136954627032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 217,957<span></span>
</td>
<td class="nump">$ 165,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities at fair value</a></td>
<td class="nump">387,120<span></span>
</td>
<td class="nump">109,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Equity securities without readily determinable fair value</a></td>
<td class="nump">5,816<span></span>
</td>
<td class="nump">143,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EquityMethodInvestmentsCurrent', window );">Investment securities - equity method investments</a></td>
<td class="nump">31,840<span></span>
</td>
<td class="nump">30,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Investment at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable (Note 3)</a></td>
<td class="nump">21,539<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,986<span></span>
</td>
<td class="nump">5,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">669,431<span></span>
</td>
<td class="nump">457,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">35,424<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, net of accumulated amortization</a></td>
<td class="nump">39,826<span></span>
</td>
<td class="nump">16,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Leased right-of-use assets</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,482<span></span>
</td>
<td class="nump">4,988<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">749,834<span></span>
</td>
<td class="nump">515,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,196<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">5,586<span></span>
</td>
<td class="nump">3,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">2,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccruedPatentInvestmentCostsCurrent', window );">Accrued patent investment costs</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Senior Secured Notes Payable</a></td>
<td class="nump">182,855<span></span>
</td>
<td class="nump">115,663<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">204,449<span></span>
</td>
<td class="nump">124,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Series A warrant liabilities</a></td>
<td class="nump">18,527<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Series A embedded derivative liabilities</a></td>
<td class="nump">41,411<span></span>
</td>
<td class="nump">26,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DerivativeLiabilitiesNoncurrent1', window );">Series B warrant liabilities</a></td>
<td class="nump">229,637<span></span>
</td>
<td class="nump">52,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">5,591<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">500,286<span></span>
</td>
<td class="nump">212,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2021 and December 31, 2020; aggregate liquidation preference of $35,000 as of September 30, 2021 and December 31, 2020</a></td>
<td class="nump">13,686<span></span>
</td>
<td class="nump">10,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,591,852 and 49,279,453 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 4,604,365 shares as of September 30, 2021 and December 31, 2020</a></td>
<td class="num">(43,270)<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">649,349<span></span>
</td>
<td class="nump">651,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(382,215)<span></span>
</td>
<td class="num">(326,708)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Acacia Research Corporation stockholders' equity</a></td>
<td class="nump">223,914<span></span>
</td>
<td class="nump">281,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">11,948<span></span>
</td>
<td class="nump">11,042<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">235,862<span></span>
</td>
<td class="nump">292,529<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</a></td>
<td class="nump">$ 749,834<span></span>
</td>
<td class="nump">$ 515,520<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccruedPatentInvestmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccruedPatentInvestmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DerivativeLiabilitiesNoncurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DerivativeLiabilitiesNoncurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EquityMethodInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EquityMethodInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_RoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_RoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136960579592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">49,591,852<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">49,591,852<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">4,604,365<span></span>
</td>
<td class="nump">4,604,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series A redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Series A redeemable convertible preferred stock, value per share</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Series A redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Series A redeemable convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956585832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,582<span></span>
</td>
<td class="nump">$ 19,466<span></span>
</td>
<td class="nump">$ 24,785<span></span>
</td>
<td class="nump">$ 25,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Patent portfolio operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">5,772<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="nump">6,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ContingentLegalFees', window );">Contingent legal fees</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">5,735<span></span>
</td>
<td class="nump">6,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_LitigationAndLicensingExpensesPatents', window );">Litigation and licensing expenses - patents</a></td>
<td class="nump">782<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">2,612<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">7,086<span></span>
</td>
<td class="nump">3,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other patent portfolio income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Patent portfolio expenses</a></td>
<td class="nump">3,959<span></span>
</td>
<td class="nump">14,556<span></span>
</td>
<td class="nump">18,525<span></span>
</td>
<td class="nump">20,409<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetPortfolioIncomeLoss', window );">Net patent portfolio (loss) income</a></td>
<td class="num">(2,377)<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
<td class="nump">6,260<span></span>
</td>
<td class="nump">4,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">10,345<span></span>
</td>
<td class="nump">7,692<span></span>
</td>
<td class="nump">23,014<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(12,722)<span></span>
</td>
<td class="num">(2,782)<span></span>
</td>
<td class="num">(16,754)<span></span>
</td>
<td class="num">(13,099)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(2,752)<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (loss) on sale of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,591<span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of the Series A and B warrants and embedded derivatives</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">20,672<span></span>
</td>
<td class="num">(203,866)<span></span>
</td>
<td class="num">(46,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfEquitySecurities', window );">Change in fair value of equity securities</a></td>
<td class="nump">66,502<span></span>
</td>
<td class="nump">20,488<span></span>
</td>
<td class="nump">115,509<span></span>
</td>
<td class="nump">99,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Gain (loss) on sale of equity securities</a></td>
<td class="nump">37,688<span></span>
</td>
<td class="nump">2,737<span></span>
</td>
<td class="nump">53,124<span></span>
</td>
<td class="num">(4,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsOnEquityInvestmentInJointVenture', window );">Earnings on equity investment in joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,737<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Loss on foreign currency exchange</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(193)<span></span>
</td>
<td class="num">(4,938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on Senior Secured Notes</a></td>
<td class="num">(2,531)<span></span>
</td>
<td class="num">(2,410)<span></span>
</td>
<td class="num">(5,601)<span></span>
</td>
<td class="num">(3,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InterestIncomeExpenseAndOther', window );">Interest income and other</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">102,337<span></span>
</td>
<td class="nump">41,213<span></span>
</td>
<td class="num">(37,316)<span></span>
</td>
<td class="nump">45,047<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">89,615<span></span>
</td>
<td class="nump">38,431<span></span>
</td>
<td class="num">(54,070)<span></span>
</td>
<td class="nump">31,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(531)<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) including noncontrolling interests in subsidiaries</a></td>
<td class="nump">89,604<span></span>
</td>
<td class="nump">38,348<span></span>
</td>
<td class="num">(54,601)<span></span>
</td>
<td class="nump">33,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests in subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(906)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="nump">$ 89,604<span></span>
</td>
<td class="nump">$ 38,348<span></span>
</td>
<td class="num">$ (55,507)<span></span>
</td>
<td class="nump">$ 33,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net income (loss) attributable to common stockholders - Basic</a></td>
<td class="nump">$ 72,984<span></span>
</td>
<td class="nump">$ 30,529<span></span>
</td>
<td class="num">$ (59,054)<span></span>
</td>
<td class="nump">$ 24,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 1.49<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares outstanding - Basic</a></td>
<td class="nump">48,949,504<span></span>
</td>
<td class="nump">48,467,885<span></span>
</td>
<td class="nump">48,759,873<span></span>
</td>
<td class="nump">48,949,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) attributable to common stockholders - Diluted</a></td>
<td class="nump">$ 80,171<span></span>
</td>
<td class="nump">$ 29,204<span></span>
</td>
<td class="num">$ (59,054)<span></span>
</td>
<td class="nump">$ 21,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average number of shares outstanding - Diluted</a></td>
<td class="nump">93,081,502<span></span>
</td>
<td class="nump">90,624,702<span></span>
</td>
<td class="nump">48,759,873<span></span>
</td>
<td class="nump">60,153,773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ContingentLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ContingentLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EarningsOnEquityInvestmentInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EarningsOnEquityInvestmentInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InterestIncomeExpenseAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InterestIncomeExpenseAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_LitigationAndLicensingExpensesPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_LitigationAndLicensingExpensesPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetPortfolioIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetPortfolioIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136953912232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Series A Redeemable Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 8,089<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (39,272)<span></span>
</td>
<td class="nump">$ 652,003<span></span>
</td>
<td class="num">$ (439,656)<span></span>
</td>
<td class="nump">$ 1,833<span></span>
</td>
<td class="nump">$ 174,958<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning, shares at Dec. 31, 2019</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">50,370,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,205<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits', window );">Issuance of common stock for vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares', window );">Issuance of common stock for vesting of restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(3,998)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,999)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,684,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 10,134<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,130<span></span>
</td>
<td class="num">(406,451)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">202,291<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending, shares at Sep. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,843<span></span>
</td>
<td class="num">(444,799)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">164,656<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning, shares at Jun. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,306,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,348<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">734<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(734)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(467)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 10,134<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,130<span></span>
</td>
<td class="num">(406,451)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">202,291<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending, shares at Sep. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 10,924<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">651,416<span></span>
</td>
<td class="num">(326,708)<span></span>
</td>
<td class="nump">11,042<span></span>
</td>
<td class="nump">292,529<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning, shares at Dec. 31, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income attributable to Acacia Research Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,601)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries', window );">Net (loss) income including noncontrolling interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(55,507)<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="num">(54,601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">2,762<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(785)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits', window );">Issuance of common stock for vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares', window );">Issuance of common stock for vesting of restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,279<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,279<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="nump">$ 13,686<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">649,349<span></span>
</td>
<td class="num">(382,215)<span></span>
</td>
<td class="nump">11,948<span></span>
</td>
<td class="nump">235,862<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending, shares at Sep. 30, 2021</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,591,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 12,695<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,194<span></span>
</td>
<td class="num">(471,819)<span></span>
</td>
<td class="nump">11,948<span></span>
</td>
<td class="nump">147,103<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning, shares at Jun. 30, 2021</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,616,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income attributable to Acacia Research Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries', window );">Net (loss) income including noncontrolling interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">991<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(991)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(991)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(262)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares', window );">Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="nump">$ 13,686<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (43,270)<span></span>
</td>
<td class="nump">$ 649,349<span></span>
</td>
<td class="num">$ (382,215)<span></span>
</td>
<td class="nump">$ 11,948<span></span>
</td>
<td class="nump">$ 235,862<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending, shares at Sep. 30, 2021</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,591,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of Series A Convertible Preferred Stock to redemption value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956395352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net (loss) income including noncontrolling interests in subsidiaries</a></td>
<td class="num">$ (54,601)<span></span>
</td>
<td class="nump">$ 33,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="num">(3,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">(Gain) loss on sale of investment</a></td>
<td class="num">(3,591)<span></span>
</td>
<td class="nump">2,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">7,198<span></span>
</td>
<td class="nump">3,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative', window );">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</a></td>
<td class="nump">14,683<span></span>
</td>
<td class="nump">7,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of Series A warrants</a></td>
<td class="nump">11,887<span></span>
</td>
<td class="nump">2,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_UnrealizedGainLossOnDerivatives1', window );">Change in fair value of Series B warrants</a></td>
<td class="nump">177,296<span></span>
</td>
<td class="nump">36,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Loss on foreign currency exchange</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">4,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfEquitySecurities', window );">Change in fair value of equity securities</a></td>
<td class="num">(115,509)<span></span>
</td>
<td class="num">(99,449)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">(Gain) loss on sale of equity securities</a></td>
<td class="num">(53,124)<span></span>
</td>
<td class="nump">4,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Earnings on equity investment in joint venture, net of distributions received</a></td>
<td class="num">(907)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(2,345)<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">7,002<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="num">(369)<span></span>
</td>
<td class="nump">12,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(7,602)<span></span>
</td>
<td class="nump">5,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent acquisition</a></td>
<td class="num">(13,000)<span></span>
</td>
<td class="num">(13,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment', window );">Sale of investment at fair value</a></td>
<td class="nump">3,591<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of equity securities</a></td>
<td class="num">(57,978)<span></span>
</td>
<td class="num">(33,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Maturities and sales of equity securities</a></td>
<td class="nump">64,235<span></span>
</td>
<td class="nump">316,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PurchasesOfPrepaidInvestment', window );">Purchases of prepaid investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276,275)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost', window );">Equity securities derivative and forward contract acquisition cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,219)<span></span>
</td>
<td class="num">(9,815)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of Senior Secured Notes, net of lender fee</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">110,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties', window );">Senior Secured Notes issuance costs paid to other parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="num">(785)<span></span>
</td>
<td class="num">(1,120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of Series B warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Paydown of Senior Secured Notes</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Reissuance of Senior Secured Notes</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">64,417<span></span>
</td>
<td class="nump">109,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase in cash and cash equivalents and restricted cash</a></td>
<td class="nump">53,596<span></span>
</td>
<td class="nump">105,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning</a></td>
<td class="nump">200,546<span></span>
</td>
<td class="nump">92,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents and restricted cash, ending</a></td>
<td class="nump">254,142<span></span>
</td>
<td class="nump">197,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidInterest', window );">Interest paid</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NoncashInvestingActivitesAbstract', window );"><strong>Noncash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3', window );">Trade date receivable from sale of equity securities (Note 3)</a></td>
<td class="nump">21,539<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PatentAcquisitionInExchangeOfNotesReceivable', window );">Patent acquisition in exchange of notes receivable</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PatentAcquisitionAccruedLiabilityShortTerm', window );">Patent acquisition accrued liability - short-term</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PatentAcquisitionAccruedLiabilityLongTerm', window );">Patent acquisition accrued liability - long-term</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AcquisitionOfPrepaidInvestmentSecurities', window );">Acquisition of prepaid investment securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 231,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AcquisitionOfPrepaidInvestmentSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AcquisitionOfPrepaidInvestmentSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NoncashInvestingActivitesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NoncashInvestingActivitesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PatentAcquisitionAccruedLiabilityLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PatentAcquisitionAccruedLiabilityLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PatentAcquisitionAccruedLiabilityShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PatentAcquisitionAccruedLiabilityShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PatentAcquisitionInExchangeOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PatentAcquisitionInExchangeOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PurchasesOfPrepaidInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PurchasesOfPrepaidInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_UnrealizedGainLossOnDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_UnrealizedGainLossOnDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for interest that provides economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952316088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract', window );"><strong>Description Of Business And Basis Of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_BusinessDescriptionTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_808_ecustom--BusinessDescriptionTextBlock_zLQd26KmL4Da" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. <span id="xdx_823_zVPOKEhMhwLg">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_84A_ecustom--DescriptionOfBusinessPolicyTextBlock_znfMED2mVuqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_861_z58pdAAvzUra">Description of Business</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled
operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia was incorporated on January 25, 1993 under the laws of the State
of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia acquires businesses and operating assets that the Company believes
to be undervalued and where the Company believes it can leverage its resources and skill sets to realize and unlock value. The Company
intends to leverage its (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and
operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount
and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions
of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. Acacia
seeks to identify opportunities where the Company believes it is an advantaged buyer, where the Company can avoid structured sale processes
and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to the Company&#8217;s
unique capabilities, relationships, or expertise, or where Acacia believes the target would be worth more to the Company than to other
buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia operates its business based on three key principles of People,
Process and Performance and has built a management team with identified expertise in Research, Execution and Operation of the Company&#8217;s
targeted acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia, through its operating subsidiaries, also currently engages
in its legacy business of investing in, licensing and enforcing patented technologies. Acacia&#8217;s operating subsidiaries partner with
inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented
inventions. In recent years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships
developed as a leader in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities
will complement and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries generate revenues and related
cash flows from the granting of IP rights (hereinafter, &#8220;IP Rights&#8221;) for the use of patented technologies that its operating
subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through
the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries are principals in the licensing
and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia&#8217;s
operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through
its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s operating subsidiaries
are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based
opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, Acacia obtained
control of one <span id="xdx_90D_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20210101__20210930_zFPmsscH2NBj" style="display: none" title="Number of new patent portfolios acquired">1</span>
new patent portfolio. During fiscal year 2020, Acacia obtained control of five <span id="xdx_907_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20200101__20201231_z0DlQoQ7KXz8" style="display: none" title="Number of new patent portfolios acquired">5</span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p id="xdx_846_ecustom--BasisOfAccountingPoliesPolicyTextBlock_zTkfyraUtA34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zJRRpXQOfCwi">Basis of Presentation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;)
for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information
and note disclosures required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly
reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed consolidated financial
statements and notes hereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2020, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March 29, 2021, as well as in our other
public filings with the SEC. The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring
nature which, in the opinion of management, are necessary for a fair statement of Acacia&#8217;s consolidated financial position as of
September 30, 2021, and results of its operations and its cash flows for the interim periods presented. The consolidated results of operations
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal
year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reclassifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain prior period amounts in the consolidated financial statements
have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated
results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p id="xdx_84E_ecustom--Covid19PandemicAndCaresActPolicyTextBlock_zazWKBu653X5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zJQM5ugWaLIa">COVID-19 Pandemic</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#8217;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_BusinessDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_BusinessDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951224824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zxLzCpbkUtD5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. <span id="xdx_82F_zUjdVBQzojDh">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1ORXFzaCLxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zDJple5wwSO8">Accounting Principles</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The consolidated financial statements and accompanying notes are prepared
on the accrual basis of accounting in accordance with U.S. GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zZGNypmCv9a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zfiRWS9j1Ysd">Principles of Consolidation</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited consolidated financial statements include
the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Noncontrolling interests in Acacia&#8217;s majority-owned and controlled
operating subsidiaries (&#8220;noncontrolling interests&#8221;) are separately presented as a component of stockholders&#8217; equity.
Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated
statements of operations. Refer to the accompanying Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders&#8217;
Equity for total noncontrolling interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2020, in connection with the transaction with Link Fund Solutions
Limited, which is more fully described in Note 3, the Company acquired equity securities of Malin J1 Limited (&#8220;MalinJ1&#8221;).
MalinJ1 is included in the Company&#8217;s consolidated financial statements because the Company, through its interest in the equity securities
of MalinJ1, has the ability to control the operations and activities of MalinJ1. Viamet HoldCo LLC, a Delaware limited liability company
and wholly-owned subsidiary of Acacia, is the majority shareholder of MalinJ1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A wholly-owned subsidiary of Acacia is the general partner of the Acacia
Intellectual Property Fund, L.P. (the &#8220;Acacia IP Fund&#8221;), which was formed in August 2010. The Acacia IP Fund has been included
in the Company&#8217;s consolidated financial statements since 2010, as Acacia&#8217;s wholly-owned subsidiary, the general partner of
Acacia IP Fund, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia IP Fund was terminated as of
December 31, 2017 and dissolved in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_844_ecustom--SegmentReportingPolicyTextBlock_zADk5K4ldVx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zeJga3udMrb8">Segment Reporting</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia uses the management approach, which designates the internal
organization that is used by management for making operating decisions and assessing performance as the basis of Acacia&#8217;s reportable
segments. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_84C_ecustom--EstimatesPolicytextBlock_z7iuQVnnEnC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zSX0sSXVwUHk">Use of Estimates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described
herein, the accounting policies associated with revenue recognition, the valuation of the equity instruments, the valuation of Series
A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible Preferred Stock&#8221;), embedded derivatives, Series
A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series B Warrants&#8221;), stock-based compensation expense,
impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income
taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zp4pqpx2Pche" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z0axyN6kaGS5">Revenue Recognition</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue is recognized upon transfer of control (i.e., by the granting)
of promised bundled IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they
exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition
criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods presented, revenue contracts executed by the Company
primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain
IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based revenue contracts,
the majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on quarterly
sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may also include court ordered settlements
or awards related to our patent portfolio or sales of our patent portfolio. IP Rights granted included the following, as applicable: (i)
the grant of a non-exclusive, future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue,
(iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were generally
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for
as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to grant combined items
to which the promised IP Rights are inputs and (ii) the Company's promise to grant each individual IP right described above to the customer
is not separately identifiable from other promises to grant IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the promised IP Rights are not individually distinct, the Company
combined each individual IP Right in the contract into a bundle of IP Rights that is distinct, and accounted for all of the IP Rights
promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional IP rights&#8221; that have significant
standalone functionality. Acacia&#8217;s subsequent activities do not substantively change that functionality and do not significantly
affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect
to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support
or services. The contracts provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon
execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process
is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition
criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 15-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are
generally non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the
amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently
resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later
of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been
allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues from contracts with significant financing components (either
explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash
for the IP Rights when they are granted to the licensee. In determining the transaction price, the Company adjusts the promised amount
of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount
of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between
when the entity grants promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In general, the Company is required to make certain judgments and estimates
in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in
the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct
from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating
the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and
estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Revenues
were comprised of the following for the periods presented:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none">Disaggregation
    of revenue</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Paid-up
    revenue agreements</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,385</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">23,110</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,477</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Recurring
    Revenue Agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">482</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">81</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,675</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">922</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,582</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,466</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,785</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">25,399</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p id="xdx_8AE_z9c4bc72xOyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b/></span><span style="font: 10pt Times New Roman, Times, Serif">Refer to &#8220;<i>Inventor Royalties and
Contingent Legal Expenses</i>&#8221; below for information on related direct costs of revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p id="xdx_847_ecustom--PatentPortfolioOperationsPolicyTextBlock_zt9WnCalrHff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zqjcrZxcdwW3">Patent Portfolio Operations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cost of revenues include the costs and expenses incurred in connection
with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, patent maintenance
and prosecution costs, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent
counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related
investment costs. These costs are included under the caption &#8220;Patent portfolio operations&#8221; in the consolidated statements
of operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalties are expensed in the consolidated statements of operations
in the period that the related revenues are recognized. Patent costs, including any upfront advances paid to patent owners by Acacia&#8217;s
operating subsidiaries, that are recoverable from future net revenues are amortized over the estimated economic useful life of the related
patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period
recovered and included in amortization expense in the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contingent legal fees are expensed in the consolidated statements of
operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers,
no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain out of pocket legal costs
incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalty and contingent legal agreements generally provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments
are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p id="xdx_845_ecustom--ConcentrationsPolicyTextBlock_zdCisWyLDcGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_z629mh8x2Fg3">Concentrations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, equity securities and accounts receivable. Acacia places its cash equivalents and equity securities
primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in
deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Four licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z08Z9l632Sma" title="Concentration risk percentage">32</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z3sOv6LAIQUd" title="Concentration risk percentage">25</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zxTh9mIiCwge" title="Concentration risk percentage">22</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zLScaSSvNJK9" title="Concentration risk percentage">13</span>% of
revenues recognized during the three months ended September 30, 2021, and one licensee accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z30FpxRpeW0k" title="Concentration risk percentage">98</span>% of revenues recognized during
the three months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_znyPUuufBOm3" title="Concentration risk percentage">50</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zx39kZPTH5Yd" title="Concentration risk percentage">19</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zENUWIIMvvqc" title="Concentration risk percentage">12</span>% of revenues recognized during the
nine months ended September 30, 2021, and two licensees accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee3Member_z2vQAS6oMQnh" title="Concentration risk percentage">75</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z7RGndZS4Sr1" title="Concentration risk percentage">9</span>% of revenues recognized during the nine months ended September
30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company does not have any material foreign operations. Based on
the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for the three
and nine months ended September 30, 2021, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zXbwkFsoK2F8" title="Concentration risk percentage">8</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_z9U13b52KX1g" title="Concentration risk percentage">15</span>%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions.
For the three and nine months ended September 30, 2020, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zzAcapFYsMyg" title="Concentration risk percentage">0.1</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zdyx2eenqfSb" title="Concentration risk percentage">5</span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Two licensees represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zlW1ntM3cEX8" title="Concentration risk percentage"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zPMhqdsSsote">100</span></span>% of accounts receivable at September
30, 2021. Two licensees individually represented approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zg6fPuOeDpqc" title="Concentration risk percentage">62</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zVRo2X70XVZk" title="Concentration risk percentage">21</span>% of accounts receivable at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_842_ecustom--RelatedPartyTransactionsPolicyTextBlock_zUtnhFN0ysLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zZ9svsDlVKPl">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2019, the Company purchased shares of common stock of Drive
Shack, Inc. (&#8220;Drive Shack&#8221;) for an aggregate purchase price of $2.4 million. At the time, Drive Shack and Clifford Press,
Chief Executive Officer and director of Acacia, were related parties as Mr. Press was a board member of Drive Shack until June 2021. The
market value of the investment was $1.4 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company
sold its investment receiving proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromSaleOfLongtermInvestments_pn3n3_dm_c20210101__20210930_z8wZGQ7XLEvl" title="Proceeds from sale of investment">1.8 </span>million and recognized a loss of $<span id="xdx_909_eus-gaap--LossOnSaleOfInvestments_pn3p0_c20210101__20210930_zbEpXupgctJj" title="Loss on sale of investment">515,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znBggoYpGtE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zApTIkBILrjc">Cash and Cash Equivalents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia considers all highly liquid, equity securities with original
maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash equivalents are
comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic
commercial paper and securities issued or guaranteed by the U.S. government or its agencies. Acacia&#8217;s cash equivalents are measured
at fair value using observable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p id="xdx_845_ecustom--EquitySecuritiesAtFairValuePolicyTextBlock_zKwKzjxaIxTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zMr6TNNWWq8h">Equity Securities at Fair Value </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments in equity securities are reported at fair value on a recurring
basis, with related realized and unrealized gains and losses in the value of such securities recorded in the consolidated statements of
operations in other income or (expense). Dividend income is included in the consolidated statements of operations in other income or (expense).
Refer to Note 7 for additional information related to fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity securities at fair value for the periods presented were comprised
of the following:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Security
    Type</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Cost</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Gain</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Fair
    Value</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - Life Sciences Portfolio (Note 3)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">62,042</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">288,508</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,812</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">348,738</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">35,178</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">3,289</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(85</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">38,382</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">97,220</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">291,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,897</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    - Life Sciences Portfolio (Note 3)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">32,765</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">72,689</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(583</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">104,871</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">4,086</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">1,410</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,264</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">4,232</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">36,851</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">74,099</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,847</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p id="xdx_8A6_zpdhH9K9HW7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84E_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_zA5jIua165jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_ztj8KnAgfmB2">Equity Securities Without Readily Determinable Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For equity securities that do not have readily determinable fair value,
the Company elected to report them under the measurement alternative. They are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The
fair values of the private company securities were estimated based on recent financing transactions and secondary market transactions
and factoring in any adjustments for illiquidity or preference of these securities. Changes in fair value are reported in the consolidated
statements of operations in other income or (expense). Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_844_eus-gaap--EquityMethodInvestmentsPolicy_zEKMmci1k7Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_zLpxVmZXnVai">Equity Method Investments </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity investments in common stock and in-substance common stock without
readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted
for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees
in earnings on equity investment in joint venture in the consolidated statements of operations. Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_znHRNqpxtPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zSHlKiT5CP7b">Investment at Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On an individual investment basis, Acacia may elect to account for
investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of
the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under the equity
method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and
warrants). We elected the fair value method for our investment in Veritone, Inc. (&#8220;Veritone&#8221;) upon acquisition of the investment.
Since March 2021, we have no more investment in Veritone stocks and warrants. Refer to Note 4 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<p id="xdx_847_ecustom--ImpairmentOfInvestmentPolicyTextBlock_zRWgCZILRST4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z8aUtYt7Lw5e">Impairment of Investments</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative
evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates,
among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_847_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zLoyDWm9Wmw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_z2TQncf3udej">Long-Term Restricted Cash </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted cash relates primarily to the proceeds received from the
issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account (refer to Note 6). The amounts are to
be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii)
the conversion of Series A Redeemable Convertible Preferred Stock into common stock. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Refer to Note 11 for additional information related to the subsequent
period acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zuh4nTi8mO3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zoKMVuQnHAik">Patents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Patents include the cost of patents or patent rights acquired from
third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over
their remaining economic useful lives. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zruaHSR5TAmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zpvZ1zkYyGje">Impairment of Long-lived Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not
be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying
amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying value over its fair
value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If
quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value
of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic useful
life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including an estimated
rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based
on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are
based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license
fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and
enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status
and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent
information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84C_ecustom--SeriesAandBWarrantsPolicyTextBlock_zuTOJOxjyock" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_zVQjbnwmj3A4">Series A and B Warrants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the Series A and B Warrants are estimated using a
Black-Scholes option-pricing model. Refer to Notes 6 and 7 for additional information related to the Series A and B Warrants and their
fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_84F_eus-gaap--DerivativesEmbeddedDerivatives_zRArdVHPPach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zIbQuddiHXx5">Embedded derivatives</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Embedded derivatives that are required to be bifurcated from their
host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded
derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019. Refer to Notes 6 and 7 for additional
information related to the embedded derivatives and their fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zAgIWGu5eFW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zIEBNkgpHQm3">Fair Value Measurements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. Refer to Note 7 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zLIMZCIP7dyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_z8pF6IErMmu4">Treasury Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Repurchases of the Company&#8217;s outstanding common stock are accounted
for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive
retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital and
reflected as treasury stock in the consolidated balance sheets. Refer to Note 9 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvPvcmTx8j3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_zIGubIqJW9Il">Stock-Based Compensation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The compensation cost for all stock-based awards is measured at the
grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite
service period (generally the vesting period of the equity award) which is generally one to three years. The fair value of restricted
stock awards (&#8220;RSAs&#8221;) and restricted stock units (&#8220;RSUs&#8221;) are determined by the product of the number of shares
or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the
date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RSUs granted in September 2019 with market-based vesting conditions
vest based upon the Company achieving specified stock price targets over a three-year period. The effect of a market condition is reflected
in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized
with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition
is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique, that resulted in a fair value of $1.42 per
unit, included: estimated risk-free interest rate of <span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">1.38 percent</span>; term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z0Hir3knAOO2" title="Assumptions used for derivatives">3.00 years</span>; expected volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">38 percent</span>; and expected
dividend yield of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">0 percent</span>. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues.
The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations
regarding dividend payments. During the nine months ended September 30, 2021, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfsoNSr2NIc5" title="Option Forfeited">450,000</span> RSUs were forfeited, leaving <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkA1kLOVQEc" title="Option Forfeited">450,000</span> units with
market-based vesting conditions outstanding and unvested at period end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, the Company granted
<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zJ99UTGtC3i7" title="Weighted Average Grant">324,401</span> RSAs at a weighted average grant-date fair value of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zXdwiRqa7Bg2" title="Weighted average grant-date fair value">5.56 </span>per share, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3I4cREBWCte">473,000</span> RSUs at a weighted average grant-date fair value
of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsbs1hsoSqb" title="Weighted average grant-date fair value">5.86</span> per unit and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEBfRxUcHaa6">393,750</span> non-qualified stock options at a grant-date fair value of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zogY04uAPWJa">1.79</span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stock-based compensation is reported in the consolidated statements
of operations in general and administrative expenses. Total stock-based compensation for the three and nine months ended September 30,
2021 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_pn3p0_c20210701__20210930_zmrcwGz6Jdza" title="Stock-based compensation">300,000</span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210101__20210930_pn3p0" title="Stock-based compensation">1,279,000</span>, respectively. Total unrecognized stock-based compensation expense as of September 30, 2021 was $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20210930_pn3p0" title="Unrecognized stock-based compensation expense">5,952,000</span>,
which will be amortized over a weighted average remaining vesting period of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930_zdmyqOeYYNDb" title="Weighted-average remaining vesting period">2.20</span> years. Total stock-based compensation for the three and
nine months ended September 30, 2020 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930_pn3p0" title="Stock-based compensation">488,000</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200930_pn3p0" title="Stock-based compensation">1,243,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Profits Interest Units (&#8220;PIUs&#8221;) were accounted for in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221; The vesting conditions
did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the PIUs were classified as
liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion of the requisite service period
rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite service period (generally
the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended
September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period. The Company has a purchase
option to purchase the vested PIUs that are not otherwise forfeited after termination of continuous service. The exercise price of the
purchase option is the fair market value of the PIUs on the date of termination of continuous service. The individuals holding PIUs are
no longer employed by the Company. Included in other long-term liabilities in the consolidated balance sheets as of September 30, 2021
and December 31, 2020, the PIUs totaled $591,000, which was their fair value as of December 31, 2018 after termination of service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhkUQWPPd5J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_za3TxTxZzFm3">Income Taxes</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income taxes are accounted for using an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been
recognized in Acacia&#8217;s consolidated financial statements or consolidated income tax returns. A valuation allowance is established
to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that
there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The provision for income taxes for interim periods is determined using
an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant
period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative
adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s effective tax rates were <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210701__20210930_z11XD73sdRb4" title="Effective tax rate">0</span>% and (<span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210930_zpSd4wOSJbW3" title="Effective tax rate">1</span>%) for the three
and nine months ended September 30, 2021, respectively, and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200701__20200930_zgvk1NgPLcZh" title="Effective tax rate">0</span>% and (<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20200930_z9kHwwZ0ewu9" title="Effective tax rate">4</span>%) for the three and nine months ended September 30, 2020, respectively.
Tax expense/benefit for the periods presented primarily reflects the impact of state taxes and foreign tax withholding (or refund) incurred
on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. The Company has recorded a full valuation
allowance against our net deferred tax assets as of September 30, 2021 and December 31, 2020. These assets primarily consist of foreign
tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZXOl0XkMU5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zviHK9QTSmF9">Recent Accounting Pronouncements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December of 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes.&#8221; The update removed certain exceptions to the general principles in Topic 740 in U.S. GAAP. The Company adopted the update
on January 1, 2021. The adoption of the update did not have a material effect on the Company&#8217;s financial position, results of operations
or financial statement disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Not Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments&#8212;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset,
including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected
credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019,
the FASB issued ASU No. 2019-04, &#8220;Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments,&#8221; to clarify the inclusion of recoveries of trade receivables previously
written off when estimating an allowance for credit losses. The amendments in these updates will currently be effective for the Company
on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments in these updates
may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity,&#8221; to simplify the accounting for convertible
instruments by eliminating large sections of the existing guidance in this area. It also eliminates several triggers for derivative accounting,
including a requirement to settle certain contracts by delivering registered shares. This update reduces the number of accounting models
for convertible instruments, revises the derivatives scope exception, and provides targeted improvements for earnings per share. Upon
adoption, companies have the option to apply a modified or full retrospective transition approach. The amendments in this update will
currently be effective for the Company on January 1, 2024, with early adoption permitted. Management is currently evaluating the impact
that the amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2021, the FASB issued ASU No. 2021-08, &#8220;Business Combinations
(Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,&#8221; to require that an acquirer
recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with &#8220;Revenue from
Contracts with Customers (Topic 606).&#8221; At the acquisition date, an acquirer should account for the related revenue contracts in
accordance with Topic 606 as if it had originated the contracts. The amendments in this update should be applied prospectively and will
be effective for the Company on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the
amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951250616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY SECURITIES PORTFOLIO INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">EQUITY SECURITIES PORTFOLIO INVESTMENT</a></td>
<td class="text"><p id="xdx_800_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zsvFU5CLq6Uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. <span id="xdx_823_zq6fDjbnU4I3">EQUITY SECURITIES PORTFOLIO INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 3, 2020, the Company entered into an Option Agreement with
LF Equity Income Fund (&#8220;Seller&#8221;), which included general terms through which the Company was provided the option to purchase
life sciences equity securities in a portfolio of public and private companies (&#8220;Life Sciences Portfolio&#8221;) for an aggregate
purchase price of &#163;223.9 million, approximately $<span id="xdx_90F_eus-gaap--PaymentsToAcquireInvestments_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zwMDlfL5mK6e" title="Payment to acquire equity securities">277.5</span> million at the exchange rate on April 3, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2020, the Company executed the Transaction Agreement between
Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the Company agreed to purchase from Seller
and Seller agreed to transfer to the Company the specified equity securities of all companies in the Life Sciences Portfolio at set prices
at various future dates. The transfer dates would vary among the Life Sciences Portfolio companies as the Transaction Agreement gives
the Company the exclusive right to determine when to call for transfer of each security, and because each Life Sciences Portfolio company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific terms
and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase equity securities
in each public and private company at a specified price on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with the Transaction Agreement, the Company transferred
the total purchase price of &#163;223.9 million into an escrow account. Upon the transfer of equity securities in the Life Sciences Portfolio
to the Company, the associated funds were released from the escrow account to Seller based on the consideration amount assigned to the
equity securities for such Life Sciences Portfolio company in the Transaction Agreement. As of December 31, 2020, all of the equity securities
in the Life Sciences Portfolio were transferred to the Company pursuant to the Transaction Agreement. The Company has sold a portion of
the equity securities of such Life Sciences Portfolio while retaining an interest in a number of operating businesses, including a controlling
interest in one of the companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For accounting purposes, the total purchase price of the Life Sciences
Portfolio was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their quoted
market price. The fair values of the private company securities were estimated based on recent financing transactions and secondary market
transactions and factoring in a discount for the illiquidity of these securities. As of September 30, 2021 and December 31, 2020, the
fair value of the Life Sciences Portfolio equity securities, excluding the equity method investment discussed below, was $354.6 million
and $248.1 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in the Life
Sciences Portfolio are recorded as unrealized gains or losses in the consolidated statements of operations. In late September 2021, the
Company sold one security which resulted in a gain of $18.6 million. The proceeds of that sale were settled and received in early October
2021, and therefore the Company recorded a $21.5 million other receivable as included in the consolidated balance sheet as of September
30, 2021. Accordingly, this trade date receivable from the sale of equity securities has been reflected as a noncash investing activity
in the consolidated statement of cash flows for the nine months ended September 30, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three and nine months ended September 30, 2021 and 2020, the
consolidated statements of operations reflected the following from the Life Sciences Portfolio:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zxL2We0nCSN5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BE_zKXQW0rympAg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of unrealized gains or losses</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of equity securities</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_zMEUkkqcH3d6" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">63,907</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">84,299</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">112,180</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">83,230</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zuJEfw7epRQj" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">10,651</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zdgMTswNPWpe" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">17,542</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities forward contract</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zdxfROMNNJX2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(74,662</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zw18vjWcmTk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_ztucdF4aE139" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain (loss)
    on sale of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zNqcMfNxvUZ1" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">37,112</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RealizedInvestmentGainsLosses_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">1,908</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_znTGs2UIlfOe" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">52,167</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zrfTas6FX2Qf" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">(4,202</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Gain
    on sale of prepaid investment and derivative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zQb3u7swTyr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivativey_pn3n3_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zmnv5aeeFWa6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivativey"><span style="font: 10pt Times New Roman, Times, Serif">2,845</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_z7nIFl2ff16c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zqCCa3FwKtGh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">2,845</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_ztnyFAXHjkh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">101,019</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">25,041</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--GainLossOnInvestments_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">164,347</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">99,415</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">As part of the Company&#8217;s
acquisition of equity securities in the Life Sciences Portfolio, the Company acquired a majority interest in the equity securities of
MalinJ1 (63.9%), which were transferred to the Company on December 3, 2020. The acquisition of the MalinJ1 securities was accounted for
as an asset acquisition as there was a change of control of MalinJ1 and substantially all of the fair value of the assets acquired was
concentrated in a single identifiable asset, an investment in Viamet Pharmaceuticals Holdings, LLC (&#8220;Viamet&#8221;). As such, the
cost basis of the MalinJ1 securities was used to allocate to the Viamet investment, the single identifiable asset, and no goodwill was
recognized. The Company through its consolidation of MalinJ1 accounts for the Viamet investment under the equity method as MalinJ1 owns
41.0% of outstanding shares of Viamet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952585848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT AT FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsTextBlock', window );">INVESTMENT AT FAIR VALUE</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--InvestmentHoldingsTextBlock_zKzfd8qQ8iSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. <span id="xdx_827_z2hL1KiZKkxl">INVESTMENT AT FAIR VALUE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2016 and 2017, Acacia made certain investments in Veritone.
As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone common stock and warrants to purchase
a total of 1,120,432 shares of Veritone common stock at an exercise price of $13.61 per share expiring between 2020 and 2027. During the
nine months ended September 30, 2020, Acacia sold all remaining 298,450 shares Veritone common stock and recorded a realized loss of $3.3
million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2020, Acacia exercised 154,312
warrants, and recognized a realized gain of $554,000 on the sale of common stock. During the nine months ended September 30,
2021, Acacia exercised all remaining 156,720 warrants, and recognized a realized gain of $3.6 million on the sale of common stock. The
Company no longer has an investment in Veritone common stock and warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in Veritone
are recorded as unrealized gains or losses in the consolidated statements of operations. For the three and nine months ended September
30, 2021 and 2020, the consolidated statements of operations reflected the following:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_zb8KfomJmqyl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENT AT FAIR VALUE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zeRXAGEneIue" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of gain on investments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of investment, warrants</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zHWFPxmYQpCk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zBALI1iOvgBk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,081</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zyACk9VbfrKh" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(2,752</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">225</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of investment, common stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2aYF2y3cM6c" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zfSP8TYgl9Xk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zy9OuX3Ssi01" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">3,479</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on sale
    of investment, warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zw1VJthNG0oi" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zu11xIn4bKyc" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">3,591</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">554</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Loss
    on sale of investment, common stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zpanvTIk1fGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2c64wloIrl1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z08tvJcl3vQ6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zxbeb8UKZ8W3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,316</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized (loss) gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20210701__20210930_z7p5QeItbWLd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_iN_pn3n3_di_c20200701__20200930_zwv5wA4AXM9f" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,081</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--GainLossOnInvestments_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">839</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">942</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611322-123010<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13)<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611282-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951097352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENTS, NET OF ACCUMULATED AMORTIZATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract', window );"><strong>Patents Net Of Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PatentsNetOfAccumulatedAmortizationTextBlock', window );">PATENTS, NET OF ACCUMULATED AMORTIZATION</a></td>
<td class="text"><p id="xdx_809_ecustom--PatentsNetOfAccumulatedAmortizationTextBlock_zTpxf0aZQPNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. <span id="xdx_826_zij6bxuAdYCi">PATENTS, NET OF ACCUMULATED AMORTIZATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s only identifiable intangible assets as of September
30, 2021 and December 31, 2020 are patents and patent rights. Patent-related accumulated amortization totaled $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20210930_zWMfi9WnMjRl" title="Accumulated amortization">291.6</span> million and $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3n3_dm_c20201231_zDLvRdd58j29" title="Accumulated amortization">319.9</span>
million as of September 30, 2021 and December 31, 2020, respectively. Acacia&#8217;s patents have remaining estimated economic useful
lives ranging from twenty-six to fifty-two months. The weighted average remaining estimated economic useful life of Acacia&#8217;s patents
is approximately four years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the scheduled annual aggregate amortization
expense as of September 30, 2021:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zUT140DEdHl3" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zuiqmEMygJp9" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of intangible assets</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210930_zz4FFSJwI0E1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJix_ze9vNrN0UJf9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,612</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJix_zTiA3MPpqzjk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,448</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJix_zFlxBGuOz923" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,381</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJix_zEvY4MqUajF2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,005</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJix_z3cmojYdLkNi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2025</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,630</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJix_zmEDNRUUDwe3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">750</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJix_znHIRvRyAwCj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Patents,
    net&#160;&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">39,826</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the nine months ended September 30, 2021, Acacia accrued patent
and patent rights acquisition costs totaling $<span id="xdx_90F_ecustom--AccruedPatentAcquisitionCosts_iI_pn3n3_dm_c20210930_zMIyiWiJNvVf" title="Accrued patent acquisition costs">13.0</span> million, of which $<span id="xdx_90C_eus-gaap--OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_dm_c20210930_z11shg8Vq3Af" title="Accrued patent acquisition costs due within a year">8.0</span> million is due December 1, 2021 and $<span id="xdx_908_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_pn3n3_dm_c20210930_zJcRlYw3UMz7" title="Accrued patent acquisition costs due within 2 years">5.0</span> million is due February
18, 2023. Such amounts are included in accrued patent investment costs and other long-term liabilities in the consolidated balance sheet
as of September 30, 2021, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PatentsNetOfAccumulatedAmortizationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PatentsNetOfAccumulatedAmortizationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955723928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STARBOARD INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosureStarboardInvestmentAbstract', window );"><strong>Starboard Investment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_StarboardInvestmentTextBlock', window );">STARBOARD INVESTMENT</a></td>
<td class="text"><p id="xdx_803_ecustom--StarboardInvestmentTextBlock_zziu1Lyfzex3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. <span id="xdx_821_zMcYgilkxbti">STARBOARD INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Redeemable Convertible Preferred Stock&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, the Company entered into a Securities Purchase
Agreement with Starboard Value LP (&#8220;Starboard&#8221;) and certain funds and accounts affiliated with, or managed by, Starboard (collectively,
the &#8220;Buyers&#8221;) pursuant to which the Company issued (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20191101__20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Stock issued">350,000</span> shares of Series A Redeemable Convertible Preferred Stock with
a par value of $0.001 per share and a stated value of $100 per share, and (ii) Series A Warrants to purchase up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_pdd" title="Warrants issued, shares">5,000,000</span> shares of
the Company&#8217;s common stock to the Buyers. The Securities Purchase Agreement also established the terms of certain senior secured
notes and additional Series B Warrants which may be issued to Starboard in the future. On June 4, 2020, the Company entered into a Supplemental
Agreement, as defined below under &#8220;Senior Secured Notes&#8221;, with certain contractual agreements affecting the Series A Redeemable
Convertible Preferred Stock, reflected below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii) the conversion
price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Conversion price">3.65</span> (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable Convertible Preferred
Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible Preferred Stock into shares
of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#8217;s common stock equals or
exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions of the common stock have been
met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders have the option to redeem all or a portion of the Series A
Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August 15,
2022, provided that there is not outstanding at least $50.0 million aggregate principal of senior secured notes to the Buyers pursuant
to the Securities Purchase Agreement at the time of the redemption. Holders also have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have
the option to redeem all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control
or (ii) various other triggering events, such as the suspension from trading or delisting of the Company&#8217;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company may redeem all, and not less than all, of the Series A
Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August 15, 2022,
provided that there is not outstanding at least $50.0 million aggregate principal of the senior secured notes at the time of the redemption,
and assuming certain conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed
at the option of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any Series A Redeemable Convertible Preferred Stock remains outstanding
on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In all redemption scenarios, the redemption price for the Series A
Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on the redemption
scenario, the redemption price may also include a make-whole amount or stated premium as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When the Company issues Notes, the Holder may exchange the Series A
Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Redeemable Convertible Preferred Stock accrues cumulative
dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of the approved investment in June 2020, the dividend
rate increased to 8.0% on the stated value. Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering
event occurs before an approved investment or 10.0% on the stated value if the triggering event occurs after an approved investment. In
connection with the approved investment in June 2020, the Company and the Buyers agreed that the dividend rate on the Series A Redeemable
Convertible Preferred Stock would accrue at 3.0% so long as no triggering event occurs and the Company maintains $35.0 million in escrow.
Series A Redeemable Convertible Preferred Stock also participates on an as-converted basis in any regular or special dividends paid to
common stockholders. No accrued and unpaid dividends as of September 30, 2021. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Upon consummation of the approved acquisition in October 2021, the
dividend rate increased to 8.0% on the stated value. Refer to Note 11 for additional information related to the subsequent period acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of the Series A Redeemable Convertible Preferred Stock have
the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible Preferred
Stock will also be entitled to a separate class vote with respect to amendments to the Company&#8217;s organizational documents that generally
have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon liquidation of the Company, holders of Series A Redeemable Convertible
Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior to any distribution
to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid dividends or (ii) the amount
that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted into common stock immediately
prior to the liquidation event at the then effective conversion price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company determined that certain features of the Series A Redeemable
Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled together as a single,
compound embedded derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2019, total proceeds received and transaction costs incurred
from the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkNsLZ672zWc" title="Proceeds from issuance of preferred stock">35.0</span> million and $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_pn3n3_dm_c20200519__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zs75OjSbOHoc" title="Payment of stock issuance costs">1.3</span> million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated between
the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and the Series A
Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the Series A Warrants,
embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and $8.9 million, respectively.
Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and the Series A Warrants on the same
basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible Preferred Stock were treated as a discount
to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated to the Series A Warrants were expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise on November
15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company accretes the
instrument to its redemption value using the effective interest method and recognizes any changes against additional paid in capital in
the absence of retained earnings. Accretion for the three and nine months ended September 30, 2021 was $<span id="xdx_908_eus-gaap--AccretionExpense_pn3p0_c20210701__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zKHVd9iYmgRc" title="Accretion expense">991,000</span> and $<span id="xdx_90C_eus-gaap--AccretionExpense_pn3n3_dm_c20210101__20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkyTiXbW3UI5" title="Accretion expense">2.8</span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers and a Governance Agreement with Starboard
and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain registration rights
with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon conversion. In accordance with
the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors from six to seven members, (ii) appoint
Jonathan Sagal as a director of the Company, (iii) grant Starboard the right to recommend two additional directors for appointment to
the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing due diligence on potential acquisition targets,
(v) appoint certain directors to the Strategic Committee, and (vi) appoint a director to the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following features of the Series A Redeemable Convertible Preferred
Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative: (i) the right
of the holders to redeem the shares (the &#8220;put option&#8221;), (ii) the right of the holders to receive common stock upon conversion
of the shares (the &#8220;conversion option&#8221;), (iii) the right of the Company to redeem the shares (the &#8220;call option&#8221;),
and (iv) the change in dividend rate upon consummation of an approved investment or a triggering event (the &#8220;contingent dividend
rate feature&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These features are required to be accounted for separately from the
Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related to the debt-like
host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are bundled together and are
accounted for as a single, compound embedded derivative liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, we have recorded an embedded derivative liability representing
the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value at each period
end with changes in fair value recorded other income or (expense) in the &#8220;Change in fair value of the Series A and B warrants and
embedded derivatives&#8221; financial statement line item of the consolidated statements of operations. As of September 30, 2021 and December
31, 2020, the fair value of the Series A embedded derivative liabilities was $<span id="xdx_90C_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20210930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zwK8Z9P5ipT5" title="Fair value of embedded derivative">41.4</span> million and $<span id="xdx_90A_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20201231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zkMfyAsve7Ig" title="Fair value of embedded derivative">26.7</span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, in connection with the issuance of the Series
A Redeemable Convertible Preferred Stock, the Company issued a detachable Series A Warrants to acquire up to purchase 5 million shares
of common stock at a price of $3.65 per share (subject to certain anti-dilution adjustments) at any time during a period of eight years
beginning on the instrument&#8217;s issuance date of the Series A Warrants. The fair value of the Series A Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191118__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zVduOVdhfJW3" title="Fair value of warrants">4.8</span> million upon
issuance. The Series A Warrants will be recognized at fair value at each reporting period until exercised, with changes in fair value
recognized in other income or (expense) in the consolidated statements of operations. As of September 30, 2021 and December 31, 2020,
the fair value of the Series A Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zmkROtM85Gnb" title="Fair value of warrants">18.5</span> million and $<span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zDSBS5WvWmKa">6.6</span> million, respectively. As of September 30, 2021, the Series A Warrants
have <span id="xdx_907_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zFNzS50Vw9Uc" title="Warrants exercised">no</span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series A Warrants are classified as a liability in accordance with
ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series B Warrants </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities Purchase
Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_dm_c20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zv5GbrN3S5a7" title="Warrants issued, shares">100</span> million shares of the Company&#8217;s
common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i) $5.25 per share, if exercising
by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65 per share, if exercising by cancellation
of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn3n3_dm_c20200201__20200225__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zMyMexkZuAig" title="Proceeds from issuance of preferred stock">4.6</span> million. The Series B Warrants
expire on November 15, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the issuance of the Notes on June 4, 2020, the terms
of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the payment of cash,
rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November 15, 2027. 31,506,849
of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their
original terms. As of September 30, 2021, the Series B Warrants have <span id="xdx_900_ecustom--WarrantsExercisedShares_do_c20210101__20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zbleMgenLO05" title="Warrants exercised">no</span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series B Warrants will be recognized at fair value at each reporting
period until exercised, with changes in fair value recognized in other income or (expense) in the consolidated statements of operations.
As of September 30, 2021 and December 31, 2020, the fair value of the Series B Warrants was $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zVvHHwpTRnP8" title="Fair value of warrants">229.6</span> million and $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20201231__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zDr0DS4EoiC7" title="Fair value of warrants">52.3</span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Series B Warrants are classified as a liability in accordance with
ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Senior Secured Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Securities Purchase Agreement dated November 18, 2019
with Starboard and the Buyers, on June 4, 2020, the Company issued $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zri2UsNCqTqe" title="Proceeds from issuance of debt">115.0</span> million in Notes to the Buyers. Also on June 4, 2020, in connection
with the issuance of the Notes, the Company entered into a Supplemental Agreement with Starboard (the &#8220;Supplemental Agreement&#8221;),
pursuant to which the Company agreed to redeem $<span id="xdx_905_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeptemberRedemptionMember_zLsTwy9lCgs" title="Repayment of debt">80.0</span> million aggregate principal amount of the Notes by September 30, 2020, and $<span id="xdx_903_ecustom--RedemptionOfSecuredNotes_iI_pn3n3_dm_c20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--DecemberRedemptionMember_zXgD1ONnFORb" title="Repayment of debt">35.0</span>
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid by December
31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zei6ZnSUFmb6" title="Debt stated interest rate">6.00</span>% per annum, and in an event of default, the
interest rate is increased to <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zYIcyIroiFtl" title="Debt stated interest rate">10.00</span>% per annum. The Notes include certain financial and non-financial covenants. Additionally, all or
any portion of the principal amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation
in payment of the exercise price upon the exercise of Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into an Exchange Agreement (the
&#8220;Exchange Agreement&#8221;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned subsidiary
of the Company (&#8220;Merton&#8221;) and Starboard, on behalf of itself and on behalf of certain funds and accounts under its management,
including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal
amount for new senior notes (the &#8220;New Notes&#8221;) issued by Merton having an aggregate outstanding original principal amount of
$<span id="xdx_900_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_pn3n3_dm_c20200101__20200630__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zkA8NOn0ZtN2" title="Notes exchanged">115.0</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The New Notes bear interest at a rate of 6.00% per annum and had a
maturity date of December 31, 2020. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of the Company
and Merton and non-recourse equity pledges of each of the Company&#8217;s material subsidiaries. Pursuant to the Exchange Agreement, the
New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes of the Securities Purchase Agreement, (ii) are deemed to be &#8220;June
2020 Approved Investment Notes&#8221; for purposes of the Supplemental Agreement, and with the Company agreeing to redeem $80 million
principal amount of the New Notes by September 30, 2020 and $35 million principal amount of the New Notes by December 31, 2020, and (iii)
are deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of the New
Notes will also satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#8217;s
Series A Convertible Preferred Stock, par value $0.001 per share. The New Notes will not be deemed to be &#8220;Notes&#8221; for the purposes
of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the New Notes are to be settled within twelve months pursuant
to their terms, they are classified as current liabilities in the consolidated balance sheets. The Company capitalized $<span id="xdx_907_eus-gaap--DeferredFinanceCostsGross_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zwG59JrVgGCh" title="Capitalized lender fees">4.6</span> million in
lender fees and $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zWS0zSted7" title="Unamortized discount">0.5</span> million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long-term deferred debt issuance costs and are included in other non-current assets in the consolidated balance sheets, and will be
amortized to interest expense until November 15, 2027, the maturity date of Series A Redeemable Convertible Preferred Stock. The $0.5
million issuance costs are recognized as a discount on the Notes and will be amortized to interest expense over the contractual life of
the Notes. There was $3.1 million and $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zrmbQ1F2oYF7" title="Accrued interest">863,000</span> accrued and unpaid interest on the New Notes as of September 30, 2021 and December 31,
2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 29, 2021, the Company redeemed $<span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zUtTeJV7zK22" title="Repayment of debt">50.0</span> million of the New
Notes and on March 31, 2021, the Company reissued $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zqP8l3s0DDs3" title="Proceeds from issuance of debt">50.0</span> million of the New Notes. On June 30, 2021, the Company issued $30.0 million in
additional New Notes (the &#8220;June 2021 Merton Notes&#8221;) and amended the maturity date of the New Notes to <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20210101__20210129__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__srt--CounterpartyNameAxis__custom--MertonMember_zy1M9PDT01d3" title="Debt maturity date">October 15, 2021</span>. On
September 30, 2021, the Company issued $35.0 million in additional New Notes (the &#8220;September 2021 Merton Notes&#8221;) and amended
the maturity date of the New Notes to December 1, 2021. The June and September 2021 Merton Notes cannot be used to exercise Series B Warrants
issued to Starboard Value. The total principal amount outstanding of New Notes as of September 30, 2021 and December 31, 2020 was $<span id="xdx_901_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20210930__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_z5xPYi3ltAVg">180.0</span>
million and $<span id="xdx_907_eus-gaap--LongTermDebt_iI_pn3n3_dm_c20201231__us-gaap--LongtermDebtTypeAxis__custom--NewNotesMember_zCmJBAeei48k">115.0</span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Modifications to Series A Redeemable Convertible Preferred Stock
and Series B Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The June 4, 2020 Supplemental Agreement also provided for (i) a waiver
of increased dividends under the original terms of the Series A Redeemable Convertible Preferred Stock that would have otherwise accrued
due to the Company&#8217;s use of the $35.0 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series A
Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified through the
issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the payment of the lower
exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding, at any time until
the expiration of the Series B Warrants on November 15, 2027. 31,506,849 of the Series B Warrants are subject to this adjustment with
the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We analyzed the amendments to the terms of the Series A Redeemable
Convertible Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a
modification on a prospective basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The incremental fair value of the Series B Warrants associated with
the modification of their terms in connection with the issuance of the Notes was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEOtlWdTPO0c" title="Fair value of warrants">1.3</span> million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. As of September 30, 2021, $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_dm_c20210101__20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zEyeYmxPGXi2" title="Amortization of discount">1.2</span> million was amortized
to interest expense and $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3p0_c20210930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zAjLlS0B38dd" title="Unamortized discount">151,000</span> is remaining to be amortized until the maturity date of December 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosureStarboardInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosureStarboardInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_StarboardInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_StarboardInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951010744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zpKhLwp8QjW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. <span id="xdx_828_zCMtKAoIWlh7">FAIR VALUE MEASUREMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is
defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 1 - <i>Observable Inputs</i>:&#160;&#160;Quoted prices in active markets for identical investments;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 2 - <i>Pricing Models with Significant Observable Inputs</i>:&#160;&#160;Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 96px"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level 3 - <i>Unobservable Inputs</i>:&#160;&#160;Unobservable inputs reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Management estimates include certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs, including the entity&#8217;s own assumptions in determining the fair value of derivatives and certain investments.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whenever possible, the Company is required to use observable market
inputs (Level 1 - quoted market prices) when measuring fair value. In such cases, the level at which the fair value measurement falls
is determined based on the lowest level input that is significant to the fair value measurement. The assessment of the significance of
a particular input requires judgment and considers factors specific to the asset or liability being measured. In certain cases, inputs
used to measure fair value may fall into different levels of the fair value hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia holds the following types of financial instruments at September
30, 2021 and December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Equity Securities at Fair Value. </i>Equity securities includes
investments in public company common stock and are recorded at fair value based on the quoted market price of each share on the valuation
date. The fair value of these securities are within Level 1 of the valuation hierarchy. Equity investments that do not have regular market
pricing, but for which fair value can be determined based on other data values or market prices, are recorded at fair value within Level
2 of the valuation hierarchy. At September 30, 2021, our Level 2 equity securities include an investment measured with an applied pricing
model that includes significant observable inputs to the public company common stock value. The fair value of the Level 2 equity securities
investment as of September 30, 2021 was estimated based on a discount of 7.5 percent determined using the following significant inputs
to the pricing model: expected term of restriction of 6 months and volatility of approximately 45 percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investments at Fair Value - Common Stock and Warrants. </i>Acacia&#8217;s
equity investment in Veritone common stock was recorded at fair value based on the quoted market price of Veritone&#8217;s common stock
on the applicable valuation date (Level 1). Warrants were recorded at fair value, as based on the Black-Scholes option-pricing model (Level
2). Refer to Note 4 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series A Warrants. </i>Series A Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in estimate with regard to
the calculation of the volatility assumption used in the Black Scholes option-pricing model. As a result, the Series A Warrants are now
measured as Level 3 as opposed to Level 2 as measured previously. The fair value of the Series A Warrants as of September 30, 2021 was
estimated based on the following significant assumptions: volatility of 30 percent, risk-free rate of 1.16 percent, term of 6.04 years
and a dividend yield of 0 percent.<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Series B Warrants. </i>Series B Warrants are recorded at fair value,
using Black-Scholes option-pricing model (Level 3). In the quarter ended March 31, 2021, there was a change in methodology used to an
acceptable Black-Scholes option-pricing model from a Monte Carlo valuation technique used to value the Series B Warrants as of December
31, 2020. The fair value of the Series B Warrants as of September 30, 2021 was estimated based on the following significant assumptions:
(1) volatility of 30 percent, risk-free rate of 1.17 percent, term of 6.13 years and a dividend yield of 0 percent, and (2) volatility
of 25 percent, risk-free rate of 0.08 percent, term of 0.90 years and a dividend yield of 0 percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Embedded Derivative Liability. </i>Embedded derivatives that are
required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial lattice framework
is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company
in 2019 (Level 3). The binomial model utilizes the Tsiveriotis and Fernandes implementation in which a convertible instrument is split
into two separate components within a single lattice framework: a cash-only component which is subject to the selected risk-adjusted discount
rate and an equity component which is subject only to the risk-free rate. The model considers the (i) implied volatility of the value
of our common stock, (ii) appropriate risk-free interest rate, (iii) credit spread, (iv) dividend yield, (v) dividend accrual (and a step-up
in rates), and (vi) event probabilities of the various conversion and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The volatility of the Company&#8217;s common stock is estimated by
analyzing the Company&#8217;s historical volatility, implied volatility of publicly traded stock options, and the Company&#8217;s current
asset composition and financial leverage. The selected volatility, as described below, represents a haircut from the Company&#8217;s actual
realized historical volatility. A volatility haircut is a concept used to describe a commonly observed occurrence in which the volatility
implied by market prices involving options, warrants, and convertible debt is lower than historical actual realized volatility. The assumed
base case term used in the valuation model is the period remaining until November 15, 2027, the Series A Redeemable Convertible Preferred
Stock maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term equal to the expected
term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s valuation of the embedded
derivative at September 30, 2021 are as follows: volatility of 30 percent, risk-free rate of 1.20 percent, term of 6.13 years, discount
rate of 9.40 percent and a dividend yield of 0 percent. The fair value measurement of the embedded derivative is sensitive to these assumptions
and changes in these assumptions could result in a materially different fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial assets and liabilities measured at fair value on a recurring
basis were as follows:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_pn3n3_z5kmnjed5E3k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span id="xdx_8BC_zDbtPuaj44Q3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of financial assets and liabilities at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Assets</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities at fair value</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">119,280</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">267,840</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zZVGoE48BD8" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">119,280</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">267,840</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFd2v3vOBIX9" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_z12hfjlqUkOg" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zNn5o9jioYY8" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1363">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zN4HkkyX1IZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2Rk1i7V7BS7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">111,855</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1XPiKQebxPi" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0h2bMhasRM8" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zGptlAREhr5b" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zbUAXEhdiYoe" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zszAV4gWLbAf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3llNtszR3bb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRePaEdnRYff" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zulGZMy3unc2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxBmcUIyZc3b" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6jzNfrJFBzl" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zFozVzESS9Mg" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ztuwH6r7aNWe" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z1HETD3mtmD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3Hr5U8tBAhk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zK9m32J7ly9a" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">79,069</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">85,709</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8AC_zPROrwdnk37i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following tables set forth a summary of the changes in the estimated
fair value of the Company&#8217;s Level 3 liabilities, which are measured at fair value on a recurring basis:<span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zJtwOdyWcwLg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B2_zIPeRQjNeech" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of changes in fair value Level 3 liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br/>
    Warrant <br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br/>
    Embedded<br/>
    Derivative<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br/>
    Warrant<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2021</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zSPzxpg6DGq4" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zujtjgtXKbQ1" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_znuUhmeXlKqa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zSR2lyFjgLFi" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">79,069</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br/></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zlQZnye4JgA7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zGrY5yXshLu2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhyJh3RikVw3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1455">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHYe0aNOPkd7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zXhrft1TTTZ" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,824</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zcWTPiOMsHl8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,463</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z0J95BCXdmh8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">178,198</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlebWdggdMs7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,485</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2021</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGFuWMIvIS17" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,464</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwX7uhS4u3Fd" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,191</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z9mgILvYsVA6" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230,539</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOxnHuGUb8xj" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">290,194</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zFbBIGc4Y8K4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zaWhKZtdHvw1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">220</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zYGjpF1DHtc6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(902</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zioDjYCWSYN8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(619</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2021</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGzvcijAnNYf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zk1RCguf9FSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zPpqonDA4Ft2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zro8i4u4bx5c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: bottom"><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br/>
    Warrant <br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br/>
    Embedded<br/>
    Derivative<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br/>
    Warrant<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2020</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zp9cRBopGs62" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,568</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zDpoRIa5BQc3" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">17,974</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z84jGZDL2Lpa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1479">&#8211;</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqmsElSo18Sc" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">21,542</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br/></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zzraf0BsSHQ" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z0hxfQQe1KUk" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1484">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zGFOHDDByka8" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,929</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2734OILGBl9" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">5,929</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zOu2doI0EZ87" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,384</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zzGpS86ipsdl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,539</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ze9KisgH5gpg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,361</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKhFU982rY3f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,284</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2020</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zmbMqnh9IrR5" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,952</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrg6VIxa6VV3" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,513</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z8qoSeDp3adl" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,290</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGoptiET9TH" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,755</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zA2rM9qQmwK6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zXyzG31qtlfb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,831</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhrd7tO3fLT3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(15,493</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlXHxnpiqD0c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(20,672</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2020</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zNOVurYjPAue" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,604</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwGjuEo589wc" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,682</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ziAHBWp4jxia" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLHn752plRSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">74,083</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"/>


<p id="xdx_8A2_zZbK9lJySAu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with U.S. GAAP, from time to time, the Company measures
certain assets at fair value on a nonrecurring basis. The Company reviews the carrying value of equity securities without readily determinable
fair value, equity method investments and patents on a quarterly basis for indications of impairment, and other long-lived assets at least
annually. When indications of potential impairment are identified, the Company may be required to determine the fair value of those assets
and record an adjustment for the carrying amount in excess of the fair value determined. Any fair value determination would be based on
valuation approaches, which are appropriate under the circumstances and utilize Level 2 and Level 3 measurements as required.</p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951167432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0fkI4SvQ047" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. <span id="xdx_821_zefBAmB1niW6">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Facility Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company primarily leases office facilities under operating lease
arrangements that will end in various years through July 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 7, 2019, we entered into a building lease agreement (the &#8220;New
Lease&#8221;) with Jamboree Center 4 LLC (the &#8220;Landlord&#8221;). Pursuant to the New Lease, we have leased approximately 8,293 square
feet of office space in Irvine, California. The New Lease commenced on August 1, 2019. The term of the New Lease is 60 months from the
commencement date, provides for annual rent increases, and does not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January 7, 2020, we entered into a building lease agreement (the
&#8220;New York Office Lease&#8221;) with Sage Realty Corporation (the &#8220;New York Office Landlord&#8221;). Pursuant to the New York
Office Lease, we have leased approximately 4,000 square feet of office space for our corporate headquarters in New York, New York. The
New York Office Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides
for annual rent increases, and does not provide us the right to early terminate or extend our lease terms. During August 2021, we entered
into a first amendment of the New York Office Lease, to commence for a period of three years upon landlords&#8217; substantial completion
of adequate substitution space, as defined. To date, the substitution space is not ready for use, accordingly the term extension has not
begun.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Operating lease costs were $<span id="xdx_906_eus-gaap--OperatingLeaseCost_pn3p0_c20210701__20210930_zrjiEKtJyBD6" title="Operating lease costs, net of sublease income">155,000</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseCost_pn3p0_c20200701__20200930_z51rOJ1fpYu6" title="Operating lease costs, net of sublease income">174,000</span> for the three months
ended September 30, 2021 and 2020, respectively, and $<span id="xdx_905_eus-gaap--OperatingLeaseCost_pn3p0_c20210101__20210930_zmM3AphN5NRj" title="Operating lease costs, net of sublease income">457,000</span> and $<span id="xdx_90A_eus-gaap--OperatingLeaseCost_pn3p0_c20200101__20200930_zitkPtxlCxo9" title="Operating lease costs, net of sublease income">459,000</span> for the nine months ended September 30, 2021 and 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below presents aggregate future minimum payments due under
the New Lease and the New York Office Lease discussed above, reconciled to long-term lease liabilities and short-term lease liabilities
(included in accrued expenses and other current liabilities) included in the consolidated balance sheet as of September 30, 2021:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zYQioXzgu3R7" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B9_z9otGpxq51zf" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of future minimum operating lease payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_495_20210930_zPhAs40X9ILd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Operating
    Leases</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maOLFMPzNL8_zxCD2Hqv0Pk3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 26%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">149</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maOLFMPzNL8_zCUrJidv2kK1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">370</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maOLFMPzNL8_zY8NTYWvgYui" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">364</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maOLFMPzNL8_zET1tgSv8Ts2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">218</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_d0_maOLFMPzNL8_zoCNEil6fSRl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtOLFMPzNL8_zJT3wzL1sCs2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total minimum
    payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,101</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zW62Da70zQqh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    short-term lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(430</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term
    lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the investment in certain patents and patent rights,
certain of Acacia&#8217;s operating subsidiaries executed related agreements which grant to the former owners of the respective patents
or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated
as a result of licensing and otherwise enforcing the respective patents or patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries may retain the services of law
firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities.
These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees,
settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of Acacia&#8217;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#8217;s operating subsidiaries&#8217;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated
statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural
aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries
or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia is subject to claims, counterclaims and legal actions that arise
in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if
any, will not have a material effect on Acacia&#8217;s consolidated financial position, results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December 2017, the Federal Court of Canada allowed a counterclaim
for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions LLC in amounts that are included
in the 2021 and 2020 accrual balances discussed below. During the three months ended September 30, 2021, the Company made approximately
$1.0 million in settlement payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 6, 2019, Slingshot Technologies, LLC, or Slingshot, filed
a lawsuit in Delaware Chancery Court against the Company and Acacia Research Group, LLC, or collectively, the Acacia Entities, Monarch
Networking Solutions LLC (&#8220;Monarch&#8221;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd., or Transpacific.
Slingshot alleges that the Acacia Entities and Monarch misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities and Monarch by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive
option to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. On March 15, 2021, the court issued orders granting Monarch&#8217;s
motion to dismiss for lack of personal jurisdiction and Ms. Wolanyk&#8217;s motion to dismiss for lack of subject matter jurisdiction.
The remaining parties then commenced discovery, and have since served initial written requests and responses, and notices of the depositions
of the parties&#8217; corporate designees. The Acacia Entities maintain that Slingshot&#8217;s allegations are baseless, that the Acacia
Entities neither had access to nor used Slingshot&#8217;s information in acquiring the portfolio, that the Acacia Entities acquired the
portfolio as a result of the independent efforts of its IP licensing group, and that Slingshot suffered no damages given its exclusive
option to purchase the portfolio had already ended and it has proven itself incapable of closing on the portfolio purchase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the three months ended September 30, 2021 and 2020, there were
no operating expenses related to settlement and contingency accruals. During the nine months ended September 30, 2021, we incurred $338,000
in operating expenses for settlement and contingency accruals. During the nine months ended September 30, 2020, operating expenses included
a net income for settlement offset by contingency accruals totaling $<span id="xdx_908_ecustom--NetIncomeForSettlementOffsetByContingencyAccruals_pn3p0_c20200101__20200930_zhd1bgFna53j" title="Income from settlement">308,000</span>, net of prior accruals. At September 30, 2021 and December
31, 2020, our contingency accrual balance was $<span id="xdx_906_eus-gaap--LossContingencyAccrualAtCarryingValue_c20210930_pn3p0" title="Contingency accruals">587,000</span> and $<span id="xdx_90E_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20201231_zy4230WGNSOa" title="Contingency accruals">1.3</span> million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136950946888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_znZoqUbX7sf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>9. <span id="xdx_829_zJ9CaZ4j8l59">STOCKHOLDERS&#8217; EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Repurchases of Common Stock </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 5, 2019, Acacia&#8217;s Board of Directors approved a stock
repurchase program, which authorized the purchase of up to $<span id="xdx_901_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_zpuRECaiCtIa">10.0
</span>million of the Company&#8217;s common stock through open market purchases, through block trades, through 10b5-1 plans, or by means
of private purchases, from time to time, through July 31, 2020. Stock repurchases for the periods presented, all of which were purchased
as part of a publicly announced plan or program, were as follows:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_zRhwhpin0KBh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  STOCKHOLDERS' EQUITY (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B6_zqWEq4Bw0Jrj" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of repurchased shares</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total
    Number<br/> of Shares<br/> Purchased</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Average<br/>
    Price<br/> paid per<br/> Share</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Approximate<br/>
    Dollar<br/> Value of Shares<br/>
    that<br/> May Yet be<br/>
    Purchased<br/> under the<br/>
    Program</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Plan
    Expiration Date</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">March
    20, 2020 - March 31, 2020</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--TreasuryStockSharesAcquired_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">576,898</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.28</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="width: 11%; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"><span style="font: 10pt Times New Roman, Times, Serif">8,686,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 13%; font-size: 10pt; text-align: center"><span id="xdx_902_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1jSPqRNZTKh" style="font: 10pt Times New Roman, Times, Serif">July
    31, 2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">April
    1, 2020 - April 23, 2020</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">1,107,639</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.42</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"><span style="font: 10pt Times New Roman, Times, Serif">6,001,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"><span id="xdx_901_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2duEkvoJjWk" style="font: 10pt Times New Roman, Times, Serif">July
    31, 2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    repurchases in 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">1,684,537</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.37</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In determining whether or not to repurchase any shares of Acacia&#8217;s
common stock, Acacia&#8217;s Board of Directors consider such factors, among others, as the impact of the repurchase on Acacia&#8217;s
cash position, as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s capital. Acacia
has no obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding
share count and enhance stockholder value.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tax Benefits Preservation Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March 12, 2019, Acacia&#8217;s Board of Directors announced that
it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#8220;Plan&#8221;). Our stockholders ratified the adoption
of the Plan in July 2019. The purpose of the Plan is to protect the Company&#8217;s ability to utilize potential tax assets, such as net
operating loss carryforwards and tax credits to offset potential future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Plan is designed to reduce the likelihood that the Company will
experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more of the Company&#8217;s
outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement of the adoption of the
Plan, beneficially own more than 4.9% of the Company&#8217;s then-outstanding shares of the Company&#8217;s common stock from acquiring
additional shares of the Company&#8217;s common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will
prevent the Company from experiencing an ownership change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the adoption of the Plan, Acacia&#8217;s Board of
Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#8217;s common stock
to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right would initially entitle
the holder to purchase one one-thousandth of a share of the Company&#8217;s Series B Junior Participating Preferred Stock, $0.001 par
value for a purchase price of $12.00. On March 15, 2021 the rights expired pursuant to their terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has a provision in its Amended and Restated Certificate
of Incorporation, as amended (the &#8220;Charter Provision&#8221;) which generally prohibits transfers of its common stock that could
result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#8217;s ability to utilize
potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income. The Charter
Provision was approved by the Company&#8217;s stockholders on July 15, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952620088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME/LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">INCOME/LOSS PER SHARE</a></td>
<td class="text"><p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zkerc449FzF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. <span id="xdx_824_zzJEAzxtxPYd">INCOME/LOSS PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zgbXg2sOefXg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME/LOSS PER SHARE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span id="xdx_8B9_zVrmlA3L6504" style="font: 10pt Times New Roman, Times, Serif; display: none">Calculation
    of basic and diluted net loss per share</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20210701__20210930_zpblr4UDGed6" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49E_20200701__20200930_z7qOwCUpQKp1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210101__20210930_zFBF3yU6vn4f" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20200101__20200930_z5QXqKuQujHd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands, except share and per share information)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Numerator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 44%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to Acacia Research Corporation</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">89,604</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">38,348</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(55,507</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">33,205</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di_zytxWlyW6E8c" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Dividend
    on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(262</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(467</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(785</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,118</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di_zykUE09mVaKh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Accretion
    of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(991</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(733</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(2,762</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(2,045</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zuHjVJ4perMi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Undistributed
    earnings allocated to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(15,367</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(6,619</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,204</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">72,984</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,529</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(59,054</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">24,838</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DividendOnSeriesRedeemableConvertiblePreferredStock_d0_zvQN6GcEwcpj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Dividend on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">467</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_d0_z5ju7nq3fJL6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Accretion of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">733</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_d0_zBu9eOfBc129" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A redeemable convertible preferred stock embedded derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,831</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ChangeInFairValueOfSeriesWarrants_d0_zHLx0s1KWuw1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of dilutive Series B warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(902</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,557</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1633">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,557</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_ecustom--InterestExpenseAssociatedWithStarboardNotesNetOfTax_zOXosm3OcbC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Interest expense associated with Starboard Notes, net of tax</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,536</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,889</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1638">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,889</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_d0_zz2ju8XPbY3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Undistributed earnings allocated to participating securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">15,367</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,619</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,204</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_d0_zIrNoG0YtTlk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Reallocation
    of undistributed earnings to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(8,877</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(296</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,645</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_ecustom--NetIncomeLossAvailableToCommonStockholderDiluted_zIr9KIFNSS4h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">80,171</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29,205</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(59,054</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">21,381</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Denominator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,949,504</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,467,885</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,759,873</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,949,706</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB_zEk8nkeJ0rCd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Potentially
    dilutive common shares:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKkMuV7VIDVa" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zETSzCWfjRT5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">9,589,041</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKirbQ2Yoor5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKnaiHzRzR8" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Restricted
    stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zJF7f4mvOp0l" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">798,356</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zMkU0EdviRii" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">728,936</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zOJu5omQ8n8g" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zYRXlPFFIb9j" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">598,328</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Stock
    options</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zeaYyeQPthn" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">35,815</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zkUd73Hfl71h" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">21,624</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zPgEbZO4A6se" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zaVQrUnVwe71" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zDzc4FbOzBkl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">2,019,724</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z7WoPzAd95ti" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">310,367</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zZnhIcNFlxh6" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zUvgbSo8UNFj" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">103,456</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zW9XGGHHTqMk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">41,278,103</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zINAkGS70pp8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">31,506,849</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ziIjUwWeiJv1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zPAZ0GYoyFfi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">10,502,283</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zzeKVIBoiv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">93,081,502</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">90,624,702</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,759,873</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">60,153,773</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Basic
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1.49</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1.21</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.51</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Diluted
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.86</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.32</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1.21</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.36</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_iB_zAA51t9fyYb9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Anti-dilutive
    potential common shares excluded from the computation of diluted net income (loss) per common share:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity-based
    incentive awards</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zjonp0WplYTk" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">398,168</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zo9B1P8eBkx7" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">191,312</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zpCE74DNTtRh" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">2,230,624</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zUHZgQbwXMX1" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">310,083</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zAvEczJmdNx8" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zjhYgVn24X8j" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zSFBrX3kdS6e" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">5,000,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zhX75AYVh6T4" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_z2xXFsqBcTB" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zLiFotOF4Xf5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,493,151</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_znuuZyWd7Af8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">100,000,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zY6ZhpOBfTl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,493,151</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930_zfPhf3MEWAYh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">398,168</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930_zhxNnhzLXLXd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,684,463</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930_zpdjGBzpfpm3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">107,230,624</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930_z70wa1rdKsb4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,803,234</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136951045960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zQvSRAB0ruI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. <span id="xdx_82F_z4hFLwyCzOZ2">SUBSEQUENT EVENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On October 8, 2021, the Company acquired all of the outstanding stock
of a leading printing technology company, for a cash purchase price of $37.0 million, which includes an initial $33.0 million cash payment
and a $4.0 million working capital adjustment. The business services a diverse group of customers that operate across healthcare, food
and beverage, manufacturing and logistics, and other sectors. The acquisition triggered the release of $35.0 million held in escrow (refer
to Note 2 &#8220;Long-Term Restricted Cash&#8221; for additional information).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955813672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract', window );"><strong>Description Of Business And Basis Of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DescriptionOfBusinessPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_84A_ecustom--DescriptionOfBusinessPolicyTextBlock_znfMED2mVuqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_861_z58pdAAvzUra">Description of Business</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled
operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia was incorporated on January 25, 1993 under the laws of the State
of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia acquires businesses and operating assets that the Company believes
to be undervalued and where the Company believes it can leverage its resources and skill sets to realize and unlock value. The Company
intends to leverage its (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and
operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount
and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions
of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. Acacia
seeks to identify opportunities where the Company believes it is an advantaged buyer, where the Company can avoid structured sale processes
and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to the Company&#8217;s
unique capabilities, relationships, or expertise, or where Acacia believes the target would be worth more to the Company than to other
buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia operates its business based on three key principles of People,
Process and Performance and has built a management team with identified expertise in Research, Execution and Operation of the Company&#8217;s
targeted acquisitions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia, through its operating subsidiaries, also currently engages
in its legacy business of investing in, licensing and enforcing patented technologies. Acacia&#8217;s operating subsidiaries partner with
inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented
inventions. In recent years, Acacia has also invested in technology companies. Acacia leverages its experience, expertise, data and relationships
developed as a leader in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities
will complement and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries generate revenues and related
cash flows from the granting of IP rights (hereinafter, &#8220;IP Rights&#8221;) for the use of patented technologies that its operating
subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of
their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through
the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s operating subsidiaries are principals in the licensing
and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia&#8217;s
operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP through
its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s operating subsidiaries
are unable to maintain those relationships and identify and grow new relationships, then they may not be able to identify new technology-based
opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, Acacia obtained
control of one <span id="xdx_90D_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20210101__20210930_zFPmsscH2NBj" style="display: none" title="Number of new patent portfolios acquired">1</span>
new patent portfolio. During fiscal year 2020, Acacia obtained control of five <span id="xdx_907_ecustom--NumberOfPatentPortfoliosAcquired_uInteger_c20200101__20201231_z0DlQoQ7KXz8" style="display: none" title="Number of new patent portfolios acquired">5</span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_BasisOfAccountingPoliesPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_846_ecustom--BasisOfAccountingPoliesPolicyTextBlock_zTkfyraUtA34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zJRRpXQOfCwi">Basis of Presentation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances
have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;)
for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information
and note disclosures required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance with quarterly
reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed consolidated financial
statements and notes hereto should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2020, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March 29, 2021, as well as in our other
public filings with the SEC. The condensed consolidated interim financial statements of Acacia include all adjustments of a normal recurring
nature which, in the opinion of management, are necessary for a fair statement of Acacia&#8217;s consolidated financial position as of
September 30, 2021, and results of its operations and its cash flows for the interim periods presented. The consolidated results of operations
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal
year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Reclassifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain prior period amounts in the consolidated financial statements
have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated
results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_Covid19PandemicAndCaresActPolicyTextBlock', window );">COVID-19 Pandemic</a></td>
<td class="text"><p id="xdx_84E_ecustom--Covid19PandemicAndCaresActPolicyTextBlock_zazWKBu653X5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zJQM5ugWaLIa">COVID-19 Pandemic</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The full impact of the COVID-19 pandemic continues to evolve as of
the date of this report. While the Company does not expect the current situation to present direct risks to its business, and it has not
had a material impact to date, the COVID-19 pandemic could adversely impact the Company&#8217;s operations, as well as the operations
of its licensees and other business partners. Our cash is held in major financial institutions primarily in government instruments. Our
business is fully able to operate in a socially distanced and/or remote capacity and in accordance with applicable laws, policies and
best practices. Our workforce is provided ample paid sick leave, and we have in place robust disaster recovery and business continuity
policies that have been revised to account for a long-term remote work contingency such as this. However, the ongoing pandemic may present
risks that we do not currently consider material or risks that may evolve quickly that could have a materially adverse effect on our business,
results of operations and financial condition.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_BasisOfAccountingPoliesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_BasisOfAccountingPoliesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_Covid19PandemicAndCaresActPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_Covid19PandemicAndCaresActPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DescriptionOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DescriptionOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956487848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting Principles</a></td>
<td class="text"><p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z1ORXFzaCLxk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zDJple5wwSO8">Accounting Principles</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The consolidated financial statements and accompanying notes are prepared
on the accrual basis of accounting in accordance with U.S. GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ConsolidationPolicyTextBlock_zZGNypmCv9a6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zfiRWS9j1Ysd">Principles of Consolidation</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited consolidated financial statements include
the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Noncontrolling interests in Acacia&#8217;s majority-owned and controlled
operating subsidiaries (&#8220;noncontrolling interests&#8221;) are separately presented as a component of stockholders&#8217; equity.
Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated
statements of operations. Refer to the accompanying Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders&#8217;
Equity for total noncontrolling interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2020, in connection with the transaction with Link Fund Solutions
Limited, which is more fully described in Note 3, the Company acquired equity securities of Malin J1 Limited (&#8220;MalinJ1&#8221;).
MalinJ1 is included in the Company&#8217;s consolidated financial statements because the Company, through its interest in the equity securities
of MalinJ1, has the ability to control the operations and activities of MalinJ1. Viamet HoldCo LLC, a Delaware limited liability company
and wholly-owned subsidiary of Acacia, is the majority shareholder of MalinJ1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A wholly-owned subsidiary of Acacia is the general partner of the Acacia
Intellectual Property Fund, L.P. (the &#8220;Acacia IP Fund&#8221;), which was formed in August 2010. The Acacia IP Fund has been included
in the Company&#8217;s consolidated financial statements since 2010, as Acacia&#8217;s wholly-owned subsidiary, the general partner of
Acacia IP Fund, has the ability to control the operations and activities of the Acacia IP Fund. The Acacia IP Fund was terminated as of
December 31, 2017 and dissolved in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SegmentReportingPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p id="xdx_844_ecustom--SegmentReportingPolicyTextBlock_zADk5K4ldVx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zeJga3udMrb8">Segment Reporting</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia uses the management approach, which designates the internal
organization that is used by management for making operating decisions and assessing performance as the basis of Acacia&#8217;s reportable
segments. The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EstimatesPolicytextBlock', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84C_ecustom--EstimatesPolicytextBlock_z7iuQVnnEnC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_865_zSX0sSXVwUHk">Use of Estimates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with U.S. GAAP
requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described
herein, the accounting policies associated with revenue recognition, the valuation of the equity instruments, the valuation of Series
A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible Preferred Stock&#8221;), embedded derivatives, Series
A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series B Warrants&#8221;), stock-based compensation expense,
impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income
taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zp4pqpx2Pche" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z0axyN6kaGS5">Revenue Recognition</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue is recognized upon transfer of control (i.e., by the granting)
of promised bundled IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration
we expect to receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they
exist at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue recognition
criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods presented, revenue contracts executed by the Company
primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the grant of certain
IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based revenue contracts,
the majority of which were originally executed in prior periods, which provide for the payment of quarterly license fees based on quarterly
sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may also include court ordered settlements
or awards related to our patent portfolio or sales of our patent portfolio. IP Rights granted included the following, as applicable: (i)
the grant of a non-exclusive, future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-sue,
(iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The IP Rights granted were generally
perpetual in nature, extending until the legal expiration date of the related patents. The individual IP Rights are not accounted for
as separate performance obligations, as (i) the nature of the promise, within the context of the contract, is to grant combined items
to which the promised IP Rights are inputs and (ii) the Company's promise to grant each individual IP right described above to the customer
is not separately identifiable from other promises to grant IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the promised IP Rights are not individually distinct, the Company
combined each individual IP Right in the contract into a bundle of IP Rights that is distinct, and accounted for all of the IP Rights
promised in the contract as a single performance obligation. The IP Rights granted were &#8220;functional IP rights&#8221; that have significant
standalone functionality. Acacia&#8217;s subsequent activities do not substantively change that functionality and do not significantly
affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating subsidiaries have no further obligation with respect
to the grant of IP Rights, including no express or implied obligation to maintain or upgrade the technology, or provide future support
or services. The contracts provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon
execution of the contract. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process
is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition
criteria have been met. Revenue contracts generally provide for payment of contractual amounts within 15-90 days of execution of the contract,
or the end of the quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are
generally non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal in the
amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently
resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP Rights when the later
of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the sales-based royalty has been
allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues from contracts with significant financing components (either
explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee had paid cash
for the IP Rights when they are granted to the licensee. In determining the transaction price, the Company adjusts the promised amount
of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust the promised amount
of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between
when the entity grants promised IP Rights to a customer and when the customer pays for the IP Rights will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In general, the Company is required to make certain judgments and estimates
in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance obligations in
the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to grant a license is distinct
from other promised goods or services, evaluating whether a license transfers to a customer at a point in time or over time, allocating
the transaction price to separate performance obligations, determining whether contracts contain a significant financing component, and
estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Revenues
were comprised of the following for the periods presented:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none">Disaggregation
    of revenue</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Paid-up
    revenue agreements</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,385</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">23,110</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,477</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Recurring
    Revenue Agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">482</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">81</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,675</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">922</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,582</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,466</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,785</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">25,399</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p id="xdx_8AE_z9c4bc72xOyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b/></span><span style="font: 10pt Times New Roman, Times, Serif">Refer to &#8220;<i>Inventor Royalties and
Contingent Legal Expenses</i>&#8221; below for information on related direct costs of revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PatentPortfolioOperationsPolicyTextBlock', window );">Patent Portfolio Operations</a></td>
<td class="text"><p id="xdx_847_ecustom--PatentPortfolioOperationsPolicyTextBlock_zt9WnCalrHff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_869_zqjcrZxcdwW3">Patent Portfolio Operations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cost of revenues include the costs and expenses incurred in connection
with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, patent maintenance
and prosecution costs, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent
counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related
investment costs. These costs are included under the caption &#8220;Patent portfolio operations&#8221; in the consolidated statements
of operations.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalties are expensed in the consolidated statements of operations
in the period that the related revenues are recognized. Patent costs, including any upfront advances paid to patent owners by Acacia&#8217;s
operating subsidiaries, that are recoverable from future net revenues are amortized over the estimated economic useful life of the related
patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense
in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period
recovered and included in amortization expense in the consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contingent legal fees are expensed in the consolidated statements of
operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers,
no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain out of pocket legal costs
incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalty and contingent legal agreements generally provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee payments
are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ConcentrationsPolicyTextBlock', window );">Concentrations</a></td>
<td class="text"><p id="xdx_845_ecustom--ConcentrationsPolicyTextBlock_zdCisWyLDcGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_z629mh8x2Fg3">Concentrations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, equity securities and accounts receivable. Acacia places its cash equivalents and equity securities
primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in
deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant
losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Four licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z08Z9l632Sma" title="Concentration risk percentage">32</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z3sOv6LAIQUd" title="Concentration risk percentage">25</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zxTh9mIiCwge" title="Concentration risk percentage">22</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zLScaSSvNJK9" title="Concentration risk percentage">13</span>% of
revenues recognized during the three months ended September 30, 2021, and one licensee accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_z30FpxRpeW0k" title="Concentration risk percentage">98</span>% of revenues recognized during
the three months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_znyPUuufBOm3" title="Concentration risk percentage">50</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zx39kZPTH5Yd" title="Concentration risk percentage">19</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeLicenseeMember_zENUWIIMvvqc" title="Concentration risk percentage">12</span>% of revenues recognized during the
nine months ended September 30, 2021, and two licensees accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee3Member_z2vQAS6oMQnh" title="Concentration risk percentage">75</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_z7RGndZS4Sr1" title="Concentration risk percentage">9</span>% of revenues recognized during the nine months ended September
30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company does not have any material foreign operations. Based on
the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for the three
and nine months ended September 30, 2021, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zXbwkFsoK2F8" title="Concentration risk percentage">8</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_z9U13b52KX1g" title="Concentration risk percentage">15</span>%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions.
For the three and nine months ended September 30, 2020, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zzAcapFYsMyg" title="Concentration risk percentage">0.1</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ForeignLicenseeMember_zdyx2eenqfSb" title="Concentration risk percentage">5</span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Two licensees represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zlW1ntM3cEX8" title="Concentration risk percentage"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoLicenseeMember_zPMhqdsSsote">100</span></span>% of accounts receivable at September
30, 2021. Two licensees individually represented approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicenseeMember_zg6fPuOeDpqc" title="Concentration risk percentage">62</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneLicensee2Member_zVRo2X70XVZk" title="Concentration risk percentage">21</span>% of accounts receivable at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RelatedPartyTransactionsPolicyTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_842_ecustom--RelatedPartyTransactionsPolicyTextBlock_zUtnhFN0ysLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zZ9svsDlVKPl">Related Party Transactions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2019, the Company purchased shares of common stock of Drive
Shack, Inc. (&#8220;Drive Shack&#8221;) for an aggregate purchase price of $2.4 million. At the time, Drive Shack and Clifford Press,
Chief Executive Officer and director of Acacia, were related parties as Mr. Press was a board member of Drive Shack until June 2021. The
market value of the investment was $1.4 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company
sold its investment receiving proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromSaleOfLongtermInvestments_pn3n3_dm_c20210101__20210930_z8wZGQ7XLEvl" title="Proceeds from sale of investment">1.8 </span>million and recognized a loss of $<span id="xdx_909_eus-gaap--LossOnSaleOfInvestments_pn3p0_c20210101__20210930_zbEpXupgctJj" title="Loss on sale of investment">515,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_znBggoYpGtE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_864_zApTIkBILrjc">Cash and Cash Equivalents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia considers all highly liquid, equity securities with original
maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash equivalents are
comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic
commercial paper and securities issued or guaranteed by the U.S. government or its agencies. Acacia&#8217;s cash equivalents are measured
at fair value using observable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EquitySecuritiesAtFairValuePolicyTextBlock', window );">Equity Securities at Fair Value</a></td>
<td class="text"><p id="xdx_845_ecustom--EquitySecuritiesAtFairValuePolicyTextBlock_zKwKzjxaIxTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zMr6TNNWWq8h">Equity Securities at Fair Value </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investments in equity securities are reported at fair value on a recurring
basis, with related realized and unrealized gains and losses in the value of such securities recorded in the consolidated statements of
operations in other income or (expense). Dividend income is included in the consolidated statements of operations in other income or (expense).
Refer to Note 7 for additional information related to fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity securities at fair value for the periods presented were comprised
of the following:&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Security
    Type</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Cost</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Gain</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Fair
    Value</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - Life Sciences Portfolio (Note 3)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">62,042</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">288,508</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,812</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">348,738</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">35,178</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">3,289</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(85</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">38,382</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">97,220</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">291,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,897</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    - Life Sciences Portfolio (Note 3)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">32,765</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">72,689</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(583</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">104,871</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">4,086</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">1,410</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,264</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">4,232</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">36,851</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">74,099</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,847</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p id="xdx_8A6_zpdhH9K9HW7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock', window );">Equity Securities Without Readily Determinable Fair Value</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_zA5jIua165jk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_ztj8KnAgfmB2">Equity Securities Without Readily Determinable Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For equity securities that do not have readily determinable fair value,
the Company elected to report them under the measurement alternative. They are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. The
fair values of the private company securities were estimated based on recent financing transactions and secondary market transactions
and factoring in any adjustments for illiquidity or preference of these securities. Changes in fair value are reported in the consolidated
statements of operations in other income or (expense). Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><p id="xdx_844_eus-gaap--EquityMethodInvestmentsPolicy_zEKMmci1k7Kg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_862_zLpxVmZXnVai">Equity Method Investments </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Equity investments in common stock and in-substance common stock without
readily determinable fair values in companies over which the Company has the ability to exercise significant influence, are accounted
for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its equity method investees
in earnings on equity investment in joint venture in the consolidated statements of operations. Refer to Note 3 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment at Fair Value</a></td>
<td class="text"><p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_znHRNqpxtPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zSHlKiT5CP7b">Investment at Fair Value</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On an individual investment basis, Acacia may elect to account for
investments in companies where the Company has the ability to exercise significant influence over operating and financial policies of
the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under the equity
method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e., common stock and
warrants). We elected the fair value method for our investment in Veritone, Inc. (&#8220;Veritone&#8221;) upon acquisition of the investment.
Since March 2021, we have no more investment in Veritone stocks and warrants. Refer to Note 4 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ImpairmentOfInvestmentPolicyTextBlock', window );">Impairment of Investments</a></td>
<td class="text"><p id="xdx_847_ecustom--ImpairmentOfInvestmentPolicyTextBlock_zRWgCZILRST4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86F_z8aUtYt7Lw5e">Impairment of Investments</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative and qualitative
evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value, Acacia evaluates,
among other factors, general market conditions and the duration and extent to which the fair value is less than cost. Acacia also considers
specific adverse conditions related to the financial health of and business outlook for the investee, including industry and sector performance,
changes in technology, and operational and financing cash flow factors. Once a decline in fair value is determined to be other-than-temporary,
an impairment charge is recorded in the consolidated statements of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Long-Term Restricted Cash</a></td>
<td class="text"><p id="xdx_847_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zLoyDWm9Wmw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_z2TQncf3udej">Long-Term Restricted Cash </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Restricted cash relates primarily to the proceeds received from the
issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account (refer to Note 6). The amounts are to
be released to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii)
the conversion of Series A Redeemable Convertible Preferred Stock into common stock. During October 2021, the Company consummated a suitable
acquisition, accordingly $35.0 million was released to the Company. Refer to Note 11 for additional information related to the subsequent
period acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Patents</a></td>
<td class="text"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zuh4nTi8mO3l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zoKMVuQnHAik">Patents</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Patents include the cost of patents or patent rights acquired from
third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over
their remaining economic useful lives. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zruaHSR5TAmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86A_zpvZ1zkYyGje">Impairment of Long-lived Assets</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not
be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying
amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying value over its fair
value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If
quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value
of estimated future cash flows. In the event that management decides to no longer allocate resources to a patent portfolio, an impairment
loss equal to the remaining carrying value of the asset is recorded. Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic useful
life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including an estimated
rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based
on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated cash outflows are
based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license
fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s licensing and
enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status
and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent
information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesAandBWarrantsPolicyTextBlock', window );">Series A and B Warrants</a></td>
<td class="text"><p id="xdx_84C_ecustom--SeriesAandBWarrantsPolicyTextBlock_zuTOJOxjyock" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_zVQjbnwmj3A4">Series A and B Warrants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The fair value of the Series A and B Warrants are estimated using a
Black-Scholes option-pricing model. Refer to Notes 6 and 7 for additional information related to the Series A and B Warrants and their
fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesEmbeddedDerivatives', window );">Embedded derivatives</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--DerivativesEmbeddedDerivatives_zRArdVHPPach" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_zIbQuddiHXx5">Embedded derivatives</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Embedded derivatives that are required to be bifurcated from their
host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded
derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019. Refer to Notes 6 and 7 for additional
information related to the embedded derivatives and their fair value measurements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zAgIWGu5eFW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_867_zIEBNkgpHQm3">Fair Value Measurements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. GAAP defines fair value as the price that would be received for
an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction
between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize
the use of observable inputs, where available. Refer to Note 7 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zLIMZCIP7dyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_866_z8pF6IErMmu4">Treasury Stock</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Repurchases of the Company&#8217;s outstanding common stock are accounted
for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive
retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital and
reflected as treasury stock in the consolidated balance sheets. Refer to Note 9 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvPvcmTx8j3j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86D_zIGubIqJW9Il">Stock-Based Compensation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The compensation cost for all stock-based awards is measured at the
grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s requisite
service period (generally the vesting period of the equity award) which is generally one to three years. The fair value of restricted
stock awards (&#8220;RSAs&#8221;) and restricted stock units (&#8220;RSUs&#8221;) are determined by the product of the number of shares
or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the
date of grant using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RSUs granted in September 2019 with market-based vesting conditions
vest based upon the Company achieving specified stock price targets over a three-year period. The effect of a market condition is reflected
in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized
with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition
is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique, that resulted in a fair value of $1.42 per
unit, included: estimated risk-free interest rate of <span id="xdx_902_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">1.38 percent</span>; term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember_z0Hir3knAOO2" title="Assumptions used for derivatives">3.00 years</span>; expected volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">38 percent</span>; and expected
dividend yield of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20210101__20210930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMethodMember__us-gaap--AwardTypeAxis__custom--RestrictedStockUnitsMember" title="Assumptions used for derivatives">0 percent</span>. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues.
The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations
regarding dividend payments. During the nine months ended September 30, 2021, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfsoNSr2NIc5" title="Option Forfeited">450,000</span> RSUs were forfeited, leaving <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pn3p0_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkA1kLOVQEc" title="Option Forfeited">450,000</span> units with
market-based vesting conditions outstanding and unvested at period end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2021, the Company granted
<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zJ99UTGtC3i7" title="Weighted Average Grant">324,401</span> RSAs at a weighted average grant-date fair value of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--RSAsMember_zXdwiRqa7Bg2" title="Weighted average grant-date fair value">5.56 </span>per share, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3I4cREBWCte">473,000</span> RSUs at a weighted average grant-date fair value
of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsbs1hsoSqb" title="Weighted average grant-date fair value">5.86</span> per unit and <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zEBfRxUcHaa6">393,750</span> non-qualified stock options at a grant-date fair value of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zogY04uAPWJa">1.79</span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stock-based compensation is reported in the consolidated statements
of operations in general and administrative expenses. Total stock-based compensation for the three and nine months ended September 30,
2021 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_pn3p0_c20210701__20210930_zmrcwGz6Jdza" title="Stock-based compensation">300,000</span> and $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20210101__20210930_pn3p0" title="Stock-based compensation">1,279,000</span>, respectively. Total unrecognized stock-based compensation expense as of September 30, 2021 was $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c20210930_pn3p0" title="Unrecognized stock-based compensation expense">5,952,000</span>,
which will be amortized over a weighted average remaining vesting period of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930_zdmyqOeYYNDb" title="Weighted-average remaining vesting period">2.20</span> years. Total stock-based compensation for the three and
nine months ended September 30, 2020 was $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200701__20200930_pn3p0" title="Stock-based compensation">488,000</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20200101__20200930_pn3p0" title="Stock-based compensation">1,243,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Profits Interest Units (&#8220;PIUs&#8221;) were accounted for in accordance
with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221; The vesting conditions
did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such, the PIUs were classified as
liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion of the requisite service period
rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s requisite service period (generally
the vesting period of the equity award) which was five years. Upon full vesting of the award, which occurred during the three months ended
September 30, 2017, previously unrecognized compensation expense was immediately recognized in the period. The Company has a purchase
option to purchase the vested PIUs that are not otherwise forfeited after termination of continuous service. The exercise price of the
purchase option is the fair market value of the PIUs on the date of termination of continuous service. The individuals holding PIUs are
no longer employed by the Company. Included in other long-term liabilities in the consolidated balance sheets as of September 30, 2021
and December 31, 2020, the PIUs totaled $591,000, which was their fair value as of December 31, 2018 after termination of service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhkUQWPPd5J3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_86C_za3TxTxZzFm3">Income Taxes</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income taxes are accounted for using an asset and liability approach
that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been
recognized in Acacia&#8217;s consolidated financial statements or consolidated income tax returns. A valuation allowance is established
to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that
there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The provision for income taxes for interim periods is determined using
an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant
period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, a cumulative
adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s effective tax rates were <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210701__20210930_z11XD73sdRb4" title="Effective tax rate">0</span>% and (<span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20210930_zpSd4wOSJbW3" title="Effective tax rate">1</span>%) for the three
and nine months ended September 30, 2021, respectively, and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200701__20200930_zgvk1NgPLcZh" title="Effective tax rate">0</span>% and (<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20200930_z9kHwwZ0ewu9" title="Effective tax rate">4</span>%) for the three and nine months ended September 30, 2020, respectively.
Tax expense/benefit for the periods presented primarily reflects the impact of state taxes and foreign tax withholding (or refund) incurred
on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions. The Company has recorded a full valuation
allowance against our net deferred tax assets as of September 30, 2021 and December 31, 2020. These assets primarily consist of foreign
tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zZXOl0XkMU5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="xdx_860_zviHK9QTSmF9">Recent Accounting Pronouncements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recently Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In December of 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes.&#8221; The update removed certain exceptions to the general principles in Topic 740 in U.S. GAAP. The Company adopted the update
on January 1, 2021. The adoption of the update did not have a material effect on the Company&#8217;s financial position, results of operations
or financial statement disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Not Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments&#8212;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&#8221; to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of the asset,
including current conditions and reasonable and supportable forecasts in addition to historical loss information, to determine expected
credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required. Also, in April 2019,
the FASB issued ASU No. 2019-04, &#8220;Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments,&#8221; to clarify the inclusion of recoveries of trade receivables previously
written off when estimating an allowance for credit losses. The amendments in these updates will currently be effective for the Company
on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments in these updates
may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2020, the FASB issued ASU No. 2020-06, &#8220;Debt&#8212;Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity,&#8221; to simplify the accounting for convertible
instruments by eliminating large sections of the existing guidance in this area. It also eliminates several triggers for derivative accounting,
including a requirement to settle certain contracts by delivering registered shares. This update reduces the number of accounting models
for convertible instruments, revises the derivatives scope exception, and provides targeted improvements for earnings per share. Upon
adoption, companies have the option to apply a modified or full retrospective transition approach. The amendments in this update will
currently be effective for the Company on January 1, 2024, with early adoption permitted. Management is currently evaluating the impact
that the amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In October 2021, the FASB issued ASU No. 2021-08, &#8220;Business Combinations
(Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,&#8221; to require that an acquirer
recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with &#8220;Revenue from
Contracts with Customers (Topic 606).&#8221; At the acquisition date, an acquirer should account for the related revenue contracts in
accordance with Topic 606 as if it had originated the contracts. The amendments in this update should be applied prospectively and will
be effective for the Company on January 1, 2023, with early adoption permitted. Management is currently evaluating the impact that the
amendments in this update may have on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ConcentrationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ConcentrationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EquitySecuritiesAtFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EquitySecuritiesAtFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EstimatesPolicytextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EstimatesPolicytextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ImpairmentOfInvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ImpairmentOfInvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PatentPortfolioOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PatentPortfolioOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_RelatedPartyTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_RelatedPartyTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SegmentReportingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SegmentReportingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesAandBWarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesAandBWarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesEmbeddedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=107671284&amp;loc=SL5844817-113951<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515679&amp;loc=d3e40733-113955<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56949186&amp;loc=d3e50579-113967<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123589689&amp;loc=d3e48542-113965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesEmbeddedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955148680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zJ9sIY37LBn9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zFDerkJoCRt2" style="font: 10pt Times New Roman, Times, Serif; display: none">Disaggregation
    of revenue</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Paid-up
    revenue agreements</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20210701__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_zxcmXZAq1LAd" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,100</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,385</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">23,110</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,477</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Recurring
    Revenue Agreements</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">482</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">81</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,675</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">922</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">1,582</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">19,466</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">24,785</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"><span style="font: 10pt Times New Roman, Times, Serif">25,399</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of equity securities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--EquityMethodInvestmentsTextBlock_zmq1bnZ0ZgYa" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B5_zKRfThUHtiU4" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Security
    Type</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Cost</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Gain</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Gross<br/>
    Unrealized<br/> Loss</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Fair
    Value</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - Life Sciences Portfolio (Note 3)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">62,042</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">288,508</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zDnSvqc9dW89" style="width: 11%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,812</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">348,738</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiCost_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">35,178</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">3,289</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_zazoZSkOV5Gk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(85</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">38,382</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiCost_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">97,220</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">291,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20210101__20210930_znk7BHULQWn7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,897</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    - Life Sciences Portfolio (Note 3)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiCost_iI_pn3n3_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMbxkYAtU5we" style="font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">32,765</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">72,689</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_zMVeXtbV9Jy9" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(583</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundPublicSecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">104,871</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities - other equity</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiCost_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">4,086</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">1,410</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_z00aWUyRTGWh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,264</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesOtherEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">4,232</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--EquitySecuritiesFvNiCost_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities - cost"><span style="font: 10pt Times New Roman, Times, Serif">36,851</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20200101__20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"><span style="font: 10pt Times New Roman, Times, Serif">74,099</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_iN_pn3n3_di_c20200101__20201231_zvWlukMVK3Q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"><span style="font: 10pt Times New Roman, Times, Serif">(1,847</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentsFairValueDisclosure_c20201231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Equity securities at fair value"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956413496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of unrealized gains or losses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zxL2We0nCSN5" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BE_zKXQW0rympAg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of unrealized gains or losses</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of equity securities</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_zMEUkkqcH3d6" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">63,907</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">84,299</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">112,180</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesLfFundSecuritiesMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">83,230</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zuJEfw7epRQj" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">10,651</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_zdgMTswNPWpe" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesDerivativeMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">17,542</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of equity securities forward contract</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zdxfROMNNJX2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(74,662</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_zw18vjWcmTk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--EquitySecuritiesFvNiUnrealizedGainLoss_pn3n3_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritesForwardContractMember_ztucdF4aE139" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain (loss)
    on sale of equity securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zNqcMfNxvUZ1" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">37,112</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RealizedInvestmentGainsLosses_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">1,908</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_znTGs2UIlfOe" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">52,167</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RealizedInvestmentGainsLosses_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zrfTas6FX2Qf" style="font-size: 10pt; text-align: right" title="Loss on sale of trading security"><span style="font: 10pt Times New Roman, Times, Serif">(4,202</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Gain
    on sale of prepaid investment and derivative</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zQb3u7swTyr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivativey_pn3n3_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zmnv5aeeFWa6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivativey"><span style="font: 10pt Times New Roman, Times, Serif">2,845</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_z7nIFl2ff16c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--GainOnSaleOfPrepaidInvestmentAndDerivative_pn3n3_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesLFFundTradingSecurityMember_zqCCa3FwKtGh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gain on sale of prepaid investment and derivative"><span style="font: 10pt Times New Roman, Times, Serif">2,845</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_pn3n3_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_ztnyFAXHjkh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">101,019</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">25,041</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--GainLossOnInvestments_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">164,347</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--LFFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">99,415</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956439720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT AT FAIR VALUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of gain on investments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_zb8KfomJmqyl" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENT AT FAIR VALUE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zeRXAGEneIue" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of gain on investments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change
    in fair value of investment, warrants</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zHWFPxmYQpCk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zBALI1iOvgBk" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,081</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_iN_pn3n3_di_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zyACk9VbfrKh" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">(2,752</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">225</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Change in
    fair value of investment, common stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2aYF2y3cM6c" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zfSP8TYgl9Xk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zy9OuX3Ssi01" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"><span style="font: 10pt Times New Roman, Times, Serif">3,479</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Gain on sale
    of investment, warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zw1VJthNG0oi" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zu11xIn4bKyc" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">3,591</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--GainOnSaleOfInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">554</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Loss
    on sale of investment, common stock</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zpanvTIk1fGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z2c64wloIrl1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LossOnSaleOfInvestments_pn3n3_d0_c20210101__20210930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z08tvJcl3vQ6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zxbeb8UKZ8W3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,316</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    realized and unrealized (loss) gain</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20210701__20210930_z7p5QeItbWLd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_iN_pn3n3_di_c20200701__20200930_zwv5wA4AXM9f" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">(3,081</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--GainLossOnInvestments_c20210101__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">839</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"><span style="font: 10pt Times New Roman, Times, Serif">942</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955915336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract', window );"><strong>Patents Net Of Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zUT140DEdHl3" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zuiqmEMygJp9" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of intangible assets</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210930_zz4FFSJwI0E1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="4" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJix_ze9vNrN0UJf9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,612</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJix_zTiA3MPpqzjk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,448</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJix_zFlxBGuOz923" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,381</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJix_zEvY4MqUajF2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,005</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJix_z3cmojYdLkNi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2025</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,630</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJix_zmEDNRUUDwe3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">750</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJix_znHIRvRyAwCj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Patents,
    net&#160;&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">39,826</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952545368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of financial assets and liabilities at fair value</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_pn3n3_z5kmnjed5E3k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span id="xdx_8BC_zDbtPuaj44Q3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of financial assets and liabilities at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Assets</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity
    securities at fair value</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">119,280</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">267,840</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zZVGoE48BD8" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">119,280</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">267,840</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zFd2v3vOBIX9" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">387,120</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Equity securities
    at fair value</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_z12hfjlqUkOg" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_zNn5o9jioYY8" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--EquitySecuritiesMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Investment
    at fair value - warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1363">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zN4HkkyX1IZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">109,103</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">2,752</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2Rk1i7V7BS7" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">111,855</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">September
    30, 2021:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1XPiKQebxPi" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0h2bMhasRM8" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zGptlAREhr5b" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zbUAXEhdiYoe" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zszAV4gWLbAf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3llNtszR3bb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zRePaEdnRYff" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zulGZMy3unc2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20210930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">December
    31, 2020:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxBmcUIyZc3b" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6jzNfrJFBzl" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Series A
    embedded derivative liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zFozVzESS9Mg" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ztuwH6r7aNWe" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z1HETD3mtmD2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z3Hr5U8tBAhk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zK9m32J7ly9a" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">79,069</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value of assets"><span style="font: 10pt Times New Roman, Times, Serif">85,709</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of changes in fair value Level 3 liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zJtwOdyWcwLg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B2_zIPeRQjNeech" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of changes in fair value Level 3 liabilities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br/>
    Warrant <br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br/>
    Embedded<br/>
    Derivative<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br/>
    Warrant<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2021</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zSPzxpg6DGq4" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zujtjgtXKbQ1" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">26,728</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_znuUhmeXlKqa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">52,341</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zSR2lyFjgLFi" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">79,069</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br/></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zlQZnye4JgA7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zGrY5yXshLu2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1454">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhyJh3RikVw3" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1455">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zHYe0aNOPkd7" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">6,640</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zXhrft1TTTZ" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,824</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zcWTPiOMsHl8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,463</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z0J95BCXdmh8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">178,198</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210101__20210630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlebWdggdMs7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,485</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2021</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGFuWMIvIS17" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,464</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwX7uhS4u3Fd" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">41,191</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z9mgILvYsVA6" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230,539</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zOxnHuGUb8xj" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">290,194</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zFbBIGc4Y8K4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zaWhKZtdHvw1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">220</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zYGjpF1DHtc6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(902</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zioDjYCWSYN8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(619</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2021</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zGzvcijAnNYf" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">18,527</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zk1RCguf9FSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">41,411</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zPpqonDA4Ft2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">229,637</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20210701__20210930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zro8i4u4bx5c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">289,575</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: bottom"><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A <br/>
    Warrant <br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A<br/>
    Embedded<br/>
    Derivative<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B<br/>
    Warrant<br/>
    Liability</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at January 1, 2020</b></span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zp9cRBopGs62" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">3,568</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zDpoRIa5BQc3" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">17,974</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z84jGZDL2Lpa" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1479">&#8211;</span></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zqmsElSo18Sc" style="width: 11%; font-size: 10pt; text-align: right" title="Derivative liability, beginning balance"><span style="font: 10pt Times New Roman, Times, Serif">21,542</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfers
    to Level 3<br/></span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_d0_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zzraf0BsSHQ" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_z0hxfQQe1KUk" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1484">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zGFOHDDByka8" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,929</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2734OILGBl9" style="font-size: 10pt; text-align: right" title="Transfers into Level 3"><span style="font: 10pt Times New Roman, Times, Serif">5,929</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zOu2doI0EZ87" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,384</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zzGpS86ipsdl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,539</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ze9KisgH5gpg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,361</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200101__20200630__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zKhFU982rY3f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,284</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Balance at June 30, 2020</b></span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zmbMqnh9IrR5" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,952</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrg6VIxa6VV3" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,513</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_z8qoSeDp3adl" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,290</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zGoptiET9TH" style="font-size: 10pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,755</span></td><td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Remeasurement
    to fair value</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zA2rM9qQmwK6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zXyzG31qtlfb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,831</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zhrd7tO3fLT3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(15,493</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zlXHxnpiqD0c" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(20,672</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)<span style="font-size: 10pt">&#160;</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance
    at September 30, 2020</b></span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_d0_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsLiabilityMember_zNOVurYjPAue" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,604</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zwGjuEo589wc" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">25,682</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_ziAHBWp4jxia" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">42,797</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200701__20200930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zLHn752plRSa" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">74,083</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"/>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136950902344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future minimum operating lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_pn3n3_zYQioXzgu3R7" style="border-collapse: collapse; width: 40%" summary="xdx: Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B9_z9otGpxq51zf" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of future minimum operating lease payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_495_20210930_zPhAs40X9ILd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">Operating
    Leases</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pn3n3_maOLFMPzNL8_zxCD2Hqv0Pk3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 26%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Remainder
    of 2021</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">149</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pn3n3_maOLFMPzNL8_zCUrJidv2kK1" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2022</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">370</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pn3n3_maOLFMPzNL8_zY8NTYWvgYui" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2023</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">364</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pn3n3_maOLFMPzNL8_zET1tgSv8Ts2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2024</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">218</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_iI_pn3n3_d0_maOLFMPzNL8_zoCNEil6fSRl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3n3_mtOLFMPzNL8_zJT3wzL1sCs2" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total minimum
    payments</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,101</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zW62Da70zQqh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    short-term lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(430</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Long-term
    lease liabilities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">671</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952595448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of repurchased shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_zRhwhpin0KBh" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  STOCKHOLDERS' EQUITY (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B6_zqWEq4Bw0Jrj" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
    of repurchased shares</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Total
    Number<br/> of Shares<br/> Purchased</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Average<br/>
    Price<br/> paid per<br/> Share</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Approximate<br/>
    Dollar<br/> Value of Shares<br/>
    that<br/> May Yet be<br/>
    Purchased<br/> under the<br/>
    Program</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Plan
    Expiration Date</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 44%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">March
    20, 2020 - March 31, 2020</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--TreasuryStockSharesAcquired_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">576,898</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="width: 11%; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.28</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="width: 11%; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"><span style="font: 10pt Times New Roman, Times, Serif">8,686,000</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 13%; font-size: 10pt; text-align: center"><span id="xdx_902_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200920__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1jSPqRNZTKh" style="font: 10pt Times New Roman, Times, Serif">July
    31, 2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">April
    1, 2020 - April 23, 2020</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">1,107,639</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.42</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3p0" style="padding-bottom: 1pt; font-size: 10pt; text-align: right" title="Approximate value of shares that may yet be purchased"><span style="font: 10pt Times New Roman, Times, Serif">6,001,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"><span id="xdx_901_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2duEkvoJjWk" style="font: 10pt Times New Roman, Times, Serif">July
    31, 2020</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total
    repurchases in 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"><span style="font: 10pt Times New Roman, Times, Serif">1,684,537</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right" title="Average price paid per share"><span style="font: 10pt Times New Roman, Times, Serif">2.37</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952265144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME/LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Calculation of basic and diluted net loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zgbXg2sOefXg" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME/LOSS PER SHARE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span id="xdx_8B9_zVrmlA3L6504" style="font: 10pt Times New Roman, Times, Serif; display: none">Calculation
    of basic and diluted net loss per share</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20210701__20210930_zpblr4UDGed6" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49E_20200701__20200930_z7qOwCUpQKp1" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_496_20210101__20210930_zFBF3yU6vn4f" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_497_20200101__20200930_z5QXqKuQujHd" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Three
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Nine
    Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2021</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="14" style="font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(In
    thousands, except share and per share information)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Numerator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 44%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to Acacia Research Corporation</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">89,604</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">38,348</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(55,507</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="width: 11%; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">33,205</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di_zytxWlyW6E8c" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Dividend
    on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(262</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(467</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(785</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,118</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di_zykUE09mVaKh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Accretion
    of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(991</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(733</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(2,762</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(2,045</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zuHjVJ4perMi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Undistributed
    earnings allocated to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(15,367</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(6,619</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,204</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">72,984</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">30,529</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(59,054</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">24,838</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--DividendOnSeriesRedeemableConvertiblePreferredStock_d0_zvQN6GcEwcpj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Dividend on Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">467</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_d0_z5ju7nq3fJL6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Accretion of Series A redeemable convertible preferred stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">733</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock_d0_zBu9eOfBc129" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A redeemable convertible preferred stock embedded derivative</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,831</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ChangeInFairValueOfSeriesWarrants_d0_zHLx0s1KWuw1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of Series A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Less:
    Change in fair value of dilutive Series B warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(902</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,557</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1633">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(5,557</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40A_ecustom--InterestExpenseAssociatedWithStarboardNotesNetOfTax_zOXosm3OcbC4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Interest expense associated with Starboard Notes, net of tax</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,536</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,889</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1638">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,889</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_d0_zz2ju8XPbY3j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Add:
    Undistributed earnings allocated to participating securities</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">15,367</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,619</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,204</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_d0_zIrNoG0YtTlk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Reallocation
    of undistributed earnings to participating securities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(8,877</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(296</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(3,645</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_404_ecustom--NetIncomeLossAvailableToCommonStockholderDiluted_zIr9KIFNSS4h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Net
    income (loss) attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">80,171</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29,205</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(59,054</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">21,381</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Denominator:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Basic</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,949,504</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,467,885</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,759,873</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,949,706</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_iB_zEk8nkeJ0rCd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Potentially
    dilutive common shares:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKkMuV7VIDVa" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zETSzCWfjRT5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">9,589,041</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zKirbQ2Yoor5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKnaiHzRzR8" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Restricted
    stock</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zJF7f4mvOp0l" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">798,356</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zMkU0EdviRii" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">728,936</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zOJu5omQ8n8g" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zYRXlPFFIb9j" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">598,328</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Stock
    options</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zeaYyeQPthn" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">35,815</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zkUd73Hfl71h" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">21,624</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zPgEbZO4A6se" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zaVQrUnVwe71" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A Warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zDzc4FbOzBkl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">2,019,724</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z7WoPzAd95ti" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">310,367</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zZnhIcNFlxh6" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zUvgbSo8UNFj" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">103,456</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B Warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20210701__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zW9XGGHHTqMk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">41,278,103</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zINAkGS70pp8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">31,506,849</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pn3d_d0_c20210101__20210930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_ziIjUwWeiJv1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zPAZ0GYoyFfi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"><span style="font: 10pt Times New Roman, Times, Serif">10,502,283</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zzeKVIBoiv3g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    shares used in computing net income (loss) per share attributable to common stockholders - Diluted</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">93,081,502</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">90,624,702</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48,759,873</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">60,153,773</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Basic
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1.49</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.63</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1.21</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.51</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Diluted
    net income (loss) per common share</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.86</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.32</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">(1.21</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.36</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract_iB_zAA51t9fyYb9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Anti-dilutive
    potential common shares excluded from the computation of diluted net income (loss) per common share:</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Equity-based
    incentive awards</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zjonp0WplYTk" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">398,168</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zo9B1P8eBkx7" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">191,312</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zpCE74DNTtRh" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">2,230,624</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_zUHZgQbwXMX1" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">310,083</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    A warrants</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zAvEczJmdNx8" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zjhYgVn24X8j" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zSFBrX3kdS6e" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">5,000,000</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zhX75AYVh6T4" style="font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Series
    B warrants</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210701__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_z2xXFsqBcTB" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zLiFotOF4Xf5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,493,151</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_znuuZyWd7Af8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">100,000,000</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zY6ZhpOBfTl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,493,151</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210701__20210930_zfPhf3MEWAYh" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">398,168</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200701__20200930_zhxNnhzLXLXd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,684,463</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20210101__20210930_zpdjGBzpfpm3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">107,230,624</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_c20200101__20200930_z70wa1rdKsb4" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Antidilutive shares"><span style="font: 10pt Times New Roman, Times, Serif">68,803,234</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952591848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - Integer<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract', window );"><strong>Description Of Business And Basis Of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NumberOfPatentPortfoliosAcquired', window );">Number of new patent portfolios acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NumberOfPatentPortfoliosAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patent portfolios acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NumberOfPatentPortfoliosAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955504456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,582<span></span>
</td>
<td class="nump">$ 19,466<span></span>
</td>
<td class="nump">$ 24,785<span></span>
</td>
<td class="nump">$ 25,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember', window );">Paid Up Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">19,385<span></span>
</td>
<td class="nump">23,110<span></span>
</td>
<td class="nump">24,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember', window );">Recurring Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 482<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 1,675<span></span>
</td>
<td class="nump">$ 922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140137039814824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities - cost</a></td>
<td class="nump">$ 97,220<span></span>
</td>
<td class="nump">$ 36,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="nump">291,797<span></span>
</td>
<td class="nump">74,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="num">(1,897)<span></span>
</td>
<td class="num">(1,847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Equity securities at fair value</a></td>
<td class="nump">387,120<span></span>
</td>
<td class="nump">109,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundPublicSecuritiesMember', window );">Equity Securites Lf Fund Public Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities - cost</a></td>
<td class="nump">62,042<span></span>
</td>
<td class="nump">32,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="nump">288,508<span></span>
</td>
<td class="nump">72,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="num">(1,812)<span></span>
</td>
<td class="num">(583)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Equity securities at fair value</a></td>
<td class="nump">348,738<span></span>
</td>
<td class="nump">104,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesOtherEquityMember', window );">Equity Securities Other Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities - cost</a></td>
<td class="nump">35,178<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="nump">3,289<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(1,264)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Equity securities at fair value</a></td>
<td class="nump">$ 38,382<span></span>
</td>
<td class="nump">$ 4,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125513658&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundPublicSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundPublicSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesOtherEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesOtherEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140137040051432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Proceeds from sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">1,279<span></span>
</td>
<td class="nump">$ 1,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 5,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Option Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Option Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 473,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ACTG_RSAsMember', window );">R S As [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ACTG_NonQualifiedStockOptionsMember', window );">Non Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">393,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1.38 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3.00 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">38 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Black Scholes Method [Member] | Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Licensee 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Foreign Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Licensee 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_RSAsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_RSAsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_OneLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_OneLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_TwoLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_TwoLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_ThreeLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_ThreeLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_OneLicensee2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_OneLicensee2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_OneLicensee3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_OneLicensee3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ACTG_ForeignLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ACTG_ForeignLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136956474440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY SECURITIES PORTFOLIO INVESTMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">$ 2,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,081<span></span>
</td>
<td class="nump">839<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundSecuritiesMember', window );">Equity Securites Lf Fund Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Change in fair value of investment</a></td>
<td class="nump">63,907<span></span>
</td>
<td class="nump">84,299<span></span>
</td>
<td class="nump">112,180<span></span>
</td>
<td class="nump">83,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesDerivativeMember', window );">Equity Securites Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,651<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesForwardContractMember', window );">Equity Securites Forward Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(74,662)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesLFFundTradingSecurityMember', window );">Equity Securities L F Fund Trading Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Loss on sale of trading security</a></td>
<td class="nump">37,112<span></span>
</td>
<td class="nump">1,908<span></span>
</td>
<td class="nump">52,167<span></span>
</td>
<td class="num">(4,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey', window );">Gain on sale of prepaid investment and derivativey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_LFFundSecuritiesMember', window );">L F Fund Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">$ 101,019<span></span>
</td>
<td class="nump">$ 25,041<span></span>
</td>
<td class="nump">$ 164,347<span></span>
</td>
<td class="nump">$ 99,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesLfFundSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesForwardContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritesForwardContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesLFFundTradingSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesLFFundTradingSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_LFFundSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_LFFundSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955244088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 03, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember', window );">Option Agreement [Member] | Portfolio Companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Payment to acquire equity securities</a></td>
<td class="nump">$ 277,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_PortfolioCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_PortfolioCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955671432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT AT FAIR VALUE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3,081)<span></span>
</td>
<td class="num">$ (2,752)<span></span>
</td>
<td class="nump">$ 3,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,081<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
<td class="num">(3,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,081<span></span>
</td>
<td class="nump">839<span></span>
</td>
<td class="nump">942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(839)<span></span>
</td>
<td class="num">(942)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember', window );">Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,081<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(2,752)<span></span>
</td>
<td class="num">(225)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on sale of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,591<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember', window );">Common Stock Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3,316)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136954001624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PATENTS, NET OF ACCUMULATED AMORTIZATION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract', window );"><strong>Patents Net Of Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 2,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">10,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">10,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">9,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">6,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, net&#160;&#160;</a></td>
<td class="nump">$ 39,826<span></span>
</td>
<td class="nump">$ 16,912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136953013352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract', window );"><strong>Patents Net Of Accumulated Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 291,600<span></span>
</td>
<td class="nump">$ 319,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccruedPatentAcquisitionCosts', window );">Accrued patent acquisition costs</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear', window );">Accrued patent acquisition costs due within a year</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">Accrued patent acquisition costs due within 2 years</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccruedPatentAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued patent acquisition costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccruedPatentAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136958792968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STARBOARD INVESTMENT (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">16 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 29, 2021</div></th>
<th class="th"><div>Feb. 25, 2020</div></th>
<th class="th"><div>Nov. 18, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 04, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of embedded derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,411<span></span>
</td>
<td class="nump">$ 26,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ACTG_NewNotesMember', window );">New Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember', window );">Series A Redeemable Convertible Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of embedded derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,400<span></span>
</td>
<td class="nump">26,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeptemberRedemptionMember', window );">September Redemption [Member] | Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RedemptionOfSecuredNotes', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_DecemberRedemptionMember', window );">December Redemption [Member] | Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RedemptionOfSecuredNotes', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member] | Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard Value [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard Value [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">18,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,500<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsExercisedShares', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember', window );">Starboard Value [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,600<span></span>
</td>
<td class="nump">$ 52,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsExercisedShares', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_MertonMember', window );">Merton [Member] | Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent', window );">Notes exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Capitalized lender fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">Oct. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_RedemptionOfSecuredNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_RedemptionOfSecuredNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ACTG_NewNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ACTG_NewNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeptemberRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeptemberRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_DecemberRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_DecemberRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_StarboardValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_MertonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_MertonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136954015288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">$ 387,120<span></span>
</td>
<td class="nump">$ 111,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">387,120<span></span>
</td>
<td class="nump">109,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">119,280<span></span>
</td>
<td class="nump">109,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">119,280<span></span>
</td>
<td class="nump">109,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">267,840<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">267,840<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">289,575<span></span>
</td>
<td class="nump">85,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">18,527<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">41,411<span></span>
</td>
<td class="nump">26,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">229,637<span></span>
</td>
<td class="nump">52,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">289,575<span></span>
</td>
<td class="nump">79,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">18,527<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">41,411<span></span>
</td>
<td class="nump">26,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets</a></td>
<td class="nump">$ 229,637<span></span>
</td>
<td class="nump">$ 52,341<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136953382984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative liability, beginning balance</a></td>
<td class="nump">$ 290,194<span></span>
</td>
<td class="nump">$ 94,755<span></span>
</td>
<td class="nump">$ 79,069<span></span>
</td>
<td class="nump">$ 21,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
<td class="nump">5,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</a></td>
<td class="num">(619)<span></span>
</td>
<td class="num">(20,672)<span></span>
</td>
<td class="nump">204,485<span></span>
</td>
<td class="nump">67,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance</a></td>
<td class="nump">289,575<span></span>
</td>
<td class="nump">74,083<span></span>
</td>
<td class="nump">290,194<span></span>
</td>
<td class="nump">94,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Series A Warrants Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative liability, beginning balance</a></td>
<td class="nump">18,464<span></span>
</td>
<td class="nump">6,952<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,640<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</a></td>
<td class="nump">63<span></span>
</td>
<td class="num">(1,348)<span></span>
</td>
<td class="nump">11,824<span></span>
</td>
<td class="nump">3,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance</a></td>
<td class="nump">18,527<span></span>
</td>
<td class="nump">5,604<span></span>
</td>
<td class="nump">18,464<span></span>
</td>
<td class="nump">6,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative liability, beginning balance</a></td>
<td class="nump">41,191<span></span>
</td>
<td class="nump">29,513<span></span>
</td>
<td class="nump">26,728<span></span>
</td>
<td class="nump">17,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</a></td>
<td class="nump">220<span></span>
</td>
<td class="num">(3,831)<span></span>
</td>
<td class="nump">14,463<span></span>
</td>
<td class="nump">11,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance</a></td>
<td class="nump">41,411<span></span>
</td>
<td class="nump">25,682<span></span>
</td>
<td class="nump">41,191<span></span>
</td>
<td class="nump">29,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Series B Warrants Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative liability, beginning balance</a></td>
<td class="nump">230,539<span></span>
</td>
<td class="nump">58,290<span></span>
</td>
<td class="nump">52,341<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Transfers into Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)</a></td>
<td class="num">(902)<span></span>
</td>
<td class="num">(15,493)<span></span>
</td>
<td class="nump">178,198<span></span>
</td>
<td class="nump">52,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance</a></td>
<td class="nump">$ 229,637<span></span>
</td>
<td class="nump">$ 42,797<span></span>
</td>
<td class="nump">$ 230,539<span></span>
</td>
<td class="nump">$ 58,290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136953969512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths', window );">Remainder of 2021</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">2022</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">2023</a></td>
<td class="nump">364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">2024</a></td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum payments</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: short-term lease liabilities</a></td>
<td class="num">(430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136955184680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs, net of sublease income</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 457<span></span>
</td>
<td class="nump">$ 459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetIncomeForSettlementOffsetByContingencyAccruals', window );">Income from settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingency accruals</a></td>
<td class="nump">$ 587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetIncomeForSettlementOffsetByContingencyAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetIncomeForSettlementOffsetByContingencyAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952589000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Details) - Common Stock [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased</a></td>
<td class="nump">576,898<span></span>
</td>
<td class="nump">1,107,639<span></span>
</td>
<td class="nump">1,684,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share</a></td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 2.42<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased', window );">Approximate value of shares that may yet be purchased</a></td>
<td class="nump">$ 8,686<span></span>
</td>
<td class="nump">$ 6,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramExpirationDate', window );">Stock Repurchase Program Expiration Date</a></td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Approximate value of shares that may yet be purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ApproximateValueOfSharesThatMayYetBePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136952607112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 05, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember', window );">Stock Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140136953354648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME/LOSS PER SHARE (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="nump">$ 89,604<span></span>
</td>
<td class="nump">$ 38,348<span></span>
</td>
<td class="num">$ (55,507)<span></span>
</td>
<td class="nump">$ 33,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Dividend on Series A redeemable convertible preferred stock</a></td>
<td class="num">(262)<span></span>
</td>
<td class="num">(467)<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="num">(1,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Accretion of Series A redeemable convertible preferred stock</a></td>
<td class="num">(991)<span></span>
</td>
<td class="num">(733)<span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic', window );">Undistributed earnings allocated to participating securities</a></td>
<td class="num">(15,367)<span></span>
</td>
<td class="num">(6,619)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common stockholders - Basic</a></td>
<td class="nump">72,984<span></span>
</td>
<td class="nump">30,529<span></span>
</td>
<td class="num">(59,054)<span></span>
</td>
<td class="nump">24,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock', window );">Add: Dividend on Series A redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock', window );">Add: Accretion of Series A redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">733<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock', window );">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,831)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesWarrants', window );">Less: Change in fair value of Series A warrants</a></td>
<td class="nump">63<span></span>
</td>
<td class="num">(1,348)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants', window );">Less: Change in fair value of dilutive Series B warrants</a></td>
<td class="num">(902)<span></span>
</td>
<td class="num">(5,557)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,557)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax', window );">Add: Interest expense associated with Starboard Notes, net of tax</a></td>
<td class="nump">1,536<span></span>
</td>
<td class="nump">1,889<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Add: Undistributed earnings allocated to participating securities</a></td>
<td class="nump">15,367<span></span>
</td>
<td class="nump">6,619<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Reallocation of undistributed earnings to participating securities</a></td>
<td class="num">(8,877)<span></span>
</td>
<td class="num">(296)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,645)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetIncomeLossAvailableToCommonStockholderDiluted', window );">Net income (loss) attributable to common stockholders - Diluted</a></td>
<td class="nump">$ 80,171<span></span>
</td>
<td class="nump">$ 29,205<span></span>
</td>
<td class="num">$ (59,054)<span></span>
</td>
<td class="nump">$ 21,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Basic</a></td>
<td class="nump">48,949,504<span></span>
</td>
<td class="nump">48,467,885<span></span>
</td>
<td class="nump">48,759,873<span></span>
</td>
<td class="nump">48,949,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">93,081,502<span></span>
</td>
<td class="nump">90,624,702<span></span>
</td>
<td class="nump">48,759,873<span></span>
</td>
<td class="nump">60,153,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Diluted</a></td>
<td class="nump">93,081,502<span></span>
</td>
<td class="nump">90,624,702<span></span>
</td>
<td class="nump">48,759,873<span></span>
</td>
<td class="nump">60,153,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 1.49<span></span>
</td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract', window );"><strong>Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">398,168<span></span>
</td>
<td class="nump">68,684,463<span></span>
</td>
<td class="nump">107,230,624<span></span>
</td>
<td class="nump">68,803,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember', window );">Equity Based Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract', window );"><strong>Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">398,168<span></span>
</td>
<td class="nump">191,312<span></span>
</td>
<td class="nump">2,230,624<span></span>
</td>
<td class="nump">310,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract', window );"><strong>Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract', window );"><strong>Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">68,493,151<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">68,493,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,589,041<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">798,356<span></span>
</td>
<td class="nump">728,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">598,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember', window );">Employee Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">35,815<span></span>
</td>
<td class="nump">21,624<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">2,019,724<span></span>
</td>
<td class="nump">310,367<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">103,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Potentially dilutive common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">41,278,103<span></span>
</td>
<td class="nump">31,506,849<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,502,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetIncomeLossAvailableToCommonStockholderDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetIncomeLossAvailableToCommonStockholderDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion of the preferred stock redemption discount during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAccretionOfRedemptionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) from continuing operations allocated to participating securities for basic earnings (loss) per share or per unit calculation under two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^E;X+-:/6^V_Q=J?*+EM/C::2:7DICE<"ZX'IP'HWY=2+Z7;$W.#PQ=Q5_\
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M-%@[$K" /*HJ?>ZT%Q6Q:@NP@,*>M)LTJ;T)^E;>!'V9-P&$*=J2OM"; .)
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M[SK>?BC2=?7FW-NT*-)5=?@@HH7(R@#Y^UV:%L\?RI?Q[M\X??I_4$L#!!0
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MBN96/?PN.X>,P%05M?E+'CK;X(BDN[I1FZXQ*-CD9?LI'KN!Z#6 ?O &M&M
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M'L"V@M->=7@%,MVD@%\FSE_AJD?SF*:^%A)/4@ 7-\5'#$22=D"&.5_=]PF
M'/TRC6012W#TPR]30U]C)5_@\G+FF3DT6<I2^M/7?*G3I&NT/QJAKJMNO:$+
M;G!HEC@ 7AG@?YG&<%D;IH1E7N!C0!AR(/2UHQSACJ!QA!CX93J.?L^3+1#P
MW^"PKZOHW;OK&"[.:UTD#WBW"L%/D9M%A.@43LG\2&ZVO<![Q[EBQ!O"8KA
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M68($#!=-Y4RD " 294U2Z$;8W@&J8A48"0"B:. :Q3G0+S VQ(+%*.P1L(A
M\T$8[<]<A %\_K,#E5C7,$L '$,$6+*_*P*5^*1'6'65=7!9NQ+9V7+O77MC
M._Z&5AI)>W-+K]:U9LW!&I0.8=MD'R -Q7\-D-9P;BCY=-L6/%CAG0(QD^&=
M8"D EQF>EB.+4*]8@>RN\)PL]$,/C+U;+#?8'1HB#)X"#@^;(,O#(> EL-/G
M*J"B!#T (^!71=< \XK!-&\[LAD9O:3QE=T*:;@F5?0%@@?6F<$FJCSWM%M
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M;.1N3'U=3+,QY?*8P_"=Q] M?@[7%,4 E"[X[Q2;O^%$P;NAJK+"4V?2Y@>
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M\ 'X?555K?F "]@WN/_T_U!+ P04    " !H@6]38:-(7Z,)  "4&0  &
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MD)T(XWC=5/WXXA6CS*GG+0\QVR(UX:GK^OX#"U^%:E!#%2!V P(PE;IF"I)
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MU[0 [Z<*PWEU0QLT/\2<_P]02P,$%     @ :(%O4RR*NI1L!   ( L  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULK59-;^,V$+WS5PS4H-@ @JT/
M.[:SC@$GFVT#;((@R::'H@=:&DM")%(EZ3C;7]\A9<EVNW:;HA>+E#EOWLR\
M$6>ZENI%YX@&WJI2Z LO-Z8^[_=UDF/%=4_6*.B?I505-[1565_7"GGJC*JR
M'P7!6;_BA?!F4_?N7LVF<F7*0N"] KVJ*JZ^76(IUQ=>Z+4O'HHL-_9%?S:M
M>8:/:+[6]XIV_0XE+2H4NI "%"XOO'EX?CFPY]V!YP+7>F<--I*%E"]V<Y->
M>($EA"4FQB)P>KSB%9:E!2(:OV\PO<ZE-=Q=M^B?7>P4RX)KO)+E+T5J\@MO
M[$&*2[XJS8-<_XR;>(86+Y&E=K^P;L[&0P^2E3:RVA@3@ZH0S9._;?*P8S .
M#AA$&X/(\6X<.9:?N.&SJ9)K4/8TH=F%"]59$[E"V*(\&D7_%F1G9C=WS]>/
M3[?7=T\P?X+/\YL'>)Y_^7H][1M"MV?ZR0;ILD&*#B!-X%8*DVNX%BFF^_9]
M8M51BUIJE]%1P$>L>Q '/D1!%![!B[M08X<7'\(C0:>K$D$NX4:\HC8D+J/A
MU_E"&T7R^.V(DT'G9."<#/Z'?!Y%LMUXKFN>X(5'[:91O:(W&_3@D ?XM%*%
MR"A;X1EPD=K%R(=YPI."DV12A 25H3Z%8B=ZVCZC*HP4V&-S#9Q:39.D;99,
M3GZ!<B,T=TVD.SR%"5([I>0)>)8IS+BAH]+PTEH._#"<^,,H!)US K3O6C>0
MR*JBAB1M)R^.Z9HK\D%DC(1ZI9*<VHSQ+5KHAU'@#^+HG]&,)81OJ)*"J->J
M2%R]3\*X=Q9"C:J!H"-UX=*U0+-&%%9DP29MT:C7)I,RP 05!JI&VVBU#:1,
M@]6"P#;R#+J\:%E23LJ2$F0_B:X@D[$_& 8M]\-IH)Q*9?%M>GE9_$'+4FH7
M[DG<BUE5E"5589<=O(M=FY@4PN' C\.(M:GW.P:9<(YW.&16,Y;#D(R"( !B
M;5UKWC33;B#OX<9L8W^'VW[ZPN&9/Z+:O(LI51LVV3K.]HD*?"6KFHMO("2E
M6V1$C@1H=;3MD]TV.:S?'ESEG !<5UF?2UXH>.7ERGEN OWQAW$4CC[J ^C,
MJG.K! TKL1<>J4$Y56R])-28LBQ2ZL"46-&C:6UR29>WXJYS>T"WF#MN<H7H
M>!^I#VL_O&U/T/9?^[*WM;UVZ8C+@BSI[J=:GK/V&\SH?%.LO:\1>[+<V.Y%
M G=$<N\-VR>YMW.2:GJY6[$/-X*97*XTA:)/65,C1L[WR[/EX6^_2"?@ZA5^
MI-6'V _&(9S:9>2/AI%;1M%P TD([##DGFI:T+\^8W\PFK"?-IFQDF6'F/W=
M=#@)@5J4?2%UL(WY?V)!@<9TB9RR.S2L4Y\5PHX8/U@1GC95/)"E<3RAW\D@
M@N_=K/V=J:5"E;G93!/#E3#- -.][<:_>3/U;(\WL^,M5YEMC1*79!KT1C1M
MJ68>:S9&UFX&6DA#$Y5;YC3"HK('Z/^EE*;=6 ?=4#S[$U!+ P04    " !H
M@6]3WX["?DX#   ?!P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6RU
M55EOXS80?M>O&*A!T0*J==F.G=H&G&.Q 9H#L=,"?:.ED42L1'I):IWTUW=(
MR:JWNPGZT@=),\.9;TZ.%@>I/ND*T<!+4PN]]"MC]A=AJ+,*&Z9'<H^"3@JI
M&F:(566H]PI9[HR:.DRB:!HVC M_M7"R1[5:R-;47."C MTV#5.OEUC+P]*/
M_:/@B9>5L8)PM=BS$C=HGO>/BKAP0,EY@T)S*4!AL?37\<7EV.H[A=\Y'O0)
M#3:3G92?+'.;+_W(!H0U9L8B,/I\P2NL:PM$87SN,?W!I34\I8_H'USNE,N.
M:;R2]1\\-]72G_F08\':VCS)PT?L\YE8O$S6VKWAT.F.R6/6:B.;WICXAHON
MRU[Z.IP8S*(W#)+>('%Q=XY<E-?,L-5"R0,HJTUHEG"I.FL*C@O;E(U1=,K)
MSJP>U]N;^^TF@/N;+3Q\@/75U?/=\V\DO8;UW</3]O;/]?;VX7X1&O)F;<*L
M1[[LD),WD.=P)X6I--R('/.O[4.*<@@U.89ZF;P+N,']"-(H@"1*XG?PTB'U
MU.&E;Z7.# JCX9Y&_Z& =9:U35N3,(=U(Y7A?S$[..]X&@^>QL[3^'\H\KO(
M]LI>Z#W+<.G3G=2HOJ"_FHS@OWJDK%G&V8\_S)+X_%<-4M2OP'.J"R\XV]4(
M7!@F2FY)IC52O1BI%4#=,-CL4'G'E@ 3.5QCYJ20QDX: 5,(^[[45J.C0=GK
MHBE2Q_ZBL*L\.^D".^D"&&E83<(S2.;Q:$KX\]$<MA5"(6M:+5R48%S$KA#6
MFZ%#N\7RUAHR(5I6 RM+A27A?P7OX0NM.8W_3FZ8MPMOTR-Y=/Y-43Q:$<[?
M*S*E 45NXSDMAO?3K?!,)5M-1= _>T]H5V9.]2,\5S[*+)C&B4=, G$4C,<S
M2Z>63F>QI<<P#Z)H8LD)3(-I&GE4 5K&A2$OYY/(ZX<Z\ 1-]1FD\V"63.$8
MG:#Q@::[EFBOY7<R#?J9L*U0+1X;YGW3.U+XW'+-77LRJ6W%;9-LYF<0IZ,(
M9O1,Z/G>'0I/EE:#JG2K61-0*TRWOP;IL/W7W=+[1[W[==PQ57*AH<:"3*/1
M^<3O8CPR1N[="MQ)0PO5D17]P5!9!3HOI#1'QCH8_HFKOP%02P,$%     @
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MKLX+F28B21_21(&?(_<G\0ND'"U['/*=45&FL:+=3\7Y^.I2_$-G"7X2*_G
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MI8H58B;E^@2MB;LPT 29&'!$S6@%WQV@/&+^64S2E%WHTO#.LK)5FL$JS*.
MJDE%V'QYAXCE9WUT"]+='1(?HIYN(HDEU*H\%YHZ#$S7P/%438/:-+RBW4*)
MV'C@,Q+"7E:C<+J@;&1A7C?C2Q1XA1S%![2FK@<FUJ[$]9QX9E;,+$A]GBZ
MNJS/;<N$^,2>"J+ &<KT@2'46'R0 .QV3]A%<PH)\#"O\\1JSU)QSL^+#;EJ
M-:)84H!P(B@J))0%AF1=:'"E4EU!7>"68\1QTXJ1 RFPHI$6+L3:5!30N"J1
M1+9PL%*,9:6K4CQ'[E:GK!V<"HXQT_%Y1RSLA=)%ZC*"ISHZ<&:M_OH+O@B
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M?+9]"Z.P =%T&VQT\\\@*.:DL$3_X*%ZBN.PO?8UZ&:?,B3"F,9$?8#P+&>
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M4Z]04804@9K?-<;4O5+'=Y)$;H'#7,T9'Z.!:_G)!K%(R4E3\. <E0V.ADD
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M) 42KW- M"#WT5J/0DCV&N$623=Y5"]*Y+*BMEP1Z-.M+U=Y(^_N9,B8=OH
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M ']?6/@J/1"#_F<J[_X'4$L#!!0    ( &B!;U-=<]/%K"H  %&,   9
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M[YHV7R/8^Y!@<(1^).@.2[!B59C/$'X\H.8AI2$$D.Y"%5C5FB16XY\XD":
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M_%\2L@/6 K3^)-CUC,<&@&J3;X+-[O"2HJ@>V+Y*[A(\9;(9,@-S>,<.(UR
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M70(]?C:!NB+_Z7"5_U50^?N8''E&O?_!"0S]U?H>>\%U/%>-5Z!&TA\H.4U
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MK8M.:,TP[%20B. <AXQ%GF.U>$/BYQKTSW?4:E_TG,]59Q0M.W50V=^IG5Y
M.IVV<RN4<JKT_U*!A4;!.6DZ4] .CDZ6_<*-P.Z1@M=N@R%-L]S%(UWJ1CU\
M]MHA.71 O;TID(-<V5FG4&'!=3D0ZM5ZG([**?(:7L[B.RI7&5>$P1)3_;,+
MG%ZRG&^EH\7:SI2%T#BAK)GB+P&D"<#O2R'TSC$$]4]F^!M02P,$%     @
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MKW/?MT$T8]LXBI?UJ.RXTH-7FYG>="A,@CY/.5<GQPBTNW/R%U!+ P04
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MKR,*$Z"_KSA7.\,4:-[;\3]02P,$%     @ :(%O4V6%QO;\!0  [0X  !D
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M"YS8#4Q:0^K_ #[$]:57!_1I%_8%:SV76*8-!":>XP=A;[-XL/%=AT:Q PO
M")(6.K&_1WSHI80Z-/;^UT+VA$L\A\0F*HH38I( 1:/[I0R!CX'G1)&';/'1
MT[[W*PH\=2>PQ=\QF4"3 @:[$^I:_I)) .QM??\:$IG$H7UX]!&2%Z(Y,.NX
M9Q7:]E0[Y)<YHY2-Z<9K*2JL<]YE<CC'[9^A7@YHABZ_-87^?FPN"YF1NO$(
MC&;00#/@$[#,#6/L)B!4EP)?J&?3:OE"H,@#IX:.^XAUT*T((>;O,0\7/]J$
M(#\HH1NX0"0R&#Y,HT]"0T+ZN.!#&/L@60_61T-P,!T#?ZGGXZ=.R=.]*P@<
MXS;VHJ4@,4VMV]O(,#O<Y>;M%>9A>7L1_,#DI@#AE7P-IF02!2,LV\M5^Z+%
MUEYH5D+#]<@.<[B/<FD6P/>U@"IW+\;!<,,]^P]02P,$%     @ :(%O4RQJ
MFRQ@ @  ; 4  !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL?51-<]HP
M$/TK.SZU,RTV!M(V Y[!0*8< AZ<M&=AK[$FLN1(<DC^?279N$P+7&QI]=[;
M#VEW>A3R196(&MXKQM7,*[6N[WU?92561 U$C=R<%$)61)NM//BJEDAR1ZJ8
M'P;!G5\1RKUHZFR)C*:BT8QR3"2HIJJ(_(B1B>/,&WHGPXX>2FT-?C2MR0%3
MU,]U(LW.[U5R6B%75'"06,R\^?!^,;9X!_A%\:C.UF SV0OQ8C?K?.8%-B!D
MF&FK0,SO#1?(F!4R8;QVFE[OTA+/UR?U!Y>[R65/%"X$^TUS7<Z\[Q[D6)"&
MZ9TX_L0NGXG5RP13[@O'#AMXD#5*BZHCFP@JRML_>>_J<$8P.I<)84<(_R7<
M72&,.L+()=I&YM):$DVBJ11'D!9MU.S"U<:Q33:4VUM,M32GU/!TM%REB]TZ
M>5IO-[!]@/@Y76]6:0KSS1+B>;I.K379K=+5YFGN4)^6J EE"C9$2F(OX3-\
MA377>$ Y];4)RDK[61= W 807@G@!SP*KDL%*YYC?H&_N,T?AC<$?%.-OB3A
MJ21Q>%,QQ7H H^ +A$$XO!30;?H2,T,?.GIP(YQ1?T,CIS>ZJJ<R26OWZ+<%
MQ(TR *5@SG.(B:+*6A.)"KDF%G7#Y[CW.78^QU=\;IIJCQ)$ =PT8DVTT89:
M2%T(1H4RS??:4'GQNN)6>>*4[0QYBTP1W\[K]S]BTB/:</VS!UVA/+@^5Y")
MANOV;??6?I3,70?Y?^'M''HD\D"Y H:%H0:#;\:O;'N[W6A1N_;8"VV:S2U+
M,PY16H Y+X30IXUUT _8Z ]02P,$%     @ :(%O4X]7:JH< P  #PH  !D
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MS#%='S#A$Y@\F+!8;@3<QC[U&_Q'[?X(MP305(**+.'7+%WCUH@SNKT$0[\
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MP<^(,N+/HX.DT5+2;:':&%+Z:^F[_X-74(6]L@ZH7X$SFK!842MPL*PV#RN
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MB4@9\#,;I0G#@.G9(";,(D]308K,!*TU8SV.$\KPD<=)0/C<3/B-B+[2$.=
MXWR4;@P'SN?#N#&\[K*\O+@TAE3+ \;G9L;OC5Y?M>1 \WR41@PO/4D=QHCA
M)H,EA[:U!\-!$;A9$0: MIN:<E !/DH7AH,Z\$%<F 6ONS U:$TAU?) &[A9
M&P;IVE>+K0"-$*.T=@3(B!C&VA%_MG:,(=7R0$2$640ZXMWJB8< C1"C-' $
M*(48QL 1?S9P&D*.W[((D IAEHK> /:565'Z@<XH71P!8B&&^8V.,+DX.;KU
M$ .ZH!:BJ]?3&=UN2BM *<0H_2()TB"'\8MDW0>J_?K*%%(M#X1!]K")NC;N
MJY56@E+(45I,$L1$#F,QR;IW5,/;%%(M#Z1$]O"67OD(3(),R%&Z3!+$0@[C
M,LD&^ZC)W6V(DS-+''%W9>EGG3ULII:/37KIK02QD*,TGB1(AAS&>))U0ZG)
M!&X(.]*E-HB&/:CGU 1O-\&U03#L41I2-BB$/8PA9=?=IB:CN"',8!3;H!/V
MH,94<P>_6GAM$ Y[E&Z5#=IB#^-6Y6G*[QTT^LD-<4U^\K3T^DWZ[M.-$SVZ
M08P\]9",L]ZGBA@=7B<Z[.APF[V1<Q]J'?K9YD8Y:Q6E <GYAS#4SSOI2S[%
M2UWS_P%02P,$%     @ :(%O4P39J+*F!0  BAL  !D   !X;"]W;W)K<VAE
M971S+W-H965T,SDN>&ULU5G;;MLX$/T5PNA# R2U2-T#QX!C*]@6<1'$3?M0
M](&V:5NH)'I)VFZ!_?BE+M:%HK7.MKM-7Q*).C,<#F>.CL7!@;*O?$.( -_B
M*.$WO8T0V^M^GR\V),;\#=V21#Y9419C(6_9NL^WC.!E9A1'?6083C_&8=(;
M#K*Q!S8<T)V(PH0\,,!W<8S9]UL2T<--#_:. X_A>B/2@?YPL,5K,B/B:?O
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M:-.]W; P%RQ(N\&\7PFA7R>VA3=7]N@W4$L#!!0    ( &B!;U.U@A2U\0(
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MSM?4!U]3'YZ'1Q KN%L'W\NE7Q66;_C\4X7%\IQ(U8*D0*H\4*BNBM ET)B
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M#+M@)"86J@]/HI/VW[^4K(@V25&NDPQ;+QI9?GA(/N?PG(<TSY_*ZFN]XER
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M*-HP# QR;,(W\G5R3)1!CL40\8<4-%(2&KDU]+%Z<=ZD,^L!Q777X]X^%*)
MWUU88#C:W3MVW)@PJVBTF4,D1 ,$*3V-0N>6?\Z+,D^+L4T_4CH4N87HE_:H
MCB<G3$H')DM%=X:TJ64XRK(A^5YOV@@L#-^L>;6%OU35(XLP#2,:><9Q@14I
M16RH;WSG5F3@16% =%\-]!Y W^XNK'0MADYWW<C24(A4+OGOJN0^D],2[?(B
M5EH1N[7B>#\VVK&IOR("0^09I=V&A#ZF@8Z<6Y #M%N0/I0I/=A![M.A1"!V
MB\!_,J@=J0>;TFZ(7PMR@%\3.<2O1<:Z^57:$KNU9;N0![C;C3HK*5O3X6X=
M/Z613HB)@J>Z"I];4"?H%".="9LQ;R 78Z43L5LG=IX_E@=J&52H"T(KBAA!
M8:*L/%B-#24Y)?>PYTQR5S+SG/199_V<BO;SC]31<;9I-J#W59D#L>+=*NR5
M4'(PG<Z<J908'CG$E*/L1^U(DJ;4(5&(_%#WE(GS0S^DU(Q:$XE@@$FSX'6/
MV8R&D& R($2QDEK8+;46?V]2\;VIR9+S]T7<.$T2<27W@4D-_OS0'!A4?[F8
M5J(%NT7+ORM E#3"(V=T!P:(*1_L 6+B4(0(,A:SB</VX+!TC" ,!]([4:J%
MN$_C^E.2+]V9P"'A0)18(>B_$PY$B0KB%A4'A@,9/?*9C4/F%H@'VW]:$#AM
M[<]TYV=%=WGOSX1^R/^J;A+Z'_*_*G-DY%3C0/^/'BW,+!!9*"*"//T0U8)$
M$-H#X0"C^S-7E9*X*V6?#V[Z0^5E>ZA\2%BH@D2"-]PK$56-B/LWJ>/V2L3\
M&<APJPF)O#""U/#JJ*V%$[(_<57/B+N>W?+FH"D6O?O:2R*'.)&JTD'?<L-+
M50VA;['AI>:6,XA"XNFJVX;#8:0?U\XM.-V1%HC<K!$\<+Y/53FB[G*TR-=9
M^9WSSI>?UDU>/,R;JA!0]P63%WISY^J)>R=UI#?-TVOBR=VU[DP3AI&AIN86
MF.%+%V1_ZJJJ4'=5.4IK496ZJ?^6'E3)F[IW$T=ZT+QT@"&* MTY,PM02EWC
M]']NP1E.-"'2$O4&ML%4U17JKBM'J2:JLC>-WM"3GLK@GEO\'^=)S_P!G"(<
MA)):_6J3B90:!39:1;_?-/Z[NP6"H <Q-C9!TYT[F#FO'MK+K[6<V*80VQMW
M_=O^@NU5>ZU4>W^-SF;(\GZ.SA;;Z[/*_/8V[P=6/:0R-6?\7G8%3P,YW&I[
M07;[093K]@;H72E$F;>/*\X27C4 ^?U]*7W2?6@ZZ*\I7_X?4$L#!!0    (
M &B!;U/[B)C8$ ,  # 1   -    >&PO<W1Y;&5S+GAM;-U8;6O;,!#^*\8=
MHX51Q_'JQ6L2V *%P38*[8=]*THL.P)9\F2Y2_KKIY,<YZ6ZTO7#ELXAM72/
M[KE'=^?*9-SH-:<W2TIUL*JX:";A4NOZ8Q0UBR6M2',N:RH,4DA5$6VFJHR:
M6E&2-^!4\6@X&*1119@(IV/15E>5;H*%;(6>A$EO"MSM2SX)X_1]&#BZF<SI
M)+P[??NSE?KR3>#N)^].3@9W9Y>']E,+G(61E_3B&:3G@P%.#"!&GCZ/_"EN
M2QUU"9J."RGV\P0&$YM4-+@G?!+."&=SQ<"K(!7C:V<>@F$AN52!-@4R8F*P
M- \.CMT,:M?Q5$Q(96.[".[OO%M^ &QF()!QW@L<ALXP'==$:ZK$E9G8Q=;X
M" JZ\>VZ-@I+1=;Q\"+<.MB;"3*7*J>J#Q.'&]-TS&D!<A0KEW#7LHX U%I6
M9I S4DI!K(:-1S<PM O*^0TT]H]BCWM5[%1U #45_= (ZH:.QDV ?Y?-<>_2
M#E[$&]3L7NK/K=F.L'-H%GJM:,%6=KXJ>@$8>XRSD[KFZT^<E:*B;O//#C@=
MDXU?L)2*/9AHT"H+8Z J#.ZITFRQ:_FE2'U+5WK33JL"USQ\A9K_;IY+*J@B
M?%>TZ?UCSO*+%2<?_I5D^U_E4+!78W=:';O(B]<@,CU^D4EVE!JC[M39.=KV
M#K;>&L +Q"3\#B\K?!LTF+>,:R:ZV9+E.16/SC=#K\G<O [N\9OU.2U(R_5M
M#T["[?@;S5E;9?VJ:TA$MVH[_@K;B]/^[<7$8B*G*YK/NJDJYW88F(&)VEW@
M<(A<V<N/8#X.\R. 87$P!9B/\\+B_$_[&:'[<1BF;>1%1JC/"/5Q7CYD9C]8
M'+]/9B[_3K,L2=(4R^ALYE4PP_*6IO#ULV':P .+ Y'^+-=XM?$.>;H/L)H^
MU2'83O%.Q':*YQH0?][ (\O\U<;B@ =6!:QW(+X_#O24WR=)H*J8-NP)QI$L
MPQ#H17^/IBF2G10^_OI@3TF29)D? <RO($DP!)Y&',$4@ 8,21)[#AZ<1]'F
MG(JVOY%,?P-02P,$%     @ :(%O4Y>*NQS     $P(   L   !?<F5L<R\N
M<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9
M>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:
M+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU
M1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*
MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !H@6]3N21SB.$#  #;'0  #P
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M[6-1!+HNKN8JWQSW)H_[JI__ 5!+ P04    " !H@6]31QQ@N:0!  ";&@
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M;%!+ 0(4 Q0    ( &B!;U,4WYS1[@   "L"   1              "  :\
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M2P$"% ,4    " !H@6]3?0E]-"8#  ";"@  &               @(%#%0
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ :(%O4SG2L&Z^
M"   '2<  !@              ("!GQ@  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    ( &B!;U-'"WG0,0L  'U:   8              "
M@9,A  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !H@6]3
M]I/F &0)   **0  &               @('Z+   >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ :(%O4S'#SP4:#0  TB$  !@
M     ("!E#8  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M &B!;U-09@2VQ2@  ,U]   8              " @>1#  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    " !H@6]38:-(7Z,)  "4&0  &
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M970Q,RYX;6Q02P$"% ,4    " !H@6]3-])^0R8,  #C'@  &0
M    @(&0G   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M &B!;U.'VN623 <  *P1   9              " @>VH  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ :(%O4RU.+@\;!@  ;@\  !D
M             ("!<+   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    " !H@6]38)*#TD0#  "9!@  &0              @('"M@  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( &B!;U,#9?2&2PT
M +(B   9              " @3VZ  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ :(%O4UUST\6L*@  48P  !D              ("!
MO\<  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !H@6]3
M6BA\MKT#  !)"   &0              @(&B\@  >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    ( &B!;U.J9B[#/@,   ('   9
M      " @9;V  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ :(%O4P#XHR?4 @  < 8  !D              ("!"_H  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !H@6]3C:I  )L"  !'!0
M&0              @($6_0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    ( &B!;U-AD9W2?@0  $0,   9              " @>C_  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ :(%O4UY"M6ZW
M @  I04  !D              ("!G00! 'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    " !H@6]3 N02 )X"  ![!0  &0
M@(&+!P$ >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( &B!
M;U-EA<;V_ 4  .T.   9              " @6 * 0!X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ :(%O4RQJFRQ@ @  ; 4  !D
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M=#,R+GAM;%!+ 0(4 Q0    ( &B!;U,3Y7BN: (   ,%   9
M  " @=0F 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M:(%O4Z@+Q5P$!   IQ(  !D              ("!<RD! 'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    " !H@6]3^E'_]+,"   Z!P  &0
M            @(&N+0$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    ( &B!;U/3$"!*?0(  %,&   9              " @9@P 0!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ :(%O4R/HH(1L!P
M]"@  !D              ("!3#,! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    " !H@6]3$<AP3(T&  #@-0  &0              @('O
M.@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( &B!;U,$
MV:BRI@4  (H;   9              " @;-! 0!X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ :(%O4R+U50/) @  O@<  !D
M     ("!D$<! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &B!;U/[B)C8$ ,  # 1   -              "
M 0-< 0!X;"]S='EL97,N>&UL4$L! A0#%     @ :(%O4Y>*NQS     $P(
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9>&UL4$L%!@     T #0 (PX  /!G 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>301</ContextCount>
  <ElementCount>362</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment</Role>
      <ShortName>EQUITY SECURITIES PORTFOLIO INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - INVESTMENT AT FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentAtFairValue</Role>
      <ShortName>INVESTMENT AT FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization</Role>
      <ShortName>PATENTS, NET OF ACCUMULATED AMORTIZATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - STARBOARD INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StarboardInvestment</Role>
      <ShortName>STARBOARD INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - INCOME/LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomelossPerShare</Role>
      <ShortName>INCOME/LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SubsequentEvent</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables</Role>
      <ShortName>EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentAtFairValueTables</Role>
      <ShortName>INVESTMENT AT FAIR VALUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentAtFairValue</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables</Role>
      <ShortName>PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/FairValueMeasurements</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - STOCKHOLDERS??? EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityTables</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquity</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomelossPerShareTables</Role>
      <ShortName>INCOME/LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomelossPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails</Role>
      <ShortName>EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative</Role>
      <ShortName>EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentAtFairValueDetails</Role>
      <ShortName>INVESTMENT AT FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentAtFairValueTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails</Role>
      <ShortName>PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative</Role>
      <ShortName>PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative</Role>
      <ShortName>STARBOARD INVESTMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StarboardInvestment</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure -  STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquityTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="acacia_i10q-93021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomelossPerShareDetails</Role>
      <ShortName>INCOME/LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomelossPerShareTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="acacia_i10q-93021.htm">acacia_i10q-93021.htm</File>
    <File>acacia_ex1002.htm</File>
    <File>acacia_ex3101.htm</File>
    <File>acacia_ex3102.htm</File>
    <File>acacia_ex3201.htm</File>
    <File>acacia_ex3202.htm</File>
    <File>actg-20210930.xsd</File>
    <File>actg-20210930_cal.xml</File>
    <File>actg-20210930_def.xml</File>
    <File>actg-20210930_lab.xml</File>
    <File>actg-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "acacia_i10q-93021.htm": {
   "axisCustom": 0,
   "axisStandard": 20,
   "contextCount": 301,
   "dts": {
    "calculationLink": {
     "local": [
      "actg-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "actg-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "acacia_i10q-93021.htm"
     ]
    },
    "labelLink": {
     "local": [
      "actg-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "actg-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "actg-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 482,
   "entityCount": 1,
   "hidden": {
    "http://acaciaresearch.com/20210930": 69,
    "http://fasb.org/us-gaap/2021-01-31": 75,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 149
   },
   "keyCustom": 57,
   "keyStandard": 305,
   "memberCustom": 40,
   "memberStandard": 22,
   "nsprefix": "ACTG",
   "nsuri": "http://acaciaresearch.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://acaciaresearch.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - INVESTMENT AT FAIR VALUE",
     "role": "http://acaciaresearch.com/role/InvestmentAtFairValue",
     "shortName": "INVESTMENT AT FAIR VALUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION",
     "role": "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization",
     "shortName": "PATENTS, NET OF ACCUMULATED AMORTIZATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:StarboardInvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - STARBOARD INVESTMENT",
     "role": "http://acaciaresearch.com/role/StarboardInvestment",
     "shortName": "STARBOARD INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:StarboardInvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://acaciaresearch.com/role/FairValueMeasurements",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "role": "http://acaciaresearch.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - INCOME/LOSS PER SHARE",
     "role": "http://acaciaresearch.com/role/IncomelossPerShare",
     "shortName": "INCOME/LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://acaciaresearch.com/role/SubsequentEvent",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ACTG:BusinessDescriptionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ACTG:BusinessDescriptionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)",
     "role": "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables",
     "shortName": "EQUITY SECURITIES PORTFOLIO INVESTMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - INVESTMENT AT FAIR VALUE (Tables)",
     "role": "http://acaciaresearch.com/role/InvestmentAtFairValueTables",
     "shortName": "INVESTMENT AT FAIR VALUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)",
     "role": "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables",
     "shortName": "PATENTS, NET OF ACCUMULATED AMORTIZATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://acaciaresearch.com/role/FairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityTables",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - INCOME/LOSS PER SHARE (Tables)",
     "role": "http://acaciaresearch.com/role/IncomelossPerShareTables",
     "shortName": "INCOME/LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:DescriptionOfBusinessPolicyTextBlock",
       "ACTG:BusinessDescriptionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:NumberOfPatentPortfoliosAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:DescriptionOfBusinessPolicyTextBlock",
       "ACTG:BusinessDescriptionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:NumberOfPatentPortfoliosAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30_custom_PaidUpRevenueAgreementsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ACTG:EquitySecuritiesAtFairValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ACTG:EquitySecuritiesAtFairValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:RelatedPartyTransactionsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSaleOfLongtermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:RelatedPartyTransactionsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSaleOfLongtermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ACTG:GainOnSaleOfPrepaidInvestmentAndDerivative",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)",
     "role": "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails",
     "shortName": "EQUITY SECURITIES PORTFOLIO INVESTMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30_custom_EquitySecuritesLfFundSecuritiesMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)",
     "role": "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative",
     "shortName": "EQUITY SECURITIES PORTFOLIO INVESTMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - INVESTMENT AT FAIR VALUE (Details)",
     "role": "http://acaciaresearch.com/role/InvestmentAtFairValueDetails",
     "shortName": "INVESTMENT AT FAIR VALUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30_custom_WarrantInvestmentMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GainOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)",
     "role": "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails",
     "shortName": "PATENTS, NET OF ACCUMULATED AMORTIZATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)",
     "role": "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative",
     "shortName": "PATENTS, NET OF ACCUMULATED AMORTIZATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:PatentsNetOfAccumulatedAmortizationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - STARBOARD INVESTMENT (Details Narrative)",
     "role": "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
     "shortName": "STARBOARD INVESTMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:StarboardInvestmentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2020-12-31_custom_NewNotesMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)",
     "role": "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
     "shortName": "FAIR VALUE MEASUREMENTS (Details - Fair Value on a Recurring Basis)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_AssetsMember_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)",
     "role": "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
     "shortName": "FAIR VALUE MEASUREMENTS (Details - Changes to fair value measurement Level 3)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure -  COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2020-09-202020-09-30_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure -  STOCKHOLDERS' EQUITY (Details)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2020-09-202020-09-30_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2019-08-05_custom_StockRepurchaseProgramMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2019-08-05_custom_StockRepurchaseProgramMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - INCOME/LOSS PER SHARE (Details)",
     "role": "http://acaciaresearch.com/role/IncomelossPerShareDetails",
     "shortName": "INCOME/LOSS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PreferredStockDividendsIncomeStatementImpact",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:BusinessDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:BusinessDescriptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - EQUITY SECURITIES PORTFOLIO INVESTMENT",
     "role": "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment",
     "shortName": "EQUITY SECURITIES PORTFOLIO INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-93021.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "ACTG_AccretionOfSeriesConvertiblePreferredStockToRedemptionValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of Series A Convertible Preferred Stock to redemption value",
        "label": "AccretionOfSeriesConvertiblePreferredStockToRedemptionValue",
        "negatedLabel": "Accretion of Series A Redeemable Convertible Preferred Stock to redemption value"
       }
      }
     },
     "localname": "AccretionOfSeriesConvertiblePreferredStockToRedemptionValue",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: Accretion of Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "AccretionOfSeriesRedeemableConvertiblePreferredStock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AccruedPatentAcquisitionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued patent acquisition costs",
        "label": "Accrued patent acquisition costs"
       }
      }
     },
     "localname": "AccruedPatentAcquisitionCosts",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AccruedPatentInvestmentCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued patent investment costs"
       }
      }
     },
     "localname": "AccruedPatentInvestmentCostsCurrent",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AcquisitionOfPrepaidInvestmentSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of prepaid investment securities"
       }
      }
     },
     "localname": "AcquisitionOfPrepaidInvestmentSecurities",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ACTG_ApproximateValueOfSharesThatMayYetBePurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approximate value of shares that may yet be purchased",
        "label": "Approximate value of shares that may yet be purchased"
       }
      }
     },
     "localname": "ApproximateValueOfSharesThatMayYetBePurchased",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_BasisOfAccountingPoliesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPoliesPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_BlackScholesMethodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black Scholes Method [Member]"
       }
      }
     },
     "localname": "BlackScholesMethodMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_BusinessDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Change in fair value of dilutive Series B warrants"
       }
      }
     },
     "localname": "ChangeInFairValueOfDilutiveSeriesBWarrants",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of equity securities",
        "negatedLabel": "Change in fair value of equity securities"
       }
      }
     },
     "localname": "ChangeInFairValueOfEquitySecurities",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative",
        "negatedLabel": "Change in fair value of Series A redeemable convertible preferred stock embedded derivative"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Change in fair value of Series A warrants"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesWarrants",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_CommonStockInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Investment [Member]"
       }
      }
     },
     "localname": "CommonStockInvestmentMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ConcentrationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations"
       }
      }
     },
     "localname": "ConcentrationsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_ContingentLegalFees": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent legal fees"
       }
      }
     },
     "localname": "ContingentLegalFees",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_Covid19PandemicAndCaresActPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COVID-19 Pandemic"
       }
      }
     },
     "localname": "Covid19PandemicAndCaresActPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_DecemberRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "December Redemption [Member]"
       }
      }
     },
     "localname": "DecemberRedemptionMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_DerivativeLiabilitiesNoncurrent1": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent1",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_DescriptionOfBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description Of Business And Basis Of Presentation"
       }
      }
     },
     "localname": "DisclosureDescriptionOfBusinessAndBasisOfPresentationAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "xbrltype": "stringItemType"
    },
    "ACTG_DisclosurePatentsNetOfAccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents Net Of Accumulated Amortization"
       }
      }
     },
     "localname": "DisclosurePatentsNetOfAccumulatedAmortizationAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "xbrltype": "stringItemType"
    },
    "ACTG_DisclosureStarboardInvestmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Starboard Investment"
       }
      }
     },
     "localname": "DisclosureStarboardInvestmentAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "xbrltype": "stringItemType"
    },
    "ACTG_DividendOnSeriesRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: Dividend on Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "DividendOnSeriesRedeemableConvertiblePreferredStock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_EarningsOnEquityInvestmentInJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings on equity investment in joint venture"
       }
      }
     },
     "localname": "EarningsOnEquityInvestmentInJointVenture",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedDeniminatorAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ACTG_EmployeeStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquityBasedIncentiveAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Based Incentive Awards [Member]"
       }
      }
     },
     "localname": "EquityBasedIncentiveAwardsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquityMethodInvestmentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment securities - equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsCurrent",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_EquitySecuritesDerivativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securites Derivative [Member]"
       }
      }
     },
     "localname": "EquitySecuritesDerivativeMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritesForwardContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securites Forward Contract [Member]"
       }
      }
     },
     "localname": "EquitySecuritesForwardContractMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritesLfFundPublicSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securites Lf Fund Public Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritesLfFundPublicSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritesLfFundSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securites Lf Fund Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritesLfFundSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesAtFairValuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities at Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesAtFairValuePolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_EquitySecuritiesDerivativeAndForwardContractAcquisitionCost": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity securities derivative and forward contract acquisition cost"
       }
      }
     },
     "localname": "EquitySecuritiesDerivativeAndForwardContractAcquisitionCost",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_EquitySecuritiesLFFundTradingSecurityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities L F Fund Trading Security [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesLFFundTradingSecurityMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesOtherEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities Other Equity [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesOtherEquityMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity securities without readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValue",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_EstimatesPolicytextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "EstimatesPolicytextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_ForeignLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Licensee [Member]"
       }
      }
     },
     "localname": "ForeignLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_GainOnSaleOfPrepaidInvestmentAndDerivative": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnSaleOfPrepaidInvestmentAndDerivative",
        "negatedLabel": "Gain on sale of prepaid investment and derivative",
        "verboseLabel": "Gain on sale of prepaid investment and derivative"
       }
      }
     },
     "localname": "GainOnSaleOfPrepaidInvestmentAndDerivative",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_GainOnSaleOfPrepaidInvestmentAndDerivativey": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on sale of prepaid investment and derivativey"
       }
      }
     },
     "localname": "GainOnSaleOfPrepaidInvestmentAndDerivativey",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ImpairmentOfInvestmentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestmentPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable",
        "verboseLabel": "Royalties and contingent legal fees payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_InterestExpenseAssociatedWithStarboardNotesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Add: Interest expense associated with Starboard Notes, net of tax"
       }
      }
     },
     "localname": "InterestExpenseAssociatedWithStarboardNotesNetOfTax",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_InterestIncomeExpenseAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income and other"
       }
      }
     },
     "localname": "InterestIncomeExpenseAndOther",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for unvested restricted stock awards, net of forfeitures"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeitures",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for unvested restricted stock awards, net of forfeitures, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForUnvestedRestrictedStockAwardsNetOfForfeituresShares",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for vesting of restricted stock units"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForVestingOfRestrictedStockUnits",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for vesting of restricted stock units, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockForVestingOfRestrictedStockUnitsShares",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_LFFundSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "L F Fund Securities [Member]"
       }
      }
     },
     "localname": "LFFundSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_LitigationAndLicensingExpensesPatents": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation and licensing expenses - patents"
       }
      }
     },
     "localname": "LitigationAndLicensingExpensesPatents",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_MertonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merton [Member]"
       }
      }
     },
     "localname": "MertonMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_NetIncomeForSettlementOffsetByContingencyAccruals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income from settlement"
       }
      }
     },
     "localname": "NetIncomeForSettlementOffsetByContingencyAccruals",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NetIncomeIncludingNoncontrollingInterestsInSubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net (loss) income including noncontrolling interests in subsidiaries"
       }
      }
     },
     "localname": "NetIncomeIncludingNoncontrollingInterestsInSubsidiaries",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NetIncomeLossAvailableToCommonStockholderDiluted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NetIncomeLossAvailableToCommonStockholderDiluted",
        "verboseLabel": "Net income (loss) attributable to common stockholders - Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholderDiluted",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NetPortfolioIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NetPortfolioIncomeLoss",
        "totalLabel": "Net patent portfolio (loss) income"
       }
      }
     },
     "localname": "NetPortfolioIncomeLoss",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NewNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Notes [Member]"
       }
      }
     },
     "localname": "NewNotesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Qualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_NoncashInvestingActivitesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash investing activities:"
       }
      }
     },
     "localname": "NoncashInvestingActivitesAbstract",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ACTG_NumberOfPatentPortfoliosAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patent portfolios acquired",
        "label": "Number of new patent portfolios acquired"
       }
      }
     },
     "localname": "NumberOfPatentPortfoliosAcquired",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "ACTG_OneLicensee2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Licensee 2 [Member]"
       }
      }
     },
     "localname": "OneLicensee2Member",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OneLicensee3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Licensee 3 [Member]"
       }
      }
     },
     "localname": "OneLicensee3Member",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OneLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Licensee [Member]"
       }
      }
     },
     "localname": "OneLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Agreement [Member]"
       }
      }
     },
     "localname": "OptionAgreementMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_PaidUpRevenueAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid Up Revenue Agreements [Member]"
       }
      }
     },
     "localname": "PaidUpRevenueAgreementsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_PatentAcquisitionAccruedLiabilityLongTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patent acquisition accrued liability - long-term"
       }
      }
     },
     "localname": "PatentAcquisitionAccruedLiabilityLongTerm",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_PatentAcquisitionAccruedLiabilityShortTerm": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patent acquisition accrued liability - short-term"
       }
      }
     },
     "localname": "PatentAcquisitionAccruedLiabilityShortTerm",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_PatentAcquisitionInExchangeOfNotesReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patent acquisition in exchange of notes receivable"
       }
      }
     },
     "localname": "PatentAcquisitionInExchangeOfNotesReceivable",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_PatentPortfolioOperationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patent Portfolio Operations"
       }
      }
     },
     "localname": "PatentPortfolioOperationsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_PatentsNetOfAccumulatedAmortizationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PATENTS, NET OF ACCUMULATED AMORTIZATION"
       }
      }
     },
     "localname": "PatentsNetOfAccumulatedAmortizationTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_PortfolioCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Portfolio Companies [Member]"
       }
      }
     },
     "localname": "PortfolioCompaniesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_PurchasesOfPrepaidInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of prepaid investment"
       }
      }
     },
     "localname": "PurchasesOfPrepaidInvestment",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_RSAsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R S As [Member]"
       }
      }
     },
     "localname": "RSAsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_RecurringRevenueAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recurring Revenue Agreements [Member]"
       }
      }
     },
     "localname": "RecurringRevenueAgreementsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_RedemptionOfSecuredNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of debt"
       }
      }
     },
     "localname": "RedemptionOfSecuredNotes",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_RelatedPartyTransactionsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_RestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_RoyaltiesAndContingentLegalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalties and contingent legal fees payable"
       }
      }
     },
     "localname": "RoyaltiesAndContingentLegalFeesPayable",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_SecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SegmentReportingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_SeniorSecuredNotesIssuanceCostsPaidToOtherParties": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "SeniorSecuredNotesIssuanceCostsPaidToOtherParties",
        "negatedLabel": "Senior Secured Notes issuance costs paid to other parties"
       }
      }
     },
     "localname": "SeniorSecuredNotesIssuanceCostsPaidToOtherParties",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_SeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Notes [Member]"
       }
      }
     },
     "localname": "SeniorSecuredNotesMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeptemberRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Redemption [Member]"
       }
      }
     },
     "localname": "SeptemberRedemptionMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAEmbeddedDerivativeLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Embedded Derivative Liability [Member]"
       }
      }
     },
     "localname": "SeriesAEmbeddedDerivativeLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesARedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesARedeemableConvertiblePreferredStockMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesARedeemableConvertibleStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Redeemable Convertible Stock [Member]"
       }
      }
     },
     "localname": "SeriesARedeemableConvertibleStockMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAWarrantsLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Warrants Liability [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAandBWarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A and B Warrants"
       }
      }
     },
     "localname": "SeriesAandBWarrantsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_SeriesBWarrantsLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Warrants Liability [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesBWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Warrants [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_StarboardInvestmentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STARBOARD INVESTMENT"
       }
      }
     },
     "localname": "StarboardInvestmentTextBlock",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_StarboardValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Starboard Value [Member]"
       }
      }
     },
     "localname": "StarboardValueMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_StockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Program [Member]"
       }
      }
     },
     "localname": "StockRepurchaseProgramMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ThreeLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Licensee [Member]"
       }
      }
     },
     "localname": "ThreeLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradeDateReceivableFromSaleOfEquitySecuritiesNote3": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade date receivable from sale of equity securities (Note 3)"
       }
      }
     },
     "localname": "TradeDateReceivableFromSaleOfEquitySecuritiesNote3",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_TwoLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Licensee [Member]"
       }
      }
     },
     "localname": "TwoLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_UnrealizedGainLossOnDerivatives1": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "UnrealizedGainLossOnDerivatives1",
        "negatedLabel": "Change in fair value of Series B warrants"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives1",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_WarrantInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Investment [Member]"
       }
      }
     },
     "localname": "WarrantInvestmentMember",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_WarrantsExercisedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercised",
        "label": "Warrants exercised"
       }
      }
     },
     "localname": "WarrantsExercisedShares",
     "nsuri": "http://acaciaresearch.com/20210930",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r495",
      "r497",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r46",
      "r48",
      "r96",
      "r97",
      "r222",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r161",
      "r273",
      "r275",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r161",
      "r273",
      "r275",
      "r454"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r159",
      "r273",
      "r274",
      "r411",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r159",
      "r273",
      "r274",
      "r411",
      "r452",
      "r453"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r47",
      "r48",
      "r96",
      "r97",
      "r222",
      "r245"
     ],
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.",
        "label": "Schedule of repurchased shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r28",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r17",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r200",
      "r201",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion expense"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r18",
      "r301",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r298",
      "r299",
      "r300",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r66",
      "r82",
      "r227",
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r82",
      "r227",
      "r234",
      "r235",
      "r368"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of debt discount and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r82",
      "r190",
      "r195"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of patents"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r94",
      "r148",
      "r151",
      "r157",
      "r178",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r318",
      "r322",
      "r354",
      "r375",
      "r377",
      "r416",
      "r433"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r42",
      "r94",
      "r178",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r318",
      "r322",
      "r354",
      "r375",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Fair value of assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r286",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r328",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Accounting Principles"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r25",
      "r84"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r8",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r8",
      "r85",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Long-Term Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r78",
      "r84",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r359"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental schedule of cash flow information:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r92",
      "r94",
      "r115",
      "r116",
      "r121",
      "r126",
      "r130",
      "r138",
      "r139",
      "r140",
      "r178",
      "r209",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r242",
      "r243",
      "r247",
      "r251",
      "r354",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Warrants issued, shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r36",
      "r206",
      "r422",
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r207",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,591,852 and 49,279,453 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r161",
      "r352",
      "r353",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r161",
      "r352",
      "r353",
      "r460",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r161",
      "r352",
      "r353",
      "r460",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r142",
      "r143",
      "r161",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r161",
      "r352",
      "r353",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r61",
      "r411"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "ACTG_NetPortfolioIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "totalLabel": "Patent portfolio expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patent portfolio operations:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r141",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r220",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r32",
      "r225",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r33",
      "r221",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r366",
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Allowance for Credit Loss [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]"
       }
      }
     },
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Capitalized lender fees"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r82",
      "r198"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r329"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Change in fair value of the Series A and B warrants and embedded derivatives"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Series A warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.",
        "label": "Assumptions used for derivatives"
       }
      }
     },
     "localname": "DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesEmbeddedDerivatives": {
     "auth_ref": [
      "r326",
      "r327",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.",
        "label": "Embedded derivatives"
       }
      }
     },
     "localname": "DerivativesEmbeddedDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r265",
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedLabel": "Dividend on Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r58",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r112",
      "r115",
      "r126",
      "r129",
      "r130",
      "r134",
      "r135",
      "r338",
      "r339",
      "r427",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r58",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r115",
      "r126",
      "r129",
      "r130",
      "r134",
      "r135",
      "r338",
      "r339",
      "r427",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "INCOME/LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r330"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Series A embedded derivative liabilities",
        "verboseLabel": "Fair value of embedded derivative"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r52",
      "r53",
      "r54",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r137",
      "r180",
      "r258",
      "r265",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r337",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r455",
      "r456",
      "r457",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "verboseLabel": "Equity securities at fair value"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r26",
      "r77",
      "r177",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Schedule of equity securities"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r351"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity securities at fair value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity securities - cost"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r174",
      "r448"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Gain (loss) on sale of equity securities",
        "negatedLabel": "(Gain) loss on sale of equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Available-for-sale Securities, Gross Unrealized Gain"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r174",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Change in fair value of investment"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Loss",
        "negatedLabel": "Available-for-sale Securities, Gross Unrealized Loss"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r9",
      "r11",
      "r169",
      "r432",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.",
        "label": "Equity Securities Without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r224",
      "r232",
      "r233",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r341",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r340",
      "r341",
      "r344",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r224",
      "r276",
      "r277",
      "r282",
      "r283",
      "r341",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r224",
      "r232",
      "r233",
      "r276",
      "r277",
      "r282",
      "r283",
      "r341",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r224",
      "r232",
      "r233",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r341",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Schedule of changes in fair value Level 3 liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Ending Balance",
        "periodStartLabel": "Derivative liability, beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r224",
      "r232",
      "r233",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r228",
      "r256",
      "r336",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r194",
      "r412"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Patents, net of accumulated amortization",
        "totalLabel": "Patents, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r358"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Loss on foreign currency exchange"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r64",
      "r82",
      "r166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Net realized and unrealized gain (loss) on investment",
        "negatedLabel": "Net realized and unrealized gain (loss) on investment"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Schedule of gain on investments"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r82",
      "r428"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain on sale of prepaid investment and derivative"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (loss) on sale of investment",
        "negatedLabel": "(Gain) loss on sale of investment"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r59",
      "r60",
      "r82",
      "r424",
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on sale of investment"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Patents"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r197",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r55",
      "r148",
      "r150",
      "r153",
      "r156",
      "r158",
      "r413",
      "r425",
      "r429",
      "r449"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r94",
      "r102",
      "r148",
      "r150",
      "r153",
      "r156",
      "r158",
      "r178",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r317",
      "r339",
      "r354"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Net income attributable to Acacia Research Corporation",
        "totalLabel": "Net income (loss) including noncontrolling interests in subsidiaries",
        "verboseLabel": "Net (loss) income including noncontrolling interests in subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.",
        "label": "Net income (loss) attributable to common stockholders - Basic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r56",
      "r82",
      "r146",
      "r176",
      "r423",
      "r443"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Earnings on equity investment in joint venture, net of distributions received"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r110",
      "r111",
      "r147",
      "r304",
      "r312",
      "r313",
      "r450"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r302",
      "r303",
      "r306",
      "r307",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r79",
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInNotesPayableCurrent": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.",
        "label": "Notes exchanged"
       }
      }
     },
     "localname": "IncreaseDecreaseInNotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidInterest": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for interest that provides economic benefits in future periods.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r66",
      "r226",
      "r231",
      "r234",
      "r235"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedLabel": "Interest expense on Senior Secured Notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r421",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r461",
      "r471",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTextBlock": {
     "auth_ref": [
      "r461",
      "r471",
      "r472",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).",
        "label": "INVESTMENT AT FAIR VALUE"
       }
      }
     },
     "localname": "InvestmentHoldingsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment at Fair Value"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r414",
      "r430",
      "r481",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "EQUITY SECURITIES PORTFOLIO INVESTMENT"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Schedule of future minimum operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months",
        "verboseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r94",
      "r152",
      "r178",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r319",
      "r322",
      "r323",
      "r354",
      "r375",
      "r376"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r94",
      "r178",
      "r354",
      "r377",
      "r420",
      "r439"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock, and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r94",
      "r178",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r319",
      "r322",
      "r323",
      "r354",
      "r375",
      "r376",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r223",
      "r229",
      "r232",
      "r233",
      "r418",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r34",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r206"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Contingency accruals"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r59",
      "r60",
      "r82",
      "r424",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on sale of investment",
        "negatedLabel": "Loss on sale of investment"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r41",
      "r94",
      "r178",
      "r209",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r354",
      "r419",
      "r438"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r80",
      "r83"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r49",
      "r50",
      "r54",
      "r57",
      "r83",
      "r94",
      "r102",
      "r104",
      "r105",
      "r106",
      "r107",
      "r110",
      "r111",
      "r123",
      "r148",
      "r150",
      "r153",
      "r156",
      "r158",
      "r178",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r339",
      "r354",
      "r426",
      "r444"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income (loss) attributable to Acacia Research Corporation",
        "totalLabel": "Net income (loss) attributable to Acacia Research Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r50",
      "r54",
      "r110",
      "r111",
      "r321",
      "r325"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests in subsidiaries"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r107",
      "r112",
      "r113",
      "r125",
      "r130",
      "r148",
      "r150",
      "r153",
      "r156",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "verboseLabel": "Net income (loss) attributable to common stockholders - Basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r114",
      "r117",
      "r118",
      "r119",
      "r120",
      "r125",
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net income (loss) attributable to common stockholders - Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r265",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r44",
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r148",
      "r150",
      "r153",
      "r156",
      "r158"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease costs, net of sublease income"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: short-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r371"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Long-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Leased right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Accrued patent acquisition costs due within 2 years"
       }
      }
     },
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in remainder of current fiscal year.",
        "label": "Accrued patent acquisition costs due within a year"
       }
      }
     },
     "localname": "OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestments": {
     "auth_ref": [
      "r26",
      "r441"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments classified as other.",
        "label": "Investment at fair value"
       }
      }
     },
     "localname": "OtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other patent portfolio income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other receivable (Note 3)"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividend on Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payment of stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Patent acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payment to acquire equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Purchases of equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockAccretionOfRedemptionDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accretion of the preferred stock redemption discount during the period.",
        "label": "Preferred Stock, Accretion of Redemption Discount",
        "negatedLabel": "Accretion of Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "PreferredStockAccretionOfRedemptionDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedLabel": "Dividend on Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockRedemptionAmount": {
     "auth_ref": [
      "r37",
      "r241"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2021 and December 31, 2020; aggregate liquidation preference of $35,000 as of September 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockRedemptionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r23",
      "r24"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Issuance of Senior Secured Notes, net of lender fee"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from issuance of preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Reissuance of Senior Secured Notes",
        "verboseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Issuance of Series B warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r67",
      "r68",
      "r165"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Maturities and sales of equity securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).",
        "label": "Sale of investment at fair value"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.",
        "label": "Proceeds from sale of investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r72",
      "r297"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Loss on sale of trading security"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r7",
      "r94",
      "r178",
      "r209",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r237",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Paydown of Senior Secured Notes",
        "verboseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r87",
      "r415",
      "r436"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r8",
      "r84",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, ending"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Long-term restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r19",
      "r265",
      "r301",
      "r377",
      "r437",
      "r458",
      "r459"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r180",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r337",
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r149",
      "r154",
      "r155",
      "r159",
      "r160",
      "r161",
      "r272",
      "r273",
      "r411"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "ACTG_NetPortfolioIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Inventor royalties"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r142",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Calculation of basic and diluted net loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of financial assets and liabilities at fair value"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsNetOfAccumulatedAmortizationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r38",
      "r92",
      "r138",
      "r139",
      "r236",
      "r238",
      "r240",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r251",
      "r256",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r10",
      "r417",
      "r434"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Senior Secured Notes Payable"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held."
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Non-cash stock compensation",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Option Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Weighted Average Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Weighted average grant-date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r284",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r286",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "verboseLabel": "Option Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Weighted-average remaining vesting period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at ending, shares",
        "periodStartLabel": "Balance at beginning, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r88",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r92",
      "r94",
      "r115",
      "r116",
      "r121",
      "r126",
      "r130",
      "r138",
      "r139",
      "r140",
      "r178",
      "r209",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r242",
      "r243",
      "r247",
      "r251",
      "r258",
      "r354",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r40",
      "r52",
      "r53",
      "r54",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r137",
      "r180",
      "r258",
      "r265",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r337",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r455",
      "r456",
      "r457",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r137",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r265",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock options exercised, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r265",
      "r285",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Compensation expense for share-based awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r258",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.",
        "label": "Stock Repurchase Program Expiration Date"
       }
      }
     },
     "localname": "StockRepurchaseProgramExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Repurchase of common stock, Shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r15",
      "r16",
      "r258",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r20",
      "r21",
      "r94",
      "r164",
      "r178",
      "r354",
      "r377"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Acacia Research Corporation stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r53",
      "r94",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r178",
      "r180",
      "r265",
      "r298",
      "r299",
      "r300",
      "r310",
      "r311",
      "r315",
      "r316",
      "r324",
      "r337",
      "r354",
      "r360",
      "r361",
      "r365",
      "r456",
      "r457",
      "r513"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r243",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r265",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Treasury Stock"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Series A redeemable convertible preferred stock, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r7",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, value per share"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, shares authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r228",
      "r256",
      "r336",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-ChangesToFairValueMeasurementLevel3",
      "http://acaciaresearch.com/role/FairValueMeasurementsDetails-FairValueOnRecurringBasis",
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Average price paid per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r39",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r39",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r16",
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Number of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r39",
      "r267",
      "r270"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 4,604,365 shares as of September 30, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r124",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) from continuing operations allocated to participating securities for basic earnings (loss) per share or per unit calculation under two-class method.",
        "label": "Undistributed earnings allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r124",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Add: Undistributed earnings allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r122",
      "r124",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Reallocation of undistributed earnings to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Change in fair value of Series A warrants"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": {
     "auth_ref": [
      "r333"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.",
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax",
        "negatedLabel": "Loss on foreign currency exchange"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Change in fair value of investment, net",
        "negatedLabel": "Change in fair value of investment, net",
        "negatedTerseLabel": "Change in fair value of investment",
        "verboseLabel": "Change in fair value of investment"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentAtFairValueDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Schedule of unrealized gains or losses"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/EquitySecuritiesPortfolioInvestmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Fair value of warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StarboardInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted average number of shares outstanding - Diluted",
        "verboseLabel": "Potentially dilutive common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potentially dilutive common shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r114",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average number of shares outstanding - Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r112",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21459-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=107671284&loc=SL5844817-113951"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515679&loc=d3e40733-113955"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123589689&loc=d3e48542-113965"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=56949186&loc=d3e50579-113967"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f,g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r486": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r487": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r488": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r489": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r491": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r492": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r493": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r494": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r495": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r496": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r497": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r498": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r499": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r500": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r501": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r502": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r503": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r504": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r505": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r506": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r507": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r508": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r509": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r510": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r511": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r512": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0001683168-21-005701-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-21-005701-xbrl.zip
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M#1C:N0N*6D2M.2>#JO"M9DC?'%5?+XJ[=P)?#0TW&X2?\ >!%+0>7P:(\M-
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M>N=_!1P]PY?I(X_1%U FQL^\C%$INL2U&)]OS:E=CA6=.3P!IV4$!K$,./X
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M<9BCD:.<6AK/0E**X50ND"X=VIV/=EJO]=A8!K'K3RFXKQ5[#J/.X-0D6/Y
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MS;O/R2%MIW",\RYL@0R6WJB8LUK#F;BD!C*C+ []9$R?3#"[QP>%#^0.-NO
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M?FXDT9*<F9:%\!!0Q'^41W7UB6@1 B> ;VBP-QMX^3O@<X+WVIA+9+4!9&M
M%Q(L]?UDS:6VB<W#U'K@FDFX9%\>V.3-!KGR4(]GH)AD[2Q=CT;KTVCXF:[
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ML#YVCK=#D:9:<1'4-$$KWE&6=]7<W*QKJTDQ5:[4=A)I/9N/A:BA/1#?OO.
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M4"D?*TD-24G/0$J6^I)'T&,C:_C@*4\BI$[!G]H4U$,B/,_);8\P^PL?(IT
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MB>4$R/.>$R5$HOA3GA2V]LB'(H[1E.44UIL-O771;JJ5+=#$_=S<;VU>X""
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M)3?8,?:6+-A]JN:Q",?"<R'0;N.A@O)492R 12Y3QM-%M9*GF<X%,QG/1(*
M4D0X3"%FDL<LX@$N::82F;%,.;D-@50$PABN%R22\'L!PVLZ#:Z%\ 8V8Z(S
MLD$"@=1!GD LQ7)R)12:S2=(369R^E@IF LM"BVTA42:6/!0IF,VE]D$6S13
M$5@/2?$4OJD0&YUA6<A&B_5 O!-03WX"JF"13!$U F 5) ^(0ARW=;6R$I!I
MA'RW^8SO09R'4 HHUD+B 49)-3)%("D)*#OB>(5R$5_SR#8R*92DV".)/(8
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M7XYY<\'OB9J%Y0C'SK;GVT-]>5![%J[%0.;.*%L*DH=8:,2R'I_DK')2P!H
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M2RND5YWTBM.]\Z17H_\!4$L#!!0    ( &B!;U,>#GZT=@0  #03   1
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M-5HJB0U9AK>V!%C%&#K-_M>22L0U/D%0Y6?M"+ D,S*Z?&K.2F*S.P%IRDK
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M4G=:6Z*JOPV!X'5:$IL'#V]M"; 6,G2:_:\EQ8A#&$%0Y6?M*":Y-<!AFC/
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MROF(O'@;BN^.QXO@(DBTKF[>!"_B-.<=O(C3G7OP(I+K1<2!!_ BDN1%Q($
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M]Q(S L#Y2)3S$0\:4EM\%RZ3O$Y !J<KO4[7ZM:ZA!T'[0DY\-J2E#9+(7#
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MBYF</*V<LCO-<>NFE%E8 )Q$ "=]=A, )Q' 29\U!,!)!'#29^-\%S1-(-M
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M"[_5V]T&^7S;KE_5V_A'IM-MU;ZP3+5I??S4NKZLMSO_9>I?[QK=GULG8LM
M_<[-A?O<N'?9Z=8_?JMUO_S\D@VZ]Y!_N-D-=\:+P4+7G902MEU=V.6\M\(S
MJ>E;JVSKMPJ]%ZG+/:#)=;_X%&2X;EW$?:V>\UKVJ3GDL*=PS=0)KH9ZF>EA
M5[&R?"5%L?EXV1Y@.)[E^% +.CP:VRW3.J];$T5MAJ3UA6A%XKO?Z\.6U)&D
MRN_8XW<K&UG(^#>5K3K6K>1J]YV NG7R0M\'7_!1<YH8S9'H60DPY<^6N(AV
MP5\YF^M,IF/U&:&V>6+H5DTB:)/?^<9':9K;IT5?P'MB;/5!3\!4]%1G^K=.
M1.@!^Q 6ME.9AB#WQ&:+A6C4P,6B&49;?1;&5HRAIM)S=S&IUV@HC*\0LE7D
MBBJH/%9NLY^,7Y\*^[@1X1D5<V+L$_ L<L@INN0,<TQ05,Y&*,T8_$U6R.J"
M9TN5P'LRG,Y$!*DP^&)$Y4&UA<*P5EZS_&Y1(5DC1SV[[:>E"N/WRU5SIOSH
M7W^*=2/)LNU@'M7M/&R3GE>=2D#ZF)60U4(YC+K5$YF%]&VP=>;?:4\Q)%VB
M_GHO#2K]#R^W'UN-UNSS<US!\!WVTW:0(JL:8Q'%D*WV.G/KRV@XK;*3]6D/
MV_ H9]ER8;N)#*5%4<]Q@$%6OL 6B]O-R_ JBXH;TWR.G;)$M1$5E_VN]5[$
M_-5][<OTU\]RK,$1MYVR1Q!&C3PDDN7R;#X/01&_G ]0 63S831KC;@Z9_]$
M<-H3U4=+V/8,_"72Y ?!D!^00VK<"NOIBI']]/M7^:;T&7V+M,44,7 U$B&K
M,H^"I@G'L4!L87WHABE;R :>P3F-60ANY2BRQ>"[]6[/S]<G?21)Q$:VB9_W
MSVX-UG^T.?.\H@[JCS?JMXMA^_?G?<K5@RD8FVL&9 T;<]X>]S%HB7VG*O1N
ME&R>A_UWP4Y/@&'V(EO*;M_K$HAB<72IWZ),^55SXO+Y^JEY6RL)^_2I/]R<
MN#@&<X(&<;<Q/FS7,UMAB[D3MB;VGX0 MXYDV5P^HAVY9<^M]W,-Y^E$(*FK
M-7//'[O=/[%9#8NF/&,RZ#3+O_M.<)=I@.WX29V$%&[)OUS=DN\G?*#D4>MK
MX_<S?U^*=WNK8S/^>*$)?.N T\JG>$]O^)6_E>UPALQ97#,=H.D2T3QO[RWH
MH-ZQ.9]H+Z+%KAM8B^7&Q=\7^,NGQC['Z$16&>!,JX%JVYHI"EN7<1R;A=[9
M29K< *,M?);EBMO=WZ!56%@F5/*M<$C[[54/.U_F:NID(IM=0IW5P**U[#5Z
M+[5*^_&NW[CZ@O:QU0/:#+X8Y7)QO)AL/YVT(;!OR.A(S,A/F9$L20A?@^<B
M*S_UM3''YW*. DARSU'ZRWZ9D0^8&: H05'NIRA7#N(9(.P"F;U,VDA"DRE9
MVZL3LAMS$=^@G@$W+7UZ^OG]3^YW2#J34B,K6':P@9]9-NEV:F3@80G.DZF8
M8(0F]. NK'0I#>3SU.8&'A!F!XN?8AW;R?S'%'2;BY4EKZJ+N:9J@O9L=H&Y
M%;26UC'(CC6:*;M%6F<D:*@G-WI36>J)Q/3F*CFNUUL4;)/+:6'Z6-"Q 4?G
MH_HDZXYKVO-1+T_;#<D-X_GY.+C_/JT]J+^&Z(PQ9(.P='^2;=VV(#E[&,D<
MG\WQ 9.LB0_?+P6Y-C8"(GFCR>V3Z$V^EDU:;S-E/JWV1O-JV5B_I0/0PR3$
M\BNB(H1[PW%NT9.U+ZQ%E?Z+F2*\*I(GO,>33/N/>XAQS1O3"VUXJ\EB9%+,
MYQ_[+W\F-]_UROZ0-JF=<V$G6?9!=QBB?&]<%W]/;JO?^E*0=.\B!QZ4ITZ>
M=Z$C8G'F73>D^1;F51A?></8?&-U9HQ4#9L*H0GL5#H KY0L[/W-1[DNJ94=
M20Q!-@,G<1<PKQ(9ES3N)8F^!A^!"-J#SQ4XCSVAFT5P;1)91M9ULF.7]@B:
M&7B558C!S0@Z.?FC@Z8&'2V3XUB&3!"]\!*)UK<\_99[SPC#H8:&&*+,6,8L
MDVC;$ M%2!$1>=HNJ_;UXBFW\X>$)OM*3LGM+QKN%*^K@.H^Y(:A!T(B=Q>)
M<B4X.IVP*4X>$AVAJ(>]SCO:K"-VDWS(Y3BPL3D,$_96B1Q;A-1=PJ<[P-U\
M'%OQ<;0<)/,2%<H]6L+<8]0E9R^+S6VVI[\_%L87D\O?#_'5VSJ'^%\&T4%"
M7^>4$K;]D":2N%45.NDT7FKG2;K5=JWSDI<[O9??@[L1U\K5&Y_W0:67[G-+
MD.S9D,"DP4>BH^A.N/\DQ\N?"C_\7+M]:3SFY\Z#Q^O7?9\#7F]Z0"]78OES
MHS.\KZ.<C]=O7+A]#"  8VW?*."^H]O-M@@Q5+\I2.T@;D-DSQFI6IYC'Y&V
MBQU>9V)KM]?YG;Q=(EXAAK)V'=$A,)K'IS@:GSH@1F7JS 7?UU&U<9H;-*JU
M"Z+,.-@ZFE;KD99>TUI$S'9YER/0MO/LF90E!4L.!H0VI'R%5-BSY8);1\8M
ML0Q%6L,-YQ,W/E6#%VYRN^#&Y[M"PDT0$A\P;H(8$L9-ME1A\P6WGE>^XN1[
MQ,9-O;46)F,9_+PI$LFVR_%S<BUOW]-(S9'0J]%AJYXOE@=X^&1$QW XB]>Z
M&A+TF?:\[(@U&SU)[DUTAS.6JU]SDU_?)C>?Q=BWM#C[6MH$V-I:,-O=LAM-
MEB6J397E84*L/EZW5>[*TWD?3U]?:#R?OCD+LO[\F$P2OR,)9$5ABUR>S;GV
MDO>7> TRMQ*CSOI[ASF)8J7(Y_!2'\AJ\<^Q,SW M2)HIF^/V%6Q\B4O$<:W
M@BPUE)HPE0UA[!*X^_1E5/IYJ?UJ%+():(L^'S;^698RLL*(YLB3B[8MY_RX
M3T38S1NP29^#WJ&[L3_ -G %TDXKU :B[F+?1H8@*TBJ"YJ"94NOBN)L,J-G
MR5RB@2S*AHL&N!*OBM^'_+4DH=BMQ:VMT1T4X<F@))U8JGW+ZK8= H'K'AT/
M#W^W5E93SK)9/KQ>Z=LL$)AX/Q-_B-;SFGC2KH[;WJ[NP(G?WCM]/9,^;P*Q
MT']DNU?IZ^?>2^E'N_KK9G*-AYZ4_NE541!E@6DC'0F:.&)JJD9JZNCLZRXY
M^+0NT^L3%7J'NQQ;X;=7!1V]@>23\P$V5RACVZ@<ZEF3D=@P] OGB>[)1P*4
MP>QN73LWW-S(BJIA"6E@\="0[M@N3->/T<N7COXL-C[W(^VFOH/Q3!I X<=I
MZGA,TC.R10<T$7)JQ-59#KL:F6<K^?!L):A&WF^"@SQ.B.7RV\](C+W^>/=%
M\$06AJ,ES/-@W@T.5$,1QS,"U%M5HR7\AJ')_9E!MN=TU>4%QKE.6IWWR$(Y
M[Z^A3*=<Y[K9__*EDK@%T^F%[>%IG99&#08F8;M\N0);]G%8+:RT:<!%@ YI
M)<L6LMMS);! )W4=.UK"MC?K=S3%K"K2AGBGM>0^S6X4_/_J+^%WO$MN]DUA
M\Z+KZ''+^MYQ3:I# EFMZ?#VT,OT/D929WAXOK3#?WQIY1T>NVLO55?8A+P4
ME_(5MIS;?4^F!9KP%F.8]C!7V@)?P"OM]D*88*9]KCS?4NL"?R;__3!U@L%\
M$M.5)TAGFNB1::L306'-+UB&='P8O&<F@C:4\3O(I=SR:T5$C)3%BZ?G(;[D
M@WS>'2%&$$5U,A649Q+#4^C9X(*&OU9H0&^HT>(9S7C]2ATPQ@CI"$^#@(TN
MDC+'\RLA13<_43N/9M('LB(HHDQ]':MKAOX&S]-YR!1%PC9XR6XHLQ__/YD,
M<R6CL?2.N16&6 %U\&)*NG:\8_),)F.K1DE^\.M1F&_/&.KT'5,D$FQ]8=]0
M),KW@V&N\V@\MA3!OV=XT2%_ZU-!M/]>?B4V4,;"5,=#LS^]9QYER1@1MG!_
MK2D/\AI/$QR/STVY.#24]>A<[B^OI<:^(O^7!Y<=W+7Y^I[I/D_Q *L:5M/B
M>Z:)E;?)^Z9*&)YWWO36OHO\XO7VW%];C5.B)FT5^>$MGDRW>=60\"?31W@%
MP .:4C#XF\LY1!W <^)XZ8U.Z@C5)LA2+DW]\VJM6FM4F7:]4Z^V:Y^86JM]
MVVI7NXU6\\/;?M@J%@]@4?^NHZEQ7SBSJZWOFM6[RT:W?HG'U+RL-SOFIT[K
MNG%9)5]WNOA?-_5FM_/Z5>N*:=W6S7%WHAGXWPT%KV#J3,=V/;X7/8F(*).1
MN=Q)BZVT#%[&A'^6!N5/B]A>58ZK]GB>-SL^]5Y:@C$HE8V?+Q.RFWTVP<-]
MIA=B8;472";#[, _9HE].ZHOXG*%V5/$7WGN?$CYO*?:6WNP3<5?!_KB7D\B
MSYB[QI6+'MT84N+XGKU#Y,S7*ZAB7+S#Y25!##093*H0WG VDSA@DAN3"B:
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M0UK]R2KBJ>HZPO^3NL(3K>J[^%/"_V[>-JY?;EX>>R]W_)#_^7)_^UO;I]K
M1[W+(B"U_R%9F_EGL4+WF+6Y\^GR_H!![!.XFT;DDM/8.)S_>%#M=PQ;!^%V
MJ."ZJ;AEV^/.6%U.<Y,[S>J&4H;C@ZWM9PMEMX+#;5#:M]3L $T-0#X6('-S
M('/! ;G"YHMN_0P R8#D,%4R^9^A!EL'GF=+9;>N!(!EP'*86ID/6BMG"VRN
MXE:XGA@D1W$@QLE6AP-A0%A""-L>4JBINM$:6-ITZ3R3B_KC]8]/7^^?&X78
MSC/9K-AN!8/4^TQ5S1C@%4AEU"DRF[#H[X++.+J$S ZV'W9>#'T_;>^A 8>
M0\"A<#FTO3-66WT6QL9S_6E*=@.076(T@/M<Y7LO$[Y6''ZY_]&]BVF/F+-E
MR6;:&PI>3PQ58S1*C^P9IUVW^@]%4+B.7^ANS=+\1Q80S9;==O_LSH&@^0MX
MV(Z',.**!;94\AT@!T0D#!'AQ.?*6;=C2  1:4!$&%&N(EO.QXH(=VLJWT,B
M#0(2WU8QL-V"+9%K-!3&5PCIRQ:5]/Q9^7B7&XLE*?8.R_Z-JP59^!&8+F:
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MKFH(8].8-D>Q>A83"'1\9XU[XC(R"YOGLFS.?]42K"P Q'"L[#S/9GG?B53
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MRU22A%F:E6HIM3,C)*'4D1,U1--<IMTRI8AMR5TQG,59U/[>+Q>F.2;RV=C
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MJOW?&^ 8^#O0E&3_[G^E!,Q'')FP-?NG]\*3(EL#!$'VKSE*Q]<8BV*ZL+]
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M!KH<D$KL80;W]^.**K=K/T:EW>L!=D-"Y )<^'N('[C#O:[ #X_PV]@@M&Z
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M6,%??Q05%3W"Y[J!?_07);H"W\A=?RXJ=Y-^9:O=1]Y\X%NU8S98D9 8,M]
MWBR&^Q;IOEP$IAMUZ[[7>@6Q<(-<.5,I;JG[4-4-_3H",Z!,@]*]G'5)_UN^
M:;4;GVOW7PK)D/#SU4B)03P:E%L&W;@*COZL.J.5(1QO&FBEG,E7XB\RRKH$
M/%N!Z196 8L#?O8D&C3ZBUNIN[XO;!$[1]^#R<?/5]=?S.><M%W1WI@5X9Z"
M0BKL>^P@]$+Q)%XW'FV&G"RZW^!24K80!5N(^@+B;4.6J57C[TZ076;A@WHT
M D*?7*LB+<]$^(UL'<!OYK<?/@_5LU9/^9*H-*\YS8 =B'(/8I]F#R/BJ]JT
M"V]RF];$RR6,?U)20[Q7&(OCL1+W#88(,X8/;;LY6LBAG!RMG'QS]5N5S)_&
M.@,'MYJCQ5.T F/?KP_CP]_L3I).,_E<FG:ZO>N,5;>J9:JYE^VQ"'E9FIJ5
M>,,AQC29\LORRYG2LB U:WS[^W/YBU84UTF5B3<SJV=O/<W,2@[*Y0/L.K!P
M;\B(VT.MWJD^'.H:';/A[S8SK?8ZT^;SE_[]M#;I7:Z3RAZ-5]?=+1IO$MVO
M0%M,)\:Q,ZNN+X9QVDHJKLCMBC"/9])=+9II@DOMH.J"J.T%'P#7ZIV1KIN)
M1>GX_-G4/WW^?57ZO4YT9@/OK;TI-O9!4W1#H)XW,&F:ND5,IR>42C301;&X
M+GE4O1#(V_2;E*)*N=R#*&P(*,?BVLAE,\7"EH8^G+AQ&D88G"XH6=@ H-/Z
MKD5%OM5I7X)KT?"V@O9(:CW?[C](/[3G8GEGDCJ(P&?F4@HT)FOIO%?'B)TG
M,<A( P0K7T<JU",-T$0#_S@81#&:"3SAL[&Y;@-\4$%#49/]N964\M7'FV%I
M=/EPL]4Q$6\^V%O"YH_.%#=WFI_@&><G.//\A/:.%/>06J0'TMOLJU'=V[X[
M$<$UGA1I6"]V>BV_J(Y_YU/.O#D5E'*+7^\*RN/G5J&R.^O:KZ G=2[;<B71
M!G":'[$S*,<B;3/ER"V>!41<6)0)C=*J-:*-BAO/Q) 4D\A^T[KU\??/:>'T
MJGNJ;E?^VOMD_E?"=X=TS.:OZ6S;B<:N0/ANL^7=JVYGM1ZD8R'E+36U._'0
M\0T9.<H'-R9LQUBS,](*6L%O00^LTW-QFKNMW>ZP#GDBZT_:(F=9\M2[!3#>
M9E52=I]+D:.#[JMHA/ZR:WN&D&TZ]BC5_2^G]7.Y?B%G=]2JVI=X>$.4%SS@
M>YCSL8[VF&CN$$$/GO0&-^9 ZS&>^)K"%==*V' 3#I$=.0F'/7G<;VO3RQMY
M]XVTP^<>>KO"!65XO#K4#W_/VZW +.;BR[I]I5QLPZN,Q2.9K66*E9?;9^R\
M)]Q::E":;9B@U"]OMCR2 ?X/BP4> 3/I0 P<P2591,8_U#79_X'GF]?$4' .
MD[^%;.-94L>(HPT^__M&M$BCUR.8J<C$'Q5[HZ>Z6K<T^7$L[\[%S?>.2?14
MJM&VSO@#<8])/S0<(-"_)\X@W.Y%;G<.:BF:V&I"77$)N+EX!%HID\]&W1QB
M*[)KS]G^_NTXA,MV(RKI*.W.]*[<:_\^:U[>K#,E.\8"U--5Y$Y&Z)*^HN%H
MS5>GE6]TQ7Z^5C=;/<K-<OFC0BZ2:% V4PK1:"4UM.*]TEPMLBNMY3.%TAXT
MX4Z%5C)WO$!HG?OBC#.X/H/A=>M4-(P)H-<W[#W:41J=J:05I<GEY/KS=)UN
M*O'(J?QQ:0U)131Y-3%%7R/(^KBKDE T]M]0'&V%94/&WE:ZU4#)%&&>0JF8
MR157GP=!H1*/;/J#[C%">ZE6R93*+T_QBN0>4XGT!TFD[(P9=:[J3TU=0R;M
M%MMK<H#W^TPQ)54WQP;QUQKGC:ONUZ>+C_UM]?()57?<'H]&*L&D"%$%,AL0
M><QZ?4MV0;*@:(Q.@;#2"N0$N:$7#F&] (Z+BH6=(#V5?^CJ0[M1N?Z^U5FB
MZ"IF.Z%E2FO?Q)RDVUR,O0B[+<\)3D(E8F+ O*/,A\B3'.#T^I#<BL^$%EE1
M<IQ^[?_H=I_O"F>[Z]S.]B58N+'-*#,N]_X,Y+9(C)$T!TQHT"0,5&.):H30
MT*.2CG8-\)RNQO0S;P.8; [4LI/!U#QYR)K&MBOY^0;3$5Q)5+/.7$3"&27D
M3+3(#9$(6+G8NIPW-F_U9GN?8@9J 3 K3]6N'U??JI*6.\^5Q)U[I5@Z&K,P
MZ9$$&<XD&,ZA6-F+R2?]S#7Z%][BV81"<K*Z:6WSZK>S3<4NERD57J- B1+T
M^ZSLG7J:^].1=Y[^QA>:G4?0ZM'$=!=,CEWVB?R^>3+JHXFYF]1Z+U.8G]F'
M^3V$GP%Y@D;[3[@<(UGHN,H%;)$'%%]IFYEH8+[/Q%]90OQU23+&1+Y4Q*ZB
M(B.TIQ_YBVRF8O;KE=+.5<WRKKK,A&8&(CN2H-IG$HX$$X]U!);\,.%XN? ^
MML@)JG\4)U@-XOO,!THK\(%+7>L'L('N9<Z\R\L_3[-;'>RY$>VK<)1])'W[
M"K:9C?M'4_Y2@.\SX>==PO<</V XTLQX/Z3XVYHH?L[=U4EA5ZUJ@HG?<Y#@
MH5])G/U'\3#L%:1-;78-[#A<S/E"+E.,9K9W(.'_;:$- S_C?_^.O,NQE81;
M90C6<9,\"3?Z4-0R[(,,;0+5>R\,1:.OP#OPJUG_:R6"P3" =]=Y=Q=>/?H0
MY[N4#[<#@H)='XY$#?-UN'TO&C@&#"C>(GU#5&E+R<,#X 76@)@$P"Z.987F
MJ^F:3#23_4237T7\F)>U8C:!!1_0=@O'<"];.)$-O?1=Z[_+]Y;_'!T)YPI1
MY7^$:[%/WL-2O\=$DX!ZJL+1D<V/9.4Q;'8TV\21I8_^$<I(?_P#^X$R"J%_
M*;'!KE25RZC_O0$F@;^;(U&R?_>_$D2C*HY,V)K]TWOA29&M 4(G^]=<LA>^
M9F$:%^POB#5X& E?NE#X:Q&+M;]1_&L!L#W0M>'Z7KB=C&"#=0.4)^F]T 26
MRV#?U!'@5>]#?]M/X5\6O;WP5R!OGV5R-H/[]V^XS*![-8CX<-0EP*AA0R.*
M#.'NTL%4#_ZY[Q_YW^@]'9Z:(=GKH*WNA_II_?2B+MPTVHWZS>DGX;1U<]VZ
MJ=]>M)K;8/G;%"] IQI5E4TRLG[7X)._\2/<1+-UVV@+MRWAKEF_.[NX;9P!
M()IGC6:;_=1N75Z<U?'C\XMFO0D0NSP\:-_")U>-YFW;MWLF[9OC(>Q,"JW8
M$= B1G!DR\ $58]:<S(V%8V8YAE\PU!H<Z];6/!$Q:[WB,JV\E_USO5=]E1G
M>OE5SI>_#"^+9VX0<$U8>\DFDLNC2)$[%MSKHH?+%SK3;]>M+XW!U>#ILO_F
MPUFC?7IS<8V(*K3.A9.[]D6ST6X+]>:9<%)O7[3QTVO$Z^8M1V=VVU%BVB(,
MCA@'/+?8ZME7>PW22YHLP(5BW<6%,$]WIEKOJG&6'WX;_^YNCA, E9G[*^<Z
MTU)U)-?KC],[0X3[<W>%5IV]KVW>TN;KUDTVNFU #*+ E]'$RF??/Y$,_2GW
MWOYD;,Y^HH\-^Z/# _Y970)-0K2_B+48H.#:#YPRK=C^*^VVC%W6V4/"#6C"
MHB$-A%/=&.F&R)QDFORW;@B*90I/ U!!V#S,H7BOX^3S(_U)@\W30A" @ %?
M(#+HU2."CX/V;8Z[IB(K(K:,S=B+/>%A!7$T @1"^9RARP.L0#:B9GT<-1]7
M4*>'Y[/')46+@=]P #Z))E@8$H<>H3VO/XO:6#0F0KZ4$7*U6@%,#9Q@@;>B
MBD]TTBC^W$:K@AHDIR!T0!_1%/%8N-"$,R*181>>@(=K&?NJ6#1*IG"C!@FN
MX[X:+XXF/KB+X3V?$7@E6$+1P3<^6(ILDJ4I=#E9$U9:Y**6")_!\:V!:%$0
M<NP6ND15"!CMAP=PY"YA '_$L@V&J S[@IX < H2L!P5?C%03T/PPAZ T"3^
M>O-!4<$&I"_6X6\ WRD;,#W6D L*]$7'PJV[_.$!6IV:3)_P+?U6>8>V*AP.
M_]13R3-M@PXL7,&\=7HRW \<0B8C59\0? U:J-1'(0(U9F 16(4\X[Q/A7>O
ML!%0Z.OP-HWVE8,M.G2)C[(:K;%DC0T )ET&UGF"T\&O&M\2<Y#AFOJ8SE_I
MB8_(##1YC/4R'":>&Z);-L<]9"P4 44<Q33"DUD3059,21]K8'@S@%F Q'A>
M]HV,,!RKEG+4$R4+7F(JUICNE?$-V."C]YRLS$QEWQ@H(Y.>'/XHPK\FP27@
M03@#6QV @0ER8/V#-/4$ 4Q*<^X),K#)1_B;_5ID5QS1GA1K .?IZ2 5D;*'
M(L .$(E( TU7]3[<Q0#PP1I(0&(9!T@ :LH>^=8\C@329VX$3M2'!R8A#PSN
MR*Z4W@2P'6[20J<0 GLYYBIX&X(H/XH 6&0.W?&$&)F IQ"GX"(5-*L8"L"W
M:8[4"'NZ(1S8%6%ZL\6>=7<RP1TZP[8"03<#.3:0"UY-,<:BV[1HNB).9Q^!
M@@,(/B:XKF>;U-E8>0];@;>"28ATP9SO5);X+C\CP-L<Y*"_L6-S;N+ "=>W
M@.$02WC2QZJ,M/4$!QL(0]V8W0&BL^:,(3D\H  U]X%[,D*G>.%R4*$KFDPH
M60.#$.&!3!#X@(U (/26KHD./V8.#ZX9'E#,O28&=61R+B+ M<.2B@KWZ)'9
M0 ?BD-$(QUX%WN7C2[9^D1$:SZ!:VNJ%T+*YDBT,YQ" W1CR;P_E[JF6D$'H
MZ^/^@-[-0DU)-8%UC0T#=@0Z%]'Z &<310E]3"5]49JX-TNEOYUQBVHD:%9$
M,ZF8Q/'E6.M$F_*-:%P+(.FP+7B=S8%L@"_8%76::L#9\99Q*X^P%+!9^@JV
ML(#Z(#)>5.ZH^Q7N4S'H?AD?=-FE!SF0H?#XK&G+5BY/$1]<GDFE*^(26]8^
MC;T9BA:H-6$Z%ZPV 7PS':4)$9?"E8&*S4OV[,?A438\'&G-Z(CN5T'75,;+
M:V31$N?%T>&!# ^K $G 6G@OK"6BXL?V3AW1H"L#[T5GM#UJ_BU7U"^NN8[^
MSA8C-M,UQX2[K'VB@1[:Q/('2:2L.. [AP<HW;D\I"3+N;3I%,O-X@%PAR$J
MKT'8Q!ZP,7 /F.)+V-TG&F6:<(^ 2V-BNI>*&.94#O)6^GB+?1QU@ L!_5U<
M,R\DJ'7,EA-[%HI?YTJ%&_IGYV8!B'21,6O''TB93*'R,0I0$[R[YF872CR@
MO;"4#&2FT/HU#]$RYHT[ GPTO0R:8S*]<,:B%9"&_&'$L)ZN*CK#.GP83N!A
MYQXZ%5PR94#$N(LU %-RBJHM4A,%*[L)OH2+?/QB^*,F[EGO@73PO\,'/]B^
MK0%I!$4:H'/&/:D7E<4^Z&< E-D]&6; 068NB3)TNA-@5BK'" X@1>NABLU>
M@MI+GQYM3\77BYAE$%NI %YKLSOG#IE>Z04[Z<'/%JAL7=2/<3T'I9DVP*F*
MKS2+=537FWEB]CMHO=!59LECD:="H.WUW74]VP V3,V4D3K_'A-139&P^@6;
MKA'A[KA]S+]E^JT 4#:5/IIJ8W0MHV U0>V2T%ZC4M.+7M0_! ^)&/DA( -A
MBR LJ,RW#;&]PZ8F4>AL/RYI->YC6G ?C&\ "3_Y0 /W9R##D<&(,=\+\.0
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MW 2^(R%\)P>!/NG9 6N+R/C:VS,"Y*":[U9TV[ZA[K\EGEKF:WP/RJ#TT#>
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M+(#NJ2Y@1WV%$=X^Y3@]IK[9Y)GQ6[S'P@537SRRWB9H(/O12%68KD=AX0"
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M31VO(E?T/O6W_1C^:='K"W\%.BB]>T;?F.T7^_=ON&?OE=M0!G7WX:A+@'_
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M2AFA8(X5IOQ[8S&&SXCN3GQOP:""HKQCO@Z)'MKDRZT*%D6S=)_#X%@X&],
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M2 L?NLS0Y]1R],UQ8"U.AL1UU<@_#+Y^+5Z>E//G5S_GT.-';OV1M+/'WL/
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MRC.\BIE97;=I./AASPXM")L^-!ILSCL9\Y[=56KPP-"Q\!V^A+3RL^;"DPT
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MH=*/GQD1!:^"UDJPSQ.!AD(*BRP(<$>8R_;6&.Z".F\3I1S?W486FDS+4AO
MU^K$2,!'$('8)78)X2*F!?PZA,_&7P0_/(OBG)2QR!P7[1(#7NE9OBLL&=K>
MH:>9NJ*;3UAEJ,-AZ#]1YZ ,F1DML!^75+WTP!2@+#S"52,XWZ%1]TZZ+I@
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M2HQMA-&3[1DLKCR*J?$T8%-5#&#N$8R6-C9U<(FP7$)_=0.CZ!@')/<'^&L
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MTG<W[8Z8AL,2A;% "<.L-.PNZ(1HA&"4N2PEA-8"@#;A4\%"XV9MFM2E=8-
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M%!W8[/85.%#V=DNK\J L0/C)?3MY[';.?3+GON?HQIOF-'Z?Y"T]PKX$YIW
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M6Y%<!1B!L\4LLVD0#TCX2F%YDA*;WU7'ITL>A_PD=,6P65_M K)W&R&.) 9
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M.#'*K6C1*QQ'H\^ZQ%$@\]',.$#*1]O>RHT]6]6+C(38OJ-P[=R(NWWT"P1
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MH]57QVZL$9UV/EH/#KL&G8^F"U^L0V%NRIDF<Z:-=>ZGG8_6CC.MJO/1:Q3
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M7LEVUJG<:U7,8L.&C-6 L[M-PV$I"I[-,\%I8L+[2T@,V-[1'-A>F+9()96
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MTR)_^YH#P\!PM$+D#GA!-[J<)W$E!BS7</!]E=ZW8<&.8MI U";X-'H$!":
MQ]LJ:);E:Z8YWE&^#Y@U.=[(QOG!/HN,K&@. U+"[WL&TR> KL'JF()2U'!@
M/L",W#NC!Z.0[\$WMLO$HG M.KR)^(;%*YK^R^>PH)W&0*\-;1^^!YRRVRYS
M73Y6;/1@6GU':</*9OQ$^U1N;-_4<=$ 55BQ;6T5\#'^HS8:.;;6'2"-W@R,
M[H!V3]^.'!"&# 0.B'>^.L/I^D/70V+EZ/,]$(MW3-1%+M-WHD:R)$^!:S<
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MBI.WX5V=>K?FWJW=>FKR+B5-WM5::RGRMC"@+>R %8D[T[J&S""*"7:8:=^
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M7>[8(T C=(@PVBH,;0D9$%M  [SP&\4ZL:XTO QOF."U@-;5#6ZO$OI"G 4
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M,:4Y-XKSGZ .</WA5^'3I<>@;ZJX[E-4\VJ\.8Z?#L>Y$$J/0#-;C!Q=KCF
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MBAZ'B1:!B>T[2D_"!4TX#A:NH)P0+K:$"ZC!@>V;J+W@=PTTCMUGI)UN#&]
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M((=B9!SB SC/%6J6D[L.VS#MD>29*)&%\M%5Y<M>-&PQAQ[YUC'R!/ZX0VK
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M/.\=P1"W%*V$V5^7=AI*1Q[<!K8[5[4PT.MFN0E/R&-*X6W)]7*]F6V49W_
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M.0"L*X*\/+EI-0*F>Q64AL^?CZ\/C761?P^D -@1B2X>VN+ L &"#71@Z1J
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MS]VSMA[M5T?=S1W*T@[%&P?)-'8BD*42$!%D@7M+00(RM,Q84PM%V TJOS.
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M=VU3!C(8JG//'W(@)Q0_4.NU>6=N.8R3"3ANC"/PQ&<$5.C:L+KVD"EOQ.E
M3D/\=*!85BN51J[;UQ'O*Y<J.:!3!W2]I);*^8'7.DX6UZF 7BR8WU0::J4T
M+],RMZ62D<XUM5C-U> :J+D)!D<]+3V84[-P<9N5]1S?/H_S@2/A&^#IP)\*
M[R<K'09/N\U3B<3!4TNME])RZG,A&0FW-M5J)3]*31_0-? 5YMZ9R &=H*]0
M24TAY6".*/Y:52TV\L.P=*5S26WEB9YK\17J:K&4%J1S:A8I"O76!O@*3WN$
M<!3X N$! O@)%NL97DY&W.5,RU[-^50(PSQHDBJ &VGE:>4J/4K%J242Y60L
M7(#4(@<YA+DOJY9K^5'!.DP*M=',K?^485R=>]\X0]9_9DX*CID79!+QTP+-
M\QRCX_,&59ZMM+M:U]"P^1CU)U;V;&=D\^9C.<G)4X3\0O)Z3A$J>9QJ/:<(
MY5I:"1HYH".65Z6:GR*LPX6HJ;5B6B9N;GEQZ5Q1R\7\,'T=(8>FVBCEE_#2
M/D584V GI6[$:VEKN]G#_]UQE+]@R*D)_F][6SDTF*F_54ZU/GL'H_SVF=4%
M!%;JRO:V)&;=N)9+N:]9!E_ MF>/WBIUI!GQA7RA3BR50E?@657(YGNLL+Z9
MY!P2OQBZ4ODC9,$X>\@GJG_$APHZ0D3 *P'[3KD8CV"!;4?K&-UWRK$V9!SX
MQS8"O%*/OO67? U_FC=]Y8^97!]=,[*>9+N__P)LSD*LP[2K;9Y"]U89$3DL
MA\R 3"/$%\X_BL\8W1UNFU/9YO#2S-[DRO_[_YKE4NF=:/4]M*F[+YON\$V-
MO4M P,.1YL"/-X8WH![AWCTO*F%#\$0W%6(IH0%E66Q%9UV@*!<V\KK4V&DI
M0\,T 588:7E=VJD'GV67]"@$M@IS0%!2%<T-P4=CM79JP6"&16/Q!TC&C!P#
M)A@SS5%^^YH#C*GB=[!JPQPKND^A'RU8+8[@R"WT''NX53 -8&@7:U!0C3H+
M%MQE0^!Q&,?N.]H0]NH[^#M.+2;9(8!I?=@3/@HXO65='YO;WS"'*3U3\^2C
MB@W"*7SOC/7@(RP*::H,N#'>'UG7S/5HG*T"+/!4\W#Z4]OQ>B!U;9<>!?)#
M M$Z,!Y!%24KDJ=FPJ[@BR$1*VROKSFZ7*\!D.IZ2,XC.9RB=7_[ADOO*IX#
MJ !RMY2N[S@X+4*AYWN^PQ;!QF&P1=BN!.9.XD2;..F*7($96<3*#5#=ZV;K
M'K+EC+M56(9L*\V=ZA*#S9 ".R!EF&(Q3S0-HL7AV(Z!W :8)!80#86B]*PS
MM^L8'7B($PGBS*8[EOQI%ZG?#DJNR'*,D><F[V+BMH!F3/O&?9N>5%K.6N!F
M0M1P6'[^F!T1U7K%&5J/U!LN:Y%U,2/0+28I[I1KAA53T#R\/N_!:1N[IP'E
MC,&J& \[MDE#-2M37LC?J/KGOKL0(J_>GVJ&ONV/)/'$Q'ESIQ*0[CVR5 /0
M:$B'<AR@KE LAE)Q6H*J0,D]%ZB\,P8"1,KC@P)]OZX62VJQ6.3"&N42OBMG
M\ 8:B>9K0T<9;@>RU1QO%5S-9.YVAS;"A1?(2@;B*92[Q[;'E#+^Q56)198M
M";.>86E6UP"!ZGKPA9#LILMN!BC5\3^&M93LW2IT@68T>#JZ(KD%F-1S0"R[
ML<T$8F*DC0EZ (I@:['=*'PXF##\G>;!5[31")X5RM'6_:ZW5? M R;K!*.0
MO)[RW5:@^1G4?<]78HY'S? DG(+:V?( -8X]UDS/$ (3<0B(1CR9@'63$*,B
M3C24UAW# @P!G@SX,F"NK<+K4FFG*;E+)1,$.*X<41:H/6KU&C+ #%/&$[IA
MID$SH0!R'"^+XR_ S'W.PHC;T.P)=.0V<*5'\B B*<NE%D>30.-.46)QJX!H
M;#3+<]"H32'1#)?@^B,TUF@IWL!P]&VP*[PQ>('=@870)*D%;DI<B[NN#;++
MDVZ';?5MDD3AR#E!+$L0[2$@P+CC^$#C62!?0#M05Z@N0]X-":$<86=@^G)H
M6:H!"424'NJ)[H#IOHF\&YW;81+1-#1G_YO0F'>Y-8]F)PR"MFB.Y&61_(%9
M8+V8Q&>:/C0LP_70-@;367(5]?(T?7*G+-O:[FKN *:RNU=DDL,SA"85#?%0
M+$Q+^$:,(H!"BJ&LF"$>!D:?S':1HL!4I3]_K;S NG#(2/!PA12:]1T?A!ES
M479=,],>"=M,;I'D#,HDL"!<>)S=DO])*\=-AS88&XY,>PP^C,O0\,/(%<VN
MHMWGVI;%3/IBJX!C=FPPAKCYE=/DDC2)>2P+""T00#%[O1G50E7^D0N>"GP_
M6P.!L=EC!KKYK@RKD*X)PA:H<\ 4AC="0UW0I5P$3<@7V0=J "HT7-?G'K D
M%9?3 HZ_2_0 TG0?Y%473"HWEUFKTL<%>2(8$K!LQ;> !DSC#B#>1U\#C%3,
M?4(CU/8=I:<9#N\V#'"6(:9X,&*KL#@:,1W9@&5'IN73@<M6V2D](MR!L2:Q
MI\?NZ)[Y2B3M^,1QE[!*').X3YB3]K*D_6V"F@.#)X+U(<@\$%D<"R(4AJ_#
MN&W"+/^P5=@%'G&X3)+B!^E 1Z+0X9EKKCM#,8I:N<[M^=4(:C&';!4X'0.+
M ,DU'LHC<5*M/R!ZL558(7S!X>II#E?AYV@ &.CZYM3\*&IF8*J#(^<&\(PX
M$D2 ]<AA1Z*".DJ%<Z982E)O%>0Y 5A\AJU/S1$:&MPB=7$MML64+T8/:*IK
MX'FG&QYN\#5;8SIB:[QSB=$Y.4;=HRX:EUWZ&KU;L+?1VK ,-%&4D=\!EQWM
M%(9FZ@2[N$J99$ EE9@?ACXEUZ"*BN@E>&\*X;,8*)HQ,2>^S@GU(<=[&7IS
MJ;R$1IZ7\!1Y"8T\+V%5RL^/K=:O5<]F6XAX^(':#07P?3JVT@C-L*W"(TV]
MB%Y]N'$W2ZTNH53Y41$YZ0$ O!M[KJ*-**$Y"I*"1RF>BCU40>86YBQ>^$YA
M:"0;[H<S<I-1CL*J13I'=XP!3)Y'@%1::I"#@]A^7>5Q(GXTRSW?U3QH%:/3
M([3*KIDYSA'W$,09J+.!'X*8&I<EH8D>.3E?A)VM0H">0"IRWA8A.1YI*TKD
MS4A9B1Y"+CGKI(=* N3!+NI*HF320[4P#XP<U?^_O2]]3EQ9\OWN"/\/>O?U
MG>>>EC%BYYP[)P+O^[ZUOTP()$"VD+ 6,/[K7V96E180-K;!!K<F8LYUVU!+
M9E965BZ_Q$<W;3V5R,ECW%P*>0)0+",H<G>62Q/[1X8%\H>2?;-O9<3Q\9ZT
MC;<Y/O"&(M\[Q?CQ![RAX$VJ"U=2>'^YTWSA?7%>YR39K\>&]:[D5^OE[RUT
M[FM)*?!H"RC00ACX"^1\9/.3Y0_FBA%M_%+:Z]O27</4!A:624QW9;%&+YIT
M%;D/F('Z6B*K-'$>*RQDUHFLTK?*8SW$@,C8+-9B(2$2\SXA-,8GS%+(1XFD
M?8^=:8(,5Q;[&9/B^E*"4YKAFKH*WI7A&M&MTT]P90KRI?S6<C&?YK>F^:WS
M8OM/-;^U'%X_03I</N(;HS!7-!TNX0#R-!,X2.C35IGO(K@$N'D2/W03W7!2
M6^VQ3"ZRXB.['DAVW>19DJGLS"1O]N64R7RFN+P4E9%":%R,S9^-!@BGF#\+
M]D@D@59*\V=GFC^;CRJ#0!CB^;,QI3+;_-G00Y9R>U)NLT9^C,>1YQFWM=_R
M-, W#*4M"M]T4/2 ZM\!(X"D"?YAV+Y+\9 &6LU:>(YQ.K"[/)-9:+&[K &V
M6*/A^*J9*ODO3Y..:7AN*90B'A1R@RBAZ?#E>=+Q'&<IGN+\<AIUN.T>;( 9
MK[I#AK75T)GY##9U--.7EIM*Z;03IZ,W3RE>O9.+5^\H81ED@NB]EO8LO9[U
M+"?F6$<2LWEX6G= CLG@#49?3"?S_ \X48I2)4U1^HH4I4J:HI2Z(Q?6'7FC
MDZW:LBBK9TP51:1R[,62AS!O:0*C>N+4X'Q""M,KXU/,3]1P4 !"':[@:,:>
M>)-5<KQY5W1C1Z9.I.C;8A2CU2&3.527E]+JD!DGS<3E%SU!(;^S^6A4ZI42
MDN6E\34DTH0E)-,[B<M+P38*I00LFO?(;5HJ,O^B_:Y2$44I)A1RH(A,K52D
M6DW ,)HXP)M6BDQ>*9)FP7YE1G@Q4KSZ4<LJO(D*$12ECQ^>"?/!@SQPRJY[
M?R8X'P]=4FDF^-R?@2W5 <EJ4?83)V.<MO>V 3]@Q-/G9GIBO<)$M\>PA?$Y
MRI)OJZ-[;3N:@YD*R4S+!:KY2+U :%@O+[T4>D]K!KZ@9J 8>3!,QIPIE SD
M([ V;Y.(R$.%9>M_;<6 E!8,3*E@((ZHH.2+L:S_-XCCCXJB3/K=0*IDJ0/V
MT;AD/F-HU30/>:- 7'0GYF"#CVMZW8O8([+4;QN--EV?(*#!^9A=[AVN8H&+
M%/Y3#^1UVDC=(A5_04H&PM1'LN9=S&!P,1:"G,+ N<[\2RP3&5C\Y;G(;PHP
M_8LKE%<:R'VD.=P;6L&)_4[6\X)^T=<Q,H3K-+4/= 0!XN"O_^=?2N%?DT\X
M)D3VTB(8#OT1TX5;J L_;[O?CIA4UO1%M)RX^>)BG)V_);$H$=M3/M1B)TD&
M7@NSST1&(E8*K@W,C3$T2MC_)$M*V?)-V#+E SU*D5D?\HEF_#P)RWVM@.%S
MY V$^H+3G_)KB%_9E%^+PZ\?;$D;Y'),&;<XC/MWRKC%9%QZHRT<O](;;8'X
ME=YH"\JXN;_1%ME7-%WY2%[Z&[HBSW3I*16^D KIEO^$+:>RGE)A'M;Y)VYY
M8C/D;ZD.=EO+L7U+PPBR[8"0MNHKN7Q%YO__<S)3A8>:<PFEC*.EBF\W9 )<
MOQ4"VK-]5[4T5M.N=[T(#,WR$L^-HTH2]^<8$HO(>&+AY7NEXM6Q$XLV7WRI
MO+S\\FM33*)P%+E8R;V93&_>RHL2G[(C9$=5+I1**3_FA1\K2EFN5 JS9\B"
MJZI)Y&DZ#*GF_IUR8PY.1JX@ERO%5%/-#3^*<KY:3?DQ+_Q8*2GIM3$_U\;G
MWQH?>H;=M U/_XB;^$/O+4Q<#B!TW0!#=^8/ZTF\*!^5J@^+4OX] T]YU2F-
M4QI_W-5(32-22L^<TMEQ=T]*Y.D161GG-4F)/$4BC\M,2HD\/2*/>U2G-)X>
MC0O%3]3)7Q"0F<&CX'!LBYX7^A*YJ;BE]FRJ-K\+C5?&A0IGY<?ZT^A;F-E;
M(:4PC5Y.M<3,:5Q):3Q[33&KEUBJ)SA]\Y^CB1<X3##!BX#Z- ELS_1-D/I?
MO\1KE=(XO8\6GK[9]&F0.FD6G<:S\A^D-$ZONT]U-GYF3/=[Q \PJ6BX V7Z
M%$B? BFE4TJGE/X I=/THM2H^A8T'I<OG])XBGZ$6;UR4R<"HV]Y9IE%8^(&
M$5#X>018G_\!)VHI7$U;"G]%2^%JVE+XW6)=#R:M_S/%X[(]ME,":Y$ATU\[
MZKWM8$L+WK^3Q_XB947+2Z*N",.%/0-;+ 1=&-0!Q1&Q/YREKWJP'NS%;FBK
M?E<R*>RH2TV=&L51%P_XML.:<(@AJ/$[#M  6<>6;'NGTCG*@DL?89X([.J@
M-]J6;=JMP?*2P_YN]RWX0WU ;3SLKDAI=/TZS&.H#K5ENVS#MB7^C3YV" E[
MOM'<, 0L1T4Z=77/5TVIKKH&H5; U-0FQ+<\PV1]2Y^Z!M^ W5Q>PE_Y%NS)
M'.#GV&*Q)\C\:M&/MUAY6U=3Y$T@5-@%ML7'PU@T:[J'2"T6JA]&6?>%)A]L
MYL4@,+ZL<S"T\<]>O(G,*?.NG4:\:P:]PW/*WY):MWLZ:YXXOON2T8'[ADY-
MX**3U,:C;[C$#,ES0'*I+9GH?HC4;OK4M<X<FPX@V"$2 .::SJ W-VR7B#"3
M)C9#GM-LAK4\GY&VYE)B><#W<WN@FM1>$QFT 4,"LY _AR $IK2-^G2+=2Q#
MR?E#.MQ\]('RDH5/OUBT=BMI[YHI$G-1>]=\ZJE(VY^D76G^;+9\Y*B.;O_C
MH!]O&_X/ J%.T?D7CE\I.O\"\2M%YU]0QLT].G_*N/1&^R;\2F^T!>)7>J,M
M*./F_D:;3__.-#B?ST[64F$B/J[LO0P:+S',>+:,EX'C/TRU[\NR^>R%D&XY
MW7*ZY73+Z9;3+<_MEF==W_6F[CRO+#]()G!$,L$8JBP( OFG0/-7QCW84US^
M3V=&42Z7TX9'<\..E:)<J'X"/])&"9/VUQE;OY!RXS,/1B4WKE(GU5*?SHR2
M7"FD[)@;=JR4Y/%!D%1-??ZE4:E\C_8ZKR[Q/;&.2**U28G66+@R:5+>=$,K
M_"MO#J=,4_ ^-/EDSZUQ4-"3169F6D^:\O,=EV\I.ZZQ7<K11>0HW-_YW+AJ
M_YFP=,* 7LK-=ST92^-N_Y27"\;+HES.I[?G=^(H/%V+*4>_$T=7%%D9^_I-
M->["<?,K;\_/A9:,9+Z])#6YS.MHDI>VIYKO%<M))GBO8-+8DF;[=5.?G3?M
MHU-/9 N4)KTW:.*OOCE2IDZ$8Y>3\Y5Q^?XI7Q>6KRN*(E?&]D"=$6/?;1<L
M#D_?;AQ,F['C [(I5Q?QI);D8G%<AZQ4 2\L6Y6\7*JF?/UV?%TIRTIATM=V
MJH$7YUXMYK[T7DW";YU/0#0!^.@1+E3')BPC';&,I !(!3%4)*Q,563)&$D1
M7EY"P+&&G1 'EQE(8L/NU U"7608B9K><'35A5_\4)1,1>H8IFG8L%(8%@RB
MC"0692&^TN1K6EYR8B!H[UQ3.:/$E@2RE)%&4Z/'3H'8EX2SYDI-TV]XONKI
M4M.Q.QR:$&'^^$]UFA&Q]V"W:L?V&:JE@-*#'QIVRP(ITR1=;;3YUQ@(IZ<[
MG6 1#$_1Q2\G@G!&ODU?(11/XPD_[W;UAM$T&J/].V36X:^G.@14"6NQ[ Y\
M,)S9KL,!8?B+<E*#<)IW>8E-/-_ @,8_AT!#MAG:6]@ <4NP<Y6C,++-USI
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M-$"\Z/KHV*BDC0<=!!FUM&39I [K>@ \E9%NVIQX8L6@Q^#V--PV.\ML?G8
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M\#2A@ ><94+IA-TKPJX=S$?)8JG\S(9C!B>67"JX&)0BHP'#,&0[YB9#D*A
M$$!8X?>=#C[I,04U<FS#?2\O=:.Z706RN4">;N N3Z!00!4\SH9&CJ: I!UU
M@&>IB5DU0JD)/?OJ\6?DL=AS%%\BV+T"?C.V#\A1H-,"JF^R'B+B35>#Y\L
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M3P/.DU*-D!H+0?^]I'^=EVS(HHVKE\R^8DMIS_UI(*=D\,M2P.;0YM/)V6E
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M!K7_=<6!^5NMH@/(V,*Z+E6;JH/I/XD]OR#,CZ[MVUZ?K(/QXEP!#>2$5P=
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MXL7G*^1&2S['^^[-Q]L;,<-W)X.BUT=NGHP(Z[HRKFO-/@_0QB,1]GIAX.&
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MM&V?5G42K,S0"2HKY;9[EF;T:]NUL45YB_Z9H1L\(RMT"99;RO& Y6*R CO
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MC0R\539[VM,)I>VB'=$#=Q,&?L3X!6N+IG229#55FZ0$4(NY4GT=3U%]607
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M^V2=>@$9$E?'W5,22;)/":5LD4 !L>*!0 0$%>2XN%K="2I%42'K(CM5!ZS
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M:-=MX%R94SA''I.C%[%8VC@H N>W9!I_1[J Z!;CRC_1.GB\+7LY44YTMTF
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MBE7NS%[(HF?+ED4/.&6NFKP3I;HS\ADX)66B0A<F+?6 N<O$A611YP+MO3!
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M6(D:U>Q]H V;LXQ1[K4G%(,,.*?K*:C[9*UL7'IEPHXR1<(A([.$,*;][/[
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M&'GJ)2F9Y7OID16",%]EG?%Q@*AAPTN^L;=ZV*J81_5@U#P9/;%'5_QC#[\
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M//#<@';0.NU.(12*:Z$MG%69@X#06KS>#3-7+\B..2X<=$9ZB2VKA;;Z*5,
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MU$\H1ADP8H'5+\TE5PD53:9AS@T/^*I35//B/'.A8&@SJP)"WXJFU$* /5@
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M[\_$L5;>X1*K[SC>9\,UR9WG#WQBV2%S292<P2HWJ,=VLL(K^XKRZG)>*PI
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M]?NKWEU_O.A][$\>1GIXIIZ",&9HD)_P)=4PA]BI0S][#KO,E!WKN17TV"B
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MSJ>O>R-DU\?[(=V;0A> \SKHCDN=3_EEF&DRV)FWT2KU-A+[^IU*H3_8Z(#
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MG84+  "@]09]09AH[*U:%#YYOOT'L4YE^ELO<L,;U6T[K$UDXX?".@W:V:L
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M;)DT5./I9T.;_G@^ W-.@)5:PH[8U];)HC(@K1[H,VMG7;:K-84=E:]-NNN
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M+^S_'HV T-_\?U!+ 0(4 Q0    ( &B!;U.]O?%WQR4  !'N   1
M      "  0    !A8V%C:6%?97@Q,# R+FAT;5!+ 0(4 Q0    ( &B!;U.9
M18U$!0<  &@<   1              "  ?8E  !A8V%C:6%?97@S,3 Q+FAT
M;5!+ 0(4 Q0    ( &B!;U-+7_"^ZP8  "$=   1              "  2HM
M  !A8V%C:6%?97@S,3 R+FAT;5!+ 0(4 Q0    ( &B!;U,>#GZT=@0  #03
M   1              "  40T  !A8V%C:6%?97@S,C Q+FAT;5!+ 0(4 Q0
M   ( &B!;U,K!)%9;00  ,T2   1              "  >DX  !A8V%C:6%?
M97@S,C R+FAT;5!+ 0(4 Q0    ( &B!;U.MOASR\/T! (8%&0 5
M      "  84]  !A8V%C:6%?:3$P<2TY,S R,2YH=&U02P$"% ,4    " !H
M@6]3 ,3P[:\0  #^L   $0              @ &H.P( 86-T9RTR,#(Q,#DS
M,"YX<V102P$"% ,4    " !H@6]3<@63K.(4  #W$P$ %0
M@ &&3 ( 86-T9RTR,#(Q,#DS,%]C86PN>&UL4$L! A0#%     @ :(%O4\LD
M;+T()@  0F4" !4              ( !FV$" &%C=&<M,C R,3 Y,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( &B!;U.U R0F=%T  ,0W!0 5              "
M =:' @!A8W1G+3(P,C$P.3,P7VQA8BYX;6Q02P$"% ,4    " !H@6]3URT:
MY#!!  !#- 0 %0              @ %]Y0( 86-T9RTR,#(Q,#DS,%]P<F4N
9>&UL4$L%!@     +  L R0(  . F P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
